data_1je3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1je3 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.2 m80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.787 0.327 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -95.38 112.06 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -78.11 141.4 38.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.96 -26.28 11.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.14 161.32 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 m -104.49 143.26 33.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.22 103.85 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.613 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 22.6 t70 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CB ' HD11 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -134.26 164.82 26.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 112.21 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.786 ' HG3' ' HB2' ' A' ' 58' ' ' GLU . 4.4 ttt-85 -134.38 114.09 12.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.938 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.746 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -109.6 77.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.537 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.64 67.62 0.9 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.49 -107.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.242 178.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 34' ' ' GLY . 85.3 t -134.9 139.99 46.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.483 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -66.75 89.13 0.15 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.389 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 110.858 -179.805 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.476 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 52.8 Cg_endo . . . . . 0 CA--C 1.53 0.276 0 N-CA-C 112.771 0.258 . . . . 0.0 112.771 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 70' ' ' ILE . . . -55.89 -3.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 40' ' ' PRO . 79.4 t -51.53 -29.01 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.343 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.76 -36.12 67.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.868 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.486 ' HG1' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -57.42 -54.14 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.091 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.33 -47.69 84.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.151 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.544 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 4.8 pt-20 -64.38 -20.29 66.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.749 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.23 63.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.12 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.554 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 6.3 mmm -51.33 -54.77 34.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.692 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 48' ' ' MET . 58.7 Cg_endo -70.61 -39.69 4.65 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.785 1.657 . . . . 0.0 111.687 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.09 7.07 2.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.336 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.31 152.13 0.46 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.608 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -134.91 -165.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.779 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -85.44 45.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.464 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.14 0.38 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.007 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.606 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -122.21 158.49 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 55' ' ' GLU . 10.9 mt -159.65 154.18 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.327 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.432 HD11 ' CB ' ' A' ' 28' ' ' TYR . 3.5 tp -140.39 154.47 46.72 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.119 0.485 . . . . 0.0 110.834 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.786 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 3.8 mt-10 -141.6 111.98 6.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 30' ' ' LEU . 49.0 t -118.39 123.13 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.745 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -126.14 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.806 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -126.44 162.91 24.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.443 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.716 ' HB3' HG23 ' A' ' 90' ' ' THR . 1.4 p30 -118.16 132.04 56.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.709 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 142.53 17.05 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.077 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.93 -24.94 23.75 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.483 2.122 . . . . 0.0 112.138 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -83.58 -163.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -119.75 -24.85 6.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.67 138.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -88.72 127.21 35.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -72.56 -74.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.936 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.541 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 8.4 mm -50.64 -51.78 62.23 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.559 ' HA ' HD13 ' A' ' 82' ' ' LEU . 51.0 Cg_exo -55.94 -33.37 88.83 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.193 1.929 . . . . 0.0 112.628 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -61.06 -36.3 79.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.85 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 -57.35 10.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 44' ' ' THR . . . -60.63 -35.16 75.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.289 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -64.29 -35.62 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.06 -64.62 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -26.86 68.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.672 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.38 94.32 0.77 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.946 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -154.83 0.39 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.635 ' HG1' ' HG2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -90.79 -64.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.638 0.256 . . . . 0.0 111.04 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.669 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 2.7 t -125.42 122.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.35 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.704 HD11 HG22 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -126.72 104.61 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.791 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.59 157.88 39.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.116 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.911 HG21 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -139.95 166.08 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.412 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.0 tt0 -154.42 156.66 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.443 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.401 ' HG3' HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -131.82 158.43 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -123.96 -79.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.14 -100.3 0.44 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.163 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.29 10.38 3.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.643 2.229 . . . . 0.0 112.327 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.716 HG23 ' HB3' ' A' ' 62' ' ' ASP . 4.8 p -145.6 177.7 8.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.482 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.0 tt -146.76 145.7 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 129.89 32.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.911 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.13 163.14 21.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.503 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.54 151.99 29.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.042 0.449 . . . . 0.0 111.596 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.704 HG22 HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -134.56 162.64 38.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.243 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.669 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 3.4 pt20 -153.53 177.36 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HG2' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.794 0.33 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -105.44 91.88 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.85 -67.95 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -99.02 165.28 11.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -113.91 111.18 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.36 101.8 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -64.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.012 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.63 -179.785 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 7.2 t0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.524 0.202 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.424 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 4.2 m-85 -134.83 166.83 22.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 111.721 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 138.6 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.046 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.647 ' HG ' HD12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.37 77.97 1.8 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.793 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -103.48 69.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.397 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 61' ' ' SER . 35.9 mtt -136.85 -111.85 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.121 0.486 . . . . 0.0 111.228 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 57.9 t -135.92 126.9 43.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.73 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -68.82 100.29 0.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.321 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.165 -179.562 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' VAL . 1.9 Cg_endo . . . . . 0 CA--C 1.53 0.297 0 CA-C-O 120.615 0.173 . . . . 0.0 112.529 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.662 ' HB1' HG22 ' A' ' 70' ' ' ILE . . . -58.02 0.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.927 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.4 p -52.46 -25.12 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.307 0.575 . . . . 0.0 110.014 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.92 -36.8 67.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.646 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.523 HG22 ' HB1' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -53.18 -55.21 26.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.891 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -51.66 66.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -59.65 -21.6 60.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.14 -179.119 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.52 -34.05 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.558 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.4 mmm -49.24 -55.39 21.68 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.684 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 16.2 Cg_exo -67.73 -37.36 16.34 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.139 1.893 . . . . 0.0 111.882 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.71 4.29 4.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.516 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.669 HD13 ' HE2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -46.44 155.92 0.2 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.906 0.384 . . . . 0.0 111.536 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.63 -91.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.38 3.52 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . 157.57 99.21 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.755 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -103.09 -177.43 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 55' ' ' GLU . 4.4 mt -159.4 153.94 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.072 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.7 OUTLIER -134.79 156.52 48.73 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.058 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.71 110.26 6.35 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.095 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 30' ' ' LEU . 98.8 t -117.71 124.61 73.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.472 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' A' ' 92' ' ' ARG . 87.5 t -131.91 96.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.6 p -130.41 176.63 7.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.773 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.464 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -117.31 131.39 56.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.299 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.418 ' SG ' ' HA3' ' A' ' 34' ' ' GLY . 70.0 m -143.84 130.88 10.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.12 4.51 4.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.48 2.12 . . . . 0.0 112.371 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.412 ' HB3' ' H ' ' A' ' 66' ' ' SER . 39.6 mt-30 -127.35 -159.99 0.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.412 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 2.7 t -111.14 -27.56 8.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.127 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mt -56.68 128.54 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.337 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.617 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.4 OUTLIER -92.91 125.54 37.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.458 ' H ' HD21 ' A' ' 69' ' ' ASN . 2.0 m-80 -72.87 -73.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.179 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.662 HG22 ' HB1' ' A' ' 41' ' ' ALA . 2.5 mm -46.28 -51.74 32.3 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.822 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.634 ' HB3' HD11 ' A' ' 82' ' ' LEU . 32.2 Cg_exo -60.57 -30.1 89.91 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.334 2.023 . . . . 0.0 112.725 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.4 tp -61.11 -33.02 72.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.811 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.6 4.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB1' HG22 ' A' ' 44' ' ' THR . . . -59.63 -35.67 74.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.914 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -64.88 -37.12 86.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -58.08 10.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.741 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -64.72 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.37 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.57 82.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.997 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -86.34 -170.63 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.692 0.282 . . . . 0.0 110.636 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.44 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -76.89 -66.64 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.003 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.685 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 11.9 t -126.71 128.6 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD21 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -131.01 100.08 5.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.94 167.92 14.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.088 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.914 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.5 pt -137.59 -177.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.489 ' O ' HG13 ' A' ' 91' ' ' ILE . 3.4 mt-30 -154.51 178.65 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.33 142.21 26.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 0.0 111.306 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.29 -138.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.306 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.94 -116.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.163 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.54 27.08 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.616 2.211 . . . . 0.0 112.543 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.4 p -142.05 -177.69 5.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 111.036 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.527 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.1 tt -149.41 150.46 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.863 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.499 ' HB2' HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -139.64 140.77 37.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.919 0.39 . . . . 0.0 111.368 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.914 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -127.88 144.9 51.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.129 178.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.32 150.91 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 111.481 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.646 ' HB ' HD21 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -131.85 157.4 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 178.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.685 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.8 pt20 -154.47 158.57 40.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 111.259 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.755 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 25.2 tttp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.745 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.746 0.308 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -132.83 111.75 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -136.43 179.17 6.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -67.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -121.11 46.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.11 40.83 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 m -122.43 60.77 1.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.404 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 33.8 t70 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.557 0.218 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.436 ' HB2' HD11 ' A' ' 57' ' ' LEU . 5.8 m-85 -134.4 165.66 24.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.431 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -134.82 135.46 41.77 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.581 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.843 ' HG ' HD12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -125.89 76.74 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.273 178.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.52 66.64 0.88 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.948 0.404 . . . . 0.0 111.463 -178.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.566 ' O ' ' HA ' ' A' ' 61' ' ' SER . 2.3 mtt -137.06 -106.4 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.347 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 62' ' ' ASP . 11.7 p -134.12 142.55 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -61.53 -20.34 58.98 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.31 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 179.305 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.487 ' HA ' HD23 ' A' ' 30' ' ' LEU . 66.5 Cg_endo . . . . . 0 N--CA 1.459 -0.513 0 CA-C-O 120.663 0.193 . . . . 0.0 112.366 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -57.88 -4.16 0.28 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.968 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.1 p -50.25 -28.01 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.239 0.542 . . . . 0.0 110.024 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.41 -40.45 64.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.538 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.761 HG23 ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.35 -54.14 49.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.066 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.746 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 16.4 mt -61.43 -49.31 77.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.138 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 pt-20 -65.29 -18.29 65.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.657 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB2' ' OH ' ' A' ' 79' ' ' TYR . . . -72.88 -29.2 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.952 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.95 -54.79 33.45 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.449 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.7 Cg_endo -69.64 -36.89 10.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.864 1.709 . . . . 0.0 111.586 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.91 5.74 3.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.6 161.76 0.12 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.958 0.409 . . . . 0.0 111.753 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -131.7 -95.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.813 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -14.75 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.804 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 178.86 92.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.184 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.756 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -99.25 -176.69 3.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 111.434 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.7 mt -159.61 154.62 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.204 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -136.69 156.2 48.85 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.13 0.491 . . . . 0.0 111.194 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -140.28 116.5 10.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.056 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 30' ' ' LEU . 52.6 t -118.26 113.63 42.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.635 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 72.9 t -118.66 92.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.822 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.4 p -133.0 168.61 18.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.362 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.89 118.47 32.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.358 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.6 t -137.44 120.67 11.59 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.955 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.91 -25.6 70.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.519 2.146 . . . . 0.0 112.133 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -87.85 164.07 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -91.04 -22.8 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.002 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.24 118.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.367 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.99 118.2 14.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -72.68 -75.67 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.789 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.843 HD12 ' HG ' ' A' ' 30' ' ' LEU . 7.1 mm -48.57 -51.51 51.73 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.022 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HA ' HD12 ' A' ' 82' ' ' LEU . 51.4 Cg_exo -57.21 -36.97 99.15 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.224 1.95 . . . . 0.0 112.849 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER -57.14 -33.42 67.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.884 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.746 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 2.1 m-20 -66.97 -58.67 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.034 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 44' ' ' THR . . . -61.13 -34.98 75.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.209 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -65.9 -36.12 82.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 -60.91 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -59.9 2.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.535 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.28 88.09 0.57 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.022 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -88.06 -151.89 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.248 . . . . 0.0 110.343 178.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.48 HG21 ' HG3' ' A' ' 97' ' ' LYS . 1.2 m -93.33 -75.34 0.5 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 48.1 t -120.4 123.06 69.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 71' ' ' PRO . 1.1 mm? -123.61 105.4 9.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.792 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -134.34 157.59 45.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.525 HG21 ' HD2' ' A' ' 93' ' ' TYR . 35.4 pt -140.15 179.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.594 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.478 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -154.07 166.88 31.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 179.121 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -125.93 125.15 42.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 0.0 111.215 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.31 82.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.377 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.44 145.69 7.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.949 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -90.9 43.23 2.47 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.573 -1.428 . . . . 0.0 112.652 0.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.7 p -142.9 -172.21 3.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.872 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 85' ' ' GLN . 6.3 tt -149.53 142.59 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.855 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -123.93 133.03 53.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.173 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.525 ' HD2' HG21 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -123.66 148.15 46.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.745 178.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.98 151.72 28.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.949 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.575 HG22 HD13 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -136.17 158.34 38.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.222 178.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER -154.12 153.44 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.292 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.756 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 9.4 tttp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.793 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 p80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.793 0.33 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 133.84 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -100.89 -4.52 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.057 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -60.8 129.4 41.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -127.24 -177.36 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.63 165.61 19.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 t -116.44 -79.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.501 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.636 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 16.3 t70 . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.454 0.169 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.496 ' HB2' HD11 ' A' ' 57' ' ' LEU . 25.2 m-85 -134.61 162.04 33.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 111.841 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 127.48 30.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.345 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.618 ' HG ' HD12 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -117.57 82.1 1.77 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.568 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.52 67.06 0.89 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.47 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.638 ' O ' ' HA ' ' A' ' 61' ' ' SER . 93.0 mtp -136.94 -109.85 0.19 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.251 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 62' ' ' ASP . 14.7 t -135.19 150.34 29.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.508 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -84.66 55.77 5.0 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.472 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.0 110.785 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB2' HD12 ' A' ' 70' ' ' ILE . 99.0 Cg_endo . . . . . 0 N--CA 1.46 -0.48 0 N-CA-C 112.893 0.305 . . . . 0.0 112.893 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 70' ' ' ILE . . . -56.36 -8.54 0.53 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 49.4 t -46.9 -34.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.65 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -73.1 -40.18 65.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.166 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.55 -50.41 62.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.47 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.84 -55.39 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.599 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 42.2 mt-10 -59.53 -19.27 47.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -72.46 -34.1 67.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.64 ' HG3' ' HB3' ' A' ' 77' ' ' HIS . 5.4 mmm -49.02 -55.77 18.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.213 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 22.0 Cg_exo -64.38 -37.49 39.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.995 1.797 . . . . 0.0 111.544 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 6.15 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.42 145.43 0.27 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -141.5 -168.81 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.631 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -87.56 23.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.03 97.93 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.464 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.667 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -130.58 155.44 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 0.0 110.819 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -159.6 158.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -145.51 158.57 43.82 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.001 0.429 . . . . 0.0 111.196 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 117.65 9.94 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.197 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 30' ' ' LEU . 41.6 t -118.42 115.26 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.549 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.9 t -119.41 88.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.138 0.494 . . . . 0.0 110.123 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -129.72 170.66 13.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.401 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.57 121.96 42.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.618 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -153.21 149.4 21.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 59.1 Cg_endo -72.01 -42.92 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.557 2.171 . . . . 0.0 112.426 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.51 155.24 40.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -64.39 -63.69 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.537 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.4 mt -76.38 142.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.006 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 17.6 t30 -110.38 -176.2 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -72.52 -35.67 68.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.644 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.618 HD12 ' HG ' ' A' ' 30' ' ' LEU . 1.3 mm -69.17 -50.71 19.78 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 43.1 Cg_endo -66.56 -44.68 5.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.135 1.89 . . . . 0.0 112.368 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.537 ' HB2' HG23 ' A' ' 67' ' ' ILE . 0.6 OUTLIER -62.74 -30.88 71.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.013 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -60.46 3.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.736 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.79 74.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -64.14 -29.98 71.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.544 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -66.95 -61.45 1.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.607 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 48' ' ' MET . 0.1 OUTLIER -68.15 -20.41 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.648 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.61 93.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.817 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.429 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -91.56 -156.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 110.533 179.057 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.429 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -90.77 -64.23 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.746 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 40.4 t -128.76 120.8 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.276 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.624 HD11 HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -123.56 102.58 7.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.394 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.86 160.37 27.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.887 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.6 pt -142.0 171.62 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.4 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.501 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.0 mt-30 -154.31 158.87 40.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.8 144.39 51.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.973 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -125.77 -121.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.481 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.02 -112.26 0.51 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.215 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.17 19.75 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.724 2.283 . . . . 0.0 112.477 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.3 p -138.29 -178.78 5.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 111.101 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 85' ' ' GLN . 5.4 tt -149.43 147.91 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.823 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -131.09 131.06 43.94 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.206 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -123.43 134.34 53.96 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.998 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.97 150.76 47.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.199 0.523 . . . . 0.0 111.806 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.624 HG23 HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.15 156.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.188 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.746 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -146.98 172.16 14.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.936 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.667 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 12.1 tptt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.786 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 t60 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.775 0.321 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -120.33 15.47 12.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.22 -28.13 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.831 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.21 102.84 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -44.29 43.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.15 169.89 16.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 t -110.24 -27.85 8.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 20.9 t0 . . . . . 0 C--O 1.233 0.2 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -103.38 164.94 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.066 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 6.9 ttt180 -133.65 142.56 48.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.619 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.658 ' HB3' HG11 ' A' ' 59' ' ' VAL . 1.7 tm? -132.93 89.91 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.885 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.37 66.06 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.543 -177.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mtt -136.36 -111.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.323 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.623 HG13 ' H ' ' A' ' 35' ' ' GLU . 7.5 p -134.56 160.5 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -74.34 13.54 4.71 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.523 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.623 ' H ' HG13 ' A' ' 33' ' ' VAL . 3.2 tt0 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.56 0.219 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 42' ' ' VAL . 87.5 Cg_endo . . . . . 0 CA--C 1.531 0.347 0 N-CA-C 112.892 0.305 . . . . 0.0 112.892 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 70' ' ' ILE . . . -60.65 -0.43 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.447 ' H ' ' C ' ' A' ' 40' ' ' PRO . 80.4 t -49.27 -36.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.05 -34.67 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.56 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.74 -47.23 86.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.272 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.441 HD23 ' HD2' ' A' ' 77' ' ' HIS . 44.6 mt -64.45 -47.05 80.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.359 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.4 -12.38 61.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 0.0 110.803 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB1' ' HE2' ' A' ' 79' ' ' TYR . . . -74.26 -39.25 63.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.111 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.557 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -52.49 -46.92 95.0 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.804 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 15.8 Cg_exo -67.75 -59.51 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.919 1.746 . . . . 0.0 111.408 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -73.76 20.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.53 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.596 HD13 ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -48.1 153.29 0.7 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.014 0.435 . . . . 0.0 111.61 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 -160.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.3 53.64 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.43 52.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.643 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.46 177.52 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.066 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -159.26 149.69 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 58' ' ' GLU . 16.0 tp -134.74 162.59 31.93 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.247 0.546 . . . . 0.0 111.095 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -147.56 136.45 22.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.487 176.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 30' ' ' LEU . 41.1 t -141.5 138.71 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 111.752 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 97.6 t -140.42 107.95 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.769 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.2 -177.69 5.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.438 . . . . 0.0 111.797 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -118.01 120.87 39.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.783 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.37 108.16 2.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.64 -26.12 77.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.554 2.169 . . . . 0.0 112.277 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -73.02 -174.4 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -106.31 -27.7 10.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.94 133.72 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -95.19 136.11 35.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -72.58 -75.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.606 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 9.2 mm -46.4 -52.12 31.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.198 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 44.8 Cg_exo -58.97 -33.1 98.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.257 1.971 . . . . 0.0 112.613 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.2 tp -61.36 -29.23 69.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.96 0.409 . . . . 0.0 110.788 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.415 ' OD2' ' HB1' ' A' ' 41' ' ' ALA . 5.0 m-20 -70.45 -52.5 21.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -69.26 -27.88 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -72.24 -36.04 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.709 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -64.21 -59.6 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.441 ' HD2' HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -64.59 -42.01 95.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.638 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 102.53 2.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.781 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.53 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -105.49 -106.11 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 79' ' ' TYR . 55.4 m -140.52 -72.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.308 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.666 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 53.2 t -117.17 118.26 58.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.344 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 74' ' ' ALA . 3.0 mm? -123.94 100.54 6.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.97 156.88 40.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' HB ' ' HD1' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -140.21 167.18 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.309 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -154.59 151.29 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.62 156.82 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.929 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.28 -84.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.797 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.14 -112.0 2.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.103 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.83 10.44 2.89 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.0 112.192 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.482 HG23 ' OD1' ' A' ' 62' ' ' ASP . 25.3 p -136.09 176.97 8.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.017 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.449 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.5 tt -151.38 142.9 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -127.91 142.25 51.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.116 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.478 ' HD1' ' HB ' ' A' ' 84' ' ' ILE . 0.6 OUTLIER -123.51 155.82 36.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.32 143.08 20.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.463 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -129.16 161.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.556 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.666 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.3 pt20 -153.96 161.93 41.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.596 ' HD2' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.907 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.771 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.59 103.84 4.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 169.86 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 135.28 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -110.96 39.85 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.18 130.41 36.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.4 -23.05 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.446 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.746 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 36.0 t70 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.402 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.03 166.48 22.94 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 142.61 46.4 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.792 HD22 ' HA ' ' A' ' 40' ' ' PRO . 1.4 tm? -134.53 84.39 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.535 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p-10 -104.06 69.13 0.93 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.451 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -136.52 -108.42 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 0.0 111.398 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.704 HG11 ' HB3' ' A' ' 35' ' ' GLU . 58.1 t -134.38 142.29 41.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -12.5 11.46 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.198 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.704 ' HB3' HG11 ' A' ' 33' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.379 0.133 . . . . 0.0 110.715 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.792 ' HA ' HD22 ' A' ' 30' ' ' LEU . 63.2 Cg_endo . . . . . 0 N--CA 1.458 -0.615 0 N-CA-C 112.805 0.271 . . . . 0.0 112.805 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.778 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -58.2 -4.38 0.35 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 43' ' ' ALA . 9.9 p -47.62 -34.08 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 110.707 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -72.99 -39.7 65.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.228 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -53.41 -54.04 42.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 tp -62.04 -40.25 95.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.913 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.636 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -67.2 -20.54 65.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.567 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HB1' ' HE2' ' A' ' 79' ' ' TYR . . . -72.54 -30.7 64.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.62 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.747 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 19.1 mmt -48.47 -56.38 14.78 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 23.7 Cg_exo -62.62 -44.03 19.14 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.975 1.783 . . . . 0.0 111.288 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.25 12.53 0.56 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.585 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.48 148.59 0.14 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -174.92 4.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.941 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.22 32.91 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 176.03 101.54 0.15 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.415 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.766 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -135.93 158.55 44.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.789 0.328 . . . . 0.0 111.097 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.1 mt -159.62 156.96 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.431 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' N ' ' CG2' ' A' ' 56' ' ' ILE . 1.4 tp -147.98 159.05 44.3 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.183 0.516 . . . . 0.0 111.293 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.43 134.87 26.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.021 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 30' ' ' LEU . 38.9 t -134.09 123.91 45.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 111.326 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 77.9 t -127.5 94.46 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.77 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.7 p -135.39 170.23 16.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.221 0.534 . . . . 0.0 111.72 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -117.82 124.57 48.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.37 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 49.3 t -144.57 116.24 5.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.67 -30.39 92.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.575 2.183 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -77.91 -163.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -119.07 -24.21 6.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.169 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.35 122.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.727 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -80.14 124.45 28.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.54 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.45 ' HB3' ' H ' ' A' ' 70' ' ' ILE . 5.5 t-20 -73.89 -87.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.778 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 6.6 mm -46.45 -54.07 20.49 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.727 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -59.41 -26.29 81.42 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.071 1.847 . . . . 0.0 112.989 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.5 tp -65.55 -38.77 90.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.846 0.355 . . . . 0.0 110.841 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -49.54 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.62 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.682 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -71.51 -27.13 63.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -71.94 -34.99 69.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.28 -64.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.429 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 3.6 t-80 -64.68 -30.32 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.87 96.76 0.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.59 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.477 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -93.29 -104.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.639 0.257 . . . . 0.0 110.809 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.463 ' H ' ' HB3' ' A' ' 79' ' ' TYR . 5.3 m -133.5 -69.05 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.32 . . . . 0.0 110.825 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.689 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 2.3 t -126.21 121.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 82' ' ' LEU . 3.8 mm? -123.37 104.85 9.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.401 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.9 156.99 46.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.691 0.282 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.25 173.21 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 111.588 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.545 ' O ' HG13 ' A' ' 91' ' ' ILE . 9.8 mt-30 -154.22 162.71 41.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -144.02 149.4 36.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.05 -81.77 0.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.15 -88.17 0.15 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.356 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.79 -1.28 9.49 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.754 2.302 . . . . 0.0 112.891 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -136.48 175.94 9.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.902 0.382 . . . . 0.0 111.189 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 85' ' ' GLN . 4.6 tt -146.81 143.46 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.63 135.22 53.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.278 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.47 ' CZ ' HG12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -123.51 145.34 48.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.31 148.58 25.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.212 0.53 . . . . 0.0 111.937 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -131.6 157.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.048 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.689 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -148.48 178.74 8.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.766 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 6.7 tptt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.689 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.864 0.364 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -77.99 -8.43 58.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.999 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.28 120.01 15.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.072 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -112.22 -160.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.25 88.98 2.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -160.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.5 72.03 5.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.466 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.066 0 N-CA-C 111.391 0.145 . . . . 0.0 111.391 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.757 ' HB3' HD11 ' A' ' 57' ' ' LEU . 10.9 t80 -134.44 164.67 26.94 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.56 141.88 46.8 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 40' ' ' PRO . 1.2 tm? -134.17 83.56 2.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.076 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.64 67.63 0.91 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.567 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 61' ' ' SER . 1.0 OUTLIER -136.5 -110.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 35' ' ' GLU . 34.5 t -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.448 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' HD22 ' A' ' 68' ' ' ASN . . . -63.9 -5.8 15.57 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.226 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.55 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.3 pt-20 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.486 0.184 . . . . 0.0 110.839 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 42' ' ' VAL . 83.3 Cg_endo . . . . . 0 N--CA 1.458 -0.593 0 CA-C-O 120.6 0.166 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.764 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -60.24 -5.24 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.456 HG22 ' HD2' ' A' ' 40' ' ' PRO . 32.7 t -47.02 -32.26 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.45 -44.54 57.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.592 HG23 HD21 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -47.69 -54.55 11.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -62.5 -58.24 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 26.8 mt-10 -60.07 -15.3 22.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 111.135 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.49 68.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.818 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.531 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.7 mtp -47.91 -54.16 26.26 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.402 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 31.1 Cg_exo -60.51 -59.71 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.757 1.638 . . . . 0.0 111.357 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -73.8 23.74 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.87 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.576 HD12 ' HD3' ' A' ' 97' ' ' LYS . 1.3 pp -52.03 177.39 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 0.0 111.97 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.821 ' HG2' ' H ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -159.07 164.88 34.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.244 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -73.29 23.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 111.306 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.821 ' H ' ' HG2' ' A' ' 52' ' ' LYS . . . -168.83 69.12 0.16 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 27' ' ' ASP . 5.0 tm-20 -112.06 152.15 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -160.22 158.24 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.428 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 28' ' ' TYR . 2.5 tp -140.31 163.87 31.61 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.323 0.582 . . . . 0.0 111.156 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.95 128.52 13.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.957 175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.68 HG13 HG13 ' A' ' 70' ' ' ILE . 48.5 t -128.64 114.1 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.896 0.379 . . . . 0.0 111.462 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -118.28 96.5 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.15 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -137.14 172.84 12.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.608 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' CG ' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.432 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.3 p -159.11 140.33 9.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.218 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.77 16.75 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.606 2.204 . . . . 0.0 112.276 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -116.92 -165.83 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -72.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.5 mm -83.79 140.45 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.021 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -97.18 -179.16 4.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.69 -38.39 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.739 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 1.3 mm -67.79 -50.45 34.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 33.0 Cg_endo -62.58 -36.91 61.75 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.274 1.982 . . . . 0.0 112.244 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.17 -25.71 65.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -58.62 4.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.34 -36.32 83.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -63.51 -30.6 71.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -65.73 -70.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.404 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 1.5 t-80 -57.86 -35.54 71.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.765 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.41 79.89 1.49 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.55 -157.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 96' ' ' GLN . 2.9 m -72.5 -78.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.498 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.61 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 2.0 m -130.19 145.87 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.557 HD11 HG21 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -128.35 111.95 13.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.468 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -127.1 159.99 32.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.724 0.297 . . . . 0.0 110.958 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -140.79 -178.41 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.179 0.514 . . . . 0.0 111.69 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -154.5 -173.86 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.203 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -136.75 116.71 13.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 111.26 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.67 -176.75 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.673 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.8 117.41 1.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.755 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.474 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 82.7 Cg_endo -100.45 66.94 0.32 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 C-N-CA 124.318 -1.118 . . . . 0.0 112.653 0.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.431 HG22 ' CG ' ' A' ' 62' ' ' ASP . 3.1 p -147.81 -173.82 4.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 111.27 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.568 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tt -136.2 151.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.515 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.0 tpp85 -123.7 142.75 50.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.893 0.378 . . . . 0.0 111.762 -177.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 7.9 m-85 -136.54 117.55 14.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.078 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.87 146.24 52.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 111.724 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -129.66 161.86 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.356 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -148.24 154.17 39.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.905 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.576 ' HD3' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.33 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.35 90.12 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.91 -98.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.45 -165.01 1.83 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -99.87 148.28 24.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -82.7 120.47 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.3 39.75 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.093 0.473 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.16 160.39 14.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.598 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 10.1 ptt85 -128.53 129.42 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 0.0 111.94 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -122.23 77.27 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.525 177.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.3 p30 -101.91 68.14 1.12 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.728 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.534 ' O ' ' HA ' ' A' ' 61' ' ' SER . 10.5 mtt -137.13 -112.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.889 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.57 143.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.987 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 111.12 3.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.327 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.646 0.26 . . . . 0.0 110.946 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 42' ' ' VAL . 41.3 Cg_endo . . . . . 0 CA--C 1.53 0.299 0 CA-C-O 120.826 0.261 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.913 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -57.67 0.79 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' A' ' 40' ' ' PRO . 14.4 t -48.69 -32.64 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.391 . . . . 0.0 110.567 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . . . -72.93 -37.94 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.601 HG21 HD21 ' A' ' 57' ' ' LEU . 1.9 m -58.07 -59.02 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.243 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.88 -32.56 67.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -71.73 -28.21 63.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 110.509 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.6 -26.94 61.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.402 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 32.6 mmt -53.72 -54.85 41.7 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.652 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 59.8 Cg_endo -71.01 -39.68 3.93 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.815 1.677 . . . . 0.0 111.595 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.91 6.91 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.528 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.07 150.48 0.58 Allowed 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.917 0.389 . . . . 0.0 111.252 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 54.2 mmtt -145.88 -159.31 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.02 16.49 4.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 65.35 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.877 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.651 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 20.8 tt0 -86.67 146.73 26.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.67 0.271 . . . . 0.0 110.406 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.2 mp -155.53 153.44 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 44' ' ' THR . 15.0 tp -142.85 164.99 28.59 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.305 0.574 . . . . 0.0 111.146 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.491 ' H ' ' HG ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -149.46 135.02 18.51 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.672 HG12 ' HB3' ' A' ' 30' ' ' LEU . 15.4 t -137.85 132.31 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.11 0.481 . . . . 0.0 111.624 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.5 t -136.84 83.04 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.029 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.4 p -123.58 175.16 6.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.65 125.92 51.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.463 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 147.62 16.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.75 5.0 6.46 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.25 161.77 27.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.02 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.4 m -72.08 -52.27 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.67 143.73 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 2.9 t-20 -134.3 -172.3 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -72.33 -47.49 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.913 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 1.1 mm -59.52 -49.33 92.75 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 41.7 Cg_endo -66.47 -41.14 12.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.119 1.88 . . . . 0.0 112.505 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -21.27 64.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -62.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.413 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -57.41 -41.21 79.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.677 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.622 ' HA ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.957 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -66.75 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -59.39 4.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.563 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.74 100.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.463 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' HD1' ' HA ' ' A' ' 75' ' ' ARG . 52.8 p90 -90.41 -171.63 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 111.65 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.479 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 28.6 m -115.29 -49.72 2.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.08 176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.698 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 t -139.23 115.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.138 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.615 HD23 HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -122.67 100.21 6.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -178.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.32 150.15 50.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.11 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.463 . . . . 0.0 111.626 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' HG13 ' A' ' 91' ' ' ILE . 1.6 tm0? -145.44 171.34 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.65 126.43 46.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.165 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -174.16 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.47 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.07 121.96 2.11 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.709 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.45 ' O ' HG23 ' A' ' 90' ' ' THR . 78.4 Cg_endo -102.15 62.25 0.58 Allowed 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.759 1.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 89' ' ' PRO . 17.3 p -148.87 -174.57 4.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.98 0.419 . . . . 0.0 111.534 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 85' ' ' GLN . 8.1 tt -142.38 145.53 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -123.74 146.56 48.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.108 0.48 . . . . 0.0 111.499 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.535 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 3.1 m-85 -132.02 131.05 42.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.017 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.33 143.74 46.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 111.402 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.637 HD11 ' HG2' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -135.43 157.06 39.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.682 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.698 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -154.47 166.03 34.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.6 tttp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.791 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.7 m80 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.768 0.318 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.2 -72.32 0.59 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.937 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -86.9 175.79 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -72.2 -175.87 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -46.04 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.02 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.32 -172.42 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.6 p -77.28 -170.08 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.52 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HA ' ' C ' ' A' ' 56' ' ' ILE . 5.0 p-10 . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 121.399 0.619 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.505 ' O ' HD11 ' A' ' 57' ' ' LEU . 52.7 t80 -102.53 147.0 27.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.7 mtt85 -104.9 135.88 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.562 ' HG ' HD13 ' A' ' 70' ' ' ILE . 2.2 tm? -134.54 82.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.327 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -103.13 66.77 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.9 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -136.29 -112.61 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.119 0.485 . . . . 0.0 111.266 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 62' ' ' ASP . 6.4 t -135.01 152.46 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.794 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.78 -7.56 16.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.096 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.481 0.181 . . . . 0.0 110.841 179.561 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.556 ' HA ' HD23 ' A' ' 30' ' ' LEU . 63.8 Cg_endo . . . . . 0 N--CA 1.457 -0.643 0 CA-C-O 120.645 0.185 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.563 ' CB ' ' HA ' ' A' ' 70' ' ' ILE . . . -59.52 -4.24 0.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 9.8 p -47.12 -33.38 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.46 -39.44 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.119 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 3.6 m -55.72 -55.3 33.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.834 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.685 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 95.2 mt -57.39 -52.7 64.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.272 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 5.9 pt-20 -68.55 -11.37 59.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -72.53 -39.57 67.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.458 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.685 ' HE3' ' HA ' ' A' ' 45' ' ' LEU . 53.2 mtm -53.51 -53.7 53.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.65 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 48' ' ' MET . 53.4 Cg_endo -67.83 -52.08 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.677 1.584 . . . . 0.0 111.313 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -73.85 19.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.834 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -51.4 178.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.415 0.626 . . . . 0.0 111.795 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.517 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 31.6 mmtt -149.0 -144.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.517 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.45 26.73 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.313 . . . . 0.0 111.159 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.12 84.19 0.52 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.613 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.586 ' N ' ' HB3' ' A' ' 97' ' ' LYS . 5.3 pt-20 -74.84 -179.81 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -159.91 -178.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.766 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 28' ' ' TYR . 6.5 tp -158.85 156.0 28.84 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.05 101.25 3.14 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.988 175.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 93' ' ' TYR . 1.4 p -119.32 131.54 71.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.822 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 12.2 t -132.47 111.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.194 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -143.02 177.44 8.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 0.0 111.419 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' O ' HG11 ' A' ' 33' ' ' VAL . 5.1 p-10 -117.9 130.53 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 129.78 3.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.073 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.93 -17.79 22.17 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.527 2.151 . . . . 0.0 112.231 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.73 156.4 16.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.951 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -40.48 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.55 109.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.543 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -102.35 165.21 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.21 -75.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.563 ' HA ' ' CB ' ' A' ' 41' ' ' ALA . 2.4 mm -44.86 -53.3 16.09 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.669 ' HA ' HD12 ' A' ' 82' ' ' LEU . 22.8 Cg_endo -62.19 -39.31 49.24 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.959 1.772 . . . . 0.0 113.047 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.5 -22.14 66.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 111.148 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.12 -58.38 3.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.87 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . . . -60.14 -41.17 92.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.793 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -63.28 -31.6 72.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.41 -66.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.445 ' HB2' ' HE1' ' A' ' 48' ' ' MET . 1.1 m-70 -72.21 -64.19 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.15 104.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.62 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.816 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 52.8 p90 -90.64 -163.23 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.253 0.549 . . . . 0.0 111.466 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.553 HG22 ' HD2' ' A' ' 97' ' ' LYS . 2.2 m -115.22 -54.68 2.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.343 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.675 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.4 t -140.22 114.2 6.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.389 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -123.09 102.84 8.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -124.02 151.5 43.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.645 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.872 HG21 ' HB3' ' A' ' 93' ' ' TYR . 23.0 pt -136.08 165.1 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.407 . . . . 0.0 111.466 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -154.55 159.73 41.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -125.66 154.67 42.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.46 -85.13 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.786 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.52 -105.89 1.35 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.976 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.33 12.37 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.46 2.107 . . . . 0.0 112.086 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -140.8 179.44 6.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 HG12 ' CE1' ' A' ' 93' ' ' TYR . 20.7 tt -146.88 144.26 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.574 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 136.45 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.872 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.93 159.93 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.181 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.08 146.88 24.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.598 HG23 HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.98 160.67 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.669 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.675 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -153.95 156.53 37.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.942 0.401 . . . . 0.0 111.338 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.586 ' HB3' ' N ' ' A' ' 55' ' ' GLU . 4.2 tptp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.583 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.787 0.327 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -84.51 158.65 20.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -64.51 149.25 48.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.992 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -126.11 156.18 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.83 104.93 16.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.996 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.98 157.32 16.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -119.68 -62.57 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.144 0 N-CA-C 110.343 -0.244 . . . . 0.0 110.343 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.612 ' HB3' HD13 ' A' ' 57' ' ' LEU . 3.4 t80 -135.54 164.28 28.18 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.996 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -134.66 113.73 12.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.848 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.858 ' HB3' HG11 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -109.05 81.93 1.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.51 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.58 68.91 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.471 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 61' ' ' SER . 16.4 mtt -136.24 -109.23 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.324 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 62' ' ' ASP . 21.7 t -134.73 138.68 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.9 70.22 2.33 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.425 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.525 0.203 . . . . 0.0 110.519 -179.747 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.54 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . 3.5 Cg_endo . . . . . 0 N--CA 1.461 -0.405 0 CA-C-O 120.8 0.25 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . . . -52.85 -0.38 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 40' ' ' PRO . 93.8 t -47.17 -30.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.63 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.61 64.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.699 HG22 ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -54.87 -50.98 67.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.34 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 71.3 mt -61.77 -52.87 62.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.375 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.534 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -66.41 -13.38 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.137 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB1' ' OH ' ' A' ' 79' ' ' TYR . . . -72.62 -40.1 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.254 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.54 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 10.1 mtm -48.14 -52.99 37.18 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.551 ' O ' HD12 ' A' ' 51' ' ' LEU . 30.2 Cg_exo -60.5 -60.05 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.742 1.628 . . . . 0.0 111.434 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -74.61 24.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.954 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.645 HD21 ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.54 -159.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 112.02 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.645 ' H ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -165.89 -174.7 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.191 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -83.4 36.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 150.58 102.76 0.25 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.489 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.89 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -124.48 177.74 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 55' ' ' GLU . 17.9 mt -159.47 161.7 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.612 HD13 ' HB3' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -160.67 130.25 4.99 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.472 -0.768 . . . . 0.0 111.423 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 1.2 mt-10 -118.71 118.36 31.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.765 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.858 HG11 ' HB3' ' A' ' 30' ' ' LEU . 58.9 t -118.53 113.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.994 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.536 HG21 ' HE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -117.49 94.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 110.435 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -126.71 166.59 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.128 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.74 133.16 56.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.622 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 t -152.13 132.39 7.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.13 -18.04 24.15 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.488 2.125 . . . . 0.0 112.281 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.47 -162.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -117.64 -17.37 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mt -68.16 127.67 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.74 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -94.48 126.62 39.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.23 -82.43 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.678 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 7.3 mm -44.51 -54.82 11.45 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -61.25 -24.09 78.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.004 1.803 . . . . 0.0 112.921 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.8 tt -69.55 -33.46 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.401 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 3.6 m-20 -66.41 -53.48 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.699 ' HB1' HG22 ' A' ' 44' ' ' THR . . . -62.37 -36.29 81.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -66.62 -33.13 74.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.81 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -60.58 -61.04 2.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.54 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 0.8 OUTLIER -67.74 -62.12 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 91.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.497 ' OH ' ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -92.73 -164.21 1.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.0 110.345 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.696 HG23 ' HA ' ' A' ' 97' ' ' LYS . 24.3 m -82.35 -79.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.602 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 22.0 t -112.13 117.62 55.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.73 116.04 22.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -147.06 155.12 41.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.846 HG23 ' HB3' ' A' ' 93' ' ' TYR . 20.6 pt -135.1 170.25 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.004 0.431 . . . . 0.0 111.561 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.405 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.76 148.45 25.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.64 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.95 149.17 50.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.889 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -118.1 -83.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.19 -90.15 0.18 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.446 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.62 3.14 8.04 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.649 2.233 . . . . 0.0 112.812 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.2 p -145.4 174.93 10.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.109 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.517 HG12 ' CE1' ' A' ' 93' ' ' TYR . 16.5 tt -144.43 139.8 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.836 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.602 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -124.01 132.7 53.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.348 -177.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.846 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.75 156.33 34.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.34 145.33 22.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 112.105 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.553 HG21 HD22 ' A' ' 57' ' ' LEU . 0.6 OUTLIER -132.63 153.08 37.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.124 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.602 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.4 OUTLIER -154.6 175.26 13.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 111.235 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.89 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.77 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.795 0.331 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -119.93 119.79 34.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -110.82 179.75 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.81 96.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -88.12 167.62 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.985 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.0 p -71.99 -57.53 4.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -137.14 99.88 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.612 -179.798 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 56' ' ' ILE . 39.8 t0 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.575 0.226 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.518 ' HB3' HD12 ' A' ' 57' ' ' LEU . 10.5 t80 -136.62 166.41 23.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.391 . . . . 0.0 111.758 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.56 105.99 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.802 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.728 ' HB3' HG11 ' A' ' 59' ' ' VAL . 1.1 tm? -103.83 81.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.7 m-20 -103.62 66.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.149 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.24 -105.83 0.21 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 34' ' ' GLY . 15.0 t -134.33 148.82 29.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -81.54 55.58 4.86 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.621 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.531 0.205 . . . . 0.0 110.759 179.825 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.472 ' HB2' HD11 ' A' ' 70' ' ' ILE . 23.6 Cg_endo . . . . . 0 CA--C 1.531 0.359 0 N-CA-C 113.337 0.476 . . . . 0.0 113.337 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -56.87 -2.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.4 t -45.49 -35.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.6 -46.57 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.275 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 74' ' ' ALA . 54.7 m -49.44 -46.93 48.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.623 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.3 mt -63.48 -57.38 10.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.282 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 mm-40 -64.76 -10.58 28.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.014 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.37 63.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.154 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -51.97 -47.67 90.54 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.991 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 46' ' ' GLU . 55.3 Cg_endo -69.98 -51.76 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.711 1.607 . . . . 0.0 111.759 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 14.3 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.401 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.15 156.06 0.18 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.999 0.428 . . . . 0.0 111.868 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 8.1 mmtp -125.75 -164.91 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 72.0 mttt -88.32 40.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.844 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.4 113.27 1.52 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.29 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.849 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 15.8 pt-20 -135.3 -177.05 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -161.04 152.08 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.272 0.558 . . . . 0.0 111.141 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 28' ' ' TYR . 4.7 tp -127.02 158.98 35.5 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -144.35 107.77 4.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.196 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.728 HG11 ' HB3' ' A' ' 30' ' ' LEU . 45.5 t -117.57 112.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.616 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 90.6 t -118.59 94.73 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.694 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.2 p -125.5 171.83 10.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.897 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.444 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -118.04 122.6 43.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.581 179.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.24 131.27 8.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.971 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.48 -8.65 18.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.596 2.198 . . . . 0.0 112.314 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -97.0 -167.32 1.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.957 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.38 -26.09 8.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 mt -66.85 123.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.76 130.4 37.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.843 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.62 -70.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.101 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.885 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 2.8 mm -49.64 -52.49 50.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.1 Cg_exo -57.61 -43.25 52.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.272 1.981 . . . . 0.0 112.87 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.34 -21.98 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.203 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -71.99 -57.88 3.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.95 -41.7 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.708 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.17 -33.75 75.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.006 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.26 -61.08 2.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.569 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.58 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 8.9 m170 -72.37 -69.08 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.19 103.94 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 82' ' ' LEU . 51.3 p90 -92.93 -162.4 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.126 0.488 . . . . 0.0 111.328 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.463 HG21 ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -113.25 -52.75 2.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.258 176.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.814 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 48.1 t -143.95 118.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.171 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.713 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -122.95 115.18 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.964 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.15 155.46 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.847 HG23 ' HB3' ' A' ' 93' ' ' TYR . 19.4 pt -133.05 167.1 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.479 . . . . 0.0 111.601 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -154.63 165.44 36.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.413 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -132.1 147.33 52.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.798 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -107.85 -81.4 0.56 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.636 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.31 -92.53 0.22 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.815 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.33 3.66 7.14 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.803 2.336 . . . . 0.0 112.033 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.432 HG22 ' OD2' ' A' ' 62' ' ' ASP . 25.0 p -136.47 -178.24 5.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.498 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.7 tt -143.34 151.1 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -140.03 131.79 27.44 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.815 0.341 . . . . 0.0 111.302 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.847 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.05 140.46 53.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.246 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.87 157.01 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.713 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.22 162.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.614 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.814 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.79 155.6 34.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.849 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.502 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.847 0.356 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.13 148.63 48.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -118.01 -165.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -69.38 164.29 23.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.92 -179.82 4.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 p -119.44 88.12 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -118.4 65.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.473 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.526 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 27.6 t70 . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.91 168.42 19.36 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.651 -0.819 . . . . 0.0 112.656 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 13.2 mtp180 -134.82 118.01 16.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.721 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -116.47 78.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.947 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.9 67.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.391 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 61' ' ' SER . 15.5 mtt -136.46 -110.65 0.19 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 111.504 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.513 HG21 ' OD2' ' A' ' 62' ' ' ASP . 84.8 t -135.41 122.95 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.79 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . -68.13 92.48 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.228 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.44 0.162 . . . . 0.0 110.709 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.804 ' HB2' HD21 ' A' ' 30' ' ' LEU . 4.1 Cg_exo . . . . . 0 CA--C 1.529 0.265 0 N-CA-C 112.629 0.204 . . . . 0.0 112.629 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.34 -2.55 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.946 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' A' ' 40' ' ' PRO . 79.2 t -51.91 -28.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.046 0.45 . . . . 0.0 110.05 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -70.57 -38.74 74.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.23 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.51 -46.35 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.944 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.79 -39.26 84.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.783 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 2.5 pt-20 -72.12 -17.29 61.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.648 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB1' ' OD1' ' A' ' 27' ' ' ASP . . . -72.56 -36.75 68.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.875 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.662 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 22.0 mtp -49.6 -54.14 34.14 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.383 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 18.3 Cg_exo -65.45 -45.61 6.8 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.021 1.814 . . . . 0.0 111.485 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -73.23 12.78 0.51 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.55 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.636 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.56 159.1 0.1 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.09 0.471 . . . . 0.0 111.935 -179.289 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -142.6 -160.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.631 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -86.78 33.51 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.2 114.96 0.71 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.305 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.765 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -121.17 166.75 13.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.645 0.26 . . . . 0.0 110.907 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 55' ' ' GLU . 10.6 mm -159.22 149.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.69 131.12 5.28 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.907 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -121.73 132.93 54.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.551 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.674 HG22 HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.48 126.63 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.585 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 2.2 t -125.75 101.53 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.0 m -142.41 169.82 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.231 0.539 . . . . 0.0 112.073 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.513 ' OD2' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.16 129.2 55.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.196 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.435 ' HB2' ' OD1' ' A' ' 68' ' ' ASN . 30.5 p -156.83 136.52 8.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.333 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.92 -25.65 8.76 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.461 2.107 . . . . 0.0 112.263 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.35 -162.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -140.12 10.37 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.611 ' HA ' HD13 ' A' ' 72' ' ' LEU . 44.5 mm -111.35 -26.9 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.89 0.376 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 63' ' ' CYS . 7.6 m120 -52.1 -12.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.534 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.837 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 1.9 m-20 -50.9 119.34 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.539 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.674 HG12 HG22 ' A' ' 59' ' ' VAL . 22.7 mm -51.65 -49.93 80.16 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.311 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 36.9 Cg_exo -62.0 -22.32 74.04 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.139 1.893 . . . . 0.0 111.965 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.837 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -62.4 -39.34 92.92 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.108 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -59.75 -45.56 91.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' TYR . . . -70.46 -23.33 62.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.607 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -38.54 66.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.537 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.53 -58.72 6.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.443 ' HB2' ' SD ' ' A' ' 48' ' ' MET . 73.6 m80 -69.36 -45.16 70.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.322 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.16 87.88 1.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.162 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -87.7 -140.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.566 HG21 ' HA ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -97.85 -72.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.807 0.337 . . . . 0.0 110.991 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 26.3 t -127.68 123.63 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 71' ' ' PRO . 2.4 mm? -123.44 101.65 7.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.91 158.3 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.473 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.94 HG23 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -138.82 172.06 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 91' ' ' ILE . 26.3 mt-30 -154.36 156.33 36.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.215 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 152.53 51.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.791 0.329 . . . . 0.0 111.22 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -122.72 -78.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.99 -106.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.754 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.84 10.04 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.71 2.274 . . . . 0.0 111.949 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 67.7 p -138.98 170.73 15.44 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.466 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.9 tt -150.93 136.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.046 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -127.93 140.43 52.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.326 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.94 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -123.66 166.19 15.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.947 178.229 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.44 144.8 21.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.487 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -129.25 149.57 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.388 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.413 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 5.4 pt20 -142.94 155.92 44.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.791 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.765 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 10.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.815 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.685 0.279 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -140.14 -163.52 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.933 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -74.43 -169.76 0.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.44 17.47 4.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.037 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -72.34 117.98 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -123.67 -178.8 4.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.025 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.18 153.28 32.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.45 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.418 0.151 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.782 ' HB2' HD11 ' A' ' 57' ' ' LEU . 62.8 m-85 -134.17 160.83 36.62 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.81 0.338 . . . . 0.0 111.638 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 144.71 46.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.837 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' A' ' 70' ' ' ILE . 1.1 tm? -134.3 81.41 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.514 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.0 p-10 -103.22 65.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.89 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 61' ' ' SER . 6.2 mtp -137.2 -105.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 62' ' ' ASP . 2.4 t -134.93 156.79 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.381 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.54 -9.6 13.49 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.198 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 C--N 1.329 -0.283 0 C-N-CA 122.122 0.169 . . . . 0.0 110.987 179.708 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 42' ' ' VAL . 74.0 Cg_endo . . . . . 0 N--CA 1.457 -0.627 0 CA-C-O 121.071 0.363 . . . . 0.0 112.144 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.872 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -64.75 6.97 0.18 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.471 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.4 p -53.29 -27.48 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.457 . . . . 0.0 110.178 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.437 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -73.44 -37.28 65.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.705 178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.426 HG21 ' HB3' ' A' ' 74' ' ' ALA . 2.8 m -54.23 -63.72 1.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.321 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 20.9 mt -56.29 -38.22 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.275 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 4.9 tt0 -64.55 -28.76 69.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.639 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.08 -24.21 60.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.467 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.739 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 38.6 mmt -57.2 -55.88 39.59 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.703 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 11.7 Cg_exo -70.45 -44.49 1.58 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.117 1.878 . . . . 0.0 111.554 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.86 8.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.382 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -44.0 154.39 0.11 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.98 0.419 . . . . 0.0 111.552 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -124.33 -157.71 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.836 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -78.02 8.44 4.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.133 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' HA2' ' OXT' ' A' ' 97' ' ' LYS . . . 160.78 82.09 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.743 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -81.91 172.34 13.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 55' ' ' GLU . 4.5 mt -160.27 155.97 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.782 HD11 ' HB2' ' A' ' 28' ' ' TYR . 1.1 tp -139.59 161.17 38.17 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.019 0.437 . . . . 0.0 111.247 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -143.18 113.17 7.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -118.12 114.97 46.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.395 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 61.1 t -119.05 94.24 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.09 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -130.75 173.69 10.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.521 . . . . 0.0 111.771 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' OD2' HG21 ' A' ' 90' ' ' THR . 0.7 OUTLIER -117.43 130.85 56.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.337 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.54 117.45 3.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.93 -17.83 61.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.679 2.253 . . . . 0.0 112.09 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -108.85 -163.49 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 t -102.57 -18.46 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -69.98 130.56 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.64 ' HB3' ' HH ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -137.09 129.73 30.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.294 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.33 -48.73 69.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.872 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -56.96 -55.73 40.82 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.44 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 28.8 Cg_endo -62.57 -33.6 77.57 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.644 1.563 . . . . 0.0 112.201 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -29.46 68.93 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -57.39 12.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.719 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.816 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -66.51 -37.73 85.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 29.9 ttt-85 -63.43 -54.98 28.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.592 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -47.88 -55.01 10.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.214 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -70.13 -71.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.532 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.99 98.74 0.15 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.707 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.816 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.6 p90 -88.78 -165.35 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 0.0 111.406 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 97' ' ' LYS . 39.5 m -112.16 -52.24 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.057 175.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.753 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 41.3 t -141.84 116.6 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -122.53 105.01 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.619 -178.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -123.66 163.62 20.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.648 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.817 HG21 ' HB3' ' A' ' 93' ' ' TYR . 15.5 pt -139.91 168.3 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.431 . . . . 0.0 111.433 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.425 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.5 mt-30 -154.42 155.76 35.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.39 154.4 50.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -123.45 -80.56 0.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.63 -97.52 0.36 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.406 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 9.55 3.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.457 HG21 ' OD2' ' A' ' 62' ' ' ASP . 47.5 p -146.37 176.4 9.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.955 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.477 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.0 tt -145.04 140.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.654 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 92' ' ' ARG . 3.7 ttm-85 -133.2 132.55 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.817 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.39 164.7 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.829 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.92 158.6 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.904 0.383 . . . . 0.0 111.443 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -134.47 162.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.922 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.753 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -154.5 156.21 36.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.743 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.629 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 172.29 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.81 44.06 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.19 -70.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -112.44 53.03 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -68.17 -73.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.991 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.18 111.97 20.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.978 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.856 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 56' ' ' ILE . 26.2 t0 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -107.98 141.9 38.92 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.308 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 7.8 mtp85 -111.46 137.33 49.41 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.842 ' HB3' HG11 ' A' ' 59' ' ' VAL . 1.7 tm? -126.71 89.12 2.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.295 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.691 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.12 62.5 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.62 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.441 ' C ' HG21 ' A' ' 33' ' ' VAL . 78.3 mtp -136.69 -112.68 0.18 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.385 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 61' ' ' SER . 2.5 t -134.67 155.7 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.66 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' HA2' ' ND2' ' A' ' 69' ' ' ASN . . . -79.8 70.16 2.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.107 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.537 0.208 . . . . 0.0 110.77 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.514 ' C ' ' H ' ' A' ' 42' ' ' VAL . 32.8 Cg_endo . . . . . 0 CA--C 1.53 0.278 0 CA-C-O 120.869 0.279 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.843 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . . . -61.67 12.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.514 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -52.64 -31.65 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -73.81 -43.28 59.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.494 HG23 ' HB3' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -54.94 -45.05 74.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.11 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.91 -53.56 48.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.59 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 7.5 pt-20 -67.73 -10.38 52.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.648 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -73.79 -39.33 64.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.576 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.89 -48.96 70.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.604 -178.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 18.3 Cg_exo -65.89 -54.83 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 121.978 1.785 . . . . 0.0 111.387 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.62 18.22 0.13 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.907 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.576 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.7 157.52 0.37 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.924 0.392 . . . . 0.0 111.452 -179.324 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -138.52 -170.85 2.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.94 9.09 29.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.66 61.79 0.32 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.623 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -82.7 148.81 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 55' ' ' GLU . 29.6 mt -156.99 158.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.2 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.731 HD23 HG21 ' A' ' 70' ' ' ILE . 1.3 tp -160.58 142.11 12.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.656 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.698 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.981 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 30' ' ' LEU . 18.7 t -139.3 142.52 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.032 0.444 . . . . 0.0 111.739 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -146.91 109.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.169 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.599 ' HB2' ' HA ' ' A' ' 33' ' ' VAL . 93.4 p -150.57 -175.52 5.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.575 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.78 119.88 36.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 41.1 t -137.03 106.6 8.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.954 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -30.64 77.24 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.462 2.108 . . . . 0.0 112.196 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HB3' ' H ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -89.57 -162.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.408 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 8.5 t -108.61 -19.87 13.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 mt -55.8 119.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.061 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -74.67 137.48 42.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.911 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.5 ' ND2' ' HA2' ' A' ' 34' ' ' GLY . 49.3 t30 -73.25 -90.96 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.537 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.843 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 1.1 mm -48.38 -51.03 54.09 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.374 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.666 ' HG2' ' HD2' ' A' ' 93' ' ' TYR . 71.6 Cg_exo -52.59 -35.14 66.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.42 2.08 . . . . 0.0 113.186 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.4 tp -58.94 -41.04 86.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.494 ' HB3' HG23 ' A' ' 44' ' ' THR . 1.9 m-20 -62.08 -57.44 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.202 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.74 80.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.348 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -67.79 -31.5 71.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.91 -62.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.677 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -70.26 -37.29 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.06 107.84 3.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.946 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -110.24 -162.6 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.047 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.45 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 2.4 m -82.82 -74.76 0.34 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.159 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.605 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 23.3 t -116.59 122.0 68.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.436 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 95' ' ' ILE . 2.4 mm? -128.52 97.11 4.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.196 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.59 141.07 51.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.911 0.386 . . . . 0.0 111.326 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.74 161.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.247 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -148.01 156.15 42.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.652 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.06 151.67 45.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.912 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.34 -79.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.708 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.26 -89.74 0.17 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.136 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.403 ' C ' HG23 ' A' ' 90' ' ' THR . 95.5 Cg_endo -85.61 -2.4 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.691 2.261 . . . . 0.0 112.767 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 89' ' ' PRO . 2.1 p -136.91 -174.81 3.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.857 0.36 . . . . 0.0 111.1 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.474 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 2.5 tt -152.18 149.96 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 59' ' ' VAL . 8.0 tpt180 -123.21 133.28 54.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -123.81 146.61 48.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.466 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.516 HD23 ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -154.79 137.3 15.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.884 0.373 . . . . 0.0 111.737 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.689 HG22 HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.66 153.42 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.317 178.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.605 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.7 pt20 -154.03 169.45 23.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.287 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.573 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.9 tttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.884 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 p80 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.802 0.334 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -89.12 -178.38 5.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -93.65 115.34 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -96.38 13.45 27.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -77.2 -173.7 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.8 m -97.25 77.52 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.51 -19.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.861 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.497 179.84 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 121.165 0.507 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -102.97 154.96 18.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.4 118.04 27.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.955 -178.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.85 ' HB3' HG11 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -114.68 80.94 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.465 177.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.657 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 4.8 m-20 -102.44 65.34 0.93 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.465 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 61' ' ' SER . 11.7 mtt -136.83 -108.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.105 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.561 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.4 t -132.65 147.42 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.575 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -59.38 -14.58 27.62 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 119.985 -1.102 . . . . 0.0 111.754 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.416 ' H ' HG13 ' A' ' 33' ' ' VAL . 1.8 pt-20 . . . . . 0 C--N 1.33 -0.277 0 C-N-CA 122.138 0.175 . . . . 0.0 110.757 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.826 ' HA ' HD23 ' A' ' 30' ' ' LEU . 62.7 Cg_endo . . . . . 0 N--CA 1.457 -0.648 0 CA-C-O 120.76 0.233 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' A' ' 70' ' ' ILE . . . -54.71 -6.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG23 ' HD2' ' A' ' 40' ' ' PRO . 70.1 t -48.58 -32.1 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -72.56 -39.6 67.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.527 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.532 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.56 -47.5 85.23 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.94 179.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -57.97 -51.06 71.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 6.1 pt-20 -71.71 -13.23 61.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -72.98 -27.38 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.111 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.513 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.8 mmm -47.68 -55.65 16.22 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.388 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 68.6 Cg_endo -73.77 -37.25 3.06 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.837 1.691 . . . . 0.0 111.609 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.7 2.39 6.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.262 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.513 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -47.22 152.92 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.895 0.379 . . . . 0.0 111.269 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.478 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 11.9 mmmt -135.65 -167.87 2.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -87.0 42.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 157.3 55.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.673 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 1.7 pt-20 -72.19 155.0 40.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.65 0.262 . . . . 0.0 111.0 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.2 mt -158.12 152.66 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.215 0.531 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.584 HD22 HG22 ' A' ' 70' ' ' ILE . 15.4 tp -143.9 156.64 44.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.567 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -146.58 108.99 4.48 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.559 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 30' ' ' LEU . 57.4 t -121.93 127.55 75.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 1.4 t -129.05 100.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.267 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -125.9 -172.62 2.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.306 0.574 . . . . 0.0 111.978 -176.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.561 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -117.54 109.51 16.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.36 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 65.94 2.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.907 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.69 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.858 2.372 . . . . 0.0 112.147 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -92.89 23.22 4.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.193 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 m -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.747 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.512 HG22 ' ND2' ' A' ' 69' ' ' ASN . 11.6 mt -111.71 66.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.885 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 78.9 m-20 -99.77 51.22 0.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.396 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.801 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.95 118.21 10.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.649 -176.24 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 43.5 mm -51.22 -47.41 88.14 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.898 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.784 ' HB3' HG21 ' A' ' 95' ' ' ILE . 27.8 Cg_endo -60.82 -29.1 87.52 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.263 1.976 . . . . 0.0 111.841 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.801 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -55.14 -38.46 68.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.98 -45.09 95.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.585 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.657 ' HB3' HD12 ' A' ' 82' ' ' LEU . . . -68.07 -24.42 65.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -72.26 -36.56 69.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.339 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -63.88 -55.41 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.302 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -28.44 68.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 109.768 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.09 88.53 1.39 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.011 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.48 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.385 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 m -79.69 -87.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.826 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.449 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 91.8 t -113.14 127.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 111.234 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 74' ' ' ALA . 2.8 mm? -123.58 107.35 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.472 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -123.55 159.33 29.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.623 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.933 HG21 ' HB3' ' A' ' 93' ' ' TYR . 28.4 pt -142.8 172.27 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 111.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.405 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -153.71 173.82 15.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.343 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -137.51 139.71 40.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.972 0.415 . . . . 0.0 111.365 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 57.0 m-20 -117.21 -137.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.241 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -73.63 -106.84 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.085 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -87.47 20.02 1.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.769 2.313 . . . . 0.0 112.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.441 HG21 ' OD1' ' A' ' 62' ' ' ASP . 41.7 p -138.57 173.73 11.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.988 0.423 . . . . 0.0 111.152 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.552 HG12 ' CE2' ' A' ' 93' ' ' TYR . 8.0 tt -136.71 130.15 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.287 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.638 ' HB2' HG11 ' A' ' 60' ' ' VAL . 1.5 ttm180 -123.18 136.44 54.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.138 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.933 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -128.02 164.84 21.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.921 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.37 153.37 31.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.784 HG21 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -136.62 155.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.796 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -155.2 170.58 21.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 111.478 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.673 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.9 tttp . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.435 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.855 0.359 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -87.53 137.75 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -72.08 132.57 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -105.93 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.789 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.19 -73.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -121.77 8.88 10.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.72 138.61 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.511 -179.894 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.111 0.482 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 4.7 m-85 -103.48 161.8 13.56 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -134.6 146.42 49.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.326 0.584 . . . . 0.0 112.489 -178.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.828 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -134.28 91.15 2.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.315 177.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.643 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 37.9 t0 -101.79 58.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.742 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.464 ' C ' ' HB3' ' A' ' 61' ' ' SER . 46.6 mtt -137.32 -110.53 0.18 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.644 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 62' ' ' ASP . 9.9 p -135.55 164.28 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.262 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.49 79.02 0.73 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.389 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.489 0.185 . . . . 0.0 110.878 -179.594 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.828 ' HG2' HD22 ' A' ' 30' ' ' LEU . 31.7 Cg_exo . . . . . 0 C--O 1.23 0.1 0 N-CA-C 112.536 0.168 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . . . -65.26 -17.5 64.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.357 0.598 . . . . 0.0 110.246 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' GLU . 55.0 t -57.67 -27.76 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.823 177.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.438 ' O ' ' HB1' ' A' ' 47' ' ' ALA . . . -73.56 -31.2 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.312 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.49 ' OG1' HG23 ' A' ' 70' ' ' ILE . 3.0 m -51.75 -68.13 0.19 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 48.8 mt -61.46 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.167 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 3.3 tt0 -65.3 -18.6 65.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.738 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -72.28 -38.04 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.261 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.527 ' HE3' ' N ' ' A' ' 79' ' ' TYR . 1.2 mmt -46.16 -55.12 14.36 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.871 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 48' ' ' MET . 39.3 Cg_endo -66.39 -56.71 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.714 1.609 . . . . 0.0 111.756 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -73.56 18.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.807 179.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.522 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -44.55 151.37 0.27 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.773 0.321 . . . . 0.0 111.322 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -130.21 -179.61 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.19 61.63 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.834 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.72 43.49 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.544 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -65.3 150.51 48.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 110.815 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.8 mt -154.03 156.11 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.426 HD23 HG21 ' A' ' 70' ' ' ILE . 9.5 tp -146.75 161.05 41.44 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.21 0.528 . . . . 0.0 111.201 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -150.48 140.03 21.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 177.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.84 144.34 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.013 0.435 . . . . 0.0 111.172 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.76 97.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.167 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.506 ' HB2' HD22 ' A' ' 68' ' ' ASN . 0.3 OUTLIER -151.06 179.33 8.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -178.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.446 ' O ' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.42 137.65 53.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 179.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 11.3 p -159.51 139.51 8.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.042 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.81 -12.87 36.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.675 2.25 . . . . 0.0 112.087 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -95.15 -160.84 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -113.54 -5.43 13.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.437 HG23 HD13 ' A' ' 72' ' ' LEU . 7.5 tt -130.6 149.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.238 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.506 HD22 ' HB2' ' A' ' 61' ' ' SER . 4.4 m-20 -112.81 -169.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.097 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.681 ' ND2' HG12 ' A' ' 70' ' ' ILE . 5.6 p-10 -72.57 -55.06 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.901 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.765 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -56.98 -51.18 83.61 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 31.9 Cg_endo -62.79 -41.51 30.0 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.428 2.085 . . . . 0.0 112.837 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.437 HD13 HG23 ' A' ' 67' ' ' ILE . 0.6 OUTLIER -60.01 -25.63 65.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.095 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 10.1 m-20 -71.58 -61.78 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.192 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.496 ' HB1' HD22 ' A' ' 82' ' ' LEU . . . -60.97 -38.95 87.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -65.15 -27.48 68.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -62.92 -69.05 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -14.78 61.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.34 96.4 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.493 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 33.7 t80 -82.98 -98.78 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.653 0.263 . . . . 0.0 110.904 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 79' ' ' TYR . 1.6 m -137.57 -77.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.893 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.524 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 25.8 t -109.99 114.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.187 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.57 HD21 HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -123.23 101.77 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.348 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.69 158.5 31.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.635 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.425 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 33.0 pt -141.87 168.08 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 111.76 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 84' ' ' ILE . 3.7 mt-30 -152.4 155.64 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.483 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.39 141.92 45.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -109.74 -79.47 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.846 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.36 -97.51 0.46 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.087 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.31 6.88 5.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.243 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.1 p -135.89 172.21 13.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.037 0.446 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 61' ' ' SER . 4.0 tt -148.0 145.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.874 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 111.453 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.509 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 4.4 m-85 -131.68 130.76 42.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.72 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.57 HG23 HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -133.94 157.24 41.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.387 178.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.524 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.73 157.43 39.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.625 ' HB2' ' HE2' ' A' ' 79' ' ' TYR . 3.0 tptp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.741 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.34 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -67.05 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -91.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.46 157.61 35.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.031 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.44 21.45 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.893 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.68 126.33 39.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.007 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -134.33 28.66 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.515 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.65 ' HA ' HG21 ' A' ' 56' ' ' ILE . 11.4 t70 . . . . . 0 N--CA 1.467 0.418 0 CA-C-O 120.96 0.41 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.673 ' HB3' HD13 ' A' ' 57' ' ' LEU . 9.9 t80 -103.92 168.31 9.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.707 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -134.61 130.4 36.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 70' ' ' ILE . 1.9 tm? -123.06 78.67 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.41 -0.813 . . . . 0.0 108.973 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.634 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -102.06 70.12 1.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.762 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -136.7 -111.31 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 178.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.5 p -135.57 144.74 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.809 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -76.1 76.41 1.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.276 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.73 0.3 . . . . 0.0 111.138 -179.428 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.599 ' HB3' HD23 ' A' ' 30' ' ' LEU . 31.7 Cg_exo . . . . . 0 CA--C 1.529 0.26 0 CA-C-O 120.815 0.256 . . . . 0.0 112.461 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.68 4.7 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.485 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -48.16 -34.34 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -73.18 -38.38 66.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.954 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.531 HG23 HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -61.5 -57.63 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 9.8 mt -61.52 -54.23 45.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.48 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.35 -33.24 65.48 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.228 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -44.3 -61.49 1.49 Allowed 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.769 ' HE3' ' HA ' ' A' ' 74' ' ' ALA . 19.2 mtm -76.37 138.44 67.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 51' ' ' LEU . 63.0 Cg_endo -83.09 11.24 40.64 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.753 -0.936 . . . . 0.0 113.593 -10.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -71.91 16.54 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.135 -0.353 . . . . 0.0 111.664 -177.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD13 ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -71.12 179.28 2.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.352 . . . . 0.0 111.177 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -126.12 -148.15 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.553 ' HA ' ' HE2' ' A' ' 97' ' ' LYS . 18.8 mtmt -107.36 58.51 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 110.85 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' H ' ' HD3' ' A' ' 97' ' ' LYS . . . 126.36 93.05 0.87 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.624 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -124.1 -173.15 2.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.711 0.291 . . . . 0.0 110.984 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.65 HG21 ' HA ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -160.43 162.48 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.001 -179.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.673 HD13 ' HB3' ' A' ' 28' ' ' TYR . 15.2 tp -144.22 162.9 35.18 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.229 0.538 . . . . 0.0 111.398 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.454 ' H ' ' HG ' ' A' ' 57' ' ' LEU . 2.6 mt-10 -147.82 141.62 25.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.403 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.564 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 25.4 t -141.18 131.1 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 111.602 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.634 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 36.1 t -133.1 84.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.196 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -124.71 166.91 15.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.27 -178.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.38 135.76 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.494 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 19.3 p -159.25 143.31 11.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.134 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.95 -11.32 29.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.711 2.274 . . . . 0.0 112.046 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -93.08 -164.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -112.74 -17.52 12.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -117.68 153.49 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.505 ' ND2' ' HA3' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -125.81 177.81 6.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.067 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.68 -42.48 64.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.936 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.923 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -60.04 -49.82 89.27 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 50.5 Cg_endo -67.27 -43.46 6.12 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.189 1.926 . . . . 0.0 112.244 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.549 HD11 HG12 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -64.96 -32.58 74.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 3.8 m-20 -64.13 -57.6 9.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.769 ' HA ' ' HE3' ' A' ' 48' ' ' MET . . . -61.63 -39.55 91.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -62.6 -32.21 73.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.672 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -61.94 -67.89 0.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -33.28 72.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.575 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.14 95.03 1.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.04 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.87 -168.77 1.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.661 0.267 . . . . 0.0 110.285 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.783 HG21 HG23 ' A' ' 81' ' ' VAL . 96.7 m -77.26 -62.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.783 HG23 HG21 ' A' ' 80' ' ' THR . 21.8 t -127.44 132.34 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.334 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.717 HD12 HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -133.28 100.29 4.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.407 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.47 156.91 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.874 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.465 HD11 ' N ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.22 175.24 4.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.091 0.472 . . . . 0.0 111.804 -179.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.529 ' O ' HG13 ' A' ' 91' ' ' ILE . 17.1 mt-30 -154.04 166.95 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.439 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -145.4 145.46 31.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.877 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.6 -83.09 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.11 -97.27 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.202 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.15 5.92 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.52 2.147 . . . . 0.0 112.449 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -138.08 174.49 10.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 111.163 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.599 HG22 ' OH ' ' A' ' 93' ' ' TYR . 3.1 tt -145.17 144.19 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.741 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 138.39 54.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.928 0.394 . . . . 0.0 111.119 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.599 ' OH ' HG22 ' A' ' 91' ' ' ILE . 1.9 m-85 -123.86 149.47 45.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.205 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.39 138.39 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.926 0.393 . . . . 0.0 111.746 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.717 HG22 HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -129.34 161.34 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.534 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.706 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -152.07 145.7 24.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.676 ' HD2' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.718 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.822 0.344 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.72 3.81 5.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -82.98 -55.69 4.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -109.07 4.02 22.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.72 76.51 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.33 166.41 22.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.59 6.3 23.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.433 0.158 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.425 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -134.48 161.11 35.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 111.478 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -135.1 121.18 19.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.508 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -107.66 77.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.07 65.15 0.86 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.461 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -137.16 -104.93 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.05 178.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 33' ' ' VAL . 13.0 p -134.56 137.04 51.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.568 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -72.94 77.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' VAL . 3.0 Cg_exo . . . . . 0 CA--C 1.529 0.234 0 CA-C-O 120.698 0.208 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -59.48 1.94 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.916 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' A' ' 40' ' ' PRO . 59.8 t -51.18 -27.87 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.372 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -72.99 -36.83 67.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.697 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.7 m -57.46 -52.35 65.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.016 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 77' ' ' HIS . 4.5 tp -60.96 -63.13 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.1 -39.51 13.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.948 0.404 . . . . 0.0 110.406 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.23 -61.58 1.14 Allowed 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.458 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.501 ' HA ' HD21 ' A' ' 51' ' ' LEU . 3.3 mmt -76.97 138.85 65.39 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 51' ' ' LEU . 66.9 Cg_endo -83.27 13.79 34.04 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.643 -0.982 . . . . 0.0 113.336 -11.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 47' ' ' ALA . 35.8 mt-30 -70.41 10.55 0.45 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.177 -0.327 . . . . 0.0 111.824 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' A' ' 48' ' ' MET . 1.3 pt? -72.12 -177.35 2.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 14.7 mttm -121.72 -160.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.463 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -86.56 29.39 0.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.957 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.96 91.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.493 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.769 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -116.93 173.8 6.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.567 0.222 . . . . 0.0 110.755 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.704 HG13 ' O ' ' A' ' 55' ' ' GLU . 5.8 mt -159.22 157.53 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.235 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -143.66 161.51 38.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.092 0.472 . . . . 0.0 111.396 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.42 119.29 8.69 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.158 175.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.706 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 47.5 t -117.95 111.8 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 111.368 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 1.6 t -117.75 89.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 32' ' ' MET . 62.9 m -129.18 172.74 11.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.691 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.59 125.15 50.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 4.0 p -159.27 147.31 13.52 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.7 Cg_exo -71.3 -23.4 24.19 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.126 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -175.4 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.82 -32.28 11.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.45 ' HA ' ' HE2' ' A' ' 93' ' ' TYR . 1.5 tt -119.93 148.73 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.568 ' ND2' ' HA3' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -98.93 173.86 6.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.54 -22.05 61.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -67.65 -54.5 17.52 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 68' ' ' ASN . 21.2 Cg_exo -65.84 -35.39 35.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.277 1.985 . . . . 0.0 111.688 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -21.28 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.604 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -62.68 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.74 -39.78 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.482 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -56.53 -40.53 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.744 179.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -52.42 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.065 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.558 ' HB2' HD13 ' A' ' 45' ' ' LEU . 55.9 t-80 -68.3 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.114 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.14 98.06 0.11 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.845 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 82' ' ' LEU . 45.6 p90 -98.97 -166.02 1.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.488 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' A' ' 97' ' ' LYS . 1.4 m -125.83 -40.88 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.504 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.632 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 73.3 t -144.43 115.08 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.619 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.38 95.86 4.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.106 -178.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.97 163.27 21.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.3 pt -142.59 178.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 111.986 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.36 -172.09 4.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.243 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -144.56 142.41 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 111.226 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -118.03 -154.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.246 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -64.98 -99.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.107 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -90.74 16.31 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.744 2.296 . . . . 0.0 112.536 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -137.26 -170.72 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.001 0.429 . . . . 0.0 111.059 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.495 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt -143.19 147.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.605 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -123.79 142.87 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.063 0.459 . . . . 0.0 111.178 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.706 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.8 m-85 -131.39 155.79 46.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.564 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.7 143.93 20.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.613 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.619 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -134.98 158.62 41.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.236 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -154.11 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.769 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.1 tptp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.516 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.837 0.351 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 128.27 50.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -79.67 101.49 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 33.93 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.96 95.08 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -112.07 -13.22 13.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 p -68.9 109.92 4.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.566 -179.943 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' A' ' 58' ' ' GLU . 37.5 t0 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.78 136.55 43.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.758 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -103.52 135.68 44.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 112.384 -176.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.4 tm? -130.56 81.16 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.339 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.51 71.79 1.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.788 -176.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.86 -112.02 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.096 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 62' ' ' ASP . 47.9 t -134.87 133.31 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.69 103.43 0.32 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.604 0.24 . . . . 0.0 110.96 -179.666 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.536 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 62.7 Cg_endo . . . . . 0 CA--C 1.53 0.299 0 CA-C-O 120.818 0.258 . . . . 0.0 112.614 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . . . -58.55 4.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 40' ' ' PRO . 54.1 t -52.91 -29.29 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 110.106 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.0 66.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.639 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.26 -52.22 59.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.067 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.29 -57.6 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 47' ' ' ALA . 16.8 pt-20 -50.1 -40.57 46.14 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.53 -53.19 4.46 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.508 ' HA ' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.3 137.13 64.47 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 173.289 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' O ' HD21 ' A' ' 51' ' ' LEU . 65.0 Cg_endo -83.34 11.42 41.21 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.668 -0.972 . . . . 0.0 113.243 -11.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 47' ' ' ALA . 10.1 mm100 -73.02 25.9 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -72.46 -159.58 0.06 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -141.8 -155.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.448 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.675 ' H ' ' HD3' ' A' ' 52' ' ' LYS . 6.6 mttp -91.57 30.14 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.63 73.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.213 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.674 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -78.8 171.43 15.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 55' ' ' GLU . 61.5 mt -154.87 162.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.034 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.602 ' HG ' ' N ' ' A' ' 58' ' ' GLU . 4.3 tp -159.59 162.05 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.019 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.602 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -149.11 133.06 17.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.725 -176.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -139.25 132.23 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.849 0.356 . . . . 0.0 111.66 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -135.32 97.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.223 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.85 171.1 14.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.44 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.24 138.34 52.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.352 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.9 t -159.33 133.02 4.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.009 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.64 -30.9 86.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.558 2.172 . . . . 0.0 112.129 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -81.4 -170.91 3.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -112.35 -17.09 12.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.68 137.48 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -100.12 127.19 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.606 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.688 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -72.52 -58.71 3.16 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.775 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 15.3 mm -56.85 -54.05 58.39 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.671 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.2 Cg_exo -58.28 -32.94 97.1 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.331 2.021 . . . . 0.0 112.7 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 6.5 tp -61.51 -30.95 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.03 -58.05 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.068 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -63.51 -32.46 73.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.2 ttt-85 -68.87 -31.64 70.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -61.7 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.64 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -70.95 -24.66 62.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.309 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.7 103.37 1.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.994 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.39 -164.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.639 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 97' ' ' LYS . 2.6 m -72.77 -82.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.447 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 46.6 t -116.43 123.99 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.093 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -123.71 103.43 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.699 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.87 164.97 21.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.217 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.906 HG21 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -137.6 179.06 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.248 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.34 -177.0 6.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -150.37 138.87 20.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.053 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -122.57 -131.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.417 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.74 -123.66 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.167 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.7 29.89 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.915 2.41 . . . . 0.0 112.308 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.0 p -147.6 -177.8 5.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.506 HG12 ' CE1' ' A' ' 93' ' ' TYR . 14.3 tt -142.84 148.52 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.844 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.548 ' HB2' HG11 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -139.19 135.52 34.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.86 0.362 . . . . 0.0 111.257 -178.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.906 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.79 159.53 29.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.591 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.45 152.98 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 111.645 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.591 ' HB ' HD23 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -133.35 155.17 40.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.338 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.35 157.16 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.674 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 34.6 tttm . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.799 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.3 m80 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.741 0.305 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -92.16 21.06 5.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.28 -64.19 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.977 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -171.96 3.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -89.6 162.84 15.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.83 162.98 13.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.8 p -108.74 72.81 0.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.472 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.2 t0 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.656 ' HB3' HD12 ' A' ' 57' ' ' LEU . 1.4 t80 -105.33 137.63 42.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.8 -176.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.4 OUTLIER -103.89 131.73 50.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.48 -178.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.773 HD23 ' HA ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -123.76 86.79 2.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.047 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.644 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 41.8 t0 -102.27 64.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.8 mtp -136.66 -109.44 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.322 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 34' ' ' GLY . 10.9 p -133.93 143.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.975 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -74.09 94.29 0.79 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.46 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.773 ' HA ' HD23 ' A' ' 30' ' ' LEU . 6.6 Cg_endo . . . . . 0 CA--C 1.531 0.327 0 N-CA-C 113.379 0.492 . . . . 0.0 113.379 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.94 -0.68 0.09 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.458 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.0 t -52.22 -35.85 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.713 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.16 -36.74 72.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.602 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.456 HG22 ' CB ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.27 -42.57 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.196 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 1.2 tp -68.01 -55.62 11.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.329 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.651 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.23 -15.3 56.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.143 0.497 . . . . 0.0 110.754 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -74.63 -34.73 62.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.817 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.597 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.3 -47.83 87.38 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.461 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 14.8 Cg_exo -68.53 -51.55 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.006 1.804 . . . . 0.0 111.408 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -73.23 15.26 0.24 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.635 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.597 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -53.22 161.4 0.89 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 111.677 -178.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -153.2 -162.94 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.469 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -101.67 39.72 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 110.808 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . -174.94 67.81 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.438 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -110.17 152.92 25.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 111.414 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.4 mt -159.63 152.81 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.279 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' HB3' ' A' ' 28' ' ' TYR . 1.3 tp -160.67 137.73 9.08 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.147 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -118.75 137.93 53.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.091 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.599 HG11 ' HB3' ' A' ' 30' ' ' LEU . 15.2 t -139.9 150.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 0.0 112.359 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -154.95 100.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.752 178.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.7 m -144.07 167.92 21.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.958 0.409 . . . . 0.0 111.506 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.75 137.1 54.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.5 t -159.26 126.71 2.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.71 -12.99 36.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.385 2.057 . . . . 0.0 112.043 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HB3' ' H ' ' A' ' 66' ' ' SER . 35.0 mt-30 -86.02 -155.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 1.6 m -126.6 -56.51 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.302 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.63 74.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.0 110.964 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.598 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -136.47 5.08 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.067 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.542 HD21 HG22 ' A' ' 84' ' ' ILE . 2.8 m-20 -72.44 126.16 29.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.068 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 46.9 mm -53.83 -45.72 98.74 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.055 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 35.9 Cg_endo -63.6 -23.31 70.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.876 . . . . 0.0 111.772 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 2.4 mp -64.64 -31.3 72.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -46.49 80.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.595 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . . . -72.8 -29.94 63.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.364 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.604 ' HB2' ' HG ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -72.94 -52.54 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 19.1 t30 -50.52 -51.42 47.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.765 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -56.82 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.389 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.07 107.49 0.75 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.972 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -126.02 -135.85 0.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.558 0.218 . . . . 0.0 110.758 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.641 HG22 ' HA ' ' A' ' 97' ' ' LYS . 3.2 m -110.43 -78.66 0.59 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.798 0.332 . . . . 0.0 110.977 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.51 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 4.0 t -121.27 121.15 64.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.349 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.604 ' HG ' ' HB2' ' A' ' 75' ' ' ARG . 2.3 mm? -123.59 106.18 10.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -130.16 139.16 50.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.851 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.889 HG21 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -127.07 166.36 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.994 0.426 . . . . 0.0 111.571 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.42 142.88 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' H ' HE21 ' A' ' 86' ' ' GLN . 0.0 OUTLIER -123.89 152.78 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.855 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -121.62 -78.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.82 -99.97 0.59 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.67 5.61 6.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.606 2.204 . . . . 0.0 112.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 p -141.13 174.91 10.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.066 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.8 tt -149.85 134.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.615 ' HB2' HG11 ' A' ' 60' ' ' VAL . 2.1 ttt85 -123.81 130.64 52.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.889 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -124.01 161.18 26.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.701 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.97 146.38 23.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.537 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.457 HG23 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -123.9 155.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.009 177.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.51 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.39 -170.56 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 111.343 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.641 ' HA ' HG22 ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ttt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.777 0.322 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.62 145.52 40.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.488 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.53 -53.48 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.0 110.922 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -126.91 9.75 6.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -94.37 45.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -134.24 119.03 18.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -95.38 112.06 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -78.11 141.4 38.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.96 -26.28 11.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.14 161.32 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 m -104.49 143.26 33.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.22 103.85 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.49 70.79 0.23 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.613 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.86 116.37 28.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.733 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 t -125.69 88.92 53.42 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 102.18 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.538 2.159 . . . . 0.0 112.351 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -128.26 167.78 16.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.002 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.95 -12.5 61.98 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.32 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.0 p -118.89 164.66 15.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.804 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 159.59 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mtm -61.53 -46.3 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -131.44 -174.56 3.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.727 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.65 110.56 13.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 mm -110.39 25.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.825 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.523 HG11 HD12 ' A' ' 56' ' ' ILE . 2.3 t -87.13 -51.14 0.43 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.61 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 48.3 Cg_exo -56.44 95.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.243 1.962 . . . . 0.0 112.301 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 22.6 t70 -61.27 -76.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.633 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CB ' HD11 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -134.26 164.82 26.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 112.21 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.786 ' HG3' ' HB2' ' A' ' 58' ' ' GLU . 4.4 ttt-85 -134.38 114.09 12.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.938 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.746 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -109.6 77.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.537 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.64 67.62 0.9 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.49 -107.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.242 178.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 34' ' ' GLY . 85.3 t -134.9 139.99 46.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.483 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -66.75 89.13 0.15 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.389 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -85.83 132.91 42.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.21 -27.83 28.61 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.5 2.133 . . . . 0.0 112.191 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.69 134.8 75.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.975 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.06 89.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.624 2.216 . . . . 0.0 112.261 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.731 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 64.3 t80 -140.37 -53.83 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.446 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.731 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 52.8 Cg_endo -70.27 -72.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.164 1.909 . . . . 0.0 112.771 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 70' ' ' ILE . . . -55.89 -3.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 40' ' ' PRO . 79.4 t -51.53 -29.01 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.343 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.76 -36.12 67.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.868 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.486 ' HG1' ' HB3' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -57.42 -54.14 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.091 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.33 -47.69 84.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.151 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.544 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 4.8 pt-20 -64.38 -20.29 66.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.749 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.23 63.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.12 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.554 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 6.3 mmm -51.33 -54.77 34.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.692 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 48' ' ' MET . 58.7 Cg_endo -70.61 -39.69 4.65 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.785 1.657 . . . . 0.0 111.687 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.09 7.07 2.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.336 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.31 152.13 0.46 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.608 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -134.91 -165.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.779 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -85.44 45.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.464 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.14 0.38 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.007 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.606 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -122.21 158.49 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 55' ' ' GLU . 10.9 mt -159.65 154.18 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.327 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.432 HD11 ' CB ' ' A' ' 28' ' ' TYR . 3.5 tp -140.39 154.47 46.72 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.119 0.485 . . . . 0.0 110.834 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.786 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 3.8 mt-10 -141.6 111.98 6.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 30' ' ' LEU . 49.0 t -118.39 123.13 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.745 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.5 t -126.14 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.806 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -126.44 162.91 24.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.443 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.716 ' HB3' HG23 ' A' ' 90' ' ' THR . 1.4 p30 -118.16 132.04 56.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.709 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 142.53 17.05 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.077 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.93 -24.94 23.75 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.483 2.122 . . . . 0.0 112.138 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -83.58 -163.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -119.75 -24.85 6.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.67 138.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -88.72 127.21 35.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -72.56 -74.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.936 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.541 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 8.4 mm -50.64 -51.78 62.23 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.559 ' HA ' HD13 ' A' ' 82' ' ' LEU . 51.0 Cg_exo -55.94 -33.37 88.83 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.193 1.929 . . . . 0.0 112.628 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -61.06 -36.3 79.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.85 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 -57.35 10.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB2' HG21 ' A' ' 44' ' ' THR . . . -60.63 -35.16 75.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.289 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -64.29 -35.62 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.06 -64.62 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -26.86 68.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.672 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.38 94.32 0.77 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.946 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -154.83 0.39 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.635 ' HG1' ' HG2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -90.79 -64.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.638 0.256 . . . . 0.0 111.04 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.669 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 2.7 t -125.42 122.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.35 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.704 HD11 HG22 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -126.72 104.61 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.791 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.59 157.88 39.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.116 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.911 HG21 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -139.95 166.08 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.412 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.0 tt0 -154.42 156.66 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.443 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.401 ' HG3' HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -131.82 158.43 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -123.96 -79.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.14 -100.3 0.44 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.163 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.29 10.38 3.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.643 2.229 . . . . 0.0 112.327 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.716 HG23 ' HB3' ' A' ' 62' ' ' ASP . 4.8 p -145.6 177.7 8.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.482 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.0 tt -146.76 145.7 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 129.89 32.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.911 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.13 163.14 21.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.503 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.54 151.99 29.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.042 0.449 . . . . 0.0 111.596 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.704 HG22 HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -134.56 162.64 38.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.243 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.669 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 3.4 pt20 -153.53 177.36 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HG2' ' HG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mtt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.821 0.343 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.87 100.08 2.46 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.393 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 t -113.54 114.78 26.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.9 m -132.71 128.39 36.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -95.58 -177.49 4.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.878 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -168.18 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -105.44 91.88 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.85 -67.95 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -99.02 165.28 11.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -113.91 111.18 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.36 101.8 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -64.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.012 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.76 -124.5 2.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.63 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.77 24.57 11.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.55 72.66 73.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.03 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.56 157.52 28.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.566 2.177 . . . . 0.0 112.247 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 -135.85 149.65 49.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.98 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.7 -115.32 1.25 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.533 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.51 -176.92 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.884 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -102.44 -2.93 27.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.28 99.34 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.05 86.73 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 26' ' ' PRO . 5.9 m120 -94.21 104.55 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.72 -38.15 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.1 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.546 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 t -101.85 -51.24 0.16 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.84 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 52.4 Cg_exo -53.18 100.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.246 1.964 . . . . 0.0 112.509 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.625 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 7.2 t0 -64.53 -81.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.992 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.424 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 4.2 m-85 -134.83 166.83 22.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 111.721 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 138.6 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.046 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.647 ' HG ' HD12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -131.37 77.97 1.8 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.793 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -103.48 69.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.397 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 61' ' ' SER . 35.9 mtt -136.85 -111.85 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.121 0.486 . . . . 0.0 111.228 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 57.9 t -135.92 126.9 43.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.73 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -68.82 100.29 0.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.321 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 37' ' ' CYS . 14.3 pt-20 -99.07 153.48 37.77 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.165 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.94 -21.35 26.15 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.757 2.305 . . . . 0.0 112.431 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.425 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -75.73 146.85 80.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.806 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.47 -12.61 21.36 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.552 2.168 . . . . 0.0 112.383 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -94.13 154.53 40.56 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.942 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 42' ' ' VAL . 1.9 Cg_endo -84.28 7.92 54.09 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.951 -1.271 . . . . 0.0 112.529 0.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.662 ' HB1' HG22 ' A' ' 70' ' ' ILE . . . -58.02 0.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.927 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.4 p -52.46 -25.12 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.307 0.575 . . . . 0.0 110.014 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.92 -36.8 67.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.646 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.523 HG22 ' HB1' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -53.18 -55.21 26.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.891 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -51.66 66.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -59.65 -21.6 60.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.14 -179.119 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.52 -34.05 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.558 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.4 mmm -49.24 -55.39 21.68 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.684 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.559 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 16.2 Cg_exo -67.73 -37.36 16.34 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.139 1.893 . . . . 0.0 111.882 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.71 4.29 4.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.516 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.669 HD13 ' HE2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -46.44 155.92 0.2 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.906 0.384 . . . . 0.0 111.536 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.63 -91.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.38 3.52 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . 157.57 99.21 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.755 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -103.09 -177.43 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 55' ' ' GLU . 4.4 mt -159.4 153.94 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.072 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.7 OUTLIER -134.79 156.52 48.73 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.058 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.71 110.26 6.35 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.095 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 30' ' ' LEU . 98.8 t -117.71 124.61 73.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.472 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' A' ' 92' ' ' ARG . 87.5 t -131.91 96.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.6 p -130.41 176.63 7.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.773 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.464 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -117.31 131.39 56.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.299 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.418 ' SG ' ' HA3' ' A' ' 34' ' ' GLY . 70.0 m -143.84 130.88 10.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.12 4.51 4.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.48 2.12 . . . . 0.0 112.371 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.412 ' HB3' ' H ' ' A' ' 66' ' ' SER . 39.6 mt-30 -127.35 -159.99 0.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.412 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 2.7 t -111.14 -27.56 8.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.127 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mt -56.68 128.54 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.337 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.617 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.4 OUTLIER -92.91 125.54 37.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.458 ' H ' HD21 ' A' ' 69' ' ' ASN . 2.0 m-80 -72.87 -73.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.179 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.662 HG22 ' HB1' ' A' ' 41' ' ' ALA . 2.5 mm -46.28 -51.74 32.3 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.822 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.634 ' HB3' HD11 ' A' ' 82' ' ' LEU . 32.2 Cg_exo -60.57 -30.1 89.91 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.334 2.023 . . . . 0.0 112.725 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.4 tp -61.11 -33.02 72.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.811 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.6 4.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB1' HG22 ' A' ' 44' ' ' THR . . . -59.63 -35.67 74.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.914 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -64.88 -37.12 86.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -58.08 10.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.741 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -64.72 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.37 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.57 82.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.997 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.44 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -86.34 -170.63 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.692 0.282 . . . . 0.0 110.636 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.44 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -76.89 -66.64 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.003 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.685 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 11.9 t -126.71 128.6 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD21 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -131.01 100.08 5.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.94 167.92 14.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.088 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.914 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.5 pt -137.59 -177.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.489 ' O ' HG13 ' A' ' 91' ' ' ILE . 3.4 mt-30 -154.51 178.65 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.33 142.21 26.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 0.0 111.306 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.29 -138.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.306 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.94 -116.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.163 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.54 27.08 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.616 2.211 . . . . 0.0 112.543 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.4 p -142.05 -177.69 5.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 111.036 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.527 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.1 tt -149.41 150.46 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.863 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.499 ' HB2' HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -139.64 140.77 37.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.919 0.39 . . . . 0.0 111.368 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.914 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -127.88 144.9 51.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.129 178.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.32 150.91 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 111.481 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.646 ' HB ' HD21 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -131.85 157.4 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 178.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.685 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.8 pt20 -154.47 158.57 40.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 111.259 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.755 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 25.2 tttp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.745 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.06 -26.66 52.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.58 171.46 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.883 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 t -130.74 166.89 19.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -77.03 99.51 5.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.07 -68.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -132.83 111.75 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -136.43 179.17 6.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -67.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -121.11 46.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.11 40.83 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 m -122.43 60.77 1.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.73 149.6 51.43 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.404 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.3 mt -135.71 160.91 37.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.861 0.362 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.599 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 11.3 t -93.17 -50.6 0.27 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.647 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 52.9 Cg_exo -55.39 -21.94 31.87 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.163 1.909 . . . . 0.0 112.368 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.2 167.76 6.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.25 104.11 1.29 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.626 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.02 89.33 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.837 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -137.73 18.14 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtp -97.47 -56.1 2.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.46 -19.25 33.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -64.5 105.25 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 tt -89.64 146.64 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.8 HG12 HD12 ' A' ' 56' ' ' ILE . 1.6 t -113.91 -52.1 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.745 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.761 ' HD2' ' H ' ' A' ' 25' ' ' VAL . 20.3 Cg_endo -60.43 98.62 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.169 1.913 . . . . 0.0 112.326 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.579 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 33.8 t70 -64.2 -78.13 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.178 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.436 ' HB2' HD11 ' A' ' 57' ' ' LEU . 5.8 m-85 -134.4 165.66 24.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.431 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -134.82 135.46 41.77 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.581 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.843 ' HG ' HD12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -125.89 76.74 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.273 178.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.52 66.64 0.88 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.948 0.404 . . . . 0.0 111.463 -178.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.566 ' O ' ' HA ' ' A' ' 61' ' ' SER . 2.3 mtt -137.06 -106.4 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.347 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 62' ' ' ASP . 11.7 p -134.12 142.55 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -61.53 -20.34 58.98 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.31 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.407 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 6.8 tt0 -59.48 144.74 83.86 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.407 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 10.8 Cg_endo -53.5 91.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.629 2.22 . . . . 0.0 112.315 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -89.14 166.88 19.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.515 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.55 -57.06 2.58 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.383 2.055 . . . . 0.0 112.636 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -122.42 76.68 44.6 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 37' ' ' CYS . 66.5 Cg_endo -92.46 -129.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.096 2.531 . . . . 0.0 112.366 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -57.88 -4.16 0.28 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.968 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.1 p -50.25 -28.01 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.239 0.542 . . . . 0.0 110.024 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.41 -40.45 64.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.538 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.761 HG23 ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.35 -54.14 49.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.066 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.746 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 16.4 mt -61.43 -49.31 77.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.138 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 pt-20 -65.29 -18.29 65.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.657 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB2' ' OH ' ' A' ' 79' ' ' TYR . . . -72.88 -29.2 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.952 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.95 -54.79 33.45 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.449 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.7 Cg_endo -69.64 -36.89 10.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.864 1.709 . . . . 0.0 111.586 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.91 5.74 3.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.6 161.76 0.12 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.958 0.409 . . . . 0.0 111.753 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -131.7 -95.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.813 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -14.75 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.804 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 178.86 92.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.184 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.756 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -99.25 -176.69 3.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 111.434 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.8 HD12 HG12 ' A' ' 25' ' ' VAL . 3.7 mt -159.61 154.62 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.204 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -136.69 156.2 48.85 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.13 0.491 . . . . 0.0 111.194 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -140.28 116.5 10.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.056 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 30' ' ' LEU . 52.6 t -118.26 113.63 42.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.635 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 72.9 t -118.66 92.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.822 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.4 p -133.0 168.61 18.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.362 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.89 118.47 32.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.358 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.6 t -137.44 120.67 11.59 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.955 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.91 -25.6 70.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.519 2.146 . . . . 0.0 112.133 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -87.85 164.07 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -91.04 -22.8 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.002 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.24 118.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.367 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.99 118.2 14.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -72.68 -75.67 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.789 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.843 HD12 ' HG ' ' A' ' 30' ' ' LEU . 7.1 mm -48.57 -51.51 51.73 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.022 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.578 ' HA ' HD12 ' A' ' 82' ' ' LEU . 51.4 Cg_exo -57.21 -36.97 99.15 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.224 1.95 . . . . 0.0 112.849 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER -57.14 -33.42 67.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.884 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.746 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 2.1 m-20 -66.97 -58.67 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.034 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.761 ' HB1' HG23 ' A' ' 44' ' ' THR . . . -61.13 -34.98 75.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.209 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -65.9 -36.12 82.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 -60.91 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -59.9 2.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.535 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.28 88.09 0.57 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.022 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -88.06 -151.89 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.248 . . . . 0.0 110.343 178.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.48 HG21 ' HG3' ' A' ' 97' ' ' LYS . 1.2 m -93.33 -75.34 0.5 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 48.1 t -120.4 123.06 69.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 71' ' ' PRO . 1.1 mm? -123.61 105.4 9.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.792 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -134.34 157.59 45.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.525 HG21 ' HD2' ' A' ' 93' ' ' TYR . 35.4 pt -140.15 179.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.594 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.478 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -154.07 166.88 31.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 179.121 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -125.93 125.15 42.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 0.0 111.215 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.31 82.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.377 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.44 145.69 7.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.949 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -90.9 43.23 2.47 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.573 -1.428 . . . . 0.0 112.652 0.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.7 p -142.9 -172.21 3.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.872 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 85' ' ' GLN . 6.3 tt -149.53 142.59 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.855 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -123.93 133.03 53.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.173 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.525 ' HD2' HG21 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -123.66 148.15 46.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.745 178.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.98 151.72 28.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.949 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.575 HG22 HD13 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -136.17 158.34 38.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.222 178.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER -154.12 153.44 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.292 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.756 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 9.4 tttp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.793 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.854 0.359 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.75 -130.71 3.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.562 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -100.02 178.73 4.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 110.952 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -113.02 -75.51 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.84 -52.89 2.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.994 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -74.78 151.24 39.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 133.84 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -100.89 -4.52 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.057 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -60.8 129.4 41.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -127.24 -177.36 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.63 165.61 19.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 t -116.44 -79.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.85 -119.32 4.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 84.15 1.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 0.0 110.9 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.19 153.54 81.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.071 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.46 -162.3 2.88 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.572 -1.429 . . . . 0.0 112.462 0.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 17' ' ' ARG . 10.7 mtt180 -124.72 116.08 21.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.37 21.69 36.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.482 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.0 m -78.27 151.84 32.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.336 . . . . 0.0 110.89 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 0.01 53.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.977 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.1 mtm -138.03 151.37 47.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -115.64 174.54 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.96 102.28 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.983 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -89.04 -72.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.957 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.4 -51.86 0.26 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.255 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.34 93.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.256 1.971 . . . . 0.0 112.136 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.636 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 16.3 t70 -72.71 -77.07 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.382 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.496 ' HB2' HD11 ' A' ' 57' ' ' LEU . 25.2 m-85 -134.61 162.04 33.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 111.841 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 127.48 30.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.345 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.618 ' HG ' HD12 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -117.57 82.1 1.77 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.568 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.52 67.06 0.89 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.47 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.638 ' O ' ' HA ' ' A' ' 61' ' ' SER . 93.0 mtp -136.94 -109.85 0.19 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.251 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 62' ' ' ASP . 14.7 t -135.19 150.34 29.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.508 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -84.66 55.77 5.0 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.472 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.64 124.94 29.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.0 110.785 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.77 82.7 1.68 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.522 2.148 . . . . 0.0 112.54 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.539 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -140.2 -55.18 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.42 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 94.9 Cg_endo -84.01 -144.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.194 1.93 . . . . 0.0 112.251 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HA ' HG21 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -119.65 71.79 14.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.741 179.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB2' HD12 ' A' ' 70' ' ' ILE . 99.0 Cg_endo -86.24 -93.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.701 2.268 . . . . 0.0 112.893 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 70' ' ' ILE . . . -56.36 -8.54 0.53 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.561 HG21 ' HA ' ' A' ' 39' ' ' TYR . 49.4 t -46.9 -34.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.65 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -73.1 -40.18 65.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.166 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.55 -50.41 62.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.47 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.84 -55.39 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.599 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 42.2 mt-10 -59.53 -19.27 47.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 43' ' ' ALA . . . -72.46 -34.1 67.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.64 ' HG3' ' HB3' ' A' ' 77' ' ' HIS . 5.4 mmm -49.02 -55.77 18.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.213 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 22.0 Cg_exo -64.38 -37.49 39.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.995 1.797 . . . . 0.0 111.544 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 6.15 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.42 145.43 0.27 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -141.5 -168.81 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.631 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -87.56 23.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.03 97.93 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.464 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.667 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -130.58 155.44 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 0.0 110.819 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -159.6 158.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -145.51 158.57 43.82 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.001 0.429 . . . . 0.0 111.196 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 117.65 9.94 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.197 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 30' ' ' LEU . 41.6 t -118.42 115.26 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.549 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.9 t -119.41 88.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.138 0.494 . . . . 0.0 110.123 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -129.72 170.66 13.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.401 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.57 121.96 42.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.618 179.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -153.21 149.4 21.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 59.1 Cg_endo -72.01 -42.92 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.557 2.171 . . . . 0.0 112.426 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.51 155.24 40.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -64.39 -63.69 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.537 HG23 ' HB2' ' A' ' 72' ' ' LEU . 2.4 mt -76.38 142.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.006 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 17.6 t30 -110.38 -176.2 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -72.52 -35.67 68.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.644 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.618 HD12 ' HG ' ' A' ' 30' ' ' LEU . 1.3 mm -69.17 -50.71 19.78 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 43.1 Cg_endo -66.56 -44.68 5.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.135 1.89 . . . . 0.0 112.368 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.537 ' HB2' HG23 ' A' ' 67' ' ' ILE . 0.6 OUTLIER -62.74 -30.88 71.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.013 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -60.46 3.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.736 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.0 -33.79 74.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -64.14 -29.98 71.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.544 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -66.95 -61.45 1.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.607 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.64 ' HB3' ' HG3' ' A' ' 48' ' ' MET . 0.1 OUTLIER -68.15 -20.41 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.648 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.61 93.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.817 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.429 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -91.56 -156.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 110.533 179.057 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.429 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -90.77 -64.23 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.746 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 40.4 t -128.76 120.8 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.276 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.624 HD11 HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -123.56 102.58 7.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.394 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.86 160.37 27.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.887 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.6 pt -142.0 171.62 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.4 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.501 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.0 mt-30 -154.31 158.87 40.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.8 144.39 51.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.973 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -125.77 -121.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.481 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.02 -112.26 0.51 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.215 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.17 19.75 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.724 2.283 . . . . 0.0 112.477 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.3 p -138.29 -178.78 5.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 111.101 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 85' ' ' GLN . 5.4 tt -149.43 147.91 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.823 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -131.09 131.06 43.94 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.206 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -123.43 134.34 53.96 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.998 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.97 150.76 47.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.199 0.523 . . . . 0.0 111.806 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.624 HG23 HD11 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.15 156.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.188 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.746 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -146.98 172.16 14.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.936 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.667 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 12.1 tptt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.786 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.728 0.299 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.94 -7.33 70.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 t -88.95 -60.66 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.5 p -116.55 127.71 54.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -80.13 176.26 9.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -116.03 101.8 9.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -120.33 15.47 12.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.22 -28.13 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.831 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.21 102.84 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -44.29 43.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.15 169.89 16.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 t -110.24 -27.85 8.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.6 114.25 2.7 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 mt -131.87 -165.52 1.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.1 m -104.53 149.16 37.1 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.24 -37.62 1.46 Allowed 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.521 -1.449 . . . . 0.0 112.531 0.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.75 145.14 28.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.001 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.28 -142.43 11.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.585 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.43 -60.56 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -89.64 153.17 20.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -66.85 143.59 56.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.04 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -90.97 102.12 14.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -105.53 40.21 1.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.047 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.6 pt -134.59 -177.32 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 m -59.12 143.32 84.68 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.802 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 88.8 Cg_exo -48.65 -81.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.628 2.219 . . . . 0.0 112.802 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 20.9 t0 57.11 72.67 0.5 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -103.38 164.94 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.066 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 6.9 ttt180 -133.65 142.56 48.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.619 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.658 ' HB3' HG11 ' A' ' 59' ' ' VAL . 1.7 tm? -132.93 89.91 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.885 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.37 66.06 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.543 -177.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mtt -136.36 -111.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.323 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.623 HG13 ' H ' ' A' ' 35' ' ' GLU . 7.5 p -134.56 160.5 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -74.34 13.54 4.71 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.523 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.623 ' H ' HG13 ' A' ' 33' ' ' VAL . 3.2 tt0 -104.75 124.52 36.6 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.56 0.219 . . . . 0.0 110.558 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.0 96.29 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.522 2.148 . . . . 0.0 112.621 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.497 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 m -125.16 -54.72 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.178 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 81.5 Cg_endo -85.85 -120.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.281 1.988 . . . . 0.0 112.112 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.438 ' H ' ' HB2' ' A' ' 38' ' ' PRO . 77.2 m-85 -126.09 66.99 61.45 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.711 0.291 . . . . 0.0 110.596 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 42' ' ' VAL . 87.5 Cg_endo -83.12 -99.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.676 2.251 . . . . 0.0 112.892 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 70' ' ' ILE . . . -60.65 -0.43 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.447 ' H ' ' C ' ' A' ' 40' ' ' PRO . 80.4 t -49.27 -36.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.05 -34.67 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.56 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.74 -47.23 86.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.272 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.441 HD23 ' HD2' ' A' ' 77' ' ' HIS . 44.6 mt -64.45 -47.05 80.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.359 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.4 -12.38 61.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 0.0 110.803 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB1' ' HE2' ' A' ' 79' ' ' TYR . . . -74.26 -39.25 63.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.111 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.557 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -52.49 -46.92 95.0 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.804 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 15.8 Cg_exo -67.75 -59.51 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.919 1.746 . . . . 0.0 111.408 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -73.76 20.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.53 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.596 HD13 ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -48.1 153.29 0.7 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.014 0.435 . . . . 0.0 111.61 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 -160.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.3 53.64 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.43 52.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.643 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.802 ' HB2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -68.46 177.52 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.066 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -159.26 149.69 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 58' ' ' GLU . 16.0 tp -134.74 162.59 31.93 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.247 0.546 . . . . 0.0 111.095 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -147.56 136.45 22.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.487 176.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 30' ' ' LEU . 41.1 t -141.5 138.71 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 111.752 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 97.6 t -140.42 107.95 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.769 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.2 -177.69 5.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.438 . . . . 0.0 111.797 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -118.01 120.87 39.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.783 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.37 108.16 2.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.64 -26.12 77.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.554 2.169 . . . . 0.0 112.277 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -73.02 -174.4 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -106.31 -27.7 10.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.94 133.72 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -95.19 136.11 35.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -72.58 -75.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.606 ' HB ' ' HD3' ' A' ' 71' ' ' PRO . 9.2 mm -46.4 -52.12 31.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.198 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 44.8 Cg_exo -58.97 -33.1 98.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.257 1.971 . . . . 0.0 112.613 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.2 tp -61.36 -29.23 69.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.96 0.409 . . . . 0.0 110.788 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' OD2' ' HB1' ' A' ' 41' ' ' ALA . 5.0 m-20 -70.45 -52.5 21.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.56 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -69.26 -27.88 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -72.24 -36.04 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.709 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -64.21 -59.6 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.441 ' HD2' HD23 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -64.59 -42.01 95.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.638 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 102.53 2.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.781 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.53 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -105.49 -106.11 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 79' ' ' TYR . 55.4 m -140.52 -72.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.308 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.666 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 53.2 t -117.17 118.26 58.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.344 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 74' ' ' ALA . 3.0 mm? -123.94 100.54 6.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.97 156.88 40.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' HB ' ' HD1' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -140.21 167.18 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.309 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -154.59 151.29 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.62 156.82 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.929 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.28 -84.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.797 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.14 -112.0 2.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.103 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.83 10.44 2.89 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.0 112.192 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.482 HG23 ' OD1' ' A' ' 62' ' ' ASP . 25.3 p -136.09 176.97 8.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.017 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.449 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.5 tt -151.38 142.9 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -127.91 142.25 51.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.116 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.478 ' HD1' ' HB ' ' A' ' 84' ' ' ILE . 0.6 OUTLIER -123.51 155.82 36.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.32 143.08 20.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.463 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -129.16 161.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.556 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.666 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.3 pt20 -153.96 161.93 41.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.596 ' HD2' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.907 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ttm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.34 72.79 2.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.77 143.59 26.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -117.69 25.57 10.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.21 38.93 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.99 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -105.79 -31.45 8.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.949 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.59 103.84 4.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 169.86 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 135.28 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -110.96 39.85 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.18 130.41 36.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.4 -23.05 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.87 80.18 0.36 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.29 23.04 14.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.038 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.59 102.58 44.82 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.996 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.49 29.48 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.563 2.176 . . . . 0.0 112.509 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -20.51 58.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.973 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.74 -137.18 5.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.453 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.1 m -128.64 120.67 27.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -118.04 121.54 40.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.24 73.55 8.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -64.6 164.66 11.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -74.65 -168.04 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.998 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.708 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -110.28 -170.68 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.992 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.595 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER -64.83 -51.69 55.6 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.2 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.708 ' HD2' ' HB ' ' A' ' 24' ' ' ILE . 11.1 Cg_endo -54.59 100.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.158 1.905 . . . . 0.0 111.902 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.746 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 36.0 t70 -78.6 -80.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.555 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.402 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.03 166.48 22.94 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 142.61 46.4 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.792 HD22 ' HA ' ' A' ' 40' ' ' PRO . 1.4 tm? -134.53 84.39 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.535 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p-10 -104.06 69.13 0.93 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.451 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -136.52 -108.42 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 0.0 111.398 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.704 HG11 ' HB3' ' A' ' 35' ' ' GLU . 58.1 t -134.38 142.29 41.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -12.5 11.46 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.198 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.704 ' HB3' HG11 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -61.96 159.59 35.63 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.379 0.133 . . . . 0.0 110.715 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.31 86.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.457 2.104 . . . . 0.0 112.218 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . 1.2 m -74.68 161.91 75.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.985 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.39 -35.95 37.26 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.461 2.107 . . . . 0.0 112.222 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.62 65.31 54.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.792 ' HA ' HD22 ' A' ' 30' ' ' LEU . 63.2 Cg_endo -93.96 -123.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.014 2.476 . . . . 0.0 112.805 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.778 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -58.2 -4.38 0.35 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 43' ' ' ALA . 9.9 p -47.62 -34.08 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 110.707 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -72.99 -39.7 65.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.228 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -53.41 -54.04 42.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 tp -62.04 -40.25 95.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.913 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.636 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -67.2 -20.54 65.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.567 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.477 ' HB1' ' HE2' ' A' ' 79' ' ' TYR . . . -72.54 -30.7 64.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.62 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.747 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 19.1 mmt -48.47 -56.38 14.78 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 23.7 Cg_exo -62.62 -44.03 19.14 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.975 1.783 . . . . 0.0 111.288 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.25 12.53 0.56 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.585 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.48 148.59 0.14 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -174.92 4.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.941 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.22 32.91 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 176.03 101.54 0.15 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.415 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.766 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -135.93 158.55 44.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.789 0.328 . . . . 0.0 111.097 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.1 mt -159.62 156.96 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.431 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' N ' ' CG2' ' A' ' 56' ' ' ILE . 1.4 tp -147.98 159.05 44.3 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.183 0.516 . . . . 0.0 111.293 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.43 134.87 26.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.021 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 30' ' ' LEU . 38.9 t -134.09 123.91 45.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 111.326 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 77.9 t -127.5 94.46 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.77 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.7 p -135.39 170.23 16.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.221 0.534 . . . . 0.0 111.72 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -117.82 124.57 48.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.37 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 49.3 t -144.57 116.24 5.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.67 -30.39 92.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.575 2.183 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -77.91 -163.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -119.07 -24.21 6.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.169 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.35 122.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.727 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -80.14 124.45 28.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.54 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.45 ' HB3' ' H ' ' A' ' 70' ' ' ILE . 5.5 t-20 -73.89 -87.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.778 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 6.6 mm -46.45 -54.07 20.49 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.727 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -59.41 -26.29 81.42 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.071 1.847 . . . . 0.0 112.989 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.5 tp -65.55 -38.77 90.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.846 0.355 . . . . 0.0 110.841 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -49.54 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.62 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.682 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -71.51 -27.13 63.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -71.94 -34.99 69.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.28 -64.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.429 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 3.6 t-80 -64.68 -30.32 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.87 96.76 0.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.59 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.477 ' HE2' ' HB1' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -93.29 -104.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.639 0.257 . . . . 0.0 110.809 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.463 ' H ' ' HB3' ' A' ' 79' ' ' TYR . 5.3 m -133.5 -69.05 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.32 . . . . 0.0 110.825 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.689 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 2.3 t -126.21 121.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 82' ' ' LEU . 3.8 mm? -123.37 104.85 9.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.401 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.9 156.99 46.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.691 0.282 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.25 173.21 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 111.588 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.545 ' O ' HG13 ' A' ' 91' ' ' ILE . 9.8 mt-30 -154.22 162.71 41.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -144.02 149.4 36.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.05 -81.77 0.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.15 -88.17 0.15 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.356 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.79 -1.28 9.49 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.754 2.302 . . . . 0.0 112.891 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -136.48 175.94 9.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.902 0.382 . . . . 0.0 111.189 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 85' ' ' GLN . 4.6 tt -146.81 143.46 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.63 135.22 53.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.278 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.47 ' CZ ' HG12 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -123.51 145.34 48.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.31 148.58 25.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.212 0.53 . . . . 0.0 111.937 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -131.6 157.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.048 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.689 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -148.48 178.74 8.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.766 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 6.7 tptt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.689 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.794 0.331 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.52 23.35 12.78 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.542 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.35 147.69 49.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 t -117.0 -73.04 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -111.14 16.44 21.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -62.27 153.72 29.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -77.99 -8.43 58.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.999 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.28 120.01 15.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.072 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -112.22 -160.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.25 88.98 2.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -160.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.5 72.03 5.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -129.19 68.62 0.54 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.466 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.81 -42.92 4.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.807 0.337 . . . . 0.0 110.963 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 m -103.35 147.5 34.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.128 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.3 -156.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.464 2.109 . . . . 0.0 112.2 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.59 91.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.009 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.78 97.62 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.312 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.0 m -64.11 -70.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.766 0.317 . . . . 0.0 111.194 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -117.58 -174.94 2.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.919 0.39 . . . . 0.0 111.113 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -164.31 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.975 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.59 66.68 1.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -118.11 30.47 7.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.593 HG23 ' H ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -111.86 173.75 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.95 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.724 HG13 HD13 ' A' ' 56' ' ' ILE . 2.0 t -63.68 -50.35 72.24 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.654 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 23.5 Cg_endo -60.33 95.06 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.102 1.868 . . . . 0.0 112.02 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.639 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -59.49 -74.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.391 -179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.757 ' HB3' HD11 ' A' ' 57' ' ' LEU . 10.9 t80 -134.44 164.67 26.94 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.56 141.88 46.8 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 40' ' ' PRO . 1.2 tm? -134.17 83.56 2.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.076 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.64 67.63 0.91 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.567 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 61' ' ' SER . 1.0 OUTLIER -136.5 -110.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 35' ' ' GLU . 34.5 t -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.448 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' HD22 ' A' ' 68' ' ' ASN . . . -63.9 -5.8 15.57 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.226 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.55 ' HB3' HG13 ' A' ' 33' ' ' VAL . 1.3 pt-20 -64.47 159.32 60.68 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.486 0.184 . . . . 0.0 110.839 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.16 93.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.556 2.171 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -90.09 150.72 43.93 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -46.49 -60.5 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.716 2.278 . . . . 0.0 112.791 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.19 73.12 32.16 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.272 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 37' ' ' CYS . 83.3 Cg_endo -90.7 -98.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.896 2.397 . . . . 0.0 112.512 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.764 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -60.24 -5.24 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.456 HG22 ' HD2' ' A' ' 40' ' ' PRO . 32.7 t -47.02 -32.26 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.45 -44.54 57.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.592 HG23 HD21 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -47.69 -54.55 11.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -62.5 -58.24 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 26.8 mt-10 -60.07 -15.3 22.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 111.135 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.22 -38.49 68.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.818 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.531 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.7 mtp -47.91 -54.16 26.26 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.402 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 31.1 Cg_exo -60.51 -59.71 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.757 1.638 . . . . 0.0 111.357 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -73.8 23.74 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.87 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.576 HD12 ' HD3' ' A' ' 97' ' ' LYS . 1.3 pp -52.03 177.39 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 0.0 111.97 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.821 ' HG2' ' H ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -159.07 164.88 34.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.244 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -73.29 23.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 111.306 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.821 ' H ' ' HG2' ' A' ' 52' ' ' LYS . . . -168.83 69.12 0.16 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 27' ' ' ASP . 5.0 tm-20 -112.06 152.15 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.724 HD13 HG13 ' A' ' 25' ' ' VAL . 1.1 mt -160.22 158.24 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.428 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 28' ' ' TYR . 2.5 tp -140.31 163.87 31.61 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.323 0.582 . . . . 0.0 111.156 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.95 128.52 13.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.957 175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.68 HG13 HG13 ' A' ' 70' ' ' ILE . 48.5 t -128.64 114.1 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.896 0.379 . . . . 0.0 111.462 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -118.28 96.5 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.15 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -137.14 172.84 12.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.608 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' CG ' HG22 ' A' ' 90' ' ' THR . 0.5 OUTLIER -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.432 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.3 p -159.11 140.33 9.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.218 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.77 16.75 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.606 2.204 . . . . 0.0 112.276 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -116.92 -165.83 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -72.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.5 mm -83.79 140.45 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.021 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -97.18 -179.16 4.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.69 -38.39 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.739 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 1.3 mm -67.79 -50.45 34.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 33.0 Cg_endo -62.58 -36.91 61.75 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.274 1.982 . . . . 0.0 112.244 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.17 -25.71 65.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -58.62 4.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.34 -36.32 83.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -63.51 -30.6 71.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -65.73 -70.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.404 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 1.5 t-80 -57.86 -35.54 71.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.765 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.41 79.89 1.49 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.55 -157.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 96' ' ' GLN . 2.9 m -72.5 -78.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.498 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.61 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 2.0 m -130.19 145.87 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.557 HD11 HG21 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -128.35 111.95 13.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.468 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -127.1 159.99 32.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.724 0.297 . . . . 0.0 110.958 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -140.79 -178.41 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.179 0.514 . . . . 0.0 111.69 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -154.5 -173.86 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.203 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -136.75 116.71 13.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 111.26 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.67 -176.75 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.673 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.8 117.41 1.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.755 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.474 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 82.7 Cg_endo -100.45 66.94 0.32 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 C-N-CA 124.318 -1.118 . . . . 0.0 112.653 0.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.431 HG22 ' CG ' ' A' ' 62' ' ' ASP . 3.1 p -147.81 -173.82 4.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 111.27 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.568 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tt -136.2 151.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.515 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.0 tpp85 -123.7 142.75 50.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.893 0.378 . . . . 0.0 111.762 -177.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 7.9 m-85 -136.54 117.55 14.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.078 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.87 146.24 52.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 111.724 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -129.66 161.86 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.356 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -148.24 154.17 39.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.905 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.576 ' HD3' HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmm . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.849 0.357 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.33 -105.69 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.492 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.96 29.07 7.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.911 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.88 101.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.63 112.9 24.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.763 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.29 70.1 7.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.996 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.35 90.12 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.91 -98.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.45 -165.01 1.83 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -99.87 148.28 24.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -82.7 120.47 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.3 39.75 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.34 160.74 39.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.02 3.29 56.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 p -109.8 122.2 39.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HG2' ' H ' ' A' ' 17' ' ' ARG . 38.7 Cg_endo -67.11 -69.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.461 2.107 . . . . 0.0 112.434 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' A' ' 16' ' ' PRO . 4.8 mtm180 -111.42 -87.33 0.54 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.28 112.3 0.8 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.428 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 86.2 p -96.17 19.27 12.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 0.0 110.912 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.91 -62.55 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.798 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.42 73.58 10.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.821 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -4.55 5.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.966 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -74.64 -179.73 4.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.88 101.37 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.442 ' H ' HG21 ' A' ' 25' ' ' VAL . 3.0 m -90.91 132.15 35.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.534 ' HG2' ' HG3' ' A' ' 55' ' ' GLU . 46.5 Cg_exo -56.72 -86.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.624 2.216 . . . . 0.0 112.244 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 5.7 p-10 41.09 64.87 0.9 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.093 0.473 . . . . 0.0 110.745 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.16 160.39 14.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.598 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 10.1 ptt85 -128.53 129.42 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 0.0 111.94 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -122.23 77.27 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.525 177.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.602 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.3 p30 -101.91 68.14 1.12 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.728 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.534 ' O ' ' HA ' ' A' ' 61' ' ' SER . 10.5 mtt -137.13 -112.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.889 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.57 143.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.987 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 111.12 3.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.327 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -122.81 140.73 33.78 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.646 0.26 . . . . 0.0 110.946 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 35' ' ' GLU . 23.9 Cg_exo -64.67 -41.65 18.35 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.732 2.288 . . . . 0.0 112.336 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 32.4 t -54.25 126.05 52.43 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.094 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 28.4 Cg_exo -61.86 88.31 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.626 2.217 . . . . 0.0 112.137 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.73 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -139.71 -53.71 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.211 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.73 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 41.3 Cg_endo -67.83 -70.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.121 1.881 . . . . 0.0 112.332 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.913 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -57.67 0.79 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' A' ' 40' ' ' PRO . 14.4 t -48.69 -32.64 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.391 . . . . 0.0 110.567 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . . . -72.93 -37.94 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.601 HG21 HD21 ' A' ' 57' ' ' LEU . 1.9 m -58.07 -59.02 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.243 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.88 -32.56 67.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -71.73 -28.21 63.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 110.509 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.6 -26.94 61.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.402 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 32.6 mmt -53.72 -54.85 41.7 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.652 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 59.8 Cg_endo -71.01 -39.68 3.93 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.815 1.677 . . . . 0.0 111.595 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.91 6.91 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.528 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.07 150.48 0.58 Allowed 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.917 0.389 . . . . 0.0 111.252 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 54.2 mmtt -145.88 -159.31 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.424 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.02 16.49 4.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 65.35 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.877 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.651 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 20.8 tt0 -86.67 146.73 26.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.67 0.271 . . . . 0.0 110.406 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.2 mp -155.53 153.44 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 44' ' ' THR . 15.0 tp -142.85 164.99 28.59 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.305 0.574 . . . . 0.0 111.146 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.491 ' H ' ' HG ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -149.46 135.02 18.51 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.672 HG12 ' HB3' ' A' ' 30' ' ' LEU . 15.4 t -137.85 132.31 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.11 0.481 . . . . 0.0 111.624 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.5 t -136.84 83.04 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.029 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.4 p -123.58 175.16 6.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.65 125.92 51.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.463 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 147.62 16.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.75 5.0 6.46 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.25 161.77 27.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.02 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.4 m -72.08 -52.27 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.67 143.73 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 2.9 t-20 -134.3 -172.3 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -72.33 -47.49 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.913 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 1.1 mm -59.52 -49.33 92.75 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 41.7 Cg_endo -66.47 -41.14 12.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.119 1.88 . . . . 0.0 112.505 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -21.27 64.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -62.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.413 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -57.41 -41.21 79.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.677 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.622 ' HA ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.957 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -66.75 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -59.39 4.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.563 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.74 100.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.463 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' HD1' ' HA ' ' A' ' 75' ' ' ARG . 52.8 p90 -90.41 -171.63 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 111.65 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.479 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 28.6 m -115.29 -49.72 2.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.08 176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.698 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 t -139.23 115.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.138 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.615 HD23 HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -122.67 100.21 6.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -178.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.32 150.15 50.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.11 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.463 . . . . 0.0 111.626 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' HG13 ' A' ' 91' ' ' ILE . 1.6 tm0? -145.44 171.34 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.65 126.43 46.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.165 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -174.16 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.47 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.07 121.96 2.11 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.709 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.45 ' O ' HG23 ' A' ' 90' ' ' THR . 78.4 Cg_endo -102.15 62.25 0.58 Allowed 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.759 1.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 89' ' ' PRO . 17.3 p -148.87 -174.57 4.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.98 0.419 . . . . 0.0 111.534 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 85' ' ' GLN . 8.1 tt -142.38 145.53 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -123.74 146.56 48.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.108 0.48 . . . . 0.0 111.499 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.535 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 3.1 m-85 -132.02 131.05 42.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.017 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.33 143.74 46.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 111.402 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.637 HD11 ' HG2' ' A' ' 55' ' ' GLU . 0.7 OUTLIER -135.43 157.06 39.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.682 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.698 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -154.47 166.03 34.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.651 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.6 tttp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.791 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttp . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.705 0.288 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.25 129.58 9.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.499 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.9 t -123.1 -28.51 4.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.747 0.308 . . . . 0.0 110.961 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.92 128.75 45.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.47 137.35 53.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.999 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -115.41 -172.24 2.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.842 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.2 -72.32 0.59 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.937 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -86.9 175.79 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -72.2 -175.87 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -46.04 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.02 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.32 -172.42 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.6 p -77.28 -170.08 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.21 -90.74 0.67 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.52 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.54 81.96 1.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.885 0.374 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.6 113.2 9.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.62 -17.99 8.32 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.656 2.237 . . . . 0.0 112.619 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.9 106.01 11.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.163 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.48 14.53 63.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.508 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 p -85.02 -167.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.652 0.263 . . . . 0.0 110.874 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -54.35 113.23 1.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 tpt -115.22 -70.05 0.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.99 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 -64.49 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -133.1 135.84 45.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.561 ' HB ' ' HD1' ' A' ' 28' ' ' TYR . 3.3 mp -129.5 124.63 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.032 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.553 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -96.67 -53.64 0.21 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.294 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 25' ' ' VAL . 49.7 Cg_endo -67.69 117.38 4.83 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.928 1.752 . . . . 0.0 112.018 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' HA ' ' C ' ' A' ' 56' ' ' ILE . 5.0 p-10 48.46 87.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.399 0.619 . . . . 0.0 111.509 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.561 ' HD1' ' HB ' ' A' ' 24' ' ' ILE . 52.7 t80 -102.53 147.0 27.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.7 mtt85 -104.9 135.88 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.562 ' HG ' HD13 ' A' ' 70' ' ' ILE . 2.2 tm? -134.54 82.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.327 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.619 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -103.13 66.77 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.9 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -136.29 -112.61 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.119 0.485 . . . . 0.0 111.266 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 62' ' ' ASP . 6.4 t -135.01 152.46 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.794 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.78 -7.56 16.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.096 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.86 159.01 66.69 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.481 0.181 . . . . 0.0 110.841 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.98 89.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.483 2.122 . . . . 0.0 112.197 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 m -81.69 159.58 66.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.977 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.29 -52.63 4.54 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.569 2.179 . . . . 0.0 112.542 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -133.22 65.26 72.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.336 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.556 ' HA ' HD23 ' A' ' 30' ' ' LEU . 63.8 Cg_endo -93.13 -109.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.871 2.381 . . . . 0.0 112.496 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.563 ' CB ' ' HA ' ' A' ' 70' ' ' ILE . . . -59.52 -4.24 0.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 9.8 p -47.12 -33.38 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.46 -39.44 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.119 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 3.6 m -55.72 -55.3 33.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.834 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.685 ' HA ' ' HE3' ' A' ' 48' ' ' MET . 95.2 mt -57.39 -52.7 64.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.272 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 5.9 pt-20 -68.55 -11.37 59.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 44' ' ' THR . . . -72.53 -39.57 67.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.458 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.685 ' HE3' ' HA ' ' A' ' 45' ' ' LEU . 53.2 mtm -53.51 -53.7 53.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.65 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 48' ' ' MET . 53.4 Cg_endo -67.83 -52.08 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.677 1.584 . . . . 0.0 111.313 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -73.85 19.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.834 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -51.4 178.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.415 0.626 . . . . 0.0 111.795 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.517 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 31.6 mmtt -149.0 -144.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.45 26.73 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.313 . . . . 0.0 111.159 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.12 84.19 0.52 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.613 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.586 ' N ' ' HB3' ' A' ' 97' ' ' LYS . 5.3 pt-20 -74.84 -179.81 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -159.91 -178.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.766 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 28' ' ' TYR . 6.5 tp -158.85 156.0 28.84 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.05 101.25 3.14 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.988 175.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.606 HG13 ' HD2' ' A' ' 93' ' ' TYR . 1.4 p -119.32 131.54 71.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.822 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 12.2 t -132.47 111.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.194 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -143.02 177.44 8.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 0.0 111.419 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' O ' HG11 ' A' ' 33' ' ' VAL . 5.1 p-10 -117.9 130.53 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 129.78 3.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.073 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.93 -17.79 22.17 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.527 2.151 . . . . 0.0 112.231 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.73 156.4 16.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.951 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -40.48 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.55 109.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.543 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -102.35 165.21 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.21 -75.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.563 ' HA ' ' CB ' ' A' ' 41' ' ' ALA . 2.4 mm -44.86 -53.3 16.09 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.669 ' HA ' HD12 ' A' ' 82' ' ' LEU . 22.8 Cg_endo -62.19 -39.31 49.24 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.959 1.772 . . . . 0.0 113.047 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.5 -22.14 66.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 111.148 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.12 -58.38 3.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.87 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 79' ' ' TYR . . . -60.14 -41.17 92.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.793 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -63.28 -31.6 72.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.41 -66.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' HB2' ' HE1' ' A' ' 48' ' ' MET . 1.1 m-70 -72.21 -64.19 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.15 104.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.62 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.816 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 52.8 p90 -90.64 -163.23 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.253 0.549 . . . . 0.0 111.466 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.553 HG22 ' HD2' ' A' ' 97' ' ' LYS . 2.2 m -115.22 -54.68 2.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.343 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.675 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.4 t -140.22 114.2 6.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.389 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -123.09 102.84 8.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -124.02 151.5 43.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.645 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.872 HG21 ' HB3' ' A' ' 93' ' ' TYR . 23.0 pt -136.08 165.1 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.407 . . . . 0.0 111.466 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -154.55 159.73 41.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -125.66 154.67 42.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.46 -85.13 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.786 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.52 -105.89 1.35 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.976 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.33 12.37 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.46 2.107 . . . . 0.0 112.086 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -140.8 179.44 6.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 HG12 ' CE1' ' A' ' 93' ' ' TYR . 20.7 tt -146.88 144.26 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.574 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 136.45 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.872 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.93 159.93 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.181 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.08 146.88 24.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.598 HG23 HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.98 160.67 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.669 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.675 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -153.95 156.53 37.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.942 0.401 . . . . 0.0 111.338 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.586 ' HB3' ' N ' ' A' ' 55' ' ' GLU . 4.2 tptp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.583 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.829 0.347 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.67 -159.94 8.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.536 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 p -102.53 9.21 39.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 111.053 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.34 149.66 27.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -67.7 -74.78 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -69.77 152.93 44.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -84.51 158.65 20.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -64.51 149.25 48.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.992 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -126.11 156.18 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.83 104.93 16.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.996 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.98 157.32 16.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -119.68 -62.57 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.99 -142.14 8.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -112.96 160.81 17.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.32 143.82 45.69 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.183 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.39 104.65 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.565 2.177 . . . . 0.0 112.288 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 17' ' ' ARG . 10.0 mmm180 -69.96 134.14 48.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.37 -45.27 96.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.492 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.07 167.45 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.891 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -103.94 152.19 22.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.19 122.54 42.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.004 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.23 101.75 13.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.15 14.78 20.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.5 pt -99.34 6.06 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.039 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.461 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 t -98.51 -50.92 0.21 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.797 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 68.7 Cg_exo -51.76 111.45 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.197 1.932 . . . . 0.0 112.637 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -76.11 -76.74 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.343 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.612 ' HB3' HD13 ' A' ' 57' ' ' LEU . 3.4 t80 -135.54 164.28 28.18 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.996 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -134.66 113.73 12.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.848 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.858 ' HB3' HG11 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -109.05 81.93 1.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.51 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.58 68.91 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.471 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 61' ' ' SER . 16.4 mtt -136.24 -109.23 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.324 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 62' ' ' ASP . 21.7 t -134.73 138.68 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.9 70.22 2.33 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.425 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 21.4 tt0 -121.3 140.07 30.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.525 0.203 . . . . 0.0 110.519 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 13.1 Cg_endo -56.61 -50.36 12.02 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.72 2.28 . . . . 0.0 112.601 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.5 122.13 38.28 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.171 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.11 160.59 94.39 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.133 -0.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -76.48 114.04 34.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.54 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . 3.5 Cg_endo -88.01 -55.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.335 2.69 . . . . 0.0 112.598 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . . . -52.85 -0.38 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 40' ' ' PRO . 93.8 t -47.17 -30.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.63 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.61 64.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.699 HG22 ' HB1' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -54.87 -50.98 67.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.34 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 71.3 mt -61.77 -52.87 62.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.375 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.534 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -66.41 -13.38 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.137 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' HB1' ' OH ' ' A' ' 79' ' ' TYR . . . -72.62 -40.1 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.254 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.54 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 10.1 mtm -48.14 -52.99 37.18 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.551 ' O ' HD12 ' A' ' 51' ' ' LEU . 30.2 Cg_exo -60.5 -60.05 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.742 1.628 . . . . 0.0 111.434 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -74.61 24.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.954 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.645 HD21 ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.54 -159.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 112.02 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.645 ' H ' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -165.89 -174.7 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.191 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -83.4 36.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 150.58 102.76 0.25 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.489 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.89 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -124.48 177.74 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.629 HG13 ' O ' ' A' ' 55' ' ' GLU . 17.9 mt -159.47 161.7 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.612 HD13 ' HB3' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -160.67 130.25 4.99 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.472 -0.768 . . . . 0.0 111.423 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 1.2 mt-10 -118.71 118.36 31.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.765 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.858 HG11 ' HB3' ' A' ' 30' ' ' LEU . 58.9 t -118.53 113.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.994 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.536 HG21 ' HE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -117.49 94.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 110.435 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -126.71 166.59 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.128 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.549 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.74 133.16 56.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.622 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 t -152.13 132.39 7.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.13 -18.04 24.15 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.488 2.125 . . . . 0.0 112.281 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.47 -162.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -117.64 -17.37 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mt -68.16 127.67 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.74 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -94.48 126.62 39.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.23 -82.43 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.678 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 7.3 mm -44.51 -54.82 11.45 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -61.25 -24.09 78.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.004 1.803 . . . . 0.0 112.921 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.8 tt -69.55 -33.46 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.401 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 3.6 m-20 -66.41 -53.48 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.699 ' HB1' HG22 ' A' ' 44' ' ' THR . . . -62.37 -36.29 81.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -66.62 -33.13 74.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.81 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -60.58 -61.04 2.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.54 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 0.8 OUTLIER -67.74 -62.12 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 91.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.497 ' OH ' ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -92.73 -164.21 1.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.0 110.345 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.696 HG23 ' HA ' ' A' ' 97' ' ' LYS . 24.3 m -82.35 -79.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.602 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 22.0 t -112.13 117.62 55.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.73 116.04 22.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -147.06 155.12 41.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.846 HG23 ' HB3' ' A' ' 93' ' ' TYR . 20.6 pt -135.1 170.25 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.004 0.431 . . . . 0.0 111.561 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.405 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.76 148.45 25.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.64 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.95 149.17 50.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.889 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -118.1 -83.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.19 -90.15 0.18 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.446 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.62 3.14 8.04 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.649 2.233 . . . . 0.0 112.812 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.2 p -145.4 174.93 10.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.109 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.517 HG12 ' CE1' ' A' ' 93' ' ' TYR . 16.5 tt -144.43 139.8 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.836 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.602 ' HD3' ' O ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -124.01 132.7 53.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.348 -177.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.846 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.75 156.33 34.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.34 145.33 22.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 112.105 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.553 HG21 HD22 ' A' ' 57' ' ' LEU . 0.6 OUTLIER -132.63 153.08 37.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.124 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.602 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.4 OUTLIER -154.6 175.26 13.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 111.235 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.89 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.77 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.837 0.351 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.37 -1.25 31.19 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.634 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 t -90.12 120.04 30.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.971 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 t -114.82 109.43 18.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -137.85 44.13 2.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -116.89 95.26 4.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.905 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -119.93 119.79 34.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -110.82 179.75 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.81 96.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -88.12 167.62 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.985 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.0 p -71.99 -57.53 4.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -137.14 99.88 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.85 74.4 0.27 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.612 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.81 137.49 34.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.715 0.293 . . . . 0.0 110.829 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.99 102.01 38.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.113 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -78.6 -1.58 11.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.602 2.202 . . . . 0.0 112.325 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.13 16.29 6.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.032 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.21 -33.66 0.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.523 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.91 169.02 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.775 0.321 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -94.6 163.37 13.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.998 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.5 ptm -93.49 -12.28 30.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HD2' HD12 ' A' ' 56' ' ' ILE . 43.1 pttt -81.07 -172.35 3.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.804 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -134.35 147.39 50.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.957 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.615 HG21 ' HB3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -130.31 116.73 37.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.894 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.554 ' N ' ' HA ' ' A' ' 26' ' ' PRO . 47.5 t -68.27 -55.0 13.42 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.957 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HB3' HG21 ' A' ' 24' ' ' ILE . 69.6 Cg_endo -89.72 164.5 35.72 Favored 'Cis proline' 0 C--N 1.357 0.992 0 C-N-CA 124.621 -0.991 . . . . 0.0 111.897 -2.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 56' ' ' ILE . 39.8 t0 -68.98 -89.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.733 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.518 ' HB3' HD12 ' A' ' 57' ' ' LEU . 10.5 t80 -136.62 166.41 23.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.391 . . . . 0.0 111.758 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.543 ' NH2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -134.56 105.99 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.802 178.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.728 ' HB3' HG11 ' A' ' 59' ' ' VAL . 1.1 tm? -103.83 81.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.7 m-20 -103.62 66.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.149 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.24 -105.83 0.21 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 34' ' ' GLY . 15.0 t -134.33 148.82 29.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -81.54 55.58 4.86 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.621 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.629 ' HG3' ' HB2' ' A' ' 37' ' ' CYS . 3.1 pt-20 -79.69 159.01 72.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.531 0.205 . . . . 0.0 110.759 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -93.24 21.5 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.953 2.435 . . . . 0.0 112.732 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.629 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 1.3 m -84.88 149.7 54.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.902 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.98 66.82 8.73 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.583 2.189 . . . . 0.0 112.26 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.783 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 11.9 m-85 -140.25 -52.84 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.978 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.783 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 23.6 Cg_endo -62.11 -85.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.406 2.071 . . . . 0.0 113.337 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -56.87 -2.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.4 t -45.49 -35.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.6 -46.57 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.275 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 74' ' ' ALA . 54.7 m -49.44 -46.93 48.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.623 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.3 mt -63.48 -57.38 10.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.282 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.504 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 mm-40 -64.76 -10.58 28.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.014 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.37 63.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.154 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -51.97 -47.67 90.54 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.991 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 46' ' ' GLU . 55.3 Cg_endo -69.98 -51.76 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.711 1.607 . . . . 0.0 111.759 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 14.3 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.401 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.15 156.06 0.18 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.999 0.428 . . . . 0.0 111.868 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 8.1 mmtp -125.75 -164.91 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 72.0 mttt -88.32 40.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.844 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 25' ' ' VAL . . . 131.4 113.27 1.52 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.29 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.849 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 15.8 pt-20 -135.3 -177.05 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -161.04 152.08 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.272 0.558 . . . . 0.0 111.141 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 28' ' ' TYR . 4.7 tp -127.02 158.98 35.5 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -144.35 107.77 4.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.196 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.728 HG11 ' HB3' ' A' ' 30' ' ' LEU . 45.5 t -117.57 112.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.616 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 90.6 t -118.59 94.73 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.694 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.2 p -125.5 171.83 10.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.897 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.444 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -118.04 122.6 43.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.581 179.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.24 131.27 8.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.971 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.48 -8.65 18.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.596 2.198 . . . . 0.0 112.314 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -97.0 -167.32 1.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.957 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.38 -26.09 8.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 mt -66.85 123.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.76 130.4 37.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.843 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.62 -70.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.101 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.885 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 2.8 mm -49.64 -52.49 50.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.1 Cg_exo -57.61 -43.25 52.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.272 1.981 . . . . 0.0 112.87 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.34 -21.98 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.203 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -71.99 -57.88 3.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.95 -41.7 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.708 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.17 -33.75 75.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.006 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.26 -61.08 2.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.569 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.58 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 8.9 m170 -72.37 -69.08 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.19 103.94 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 82' ' ' LEU . 51.3 p90 -92.93 -162.4 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.126 0.488 . . . . 0.0 111.328 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.463 HG21 ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -113.25 -52.75 2.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.258 176.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.814 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 48.1 t -143.95 118.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.171 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.713 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -122.95 115.18 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.964 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.15 155.46 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.847 HG23 ' HB3' ' A' ' 93' ' ' TYR . 19.4 pt -133.05 167.1 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.479 . . . . 0.0 111.601 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -154.63 165.44 36.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.413 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -132.1 147.33 52.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.798 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -107.85 -81.4 0.56 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.636 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.31 -92.53 0.22 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.815 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.33 3.66 7.14 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.803 2.336 . . . . 0.0 112.033 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.432 HG22 ' OD2' ' A' ' 62' ' ' ASP . 25.0 p -136.47 -178.24 5.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.498 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.7 tt -143.34 151.1 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -140.03 131.79 27.44 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.815 0.341 . . . . 0.0 111.302 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.847 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.05 140.46 53.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.246 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.87 157.01 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.713 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.22 162.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.614 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.814 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.79 155.6 34.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.849 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.502 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.801 0.334 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.5 169.67 14.34 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 t -133.49 -79.28 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.78 155.99 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.009 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -95.23 -33.49 12.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.97 163.92 22.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.13 148.63 48.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -118.01 -165.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -69.38 164.29 23.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.92 -179.82 4.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 p -119.44 88.12 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -118.4 65.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.69 142.25 20.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.473 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 138.03 42.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.747 0.308 . . . . 0.0 111.007 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.14 108.07 44.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.08 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.76 -23.97 52.83 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.644 2.229 . . . . 0.0 112.373 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -43.76 88.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.13 25.32 10.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.471 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -167.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 0.0 110.872 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.7 -27.88 66.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.1 mtt -78.34 134.7 37.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.952 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.498 ' HZ1' ' H ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -111.99 -176.3 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.038 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' H ' ' HZ1' ' A' ' 22' ' ' LYS . 98.2 m-20 -99.73 -70.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mt -129.47 103.94 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.113 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -113.06 -53.48 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.486 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.28 115.2 1.91 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.004 1.803 . . . . 0.0 112.159 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.526 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 27.6 t70 -94.07 -80.37 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.675 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.91 168.42 19.36 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.651 -0.819 . . . . 0.0 112.656 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 13.2 mtp180 -134.82 118.01 16.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.721 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -116.47 78.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.947 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.9 67.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.391 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 61' ' ' SER . 15.5 mtt -136.46 -110.65 0.19 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 111.504 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.513 HG21 ' OD2' ' A' ' 62' ' ' ASP . 84.8 t -135.41 122.95 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.79 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . -68.13 92.48 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.228 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -81.87 162.62 56.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.44 0.162 . . . . 0.0 110.709 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.462 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 96.4 Cg_endo -78.66 34.66 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.529 2.152 . . . . 0.0 112.535 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 7.6 m -132.06 153.44 81.35 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.904 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.77 -22.01 21.94 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.653 2.235 . . . . 0.0 112.656 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HB3' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -96.72 154.62 38.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.026 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.804 ' HB2' HD21 ' A' ' 30' ' ' LEU . 4.1 Cg_exo -82.06 0.38 49.61 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.629 1.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.34 -2.55 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.946 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 39' ' ' TYR . 79.2 t -51.91 -28.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.046 0.45 . . . . 0.0 110.05 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -70.57 -38.74 74.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.23 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.51 -46.35 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.944 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.79 -39.26 84.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.783 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 2.5 pt-20 -72.12 -17.29 61.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.648 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB1' ' OD1' ' A' ' 27' ' ' ASP . . . -72.56 -36.75 68.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.875 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.662 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 22.0 mtp -49.6 -54.14 34.14 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.383 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 18.3 Cg_exo -65.45 -45.61 6.8 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.021 1.814 . . . . 0.0 111.485 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -73.23 12.78 0.51 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.55 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.636 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.56 159.1 0.1 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.09 0.471 . . . . 0.0 111.935 -179.289 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -142.6 -160.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.631 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -86.78 33.51 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 25' ' ' VAL . . . 150.2 114.96 0.71 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.305 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.765 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -121.17 166.75 13.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.645 0.26 . . . . 0.0 110.907 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 55' ' ' GLU . 10.6 mm -159.22 149.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.69 131.12 5.28 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.907 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -121.73 132.93 54.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.551 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.674 HG22 HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.48 126.63 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.585 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 2.2 t -125.75 101.53 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.0 m -142.41 169.82 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.231 0.539 . . . . 0.0 112.073 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.513 ' OD2' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.16 129.2 55.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.196 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.435 ' HB2' ' OD1' ' A' ' 68' ' ' ASN . 30.5 p -156.83 136.52 8.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.333 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.92 -25.65 8.76 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.461 2.107 . . . . 0.0 112.263 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.35 -162.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -140.12 10.37 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.611 ' HA ' HD13 ' A' ' 72' ' ' LEU . 44.5 mm -111.35 -26.9 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.89 0.376 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 36' ' ' PRO . 7.6 m120 -52.1 -12.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.534 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.837 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 1.9 m-20 -50.9 119.34 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.539 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.674 HG12 HG22 ' A' ' 59' ' ' VAL . 22.7 mm -51.65 -49.93 80.16 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.311 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 36.9 Cg_exo -62.0 -22.32 74.04 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.139 1.893 . . . . 0.0 111.965 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.837 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -62.4 -39.34 92.92 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.108 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -59.75 -45.56 91.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' TYR . . . -70.46 -23.33 62.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.607 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -38.54 66.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.537 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.53 -58.72 6.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.443 ' HB2' ' SD ' ' A' ' 48' ' ' MET . 73.6 m80 -69.36 -45.16 70.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.322 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.16 87.88 1.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.162 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -87.7 -140.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.566 HG21 ' HA ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -97.85 -72.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.807 0.337 . . . . 0.0 110.991 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 26.3 t -127.68 123.63 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 71' ' ' PRO . 2.4 mm? -123.44 101.65 7.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.91 158.3 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.473 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.94 HG23 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -138.82 172.06 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.404 ' O ' HG13 ' A' ' 91' ' ' ILE . 26.3 mt-30 -154.36 156.33 36.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.215 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 152.53 51.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.791 0.329 . . . . 0.0 111.22 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -122.72 -78.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.99 -106.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.754 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.84 10.04 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.71 2.274 . . . . 0.0 111.949 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 67.7 p -138.98 170.73 15.44 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.466 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.9 tt -150.93 136.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.046 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -127.93 140.43 52.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.326 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.94 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -123.66 166.19 15.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.947 178.229 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.44 144.8 21.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.487 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -129.25 149.57 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.388 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.413 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 5.4 pt20 -142.94 155.92 44.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.791 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.765 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 10.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.815 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.27 -25.12 4.82 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.452 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.34 -64.82 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.773 0.32 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.7 p -131.61 142.37 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -87.13 -91.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 -86.41 0.2 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.071 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -140.14 -163.52 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.933 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -74.43 -169.76 0.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.44 17.47 4.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.037 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -72.34 117.98 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -123.67 -178.8 4.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.025 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.18 153.28 32.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.22 140.73 28.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.45 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.09 163.06 22.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.34 . . . . 0.0 111.012 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.97 131.84 50.2 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.33 101.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.577 2.185 . . . . 0.0 112.201 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -121.44 -48.41 2.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.77 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.45 18.41 3.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.346 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.7 56.35 3.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 111.019 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -82.71 5.31 21.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.73 103.69 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -79.23 -77.25 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -134.44 -73.63 0.48 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.122 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 tt -111.01 -43.14 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.205 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.675 HG22 ' HA ' ' A' ' 26' ' ' PRO . 2.5 p -53.88 134.04 57.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.834 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.675 ' HA ' HG22 ' A' ' 25' ' ' VAL . 12.7 Cg_exo -71.89 146.16 85.03 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.495 1.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.37 -72.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.326 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.782 ' HB2' HD11 ' A' ' 57' ' ' LEU . 62.8 m-85 -134.17 160.83 36.62 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.81 0.338 . . . . 0.0 111.638 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 144.71 46.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.837 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' A' ' 70' ' ' ILE . 1.1 tm? -134.3 81.41 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.514 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.0 p-10 -103.22 65.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.89 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 61' ' ' SER . 6.2 mtp -137.2 -105.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 62' ' ' ASP . 2.4 t -134.93 156.79 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.381 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.54 -9.6 13.49 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.198 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.698 ' HG3' ' H ' ' A' ' 37' ' ' CYS . 9.2 pt-20 -60.23 165.05 5.54 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 122.122 0.169 . . . . 0.0 110.987 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.58 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 27.9 Cg_endo -62.92 3.67 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.649 2.233 . . . . 0.0 112.729 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.698 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 1.2 m -109.47 153.68 42.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.815 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD2' HD23 ' A' ' 30' ' ' LEU . 61.5 Cg_endo -74.42 -62.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.557 -1.435 . . . . 0.0 112.572 0.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.649 ' HB3' HG13 ' A' ' 42' ' ' VAL . 96.9 m-85 -69.98 -59.35 4.45 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.792 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' O ' ' HB2' ' A' ' 39' ' ' TYR . 74.0 Cg_endo -104.17 -80.94 0.0 OUTLIER 'Cis proline' 0 C--N 1.357 1.025 0 CA-C-N 119.321 0.793 . . . . 0.0 112.144 -0.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.872 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -64.75 6.97 0.18 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.471 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.649 HG13 ' HB3' ' A' ' 39' ' ' TYR . 1.4 p -53.29 -27.48 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.457 . . . . 0.0 110.178 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -73.44 -37.28 65.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.705 178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.426 HG21 ' HB3' ' A' ' 74' ' ' ALA . 2.8 m -54.23 -63.72 1.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.321 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 20.9 mt -56.29 -38.22 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.275 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.544 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 4.9 tt0 -64.55 -28.76 69.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.639 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.08 -24.21 60.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.467 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.739 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 38.6 mmt -57.2 -55.88 39.59 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.703 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 11.7 Cg_exo -70.45 -44.49 1.58 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.117 1.878 . . . . 0.0 111.554 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.86 8.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.382 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -44.0 154.39 0.11 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.98 0.419 . . . . 0.0 111.552 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -124.33 -157.71 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.836 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -78.02 8.44 4.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.133 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' HA2' ' OXT' ' A' ' 97' ' ' LYS . . . 160.78 82.09 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.743 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -81.91 172.34 13.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.67 HG23 ' HB3' ' A' ' 26' ' ' PRO . 4.5 mt -160.27 155.97 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.782 HD11 ' HB2' ' A' ' 28' ' ' TYR . 1.1 tp -139.59 161.17 38.17 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.019 0.437 . . . . 0.0 111.247 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -143.18 113.17 7.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -118.12 114.97 46.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.395 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 61.1 t -119.05 94.24 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.09 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -130.75 173.69 10.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.521 . . . . 0.0 111.771 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' OD2' HG21 ' A' ' 90' ' ' THR . 0.7 OUTLIER -117.43 130.85 56.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.337 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.54 117.45 3.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.93 -17.83 61.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.679 2.253 . . . . 0.0 112.09 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -108.85 -163.49 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 t -102.57 -18.46 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -69.98 130.56 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.64 ' HB3' ' HH ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -137.09 129.73 30.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.294 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.33 -48.73 69.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.872 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -56.96 -55.73 40.82 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.44 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 28.8 Cg_endo -62.57 -33.6 77.57 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.644 1.563 . . . . 0.0 112.201 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -29.46 68.93 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -57.39 12.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.719 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.816 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -66.51 -37.73 85.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 29.9 ttt-85 -63.43 -54.98 28.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.592 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -47.88 -55.01 10.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.214 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -70.13 -71.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.532 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.99 98.74 0.15 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.707 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.816 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.6 p90 -88.78 -165.35 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 0.0 111.406 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 97' ' ' LYS . 39.5 m -112.16 -52.24 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.057 175.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.753 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 41.3 t -141.84 116.6 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.573 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -122.53 105.01 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.619 -178.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -123.66 163.62 20.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.648 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.817 HG21 ' HB3' ' A' ' 93' ' ' TYR . 15.5 pt -139.91 168.3 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.431 . . . . 0.0 111.433 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.425 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.5 mt-30 -154.42 155.76 35.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.39 154.4 50.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -123.45 -80.56 0.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.63 -97.52 0.36 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.406 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 9.55 3.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.457 HG21 ' OD2' ' A' ' 62' ' ' ASP . 47.5 p -146.37 176.4 9.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.955 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.477 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.0 tt -145.04 140.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.654 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 92' ' ' ARG . 3.7 ttm-85 -133.2 132.55 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.817 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.39 164.7 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.829 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.92 158.6 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.904 0.383 . . . . 0.0 111.443 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -134.47 162.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.922 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.753 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -154.5 156.21 36.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.743 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.629 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.62 -153.76 8.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.551 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.7 p -109.91 8.09 24.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.5 p -95.07 150.96 19.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.49 106.07 8.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.984 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -132.11 176.87 8.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 172.29 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.81 44.06 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.19 -70.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -112.44 53.03 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -68.17 -73.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.991 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.18 111.97 20.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.978 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.67 30.45 8.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.93 -41.15 16.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.332 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.499 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 4.2 t -87.39 -52.08 0.41 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.378 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 71.8 Cg_endo -76.32 107.83 2.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.162 1.908 . . . . 0.0 112.278 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.81 122.19 28.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.25 78.18 1.89 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.481 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.96 37.39 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -99.32 75.67 2.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.86 -57.92 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.85 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -104.04 123.78 47.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.437 HD21 ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -84.95 146.25 27.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.953 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.437 ' H ' HD21 ' A' ' 23' ' ' ASN . 2.1 mm -106.54 -26.55 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.974 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -124.56 138.01 30.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.149 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.694 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 52.0 Cg_exo -54.38 -92.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.862 2.375 . . . . 0.0 112.634 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.474 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 26.2 t0 56.11 73.43 0.44 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -107.98 141.9 38.92 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.308 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 7.8 mtp85 -111.46 137.33 49.41 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.842 ' HB3' HG11 ' A' ' 59' ' ' VAL . 1.7 tm? -126.71 89.12 2.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.295 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.691 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.12 62.5 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.62 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.441 ' C ' HG21 ' A' ' 33' ' ' VAL . 78.3 mtp -136.69 -112.68 0.18 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.385 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 61' ' ' SER . 2.5 t -134.67 155.7 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.66 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' HA2' ' ND2' ' A' ' 69' ' ' ASN . . . -79.8 70.16 2.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.107 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 12.0 tt0 -86.45 139.36 33.8 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.537 0.208 . . . . 0.0 110.77 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.552 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 52.2 Cg_endo -69.55 -24.14 30.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.542 2.162 . . . . 0.0 112.789 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.477 ' HB2' ' HG2' ' A' ' 35' ' ' GLU . 45.9 m -56.63 145.01 62.92 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.999 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.22 78.72 3.14 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.562 2.175 . . . . 0.0 112.256 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.771 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 6.0 t80 -137.59 -53.28 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.519 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.771 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 32.8 Cg_endo -63.59 -82.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.3 2.0 . . . . 0.0 112.491 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.843 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . . . -61.67 12.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.514 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -52.64 -31.65 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -73.81 -43.28 59.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.494 HG23 ' HB3' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -54.94 -45.05 74.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.11 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.91 -53.56 48.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.59 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 7.5 pt-20 -67.73 -10.38 52.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.648 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -73.79 -39.33 64.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.576 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.89 -48.96 70.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.604 -178.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 18.3 Cg_exo -65.89 -54.83 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 121.978 1.785 . . . . 0.0 111.387 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.62 18.22 0.13 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.907 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.576 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.7 157.52 0.37 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.924 0.392 . . . . 0.0 111.452 -179.324 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -138.52 -170.85 2.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.94 9.09 29.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.66 61.79 0.32 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.694 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -82.7 148.81 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 55' ' ' GLU . 29.6 mt -156.99 158.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.2 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.731 HD23 HG21 ' A' ' 70' ' ' ILE . 1.3 tp -160.58 142.11 12.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.656 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.698 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.981 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 30' ' ' LEU . 18.7 t -139.3 142.52 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.032 0.444 . . . . 0.0 111.739 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -146.91 109.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.169 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.599 ' HB2' ' HA ' ' A' ' 33' ' ' VAL . 93.4 p -150.57 -175.52 5.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.575 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.78 119.88 36.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 41.1 t -137.03 106.6 8.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.954 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -30.64 77.24 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.462 2.108 . . . . 0.0 112.196 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HB3' ' H ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -89.57 -162.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.408 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 8.5 t -108.61 -19.87 13.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 mt -55.8 119.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.061 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -74.67 137.48 42.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.911 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.5 ' ND2' ' HA2' ' A' ' 34' ' ' GLY . 49.3 t30 -73.25 -90.96 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.537 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.843 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 1.1 mm -48.38 -51.03 54.09 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.374 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.666 ' HG2' ' HD2' ' A' ' 93' ' ' TYR . 71.6 Cg_exo -52.59 -35.14 66.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.42 2.08 . . . . 0.0 113.186 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.4 tp -58.94 -41.04 86.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.494 ' HB3' HG23 ' A' ' 44' ' ' THR . 1.9 m-20 -62.08 -57.44 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.202 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.74 80.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.348 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -67.79 -31.5 71.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.91 -62.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.677 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -70.26 -37.29 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.06 107.84 3.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.946 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -110.24 -162.6 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.047 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.45 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 2.4 m -82.82 -74.76 0.34 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.159 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.605 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 23.3 t -116.59 122.0 68.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.436 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 95' ' ' ILE . 2.4 mm? -128.52 97.11 4.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.196 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.59 141.07 51.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.911 0.386 . . . . 0.0 111.326 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.74 161.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.247 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -148.01 156.15 42.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.652 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.06 151.67 45.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.912 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.34 -79.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.708 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.26 -89.74 0.17 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.136 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.403 ' C ' HG23 ' A' ' 90' ' ' THR . 95.5 Cg_endo -85.61 -2.4 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.691 2.261 . . . . 0.0 112.767 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 89' ' ' PRO . 2.1 p -136.91 -174.81 3.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.857 0.36 . . . . 0.0 111.1 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.474 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 2.5 tt -152.18 149.96 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 59' ' ' VAL . 8.0 tpt180 -123.21 133.28 54.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -123.81 146.61 48.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.466 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.516 HD23 ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -154.79 137.3 15.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.884 0.373 . . . . 0.0 111.737 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.689 HG22 HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.66 153.42 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.317 178.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.605 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.7 pt20 -154.03 169.45 23.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.287 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.573 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.9 tttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.884 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.775 0.322 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.03 -162.28 22.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.596 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.3 m -104.77 -46.07 4.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.911 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.26 -176.92 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.63 -53.58 49.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -136.65 133.15 35.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.931 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -89.12 -178.38 5.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -93.65 115.34 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -96.38 13.45 27.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -77.2 -173.7 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.8 m -97.25 77.52 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.51 -19.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.861 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.95 86.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.497 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.76 155.83 34.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.784 0.326 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.98 146.35 35.45 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.34 -43.92 0.63 Allowed 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.716 -1.369 . . . . 0.0 112.247 0.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.45 -178.25 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.24 -135.34 8.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.407 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.53 33.52 2.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.955 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -69.87 148.05 49.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.34 10.79 6.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.95 -23.02 13.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.54 59.01 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.45 ' O ' ' HG3' ' A' ' 52' ' ' LYS . 3.2 pt -134.55 -18.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.011 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.37 152.62 79.63 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.066 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.844 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 50.4 Cg_exo -56.72 -81.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.631 2.221 . . . . 0.0 112.409 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 4.6 p-10 41.9 67.57 0.56 Allowed 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 121.165 0.507 . . . . 0.0 110.565 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -102.97 154.96 18.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.4 118.04 27.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.955 -178.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.85 ' HB3' HG11 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -114.68 80.94 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.465 177.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.657 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 4.8 m-20 -102.44 65.34 0.93 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.465 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 61' ' ' SER . 11.7 mtt -136.83 -108.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.105 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.561 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.4 t -132.65 147.42 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.575 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -59.38 -14.58 27.62 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 119.985 -1.102 . . . . 0.0 111.754 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' H ' HG13 ' A' ' 33' ' ' VAL . 1.8 pt-20 -60.03 161.11 13.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 122.138 0.175 . . . . 0.0 110.757 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.18 77.01 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.397 2.065 . . . . 0.0 112.241 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.547 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -67.16 168.76 10.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.477 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.11 -42.95 56.28 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.215 1.943 . . . . 0.0 112.295 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -134.18 74.75 67.01 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.826 ' HA ' HD23 ' A' ' 30' ' ' LEU . 62.7 Cg_endo -96.29 -136.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.269 2.646 . . . . 0.0 112.65 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' A' ' 70' ' ' ILE . . . -54.71 -6.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG23 ' HD2' ' A' ' 40' ' ' PRO . 70.1 t -48.58 -32.1 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -72.56 -39.6 67.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.527 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.532 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.56 -47.5 85.23 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.94 179.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -57.97 -51.06 71.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 6.1 pt-20 -71.71 -13.23 61.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 43' ' ' ALA . . . -72.98 -27.38 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.111 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.513 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.8 mmm -47.68 -55.65 16.22 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.388 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 68.6 Cg_endo -73.77 -37.25 3.06 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.837 1.691 . . . . 0.0 111.609 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.7 2.39 6.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.262 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.513 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -47.22 152.92 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.895 0.379 . . . . 0.0 111.269 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.478 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 11.9 mmmt -135.65 -167.87 2.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -87.0 42.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 157.3 55.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.844 ' HB2' ' HG2' ' A' ' 26' ' ' PRO . 1.7 pt-20 -72.19 155.0 40.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.65 0.262 . . . . 0.0 111.0 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.2 mt -158.12 152.66 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.215 0.531 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.584 HD22 HG22 ' A' ' 70' ' ' ILE . 15.4 tp -143.9 156.64 44.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.567 178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -146.58 108.99 4.48 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.559 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 30' ' ' LEU . 57.4 t -121.93 127.55 75.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 1.4 t -129.05 100.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.267 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -125.9 -172.62 2.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.306 0.574 . . . . 0.0 111.978 -176.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.561 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -117.54 109.51 16.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.36 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 65.94 2.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.907 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.69 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.858 2.372 . . . . 0.0 112.147 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -92.89 23.22 4.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.193 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 m -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.747 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.512 HG22 ' ND2' ' A' ' 69' ' ' ASN . 11.6 mt -111.71 66.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.885 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.575 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 78.9 m-20 -99.77 51.22 0.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.396 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.801 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.95 118.21 10.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.649 -176.24 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 43.5 mm -51.22 -47.41 88.14 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.898 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.784 ' HB3' HG21 ' A' ' 95' ' ' ILE . 27.8 Cg_endo -60.82 -29.1 87.52 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.263 1.976 . . . . 0.0 111.841 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.801 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -55.14 -38.46 68.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.98 -45.09 95.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.585 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.657 ' HB3' HD12 ' A' ' 82' ' ' LEU . . . -68.07 -24.42 65.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -72.26 -36.56 69.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.339 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -63.88 -55.41 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.302 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -28.44 68.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 109.768 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.09 88.53 1.39 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.011 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.48 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.385 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 m -79.69 -87.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.826 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.449 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 91.8 t -113.14 127.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 111.234 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.657 HD12 ' HB3' ' A' ' 74' ' ' ALA . 2.8 mm? -123.58 107.35 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.472 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -123.55 159.33 29.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.623 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.933 HG21 ' HB3' ' A' ' 93' ' ' TYR . 28.4 pt -142.8 172.27 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 111.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.405 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -153.71 173.82 15.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.343 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -137.51 139.71 40.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.972 0.415 . . . . 0.0 111.365 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 57.0 m-20 -117.21 -137.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.241 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -73.63 -106.84 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.085 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -87.47 20.02 1.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.769 2.313 . . . . 0.0 112.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.441 HG21 ' OD1' ' A' ' 62' ' ' ASP . 41.7 p -138.57 173.73 11.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.988 0.423 . . . . 0.0 111.152 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.552 HG12 ' CE2' ' A' ' 93' ' ' TYR . 8.0 tt -136.71 130.15 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.287 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.638 ' HB2' HG11 ' A' ' 60' ' ' VAL . 1.5 ttm180 -123.18 136.44 54.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.138 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.933 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -128.02 164.84 21.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.921 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.37 153.37 31.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.784 HG21 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -136.62 155.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.796 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -155.2 170.58 21.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 111.478 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.673 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.9 tttp . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.435 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptp . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.24 160.39 43.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.437 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -102.85 -40.07 6.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.687 0.28 . . . . 0.0 110.932 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 m -122.34 -77.47 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.81 24.51 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.831 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.35 38.5 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.928 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -87.53 137.75 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -72.08 132.57 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -105.93 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.789 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.19 -73.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -121.77 8.88 10.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.72 138.61 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.53 22.22 38.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.511 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.87 -21.26 18.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 110.95 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.52 103.96 55.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.973 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.85 170.72 11.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.491 2.128 . . . . 0.0 112.307 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 159.81 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.26 156.33 48.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.464 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 m -131.2 103.95 6.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.74 25.16 5.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -98.85 -170.3 1.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -131.87 115.7 16.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.1 -176.39 6.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.6 pt -125.0 -1.73 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.28 143.62 34.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.931 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.678 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 39.6 Cg_exo -57.94 -80.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.664 2.243 . . . . 0.0 112.572 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 5.8 p-10 41.8 75.08 0.09 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.111 0.482 . . . . 0.0 110.961 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 4.7 m-85 -103.48 161.8 13.56 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -134.6 146.42 49.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.326 0.584 . . . . 0.0 112.489 -178.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.828 HD22 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -134.28 91.15 2.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.315 177.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.643 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 37.9 t0 -101.79 58.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.742 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.464 ' C ' ' HB3' ' A' ' 61' ' ' SER . 46.6 mtt -137.32 -110.53 0.18 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.644 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 62' ' ' ASP . 9.9 p -135.55 164.28 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.262 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.49 79.02 0.73 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.389 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.649 ' HG3' ' H ' ' A' ' 37' ' ' CYS . 4.8 pt-20 -100.77 160.86 25.62 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.489 0.185 . . . . 0.0 110.878 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.28 -11.42 31.93 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.763 2.308 . . . . 0.0 112.475 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.649 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -119.33 74.15 15.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.143 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HG3' ' HB2' ' A' ' 69' ' ' ASN . 84.3 Cg_endo -89.38 -169.32 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.821 2.348 . . . . 0.0 112.68 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.635 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . 5.4 t80 -140.21 -54.95 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.178 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.828 ' HG2' HD22 ' A' ' 30' ' ' LEU . 31.7 Cg_exo -65.25 -31.2 53.82 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.211 1.941 . . . . 0.0 112.536 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . . . -65.26 -17.5 64.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.357 0.598 . . . . 0.0 110.246 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' GLU . 55.0 t -57.67 -27.76 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.823 177.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.438 ' O ' ' HB1' ' A' ' 47' ' ' ALA . . . -73.56 -31.2 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.312 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.49 ' OG1' HG23 ' A' ' 70' ' ' ILE . 3.0 m -51.75 -68.13 0.19 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 48.8 mt -61.46 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.167 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 3.3 tt0 -65.3 -18.6 65.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.738 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 43' ' ' ALA . . . -72.28 -38.04 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.261 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.527 ' HE3' ' N ' ' A' ' 79' ' ' TYR . 1.2 mmt -46.16 -55.12 14.36 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.871 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 48' ' ' MET . 39.3 Cg_endo -66.39 -56.71 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.714 1.609 . . . . 0.0 111.756 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -73.56 18.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.807 179.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.522 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -44.55 151.37 0.27 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.773 0.321 . . . . 0.0 111.322 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -130.21 -179.61 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.19 61.63 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.834 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.72 43.49 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.678 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 0.9 OUTLIER -65.3 150.51 48.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 110.815 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.8 mt -154.03 156.11 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.426 HD23 HG21 ' A' ' 70' ' ' ILE . 9.5 tp -146.75 161.05 41.44 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.21 0.528 . . . . 0.0 111.201 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -150.48 140.03 21.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 177.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.84 144.34 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.013 0.435 . . . . 0.0 111.172 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.76 97.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.167 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.506 ' HB2' HD22 ' A' ' 68' ' ' ASN . 0.3 OUTLIER -151.06 179.33 8.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -178.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.446 ' O ' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.42 137.65 53.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 179.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 11.3 p -159.51 139.51 8.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.042 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.81 -12.87 36.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.675 2.25 . . . . 0.0 112.087 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -95.15 -160.84 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -113.54 -5.43 13.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.437 HG23 HD13 ' A' ' 72' ' ' LEU . 7.5 tt -130.6 149.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.238 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.506 HD22 ' HB2' ' A' ' 61' ' ' SER . 4.4 m-20 -112.81 -169.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.097 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.681 ' ND2' HG12 ' A' ' 70' ' ' ILE . 5.6 p-10 -72.57 -55.06 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.901 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.765 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -56.98 -51.18 83.61 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 31.9 Cg_endo -62.79 -41.51 30.0 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.428 2.085 . . . . 0.0 112.837 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.437 HD13 HG23 ' A' ' 67' ' ' ILE . 0.6 OUTLIER -60.01 -25.63 65.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.095 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 10.1 m-20 -71.58 -61.78 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.192 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.496 ' HB1' HD22 ' A' ' 82' ' ' LEU . . . -60.97 -38.95 87.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -65.15 -27.48 68.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -62.92 -69.05 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -14.78 61.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.34 96.4 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.493 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 33.7 t80 -82.98 -98.78 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.653 0.263 . . . . 0.0 110.904 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 79' ' ' TYR . 1.6 m -137.57 -77.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.893 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.524 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 25.8 t -109.99 114.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.187 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.57 HD21 HG23 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -123.23 101.77 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.348 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.69 158.5 31.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.635 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.425 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 33.0 pt -141.87 168.08 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 111.76 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 84' ' ' ILE . 3.7 mt-30 -152.4 155.64 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.483 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.39 141.92 45.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -109.74 -79.47 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.846 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.36 -97.51 0.46 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.087 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.31 6.88 5.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.243 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.1 p -135.89 172.21 13.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.037 0.446 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 61' ' ' SER . 4.0 tt -148.0 145.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.874 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 111.453 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.509 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 4.4 m-85 -131.68 130.76 42.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.72 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.57 HG23 HD21 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -133.94 157.24 41.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.387 178.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.524 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.73 157.43 39.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.625 ' HB2' ' HE2' ' A' ' 79' ' ' TYR . 3.0 tptp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.741 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.837 0.351 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.83 102.73 0.73 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.475 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.1 31.09 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 m -85.98 67.15 9.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -102.85 -170.63 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -67.6 142.81 56.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.82 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -67.05 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -91.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.46 157.61 35.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.031 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.44 21.45 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.893 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.68 126.33 39.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.007 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -134.33 28.66 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.76 -169.7 43.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -120.3 43.96 2.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.612 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 7.8 t -74.81 -51.56 3.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.549 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 24.5 Cg_exo -63.62 178.97 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.331 2.021 . . . . 0.0 112.199 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -94.39 -49.88 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.847 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.45 -153.21 7.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.467 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.41 -63.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 110.887 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.87 -71.3 0.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.403 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -93.74 174.65 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -133.54 80.12 1.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.888 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.83 -167.2 1.74 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.473 HD12 ' HB1' ' A' ' 47' ' ' ALA . 1.2 pt -64.78 165.79 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.076 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.2 141.79 27.71 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.551 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 12.0 Cg_endo -55.24 109.93 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.554 2.169 . . . . 0.0 111.798 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.65 ' HA ' HG21 ' A' ' 56' ' ' ILE . 11.4 t70 91.29 81.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.165 0.915 . . . . 0.0 111.343 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.673 ' HB3' HD13 ' A' ' 57' ' ' LEU . 9.9 t80 -103.92 168.31 9.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.707 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -134.61 130.4 36.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.812 ' HG ' HD12 ' A' ' 70' ' ' ILE . 1.9 tm? -123.06 78.67 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.41 -0.813 . . . . 0.0 108.973 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.634 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -102.06 70.12 1.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.762 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -136.7 -111.31 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 178.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.5 p -135.57 144.74 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.809 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -76.1 76.41 1.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.276 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.726 ' HG3' ' HB2' ' A' ' 37' ' ' CYS . 9.1 pt-20 -92.39 145.73 31.16 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.73 0.3 . . . . 0.0 111.138 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.549 ' HA ' HD22 ' A' ' 69' ' ' ASN . 49.5 Cg_exo -55.97 -22.98 41.01 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.724 2.283 . . . . 0.0 112.406 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.726 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 7.3 m -58.55 139.84 85.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.993 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.24 23.06 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.692 2.261 . . . . 0.0 112.607 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -77.84 -50.23 1.94 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' HB3' HD23 ' A' ' 30' ' ' LEU . 31.7 Cg_exo -60.5 -75.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.385 2.057 . . . . 0.0 112.461 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.68 4.7 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.485 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -48.16 -34.34 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 47' ' ' ALA . . . -73.18 -38.38 66.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.954 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.531 HG23 HD23 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -61.5 -57.63 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 9.8 mt -61.52 -54.23 45.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.48 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.35 -33.24 65.48 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.228 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -44.3 -61.49 1.49 Allowed 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.769 ' HE3' ' HA ' ' A' ' 74' ' ' ALA . 19.2 mtm -76.37 138.44 67.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 51' ' ' LEU . 63.0 Cg_endo -83.09 11.24 40.64 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.753 -0.936 . . . . 0.0 113.593 -10.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -71.91 16.54 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.135 -0.353 . . . . 0.0 111.664 -177.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD13 ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -71.12 179.28 2.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.352 . . . . 0.0 111.177 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -126.12 -148.15 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.553 ' HA ' ' HE2' ' A' ' 97' ' ' LYS . 18.8 mtmt -107.36 58.51 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 110.85 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' H ' ' HD3' ' A' ' 97' ' ' LYS . . . 126.36 93.05 0.87 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.624 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -124.1 -173.15 2.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.711 0.291 . . . . 0.0 110.984 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.65 HG21 ' HA ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -160.43 162.48 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.001 -179.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.673 HD13 ' HB3' ' A' ' 28' ' ' TYR . 15.2 tp -144.22 162.9 35.18 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.229 0.538 . . . . 0.0 111.398 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.454 ' H ' ' HG ' ' A' ' 57' ' ' LEU . 2.6 mt-10 -147.82 141.62 25.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.403 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.564 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 25.4 t -141.18 131.1 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 111.602 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.634 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 36.1 t -133.1 84.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.196 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -124.71 166.91 15.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.27 -178.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.38 135.76 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.494 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 19.3 p -159.25 143.31 11.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.134 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.95 -11.32 29.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.711 2.274 . . . . 0.0 112.046 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -93.08 -164.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -112.74 -17.52 12.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -117.68 153.49 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.505 ' ND2' ' HA3' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -125.81 177.81 6.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.067 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.549 HD22 ' HA ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -72.68 -42.48 64.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.936 -178.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.923 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -60.04 -49.82 89.27 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 50.5 Cg_endo -67.27 -43.46 6.12 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.189 1.926 . . . . 0.0 112.244 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.549 HD11 HG12 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -64.96 -32.58 74.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 3.8 m-20 -64.13 -57.6 9.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.769 ' HA ' ' HE3' ' A' ' 48' ' ' MET . . . -61.63 -39.55 91.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -62.6 -32.21 73.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.672 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -61.94 -67.89 0.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -33.28 72.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.575 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.14 95.03 1.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.04 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.87 -168.77 1.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.661 0.267 . . . . 0.0 110.285 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.783 HG21 HG23 ' A' ' 81' ' ' VAL . 96.7 m -77.26 -62.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.783 HG23 HG21 ' A' ' 80' ' ' THR . 21.8 t -127.44 132.34 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.334 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.717 HD12 HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -133.28 100.29 4.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.407 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.47 156.91 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.874 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.465 HD11 ' N ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.22 175.24 4.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.091 0.472 . . . . 0.0 111.804 -179.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.529 ' O ' HG13 ' A' ' 91' ' ' ILE . 17.1 mt-30 -154.04 166.95 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.439 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -145.4 145.46 31.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.877 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.6 -83.09 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.11 -97.27 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.202 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.15 5.92 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.52 2.147 . . . . 0.0 112.449 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -138.08 174.49 10.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 111.163 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.599 HG22 ' OH ' ' A' ' 93' ' ' TYR . 3.1 tt -145.17 144.19 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.741 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.56 138.39 54.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.928 0.394 . . . . 0.0 111.119 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.599 ' OH ' HG22 ' A' ' 91' ' ' ILE . 1.9 m-85 -123.86 149.47 45.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.205 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.39 138.39 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.926 0.393 . . . . 0.0 111.746 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.717 HG22 HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -129.34 161.34 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.534 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.706 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -152.07 145.7 24.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.676 ' HD2' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.718 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 120.793 0.33 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.95 -177.13 39.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.533 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.54 3.63 16.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 110.907 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -116.83 139.16 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -115.21 -70.12 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -139.46 98.69 3.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.745 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.72 3.81 5.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -82.98 -55.69 4.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -109.07 4.02 22.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.72 76.51 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.33 166.41 22.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.59 6.3 23.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.16 -152.48 11.79 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 mt -113.32 32.59 5.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 0.0 111.003 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.504 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 2.7 t -85.41 -51.15 0.52 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.619 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 47.2 Cg_endo -68.47 -57.83 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.226 1.951 . . . . 0.0 112.348 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -114.87 70.59 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.41 -163.07 9.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.546 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.81 111.04 17.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.779 0.323 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -80.37 131.9 35.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.65 111.52 13.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.975 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 172.93 4.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.75 -157.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.851 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.413 ' H ' HG13 ' A' ' 24' ' ' ILE . 0.8 OUTLIER -82.91 60.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.362 -179.647 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.05 115.61 10.21 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.052 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.59 161.45 94.39 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.423 -1.49 . . . . 0.0 112.422 0.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.89 -74.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.425 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -134.48 161.11 35.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 111.478 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -135.1 121.18 19.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.508 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -107.66 77.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.07 65.15 0.86 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.461 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -137.16 -104.93 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.05 178.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 33' ' ' VAL . 13.0 p -134.56 137.04 51.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.568 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -72.94 77.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.542 ' HG2' ' HB2' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -73.81 135.1 77.89 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.11 -14.89 9.45 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.696 2.264 . . . . 0.0 112.594 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' HB2' ' HG2' ' A' ' 35' ' ' GLU . 23.1 m -80.85 154.97 73.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.069 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.72 -32.89 78.07 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.694 2.263 . . . . 0.0 112.852 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.571 ' HB3' HG23 ' A' ' 42' ' ' VAL . 2.9 p90 -86.07 156.43 57.59 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.026 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 42' ' ' VAL . 3.0 Cg_exo -82.71 5.76 49.55 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 124.037 -1.235 . . . . 0.0 112.546 1.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 70' ' ' ILE . . . -59.48 1.94 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.916 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.571 HG23 ' HB3' ' A' ' 39' ' ' TYR . 59.8 t -51.18 -27.87 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.372 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -72.99 -36.83 67.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.697 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.7 m -57.46 -52.35 65.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.016 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 77' ' ' HIS . 4.5 tp -60.96 -63.13 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.1 -39.51 13.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.948 0.404 . . . . 0.0 110.406 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.23 -61.58 1.14 Allowed 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.458 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.501 ' HA ' HD21 ' A' ' 51' ' ' LEU . 3.3 mmt -76.97 138.85 65.39 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 51' ' ' LEU . 66.9 Cg_endo -83.27 13.79 34.04 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.643 -0.982 . . . . 0.0 113.336 -11.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 47' ' ' ALA . 35.8 mt-30 -70.41 10.55 0.45 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.177 -0.327 . . . . 0.0 111.824 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' A' ' 48' ' ' MET . 1.3 pt? -72.12 -177.35 2.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 14.7 mttm -121.72 -160.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.463 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -86.56 29.39 0.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.957 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.96 91.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.493 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.769 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -116.93 173.8 6.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.567 0.222 . . . . 0.0 110.755 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.704 HG13 ' O ' ' A' ' 55' ' ' GLU . 5.8 mt -159.22 157.53 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.235 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -143.66 161.51 38.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.092 0.472 . . . . 0.0 111.396 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.42 119.29 8.69 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.158 175.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.706 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 47.5 t -117.95 111.8 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 111.368 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 1.6 t -117.75 89.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 32' ' ' MET . 62.9 m -129.18 172.74 11.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.691 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.59 125.15 50.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 4.0 p -159.27 147.31 13.52 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.7 Cg_exo -71.3 -23.4 24.19 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.126 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -175.4 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.82 -32.28 11.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.45 ' HA ' ' HE2' ' A' ' 93' ' ' TYR . 1.5 tt -119.93 148.73 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.568 ' ND2' ' HA3' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -98.93 173.86 6.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.54 -22.05 61.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -67.65 -54.5 17.52 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 68' ' ' ASN . 21.2 Cg_exo -65.84 -35.39 35.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.277 1.985 . . . . 0.0 111.688 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -21.28 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.604 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -62.68 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.74 -39.78 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.482 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -56.53 -40.53 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.744 179.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -52.42 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.065 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.558 ' HB2' HD13 ' A' ' 45' ' ' LEU . 55.9 t-80 -68.3 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.114 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.14 98.06 0.11 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.845 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 82' ' ' LEU . 45.6 p90 -98.97 -166.02 1.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.488 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' A' ' 97' ' ' LYS . 1.4 m -125.83 -40.88 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.504 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.632 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 73.3 t -144.43 115.08 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.619 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.38 95.86 4.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.106 -178.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.97 163.27 21.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.3 pt -142.59 178.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 111.986 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.36 -172.09 4.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.243 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -144.56 142.41 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 111.226 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -118.03 -154.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.246 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -64.98 -99.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.107 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -90.74 16.31 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.744 2.296 . . . . 0.0 112.536 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -137.26 -170.72 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.001 0.429 . . . . 0.0 111.059 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.495 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt -143.19 147.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.605 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -123.79 142.87 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.063 0.459 . . . . 0.0 111.178 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.706 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.8 m-85 -131.39 155.79 46.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.564 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.7 143.93 20.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.613 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.619 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -134.98 158.62 41.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.236 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -154.11 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.769 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.1 tptp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.516 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mmm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.12 70.63 1.27 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.422 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -2.78 38.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.964 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -78.62 166.43 22.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -125.32 -74.82 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -134.33 166.85 21.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 128.27 50.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -79.67 101.49 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 33.93 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.96 95.08 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -112.07 -13.22 13.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 p -68.9 109.92 4.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.14 50.31 0.81 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.566 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.44 92.02 3.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.764 0.316 . . . . 0.0 110.86 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.89 131.41 83.05 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.64 135.15 47.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.426 2.084 . . . . 0.0 112.16 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -95.11 86.15 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.21 140.51 23.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.505 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 p -115.81 11.58 15.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 0.0 110.951 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.83 168.22 19.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.008 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.98 51.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -90.47 12.73 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.999 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -91.99 57.45 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.8 -61.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.0 m -112.51 122.47 36.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.836 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 82.7 Cg_exo -47.5 -84.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.708 2.272 . . . . 0.0 112.691 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' A' ' 58' ' ' GLU . 37.5 t0 58.03 78.42 0.24 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -103.78 136.55 43.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.758 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -103.52 135.68 44.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 112.384 -176.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.4 tm? -130.56 81.16 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.339 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.51 71.79 1.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.788 -176.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.86 -112.02 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.096 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 62' ' ' ASP . 47.9 t -134.87 133.31 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.69 103.43 0.32 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 5.2 tt0 -123.58 133.88 24.89 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.604 0.24 . . . . 0.0 110.96 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 35' ' ' GLU . 15.2 Cg_exo -69.84 -29.15 23.92 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.85 2.367 . . . . 0.0 112.526 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 m -55.55 144.04 55.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.137 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.32 81.43 1.76 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.545 2.164 . . . . 0.0 112.367 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.688 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -140.28 -53.62 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.3 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.688 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 62.7 Cg_endo -74.26 -72.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.205 1.937 . . . . 0.0 112.614 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.775 ' HB3' ' HA ' ' A' ' 70' ' ' ILE . . . -58.55 4.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 40' ' ' PRO . 54.1 t -52.91 -29.29 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 110.106 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.96 -34.0 66.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.639 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.26 -52.22 59.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.067 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.29 -57.6 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 47' ' ' ALA . 16.8 pt-20 -50.1 -40.57 46.14 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.53 -53.19 4.46 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.508 ' HA ' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.3 137.13 64.47 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 173.289 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' O ' HD21 ' A' ' 51' ' ' LEU . 65.0 Cg_endo -83.34 11.42 41.21 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.668 -0.972 . . . . 0.0 113.243 -11.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 47' ' ' ALA . 10.1 mm100 -73.02 25.9 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -72.46 -159.58 0.06 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -141.8 -155.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.448 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.675 ' H ' ' HD3' ' A' ' 52' ' ' LYS . 6.6 mttp -91.57 30.14 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.63 73.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.213 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.836 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -78.8 171.43 15.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 55' ' ' GLU . 61.5 mt -154.87 162.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.034 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.602 ' HG ' ' N ' ' A' ' 58' ' ' GLU . 4.3 tp -159.59 162.05 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.019 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.602 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -149.11 133.06 17.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.725 -176.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -139.25 132.23 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.849 0.356 . . . . 0.0 111.66 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -135.32 97.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.223 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.85 171.1 14.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.44 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.24 138.34 52.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.352 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.9 t -159.33 133.02 4.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.009 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.64 -30.9 86.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.558 2.172 . . . . 0.0 112.129 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -81.4 -170.91 3.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -112.35 -17.09 12.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.68 137.48 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -100.12 127.19 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.606 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.688 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -72.52 -58.71 3.16 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.493 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.775 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 15.3 mm -56.85 -54.05 58.39 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.671 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.2 Cg_exo -58.28 -32.94 97.1 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.331 2.021 . . . . 0.0 112.7 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 6.5 tp -61.51 -30.95 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.03 -58.05 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.068 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -63.51 -32.46 73.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.2 ttt-85 -68.87 -31.64 70.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -61.7 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.64 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -70.95 -24.66 62.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.309 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.7 103.37 1.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.994 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.39 -164.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.639 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 97' ' ' LYS . 2.6 m -72.77 -82.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.447 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 46.6 t -116.43 123.99 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.093 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -123.71 103.43 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.699 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.87 164.97 21.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.217 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.906 HG21 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -137.6 179.06 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.248 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.496 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.34 -177.0 6.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -150.37 138.87 20.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.053 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -122.57 -131.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.417 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.74 -123.66 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.167 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.7 29.89 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.915 2.41 . . . . 0.0 112.308 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.0 p -147.6 -177.8 5.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.506 HG12 ' CE1' ' A' ' 93' ' ' TYR . 14.3 tt -142.84 148.52 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.844 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.548 ' HB2' HG11 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -139.19 135.52 34.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.86 0.362 . . . . 0.0 111.257 -178.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.906 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.79 159.53 29.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.591 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.45 152.98 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 111.645 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.591 ' HB ' HD23 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -133.35 155.17 40.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.338 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.35 157.16 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.674 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 34.6 tttm . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.799 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 mtm . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.737 0.303 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.85 -16.53 10.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.436 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -75.38 81.95 2.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.75 -166.14 1.04 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.09 75.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -90.31 117.37 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.855 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -92.16 21.06 5.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.28 -64.19 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.977 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -171.96 3.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -89.6 162.84 15.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.83 162.98 13.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.8 p -108.74 72.81 0.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.35 24.96 7.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.85 129.87 49.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.952 0.406 . . . . 0.0 111.007 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.27 136.39 25.86 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.005 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.66 -41.98 7.55 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.601 2.201 . . . . 0.0 112.318 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -137.25 153.01 50.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.27 142.42 41.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.46 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.15 47.69 0.87 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.929 0.395 . . . . 0.0 110.911 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -87.33 -72.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.843 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.95 151.08 22.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.816 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 -78.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.053 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -140.11 116.66 10.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.119 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.518 HG23 ' HD3' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -107.14 -75.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 179.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 54' ' ' GLY . 5.0 m -86.12 136.09 36.39 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.48 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.584 ' HD3' ' HG3' ' A' ' 55' ' ' GLU . 72.1 Cg_endo -87.08 -68.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.526 2.151 . . . . 0.0 112.822 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.472 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.2 t0 50.29 65.07 1.55 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.656 ' HB3' HD12 ' A' ' 57' ' ' LEU . 1.4 t80 -105.33 137.63 42.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.8 -176.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.4 OUTLIER -103.89 131.73 50.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.48 -178.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.773 HD23 ' HA ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -123.76 86.79 2.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.047 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.644 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 41.8 t0 -102.27 64.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.8 mtp -136.66 -109.44 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.322 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 34' ' ' GLY . 10.9 p -133.93 143.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.975 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -74.09 94.29 0.79 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.46 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.802 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 16.3 tt0 -120.58 145.18 40.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.802 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 41.6 Cg_exo -26.69 -109.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.346 3.364 . . . . 0.0 114.639 -178.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 58.78 9.69 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.624 ' HG2' ' HD2' ' A' ' 40' ' ' PRO . 98.5 Cg_endo -89.75 -52.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.54 2.16 . . . . 0.0 112.366 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.823 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -140.94 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.794 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.823 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 6.6 Cg_endo -49.34 -94.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.808 2.338 . . . . 0.0 113.379 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.94 -0.68 0.09 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' A' ' 39' ' ' TYR . 3.0 t -52.22 -35.85 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.713 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.16 -36.74 72.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.602 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.456 HG22 ' CB ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.27 -42.57 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.196 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 1.2 tp -68.01 -55.62 11.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.329 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.651 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.23 -15.3 56.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.143 0.497 . . . . 0.0 110.754 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -74.63 -34.73 62.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.817 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.597 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.3 -47.83 87.38 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.461 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 14.8 Cg_exo -68.53 -51.55 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.006 1.804 . . . . 0.0 111.408 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -73.23 15.26 0.24 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.635 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.597 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -53.22 161.4 0.89 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 111.677 -178.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.518 ' HD3' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -153.2 -162.94 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.469 179.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -101.67 39.72 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 110.808 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.603 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . -174.94 67.81 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.438 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -110.17 152.92 25.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 111.414 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.4 mt -159.63 152.81 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.279 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' HB3' ' A' ' 28' ' ' TYR . 1.3 tp -160.67 137.73 9.08 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.147 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -118.75 137.93 53.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.091 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.599 HG11 ' HB3' ' A' ' 30' ' ' LEU . 15.2 t -139.9 150.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 0.0 112.359 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -154.95 100.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.752 178.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.7 m -144.07 167.92 21.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.958 0.409 . . . . 0.0 111.506 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.75 137.1 54.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.5 t -159.26 126.71 2.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.71 -12.99 36.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.385 2.057 . . . . 0.0 112.043 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HB3' ' H ' ' A' ' 66' ' ' SER . 35.0 mt-30 -86.02 -155.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 1.6 m -126.6 -56.51 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.302 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.63 74.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.0 110.964 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.598 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -136.47 5.08 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.067 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.542 HD21 HG22 ' A' ' 84' ' ' ILE . 2.8 m-20 -72.44 126.16 29.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.068 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 46.9 mm -53.83 -45.72 98.74 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.055 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 35.9 Cg_endo -63.6 -23.31 70.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.876 . . . . 0.0 111.772 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 2.4 mp -64.64 -31.3 72.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -46.49 80.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.595 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . . . -72.8 -29.94 63.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.364 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.604 ' HB2' ' HG ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -72.94 -52.54 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 19.1 t30 -50.52 -51.42 47.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.765 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -56.82 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.389 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.07 107.49 0.75 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.972 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -126.02 -135.85 0.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.558 0.218 . . . . 0.0 110.758 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.641 HG22 ' HA ' ' A' ' 97' ' ' LYS . 3.2 m -110.43 -78.66 0.59 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.798 0.332 . . . . 0.0 110.977 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.51 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 4.0 t -121.27 121.15 64.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.349 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.604 ' HG ' ' HB2' ' A' ' 75' ' ' ARG . 2.3 mm? -123.59 106.18 10.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -130.16 139.16 50.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.851 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.889 HG21 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -127.07 166.36 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.994 0.426 . . . . 0.0 111.571 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.42 142.88 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' H ' HE21 ' A' ' 86' ' ' GLN . 0.0 OUTLIER -123.89 152.78 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.855 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -121.62 -78.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.82 -99.97 0.59 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.67 5.61 6.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.606 2.204 . . . . 0.0 112.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 p -141.13 174.91 10.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.066 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.8 tt -149.85 134.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.615 ' HB2' HG11 ' A' ' 60' ' ' VAL . 2.1 ttt85 -123.81 130.64 52.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.889 ' HB3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -124.01 161.18 26.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.701 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.97 146.38 23.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.537 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.457 HG23 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -123.9 155.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.009 177.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.51 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.39 -170.56 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 111.343 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.641 ' HA ' HG22 ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.2 m80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.787 0.327 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -95.38 112.06 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -78.11 141.4 38.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.96 -26.28 11.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.14 161.32 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 m -104.49 143.26 33.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.22 103.85 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.613 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 22.6 t70 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.652 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -134.26 164.82 26.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 112.21 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.804 ' HG3' ' HB2' ' A' ' 58' ' ' GLU . 4.4 ttt-85 -134.38 114.09 12.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.938 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.692 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -109.6 77.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.537 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.472 ' HA ' ' H ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.64 67.62 0.9 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.49 -107.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.242 178.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 62' ' ' ASP . 85.3 t -134.9 139.99 46.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.504 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -66.75 89.13 0.15 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.389 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 110.858 -179.805 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.455 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 52.8 Cg_endo . . . . . 0 CA--C 1.53 0.276 0 N-CA-C 112.771 0.258 . . . . 0.0 112.771 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.829 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -55.89 -3.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.53 -29.01 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.343 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.76 -36.12 67.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.868 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -57.42 -54.14 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.091 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.33 -47.69 84.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.151 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 4.8 pt-20 -64.38 -20.29 66.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.749 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HB1' ' OE2' ' A' ' 55' ' ' GLU . . . -72.85 -30.23 63.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.12 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.559 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 6.3 mmm -51.33 -54.77 34.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.692 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 48' ' ' MET . 58.7 Cg_endo -70.61 -39.69 4.65 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.785 1.657 . . . . 0.0 111.687 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.09 7.07 2.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.336 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.31 152.13 0.46 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.608 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -134.91 -165.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.779 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -85.44 45.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.464 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.14 0.38 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.007 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.67 ' H ' ' HB2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -122.21 158.49 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.628 HG13 ' O ' ' A' ' 55' ' ' GLU . 10.9 mt -159.65 154.18 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.327 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.652 HD12 ' H ' ' A' ' 28' ' ' TYR . 3.5 tp -140.39 154.47 46.72 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.119 0.485 . . . . 0.0 110.834 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.804 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 3.8 mt-10 -141.6 111.98 6.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.692 HG13 ' HB3' ' A' ' 30' ' ' LEU . 49.0 t -118.39 123.13 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.745 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.472 ' H ' ' HA ' ' A' ' 31' ' ' ASP . 97.5 t -126.14 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.806 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -126.44 162.91 24.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.443 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.817 ' HB3' HG22 ' A' ' 90' ' ' THR . 1.4 p30 -118.16 132.04 56.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.709 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 142.53 17.05 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.077 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.93 -24.94 23.75 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.483 2.122 . . . . 0.0 112.138 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -83.58 -163.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -119.75 -24.85 6.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.67 138.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -88.72 127.21 35.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -72.56 -74.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.936 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.829 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 8.4 mm -50.64 -51.78 62.23 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 51.0 Cg_exo -55.94 -33.37 88.83 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.193 1.929 . . . . 0.0 112.628 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -61.06 -36.3 79.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.85 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 -57.35 10.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -60.63 -35.16 75.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.289 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -64.29 -35.62 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.06 -64.62 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -26.86 68.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.672 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.38 94.32 0.77 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.946 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -154.83 0.39 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.52 HG21 ' HE3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -90.79 -64.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.638 0.256 . . . . 0.0 111.04 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.688 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 2.7 t -125.42 122.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.35 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.551 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -126.72 104.61 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.791 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.59 157.88 39.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.116 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -139.95 166.08 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.0 tt0 -154.42 156.66 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.443 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.474 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -131.82 158.43 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -123.96 -79.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.14 -100.3 0.44 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.163 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.29 10.38 3.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.643 2.229 . . . . 0.0 112.327 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 62' ' ' ASP . 4.8 p -145.6 177.7 8.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 86' ' ' GLN . 18.0 tt -146.76 145.7 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 129.89 32.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.93 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.13 163.14 21.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.503 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -154.54 151.99 29.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.042 0.449 . . . . 0.0 111.596 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -134.56 162.64 38.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.243 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.688 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 3.4 pt20 -153.53 177.36 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.67 ' HB2' ' H ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.794 0.33 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -105.44 91.88 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.85 -67.95 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -99.02 165.28 11.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -113.91 111.18 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.36 101.8 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -64.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.012 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.63 -179.785 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 7.2 t0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.524 0.202 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.629 ' H ' HD12 ' A' ' 57' ' ' LEU . 4.2 m-85 -134.83 166.83 22.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 111.721 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 138.6 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.046 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.798 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -131.37 77.97 1.8 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.793 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -103.48 69.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.397 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 61' ' ' SER . 35.9 mtt -136.85 -111.85 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.121 0.486 . . . . 0.0 111.228 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 57.9 t -135.92 126.9 43.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.73 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -68.82 100.29 0.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.321 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.165 -179.562 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.798 ' HB2' HD21 ' A' ' 30' ' ' LEU . 1.9 Cg_endo . . . . . 0 CA--C 1.53 0.297 0 CA-C-O 120.615 0.173 . . . . 0.0 112.529 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -58.02 0.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.927 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.4 p -52.46 -25.12 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.307 0.575 . . . . 0.0 110.014 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.92 -36.8 67.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.646 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.628 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -53.18 -55.21 26.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.891 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -51.66 66.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -59.65 -21.6 60.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.14 -179.119 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.52 -34.05 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.566 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.4 mmm -49.24 -55.39 21.68 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.684 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 16.2 Cg_exo -67.73 -37.36 16.34 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.139 1.893 . . . . 0.0 111.882 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.71 4.29 4.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.516 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.639 HD13 ' HE2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -46.44 155.92 0.2 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.906 0.384 . . . . 0.0 111.536 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.63 -91.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.38 3.52 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . 157.57 99.21 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.781 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -103.09 -177.43 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 55' ' ' GLU . 4.4 mt -159.4 153.94 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.072 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.629 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -134.79 156.52 48.73 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.058 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.71 110.26 6.35 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.095 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 30' ' ' LEU . 98.8 t -117.71 124.61 73.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.472 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 87.5 t -131.91 96.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.6 p -130.41 176.63 7.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.773 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.502 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -117.31 131.39 56.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.299 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.415 ' SG ' ' HA3' ' A' ' 34' ' ' GLY . 70.0 m -143.84 130.88 10.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.12 4.51 4.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.48 2.12 . . . . 0.0 112.371 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -127.35 -159.99 0.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 t -111.14 -27.56 8.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mt -56.68 128.54 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.337 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.611 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -92.91 125.54 37.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -72.87 -73.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.179 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 41' ' ' ALA . 2.5 mm -46.28 -51.74 32.3 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.822 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 32.2 Cg_exo -60.57 -30.1 89.91 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.334 2.023 . . . . 0.0 112.725 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.4 tp -61.11 -33.02 72.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.811 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.6 4.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -59.63 -35.67 74.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.914 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -64.88 -37.12 86.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -58.08 10.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.741 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -64.72 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.37 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.57 82.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.997 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.435 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -86.34 -170.63 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.692 0.282 . . . . 0.0 110.636 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.435 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -76.89 -66.64 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.003 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 11.9 t -126.71 128.6 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.621 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -131.01 100.08 5.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.94 167.92 14.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.088 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.5 pt -137.59 -177.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.499 ' O ' HG13 ' A' ' 91' ' ' ILE . 3.5 mt-30 -154.51 178.65 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.33 142.21 26.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 0.0 111.306 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.29 -138.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.306 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.94 -116.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.163 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.54 27.08 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.616 2.211 . . . . 0.0 112.543 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.4 p -142.05 -177.69 5.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 111.036 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.523 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.1 tt -149.41 150.46 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.863 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.422 ' HB2' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -139.64 140.77 37.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.919 0.39 . . . . 0.0 111.368 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.93 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -127.88 144.9 51.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.129 178.349 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.32 150.91 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 111.481 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.621 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -131.85 157.4 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 178.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.705 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.8 pt20 -154.47 158.57 40.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 111.259 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.781 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 25.2 tttp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.745 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.746 0.308 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -132.83 111.75 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -136.43 179.17 6.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -67.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -121.11 46.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.11 40.83 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 m -122.43 60.77 1.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.404 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 33.8 t70 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.557 0.218 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.666 ' H ' HD12 ' A' ' 57' ' ' LEU . 5.8 m-85 -134.4 165.66 24.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.431 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -134.82 135.46 41.77 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.581 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.843 HD21 ' HA ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -125.89 76.74 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.273 178.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.52 66.64 0.88 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.948 0.404 . . . . 0.0 111.463 -178.415 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 61' ' ' SER . 2.3 mtt -137.06 -106.4 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.347 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 35' ' ' GLU . 11.7 p -134.12 142.55 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -61.53 -20.34 58.98 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.31 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 33' ' ' VAL . 6.8 tt0 . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.843 ' HA ' HD21 ' A' ' 30' ' ' LEU . 66.5 Cg_endo . . . . . 0 N--CA 1.459 -0.513 0 CA-C-O 120.663 0.193 . . . . 0.0 112.366 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.88 -4.16 0.28 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.968 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.25 -28.01 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.239 0.542 . . . . 0.0 110.024 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.41 -40.45 64.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.538 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.35 -54.14 49.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.066 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 16.4 mt -61.43 -49.31 77.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.138 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 pt-20 -65.29 -18.29 65.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.657 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.88 -29.2 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.952 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.593 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.95 -54.79 33.45 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.449 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.7 Cg_endo -69.64 -36.89 10.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.864 1.709 . . . . 0.0 111.586 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.91 5.74 3.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.6 161.76 0.12 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.958 0.409 . . . . 0.0 111.753 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -131.7 -95.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.813 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -14.75 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.804 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 178.86 92.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.184 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.776 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -99.25 -176.69 3.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 111.434 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.7 mt -159.61 154.62 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.204 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -136.69 156.2 48.85 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.13 0.491 . . . . 0.0 111.194 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -140.28 116.5 10.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.056 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.706 HG13 ' HB3' ' A' ' 30' ' ' LEU . 52.6 t -118.26 113.63 42.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.635 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 72.9 t -118.66 92.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.822 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.4 p -133.0 168.61 18.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.362 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.89 118.47 32.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.358 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.6 t -137.44 120.67 11.59 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.955 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.91 -25.6 70.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.519 2.146 . . . . 0.0 112.133 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -87.85 164.07 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -91.04 -22.8 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.002 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.24 118.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.367 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.99 118.2 14.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -72.68 -75.67 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.789 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 7.1 mm -48.57 -51.51 51.73 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.022 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.607 ' HB3' HD12 ' A' ' 82' ' ' LEU . 51.4 Cg_exo -57.21 -36.97 99.15 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.224 1.95 . . . . 0.0 112.849 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER -57.14 -33.42 67.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.884 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.75 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 2.1 m-20 -66.97 -58.67 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.034 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.553 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -61.13 -34.98 75.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.209 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -65.9 -36.12 82.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 -60.91 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -59.9 2.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.535 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.28 88.09 0.57 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.022 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -151.89 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.248 . . . . 0.0 110.343 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 97' ' ' LYS . 1.2 m -93.33 -75.34 0.5 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.577 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 48.1 t -120.4 123.06 69.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mm? -123.61 105.4 9.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.792 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -134.34 157.59 45.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 93' ' ' TYR . 35.4 pt -140.15 179.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.594 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -154.07 166.88 31.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 179.121 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -125.93 125.15 42.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 0.0 111.215 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.31 82.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.377 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.44 145.69 7.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.949 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -90.9 43.23 2.47 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.573 -1.428 . . . . 0.0 112.652 0.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.7 p -142.9 -172.21 3.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.872 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 85' ' ' GLN . 6.3 tt -149.53 142.59 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.855 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -123.93 133.03 53.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.173 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.514 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -123.66 148.15 46.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.745 178.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.98 151.72 28.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.949 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -136.17 158.34 38.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.222 178.185 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.577 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER -154.12 153.44 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.292 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.776 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 9.4 tttp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.793 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 p80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.793 0.33 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 133.84 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -100.89 -4.52 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.057 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -60.8 129.4 41.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -127.24 -177.36 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.63 165.61 19.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 t -116.44 -79.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.501 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.659 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 16.3 t70 . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.454 0.169 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.604 ' H ' HD12 ' A' ' 57' ' ' LEU . 25.2 m-85 -134.61 162.04 33.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 111.841 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 127.48 30.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.345 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.576 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -117.57 82.1 1.77 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.568 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.52 67.06 0.89 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.47 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.645 ' O ' ' HA ' ' A' ' 61' ' ' SER . 93.0 mtp -136.94 -109.85 0.19 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.251 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.19 150.34 29.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.524 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -84.66 55.77 5.0 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.472 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.0 110.785 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo . . . . . 0 N--CA 1.46 -0.48 0 N-CA-C 112.893 0.305 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -56.36 -8.54 0.53 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.439 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 49.4 t -46.9 -34.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.65 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.18 65.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.166 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.761 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -52.55 -50.41 62.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.47 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.84 -55.39 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.599 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 42.2 mt-10 -59.53 -19.27 47.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.46 -34.1 67.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.658 ' HG3' ' HB3' ' A' ' 77' ' ' HIS . 5.4 mmm -49.02 -55.77 18.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.213 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 22.0 Cg_exo -64.38 -37.49 39.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.995 1.797 . . . . 0.0 111.544 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 6.15 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.42 145.43 0.27 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -141.5 -168.81 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.631 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -87.56 23.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.03 97.93 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.464 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.727 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -130.58 155.44 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 0.0 110.819 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -159.6 158.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -145.51 158.57 43.82 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.001 0.429 . . . . 0.0 111.196 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 117.65 9.94 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.197 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 30' ' ' LEU . 41.6 t -118.42 115.26 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.549 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.9 t -119.41 88.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.138 0.494 . . . . 0.0 110.123 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -129.72 170.66 13.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.401 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.57 121.96 42.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.618 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -153.21 149.4 21.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 59.1 Cg_endo -72.01 -42.92 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.557 2.171 . . . . 0.0 112.426 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.51 155.24 40.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -64.39 -63.69 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.38 142.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.006 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 17.6 t30 -110.38 -176.2 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -72.52 -35.67 68.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.644 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.693 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm -69.17 -50.71 19.78 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 43.1 Cg_endo -66.56 -44.68 5.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.135 1.89 . . . . 0.0 112.368 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -30.88 71.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.013 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -60.46 3.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.736 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.761 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -62.0 -33.79 74.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -64.14 -29.98 71.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.544 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -66.95 -61.45 1.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.607 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.658 ' HB3' ' HG3' ' A' ' 48' ' ' MET . 0.1 OUTLIER -68.15 -20.41 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.648 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.61 93.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.817 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.417 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -91.56 -156.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 110.533 179.057 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.642 HG21 ' HD2' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -90.77 -64.23 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.767 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 40.4 t -128.76 120.8 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.276 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.541 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -123.56 102.58 7.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.394 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.86 160.37 27.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.887 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.527 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.6 pt -142.0 171.62 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.4 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.508 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.0 mt-30 -154.31 158.87 40.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.414 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -129.8 144.39 51.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.973 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -125.77 -121.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.481 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.02 -112.26 0.51 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.215 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.17 19.75 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.724 2.283 . . . . 0.0 112.477 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.3 p -138.29 -178.78 5.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 111.101 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 85' ' ' GLN . 5.4 tt -149.43 147.91 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.823 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -131.09 131.06 43.94 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.206 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -123.43 134.34 53.96 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.998 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.97 150.76 47.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.199 0.523 . . . . 0.0 111.806 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.541 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.15 156.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.188 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.767 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -146.98 172.16 14.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.936 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.727 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 12.1 tptt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.786 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 t60 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.775 0.321 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -120.33 15.47 12.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.22 -28.13 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.831 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.21 102.84 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -44.29 43.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.15 169.89 16.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 t -110.24 -27.85 8.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 20.9 t0 . . . . . 0 C--O 1.233 0.2 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -103.38 164.94 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.066 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 6.9 ttt180 -133.65 142.56 48.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.619 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.838 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.7 tm? -132.93 89.91 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.885 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.685 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.37 66.06 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.543 -177.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mtt -136.36 -111.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.323 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.769 HG13 ' H ' ' A' ' 35' ' ' GLU . 7.5 p -134.56 160.5 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -74.34 13.54 4.71 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.523 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.769 ' H ' HG13 ' A' ' 33' ' ' VAL . 3.2 tt0 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.56 0.219 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . 87.5 Cg_endo . . . . . 0 CA--C 1.531 0.347 0 N-CA-C 112.892 0.305 . . . . 0.0 112.892 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -60.65 -0.43 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.4 t -49.27 -36.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.05 -34.67 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.74 -47.23 86.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.272 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 44.6 mt -64.45 -47.05 80.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.359 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.4 -12.38 61.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 0.0 110.803 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.25 63.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.111 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.564 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -52.49 -46.92 95.0 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.804 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 15.8 Cg_exo -67.75 -59.51 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.919 1.746 . . . . 0.0 111.408 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -73.76 20.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.53 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.1 153.29 0.7 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.014 0.435 . . . . 0.0 111.61 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 -160.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.3 53.64 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.43 52.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.643 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.46 177.52 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.066 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -159.26 149.69 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.622 HD22 HG23 ' A' ' 44' ' ' THR . 16.0 tp -134.74 162.59 31.93 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.247 0.546 . . . . 0.0 111.095 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -147.56 136.45 22.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.487 176.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.838 HG13 ' HB3' ' A' ' 30' ' ' LEU . 41.1 t -141.5 138.71 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 111.752 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 97.6 t -140.42 107.95 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.769 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.2 -177.69 5.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.438 . . . . 0.0 111.797 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' HG22 ' A' ' 90' ' ' THR . 0.2 OUTLIER -118.01 120.87 39.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.783 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.37 108.16 2.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.64 -26.12 77.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.554 2.169 . . . . 0.0 112.277 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -73.02 -174.4 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -106.31 -27.7 10.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.94 133.72 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.555 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -95.19 136.11 35.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -72.58 -75.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.84 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 9.2 mm -46.4 -52.12 31.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.198 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 44.8 Cg_exo -58.97 -33.1 98.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.257 1.971 . . . . 0.0 112.613 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.2 tp -61.36 -29.23 69.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.96 0.409 . . . . 0.0 110.788 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.45 -52.5 21.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -69.26 -27.88 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -72.24 -36.04 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.709 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -64.21 -59.6 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -42.01 95.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.638 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 102.53 2.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.781 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.461 ' HB3' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -105.49 -106.11 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.869 HG22 HG23 ' A' ' 81' ' ' VAL . 55.4 m -140.52 -72.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.308 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.869 HG23 HG22 ' A' ' 80' ' ' THR . 53.2 t -117.17 118.26 58.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.344 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 71' ' ' PRO . 3.0 mm? -123.94 100.54 6.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.97 156.88 40.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.886 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -140.21 167.18 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.309 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -154.59 151.29 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -126.62 156.82 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.929 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.28 -84.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.797 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.14 -112.0 2.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.103 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.83 10.44 2.89 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.0 112.192 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.52 HG22 ' OD1' ' A' ' 62' ' ' ASP . 25.3 p -136.09 176.97 8.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.017 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.442 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.5 tt -151.38 142.9 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -127.91 142.25 51.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.116 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.886 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -123.51 155.82 36.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.32 143.08 20.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.463 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.596 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -129.16 161.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.556 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.684 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.3 pt20 -153.96 161.93 41.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.907 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.771 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.59 103.84 4.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 169.86 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 135.28 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -110.96 39.85 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.18 130.41 36.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.4 -23.05 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.446 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.777 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 36.0 t70 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.741 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.03 166.48 22.94 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 142.61 46.4 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 40' ' ' PRO . 1.4 tm? -134.53 84.39 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.535 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p-10 -104.06 69.13 0.93 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.451 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -136.52 -108.42 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 0.0 111.398 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.774 HG12 ' H ' ' A' ' 35' ' ' GLU . 58.1 t -134.38 142.29 41.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -12.5 11.46 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.198 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.774 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.379 0.133 . . . . 0.0 110.715 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 63.2 Cg_endo . . . . . 0 N--CA 1.458 -0.615 0 N-CA-C 112.805 0.271 . . . . 0.0 112.805 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.934 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.2 -4.38 0.35 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 p -47.62 -34.08 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 110.707 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.99 -39.7 65.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.228 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.644 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -53.41 -54.04 42.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 tp -62.04 -40.25 95.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.913 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.64 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -67.2 -20.54 65.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.567 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.7 64.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.62 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.78 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 19.1 mmt -48.47 -56.38 14.78 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 23.7 Cg_exo -62.62 -44.03 19.14 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.975 1.783 . . . . 0.0 111.288 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.25 12.53 0.56 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.585 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.48 148.59 0.14 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -174.92 4.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.941 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.22 32.91 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 176.03 101.54 0.15 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.415 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.834 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -135.93 158.55 44.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.789 0.328 . . . . 0.0 111.097 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.1 mt -159.62 156.96 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.431 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.741 HD12 ' H ' ' A' ' 28' ' ' TYR . 1.4 tp -147.98 159.05 44.3 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.183 0.516 . . . . 0.0 111.293 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.43 134.87 26.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.021 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 30' ' ' LEU . 38.9 t -134.09 123.91 45.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 111.326 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 77.9 t -127.5 94.46 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.77 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.7 p -135.39 170.23 16.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.221 0.534 . . . . 0.0 111.72 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -117.82 124.57 48.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.37 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 49.3 t -144.57 116.24 5.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.67 -30.39 92.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.575 2.183 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -77.91 -163.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -119.07 -24.21 6.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.169 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.35 122.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.774 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -80.14 124.45 28.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.54 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -73.89 -87.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.934 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 6.6 mm -46.45 -54.07 20.49 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.774 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -59.41 -26.29 81.42 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.071 1.847 . . . . 0.0 112.989 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.5 tp -65.55 -38.77 90.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.846 0.355 . . . . 0.0 110.841 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -49.54 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.62 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.644 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -71.51 -27.13 63.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -71.94 -34.99 69.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.28 -64.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.448 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 3.6 t-80 -64.68 -30.32 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.87 96.76 0.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.59 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' HB2' ' HE1' ' A' ' 48' ' ' MET . 0.4 OUTLIER -93.29 -104.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.639 0.257 . . . . 0.0 110.809 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -133.5 -69.05 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.32 . . . . 0.0 110.825 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.707 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 2.3 t -126.21 121.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 74' ' ' ALA . 3.8 mm? -123.37 104.85 9.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.401 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.9 156.99 46.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.691 0.282 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.25 173.21 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 111.588 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.55 ' O ' HG13 ' A' ' 91' ' ' ILE . 9.8 mt-30 -154.22 162.71 41.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -144.02 149.4 36.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.05 -81.77 0.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.15 -88.17 0.15 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.356 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.79 -1.28 9.49 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.754 2.302 . . . . 0.0 112.891 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -136.48 175.94 9.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.902 0.382 . . . . 0.0 111.189 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 85' ' ' GLN . 4.6 tt -146.81 143.46 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.63 135.22 53.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.278 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.465 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -123.51 145.34 48.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.31 148.58 25.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.212 0.53 . . . . 0.0 111.937 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -131.6 157.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.048 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.707 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -148.48 178.74 8.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.834 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 6.7 tptt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.689 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.864 0.364 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -77.99 -8.43 58.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.999 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.28 120.01 15.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.072 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.42 ' HB2' ' H ' ' A' ' 10' ' ' HIS . 1.7 p-80 -112.22 -160.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.42 ' H ' ' HB2' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -74.25 88.98 2.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -160.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.5 72.03 5.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.466 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.65 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.066 0 N-CA-C 111.391 0.145 . . . . 0.0 111.391 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.656 ' H ' HD12 ' A' ' 57' ' ' LEU . 10.9 t80 -134.44 164.67 26.94 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.56 141.88 46.8 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 30' ' ' LEU . 1.2 tm? -134.17 83.56 2.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.076 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.64 67.63 0.91 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.567 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 61' ' ' SER . 1.0 OUTLIER -136.5 -110.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 35' ' ' GLU . 34.5 t -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.448 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.9 -5.8 15.57 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.226 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.612 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.3 pt-20 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.486 0.184 . . . . 0.0 110.839 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HD2' HG23 ' A' ' 42' ' ' VAL . 83.3 Cg_endo . . . . . 0 N--CA 1.458 -0.593 0 CA-C-O 120.6 0.166 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -60.24 -5.24 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.535 HG23 ' HD2' ' A' ' 40' ' ' PRO . 32.7 t -47.02 -32.26 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.45 -44.54 57.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -47.69 -54.55 11.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 45' ' ' LEU . 15.4 mt -62.5 -58.24 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 26.8 mt-10 -60.07 -15.3 22.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 111.135 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.22 -38.49 68.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.535 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.7 mtp -47.91 -54.16 26.26 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.402 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 31.1 Cg_exo -60.51 -59.71 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.757 1.638 . . . . 0.0 111.357 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -73.8 23.74 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.87 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 48' ' ' MET . 1.3 pp -52.03 177.39 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 0.0 111.97 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.875 ' HG2' ' H ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -159.07 164.88 34.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.244 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -73.29 23.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 111.306 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.875 ' H ' ' HG2' ' A' ' 52' ' ' LYS . . . -168.83 69.12 0.16 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HG2' ' HB2' ' A' ' 27' ' ' ASP . 5.0 tm-20 -112.06 152.15 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -160.22 158.24 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.428 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 28' ' ' TYR . 2.5 tp -140.31 163.87 31.61 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.323 0.582 . . . . 0.0 111.156 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.95 128.52 13.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.957 175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.5 t -128.64 114.1 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.896 0.379 . . . . 0.0 111.462 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -118.28 96.5 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.15 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -137.14 172.84 12.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.608 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.432 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.3 p -159.11 140.33 9.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.218 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.77 16.75 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.606 2.204 . . . . 0.0 112.276 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -116.92 -165.83 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -72.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.5 mm -83.79 140.45 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.021 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 1.6 t30 -97.18 -179.16 4.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.69 -38.39 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.739 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm -67.79 -50.45 34.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 33.0 Cg_endo -62.58 -36.91 61.75 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.274 1.982 . . . . 0.0 112.244 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.17 -25.71 65.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -58.62 4.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -63.34 -36.32 83.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -63.51 -30.6 71.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -65.73 -70.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.402 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 1.5 t-80 -57.86 -35.54 71.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.765 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.41 79.89 1.49 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.55 -157.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 97' ' ' LYS . 2.9 m -72.5 -78.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.498 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.619 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 2.0 m -130.19 145.87 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.568 HD13 HG22 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -128.35 111.95 13.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.468 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -127.1 159.99 32.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.724 0.297 . . . . 0.0 110.958 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -140.79 -178.41 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.179 0.514 . . . . 0.0 111.69 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -154.5 -173.86 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.203 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -136.75 116.71 13.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 111.26 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.67 -176.75 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.673 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.8 117.41 1.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.755 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.502 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 82.7 Cg_endo -100.45 66.94 0.32 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 C-N-CA 124.318 -1.118 . . . . 0.0 112.653 0.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 p -147.81 -173.82 4.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 111.27 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.571 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tt -136.2 151.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.515 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.678 HH11 HD22 ' A' ' 94' ' ' LEU . 3.0 tpp85 -123.7 142.75 50.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.893 0.378 . . . . 0.0 111.762 -177.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.626 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 7.9 m-85 -136.54 117.55 14.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.078 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.678 HD22 HH11 ' A' ' 92' ' ' ARG . 0.4 OUTLIER -131.87 146.24 52.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 111.724 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -129.66 161.86 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.356 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.641 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -148.24 154.17 39.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.905 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.629 ' HA ' HG21 ' A' ' 80' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.33 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.35 90.12 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.91 -98.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.45 -165.01 1.83 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -99.87 148.28 24.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -82.7 120.47 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.3 39.75 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.093 0.473 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.16 160.39 14.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.598 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 10.1 ptt85 -128.53 129.42 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 0.0 111.94 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.705 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -122.23 77.27 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.525 177.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.3 p30 -101.91 68.14 1.12 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.728 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' SER . 10.5 mtt -137.13 -112.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.889 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.406 ' H ' ' HB3' ' A' ' 32' ' ' MET . 7.6 p -135.57 143.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.987 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 111.12 3.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.327 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.646 0.26 . . . . 0.0 110.946 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 42' ' ' VAL . 41.3 Cg_endo . . . . . 0 CA--C 1.53 0.299 0 CA-C-O 120.826 0.261 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.67 0.79 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 40' ' ' PRO . 14.4 t -48.69 -32.64 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.391 . . . . 0.0 110.567 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . . . -72.93 -37.94 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.632 HG23 HD22 ' A' ' 57' ' ' LEU . 1.9 m -58.07 -59.02 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.243 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.88 -32.56 67.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.73 -28.21 63.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 110.509 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.6 -26.94 61.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.402 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.529 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 32.6 mmt -53.72 -54.85 41.7 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.652 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 59.8 Cg_endo -71.01 -39.68 3.93 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.815 1.677 . . . . 0.0 111.595 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.91 6.91 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.07 150.48 0.58 Allowed 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.917 0.389 . . . . 0.0 111.252 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 54.2 mmtt -145.88 -159.31 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.445 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.02 16.49 4.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 65.35 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.877 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.724 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 20.8 tt0 -86.67 146.73 26.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.67 0.271 . . . . 0.0 110.406 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.2 mp -155.53 153.44 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 44' ' ' THR . 15.0 tp -142.85 164.99 28.59 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.305 0.574 . . . . 0.0 111.146 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -149.46 135.02 18.51 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 30' ' ' LEU . 15.4 t -137.85 132.31 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.11 0.481 . . . . 0.0 111.624 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.5 t -136.84 83.04 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.029 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.4 p -123.58 175.16 6.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.65 125.92 51.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.463 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 147.62 16.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.75 5.0 6.46 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.25 161.77 27.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.02 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.4 m -72.08 -52.27 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.67 143.73 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' H ' ' HG2' ' A' ' 71' ' ' PRO . 2.9 t-20 -134.3 -172.3 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -72.33 -47.49 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.765 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -59.52 -49.33 92.75 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 41.7 Cg_endo -66.47 -41.14 12.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.119 1.88 . . . . 0.0 112.505 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -21.27 64.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -62.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -57.41 -41.21 79.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.677 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.628 ' HA ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.957 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -66.75 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -59.39 4.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.563 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.74 100.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.463 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.651 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.8 p90 -90.41 -171.63 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 111.65 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.479 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 28.6 m -115.29 -49.72 2.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.08 176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.711 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 t -139.23 115.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.138 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.614 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -122.67 100.21 6.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -178.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.32 150.15 50.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.11 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.463 . . . . 0.0 111.626 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 91' ' ' ILE . 1.6 tm0? -145.44 171.34 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.65 126.43 46.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.165 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -174.16 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.47 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.07 121.96 2.11 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.709 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 78.4 Cg_endo -102.15 62.25 0.58 Allowed 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.759 1.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.3 p -148.87 -174.57 4.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.98 0.419 . . . . 0.0 111.534 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 85' ' ' GLN . 8.1 tt -142.38 145.53 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -123.74 146.56 48.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.108 0.48 . . . . 0.0 111.499 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 3.1 m-85 -132.02 131.05 42.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.017 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.33 143.74 46.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 111.402 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.614 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.43 157.06 39.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.682 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.711 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -154.47 166.03 34.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.724 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.6 tttp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.791 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.7 m80 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.768 0.318 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.2 -72.32 0.59 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.937 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -86.9 175.79 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -72.2 -175.87 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -46.04 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.02 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.32 -172.42 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.6 p -77.28 -170.08 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.52 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.646 ' HB3' HD12 ' A' ' 56' ' ' ILE . 5.0 p-10 . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 121.399 0.619 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.637 ' H ' HD12 ' A' ' 57' ' ' LEU . 52.7 t80 -102.53 147.0 27.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.7 mtt85 -104.9 135.88 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.2 tm? -134.54 82.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.327 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -103.13 66.77 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.9 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -136.29 -112.61 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.119 0.485 . . . . 0.0 111.266 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG22 ' OD1' ' A' ' 62' ' ' ASP . 6.4 t -135.01 152.46 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.794 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.78 -7.56 16.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.096 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.481 0.181 . . . . 0.0 110.841 179.561 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HA ' HD23 ' A' ' 30' ' ' LEU . 63.8 Cg_endo . . . . . 0 N--CA 1.457 -0.643 0 CA-C-O 120.645 0.185 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.883 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -59.52 -4.24 0.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 9.8 p -47.12 -33.38 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.46 -39.44 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.119 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 3.6 m -55.72 -55.3 33.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.834 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.567 ' O ' ' HE2' ' A' ' 48' ' ' MET . 95.2 mt -57.39 -52.7 64.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.272 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 5.9 pt-20 -68.55 -11.37 59.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.53 -39.57 67.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.458 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.567 ' HE2' ' O ' ' A' ' 45' ' ' LEU . 53.2 mtm -53.51 -53.7 53.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.65 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 48' ' ' MET . 53.4 Cg_endo -67.83 -52.08 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.677 1.584 . . . . 0.0 111.313 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -73.85 19.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.834 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -51.4 178.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.415 0.626 . . . . 0.0 111.795 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HD2' ' HE2' ' A' ' 53' ' ' LYS . 31.6 mmtt -149.0 -144.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HE2' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.45 26.73 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.313 . . . . 0.0 111.159 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 97' ' ' LYS . . . 126.12 84.19 0.52 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.613 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.591 ' N ' ' HB3' ' A' ' 97' ' ' LYS . 5.3 pt-20 -74.84 -179.81 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -159.91 -178.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.766 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.637 HD12 ' H ' ' A' ' 28' ' ' TYR . 6.5 tp -158.85 156.0 28.84 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.05 101.25 3.14 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.988 175.323 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 70' ' ' ILE . 1.4 p -119.32 131.54 71.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.822 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 12.2 t -132.47 111.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.194 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -143.02 177.44 8.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 0.0 111.419 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' HG22 ' A' ' 33' ' ' VAL . 5.1 p-10 -117.9 130.53 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 129.78 3.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.073 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.93 -17.79 22.17 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.527 2.151 . . . . 0.0 112.231 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.73 156.4 16.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.951 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -40.48 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 72' ' ' LEU . 1.5 mp -65.55 109.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.544 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -102.35 165.21 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.21 -75.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.883 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 2.4 mm -44.86 -53.3 16.09 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.544 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 22.8 Cg_endo -62.19 -39.31 49.24 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.959 1.772 . . . . 0.0 113.047 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.596 HD13 HG23 ' A' ' 67' ' ' ILE . 5.1 tp -65.5 -22.14 66.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 111.148 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.12 -58.38 3.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.87 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.854 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -60.14 -41.17 92.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.793 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -63.28 -31.6 72.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.41 -66.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.21 -64.19 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.15 104.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.62 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.854 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.8 p90 -90.64 -163.23 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.253 0.549 . . . . 0.0 111.466 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 2.2 m -115.22 -54.68 2.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.343 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.695 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.4 t -140.22 114.2 6.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.389 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.793 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.09 102.84 8.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -124.02 151.5 43.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.645 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.986 HG22 ' HB3' ' A' ' 93' ' ' TYR . 23.0 pt -136.08 165.1 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.407 . . . . 0.0 111.466 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -154.55 159.73 41.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -125.66 154.67 42.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.46 -85.13 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.786 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.52 -105.89 1.35 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.976 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.33 12.37 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.46 2.107 . . . . 0.0 112.086 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -140.8 179.44 6.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 93' ' ' TYR . 20.7 tt -146.88 144.26 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.574 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 136.45 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.986 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.93 159.93 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.181 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.08 146.88 24.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.793 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.98 160.67 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.669 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.695 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -153.95 156.53 37.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.942 0.401 . . . . 0.0 111.338 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HB3' ' N ' ' A' ' 55' ' ' GLU . 4.2 tptp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.583 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.787 0.327 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -84.51 158.65 20.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -64.51 149.25 48.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.992 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -126.11 156.18 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.83 104.93 16.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.996 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.98 157.32 16.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -119.68 -62.57 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.144 0 N-CA-C 110.343 -0.244 . . . . 0.0 110.343 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.5 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 3.4 t80 -135.54 164.28 28.18 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.996 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -134.66 113.73 12.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.848 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.804 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -109.05 81.93 1.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.51 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.58 68.91 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.471 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 61' ' ' SER . 16.4 mtt -136.24 -109.23 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.324 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 62' ' ' ASP . 21.7 t -134.73 138.68 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.9 70.22 2.33 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.425 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.525 0.203 . . . . 0.0 110.519 -179.747 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . 3.5 Cg_endo . . . . . 0 N--CA 1.461 -0.405 0 CA-C-O 120.8 0.25 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.848 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -52.85 -0.38 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' ' 40' ' ' PRO . 93.8 t -47.17 -30.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.63 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.61 64.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -54.87 -50.98 67.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.34 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.425 HD11 ' OD1' ' A' ' 73' ' ' ASP . 71.3 mt -61.77 -52.87 62.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.375 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -66.41 -13.38 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.137 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.62 -40.1 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.254 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 10.1 mtm -48.14 -52.99 37.18 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 51' ' ' LEU . 30.2 Cg_exo -60.5 -60.05 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.742 1.628 . . . . 0.0 111.434 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -74.61 24.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.954 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.54 -159.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 112.02 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.746 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -165.89 -174.7 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.191 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -83.4 36.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 150.58 102.76 0.25 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.489 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.908 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -124.48 177.74 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 55' ' ' GLU . 17.9 mt -159.47 161.7 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.5 ' CD1' ' HB3' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -160.67 130.25 4.99 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.472 -0.768 . . . . 0.0 111.423 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 1.2 mt-10 -118.71 118.36 31.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.765 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 30' ' ' LEU . 58.9 t -118.53 113.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.994 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.638 HG22 ' HE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -117.49 94.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 110.435 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -126.71 166.59 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.128 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' HB3' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -117.74 133.16 56.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.622 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 t -152.13 132.39 7.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.13 -18.04 24.15 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.488 2.125 . . . . 0.0 112.281 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.47 -162.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -117.64 -17.37 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mt -68.16 127.67 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.785 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -94.48 126.62 39.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.23 -82.43 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.848 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 7.3 mm -44.51 -54.82 11.45 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -61.25 -24.09 78.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.004 1.803 . . . . 0.0 112.921 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.8 tt -69.55 -33.46 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 45' ' ' LEU . 3.6 m-20 -66.41 -53.48 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -62.37 -36.29 81.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 75' ' ' ARG . 11.2 ttp180 -66.62 -33.13 74.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.81 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -60.58 -61.04 2.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.544 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 0.8 OUTLIER -67.74 -62.12 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 91.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.73 -164.21 1.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.0 110.345 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.588 HG21 ' HG2' ' A' ' 97' ' ' LYS . 24.3 m -82.35 -79.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 22.0 t -112.13 117.62 55.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.567 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.73 116.04 22.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -147.06 155.12 41.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.997 HG22 ' HB3' ' A' ' 93' ' ' TYR . 20.6 pt -135.1 170.25 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.004 0.431 . . . . 0.0 111.561 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.76 148.45 25.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.64 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.95 149.17 50.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.889 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -118.1 -83.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.19 -90.15 0.18 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.446 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.62 3.14 8.04 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.649 2.233 . . . . 0.0 112.812 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 62' ' ' ASP . 32.2 p -145.4 174.93 10.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.508 HG12 ' CE1' ' A' ' 93' ' ' TYR . 16.5 tt -144.43 139.8 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.836 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.638 ' HE ' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -124.01 132.7 53.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.348 -177.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.997 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.75 156.33 34.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.34 145.33 22.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 112.105 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.567 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -132.63 153.08 37.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.124 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.61 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.4 OUTLIER -154.6 175.26 13.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 111.235 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.908 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.77 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.795 0.331 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -119.93 119.79 34.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -110.82 179.75 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.81 96.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -88.12 167.62 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.985 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.0 p -71.99 -57.53 4.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -137.14 99.88 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.612 -179.798 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 56' ' ' ILE . 39.8 t0 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.575 0.226 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.837 ' H ' HD12 ' A' ' 57' ' ' LEU . 10.5 t80 -136.62 166.41 23.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.391 . . . . 0.0 111.758 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.56 105.99 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.802 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.705 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.1 tm? -103.83 81.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.7 m-20 -103.62 66.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.149 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.24 -105.83 0.21 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.0 t -134.33 148.82 29.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.499 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -81.54 55.58 4.86 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.621 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.531 0.205 . . . . 0.0 110.759 179.825 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . 23.6 Cg_endo . . . . . 0 CA--C 1.531 0.359 0 N-CA-C 113.337 0.476 . . . . 0.0 113.337 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.786 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -56.87 -2.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 5.4 t -45.49 -35.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.6 -46.57 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.275 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 74' ' ' ALA . 54.7 m -49.44 -46.93 48.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.623 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 45' ' ' LEU . 19.3 mt -63.48 -57.38 10.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.282 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 mm-40 -64.76 -10.58 28.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.014 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -73.67 -40.37 63.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.154 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -51.97 -47.67 90.54 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.991 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.3 Cg_endo -69.98 -51.76 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.711 1.607 . . . . 0.0 111.759 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 14.3 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.401 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.15 156.06 0.18 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.999 0.428 . . . . 0.0 111.868 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -125.75 -164.91 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -88.32 40.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.844 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.4 113.27 1.52 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.29 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.893 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 15.8 pt-20 -135.3 -177.05 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -161.04 152.08 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.272 0.558 . . . . 0.0 111.141 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.837 HD12 ' H ' ' A' ' 28' ' ' TYR . 4.7 tp -127.02 158.98 35.5 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -144.35 107.77 4.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.196 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 30' ' ' LEU . 45.5 t -117.57 112.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.616 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 90.6 t -118.59 94.73 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.694 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.2 p -125.5 171.83 10.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.897 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -118.04 122.6 43.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.581 179.512 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.24 131.27 8.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.971 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.48 -8.65 18.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.596 2.198 . . . . 0.0 112.314 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -97.0 -167.32 1.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.957 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.38 -26.09 8.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 mt -66.85 123.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.76 130.4 37.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.843 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.62 -70.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.101 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.786 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 2.8 mm -49.64 -52.49 50.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.1 Cg_exo -57.61 -43.25 52.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.272 1.981 . . . . 0.0 112.87 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.34 -21.98 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.203 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -71.99 -57.88 3.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.95 -41.7 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.708 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.17 -33.75 75.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.006 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.26 -61.08 2.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.569 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.598 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 8.9 m170 -72.37 -69.08 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.19 103.94 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 51.3 p90 -92.93 -162.4 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.126 0.488 . . . . 0.0 111.328 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.466 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -113.25 -52.75 2.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.258 176.129 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.834 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 48.1 t -143.95 118.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.171 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.683 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -122.95 115.18 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.964 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.15 155.46 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.952 HG22 ' HB3' ' A' ' 93' ' ' TYR . 19.4 pt -133.05 167.1 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.479 . . . . 0.0 111.601 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 91' ' ' ILE . 30.6 tt0 -154.63 165.44 36.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.413 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -132.1 147.33 52.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.798 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -107.85 -81.4 0.56 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.636 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.31 -92.53 0.22 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.815 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.33 3.66 7.14 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.803 2.336 . . . . 0.0 112.033 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' OD2' ' A' ' 62' ' ' ASP . 25.0 p -136.47 -178.24 5.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.7 tt -143.34 151.1 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -140.03 131.79 27.44 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.815 0.341 . . . . 0.0 111.302 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.952 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.05 140.46 53.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.246 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.87 157.01 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.683 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.22 162.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.614 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.834 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.79 155.6 34.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.893 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.502 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.847 0.356 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.13 148.63 48.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -118.01 -165.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -69.38 164.29 23.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.92 -179.82 4.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 p -119.44 88.12 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -118.4 65.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.473 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.556 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 27.6 t70 . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.471 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.91 168.42 19.36 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.651 -0.819 . . . . 0.0 112.656 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 13.2 mtp180 -134.82 118.01 16.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.721 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.016 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -116.47 78.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.947 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.9 67.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.391 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 61' ' ' SER . 15.5 mtt -136.46 -110.65 0.19 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 111.504 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 62' ' ' ASP . 84.8 t -135.41 122.95 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.79 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.429 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . -68.13 92.48 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.228 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.44 0.162 . . . . 0.0 110.709 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 1.016 ' HB2' HD21 ' A' ' 30' ' ' LEU . 4.1 Cg_exo . . . . . 0 CA--C 1.529 0.265 0 N-CA-C 112.629 0.204 . . . . 0.0 112.629 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.595 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -55.34 -2.55 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.946 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' A' ' 40' ' ' PRO . 79.2 t -51.91 -28.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.046 0.45 . . . . 0.0 110.05 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -70.57 -38.74 74.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.23 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.544 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -58.51 -46.35 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.944 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 73' ' ' ASP . 1.2 tp -67.79 -39.26 84.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.783 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.556 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 2.5 pt-20 -72.12 -17.29 61.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.648 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.56 -36.75 68.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.875 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.659 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 22.0 mtp -49.6 -54.14 34.14 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.383 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 18.3 Cg_exo -65.45 -45.61 6.8 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.021 1.814 . . . . 0.0 111.485 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -73.23 12.78 0.51 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.55 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.643 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.56 159.1 0.1 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.09 0.471 . . . . 0.0 111.935 -179.289 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -142.6 -160.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.631 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -86.78 33.51 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.2 114.96 0.71 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.305 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.814 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -121.17 166.75 13.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.645 0.26 . . . . 0.0 110.907 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 55' ' ' GLU . 10.6 mm -159.22 149.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -160.69 131.12 5.28 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.907 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -121.73 132.93 54.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.551 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.48 126.63 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.585 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 2.2 t -125.75 101.53 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.0 m -142.41 169.82 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.231 0.539 . . . . 0.0 112.073 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.16 129.2 55.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.196 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 68' ' ' ASN . 30.5 p -156.83 136.52 8.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.333 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.92 -25.65 8.76 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.461 2.107 . . . . 0.0 112.263 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.35 -162.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -140.12 10.37 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.859 ' HA ' HD13 ' A' ' 72' ' ' LEU . 44.5 mm -111.35 -26.9 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.89 0.376 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 63' ' ' CYS . 7.6 m120 -52.1 -12.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.534 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.875 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 1.9 m-20 -50.9 119.34 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.539 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.724 HG12 HG21 ' A' ' 59' ' ' VAL . 22.7 mm -51.65 -49.93 80.16 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.311 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 36.9 Cg_exo -62.0 -22.32 74.04 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.139 1.893 . . . . 0.0 111.965 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.875 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -62.4 -39.34 92.92 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.108 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.508 ' HB3' HD13 ' A' ' 45' ' ' LEU . 14.2 m-20 -59.75 -45.56 91.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 79' ' ' TYR . . . -70.46 -23.33 62.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.607 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -38.54 66.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.537 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -56.53 -58.72 6.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.457 ' HB2' ' SD ' ' A' ' 48' ' ' MET . 73.6 m80 -69.36 -45.16 70.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.322 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.16 87.88 1.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.162 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -87.7 -140.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -97.85 -72.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.807 0.337 . . . . 0.0 110.991 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 26.3 t -127.68 123.63 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.4 mm? -123.44 101.65 7.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.91 158.3 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.473 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.935 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -138.82 172.06 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 91' ' ' ILE . 26.3 mt-30 -154.36 156.33 36.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.215 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 152.53 51.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.791 0.329 . . . . 0.0 111.22 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -122.72 -78.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 89' ' ' PRO . . . -139.99 -106.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HD3' ' HA3' ' A' ' 88' ' ' GLY . 2.8 Cg_exo -75.84 10.04 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.71 2.274 . . . . 0.0 111.949 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 67.7 p -138.98 170.73 15.44 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.9 tt -150.93 136.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.046 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -127.93 140.43 52.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.326 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.935 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -123.66 166.19 15.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.947 178.229 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.44 144.8 21.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.525 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -129.25 149.57 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.388 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.444 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 5.4 pt20 -142.94 155.92 44.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.791 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 10.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.815 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.685 0.279 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -140.14 -163.52 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.933 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -74.43 -169.76 0.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.44 17.47 4.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.037 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -72.34 117.98 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -123.67 -178.8 4.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.025 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.18 153.28 32.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.45 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.418 0.151 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.59 ' HB2' HD11 ' A' ' 57' ' ' LEU . 62.8 m-85 -134.17 160.83 36.62 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.81 0.338 . . . . 0.0 111.638 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 144.71 46.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.837 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.622 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.1 tm? -134.3 81.41 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.514 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.0 p-10 -103.22 65.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.89 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 61' ' ' SER . 6.2 mtp -137.2 -105.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 32' ' ' MET . 2.4 t -134.93 156.79 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.381 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.54 -9.6 13.49 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.198 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 C--N 1.329 -0.283 0 C-N-CA 122.122 0.169 . . . . 0.0 110.987 179.708 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 42' ' ' VAL . 74.0 Cg_endo . . . . . 0 N--CA 1.457 -0.627 0 CA-C-O 121.071 0.363 . . . . 0.0 112.144 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -64.75 6.97 0.18 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.471 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.4 p -53.29 -27.48 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.457 . . . . 0.0 110.178 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.574 ' HB1' ' CG ' ' A' ' 28' ' ' TYR . . . -73.44 -37.28 65.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.705 178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 74' ' ' ALA . 2.8 m -54.23 -63.72 1.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.321 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.453 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 20.9 mt -56.29 -38.22 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.275 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 4.9 tt0 -64.55 -28.76 69.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.639 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB2' ' CD2' ' A' ' 28' ' ' TYR . . . -73.08 -24.21 60.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.744 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 38.6 mmt -57.2 -55.88 39.59 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.703 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 11.7 Cg_exo -70.45 -44.49 1.58 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.117 1.878 . . . . 0.0 111.554 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.86 8.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.382 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -44.0 154.39 0.11 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.98 0.419 . . . . 0.0 111.552 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -124.33 -157.71 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.836 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -78.02 8.44 4.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.133 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' OXT' ' A' ' 97' ' ' LYS . . . 160.78 82.09 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.804 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -81.91 172.34 13.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 55' ' ' GLU . 4.5 mt -160.27 155.97 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 28' ' ' TYR . 1.1 tp -139.59 161.17 38.17 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.019 0.437 . . . . 0.0 111.247 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -143.18 113.17 7.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -118.12 114.97 46.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.395 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 61.1 t -119.05 94.24 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.09 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -130.75 173.69 10.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.521 . . . . 0.0 111.771 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.401 ' OD2' HG22 ' A' ' 90' ' ' THR . 0.7 OUTLIER -117.43 130.85 56.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.337 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.54 117.45 3.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.93 -17.83 61.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.679 2.253 . . . . 0.0 112.09 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -108.85 -163.49 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 t -102.57 -18.46 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -69.98 130.56 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -137.09 129.73 30.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.294 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.33 -48.73 69.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.73 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -56.96 -55.73 40.82 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.53 ' HA ' HD11 ' A' ' 82' ' ' LEU . 28.8 Cg_endo -62.57 -33.6 77.57 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.644 1.563 . . . . 0.0 112.201 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -29.46 68.93 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -57.39 12.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.719 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -66.51 -37.73 85.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 29.9 ttt-85 -63.43 -54.98 28.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.592 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -47.88 -55.01 10.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.214 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -70.13 -71.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.532 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.99 98.74 0.15 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.707 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.6 p90 -88.78 -165.35 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 0.0 111.406 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.594 HG21 ' HD2' ' A' ' 97' ' ' LYS . 39.5 m -112.16 -52.24 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.057 175.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 41.3 t -141.84 116.6 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -122.53 105.01 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.619 -178.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -123.66 163.62 20.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.648 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.882 HG22 ' HB3' ' A' ' 93' ' ' TYR . 15.5 pt -139.91 168.3 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.431 . . . . 0.0 111.433 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.5 mt-30 -154.42 155.76 35.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.39 154.4 50.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -123.45 -80.56 0.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.63 -97.52 0.36 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.406 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 9.55 3.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.401 HG22 ' OD2' ' A' ' 62' ' ' ASP . 47.5 p -146.37 176.4 9.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.955 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.0 tt -145.04 140.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.654 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 92' ' ' ARG . 3.7 ttm-85 -133.2 132.55 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.882 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.39 164.7 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.829 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.92 158.6 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.904 0.383 . . . . 0.0 111.443 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -134.47 162.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.922 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.778 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -154.5 156.21 36.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.629 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 172.29 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.81 44.06 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.19 -70.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -112.44 53.03 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -68.17 -73.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.991 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.18 111.97 20.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.978 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.856 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 56' ' ' ILE . 26.2 t0 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.591 ' HB2' HD12 ' A' ' 57' ' ' LEU . 1.8 m-85 -107.98 141.9 38.92 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.308 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 7.8 mtp85 -111.46 137.33 49.41 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.844 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.7 tm? -126.71 89.12 2.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.295 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.708 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.12 62.5 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.62 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 78.3 mtp -136.69 -112.68 0.18 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.385 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.621 ' HA ' ' HB2' ' A' ' 61' ' ' SER . 2.5 t -134.67 155.7 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.66 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.8 70.16 2.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.107 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.537 0.208 . . . . 0.0 110.77 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 42' ' ' VAL . 32.8 Cg_endo . . . . . 0 CA--C 1.53 0.278 0 CA-C-O 120.869 0.279 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.989 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -61.67 12.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -52.64 -31.65 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.81 -43.28 59.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -54.94 -45.05 74.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.11 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.91 -53.56 48.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.6 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 7.5 pt-20 -67.73 -10.38 52.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.648 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -73.79 -39.33 64.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.582 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.89 -48.96 70.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.604 -178.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.6 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 18.3 Cg_exo -65.89 -54.83 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 121.978 1.785 . . . . 0.0 111.387 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.62 18.22 0.13 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.907 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.7 157.52 0.37 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.924 0.392 . . . . 0.0 111.452 -179.324 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -138.52 -170.85 2.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.94 9.09 29.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.66 61.79 0.32 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.654 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -82.7 148.81 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 55' ' ' GLU . 29.6 mt -156.99 158.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.2 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.685 HD21 HG21 ' A' ' 70' ' ' ILE . 1.3 tp -160.58 142.11 12.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.656 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.714 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.981 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.844 HG13 ' HB3' ' A' ' 30' ' ' LEU . 18.7 t -139.3 142.52 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.032 0.444 . . . . 0.0 111.739 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -146.91 109.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.169 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.621 ' HB2' ' HA ' ' A' ' 33' ' ' VAL . 93.4 p -150.57 -175.52 5.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.575 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.78 119.88 36.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 41.1 t -137.03 106.6 8.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.954 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -30.64 77.24 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.462 2.108 . . . . 0.0 112.196 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HB3' ' H ' ' A' ' 66' ' ' SER . 0.9 OUTLIER -89.57 -162.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 8.5 t -108.61 -19.87 13.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 mt -55.8 119.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.061 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -74.67 137.48 42.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.911 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -73.25 -90.96 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.537 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.989 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -48.38 -51.03 54.09 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.374 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.673 ' HG2' ' HD2' ' A' ' 93' ' ' TYR . 71.6 Cg_exo -52.59 -35.14 66.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.42 2.08 . . . . 0.0 113.186 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.4 tp -58.94 -41.04 86.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.08 -57.44 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.202 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -62.34 -35.74 80.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.348 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -67.79 -31.5 71.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.91 -62.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.677 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -70.26 -37.29 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.06 107.84 3.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.946 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.458 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -110.24 -162.6 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.047 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.458 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 2.4 m -82.82 -74.76 0.34 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.159 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 23.3 t -116.59 122.0 68.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.436 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 71' ' ' PRO . 2.4 mm? -128.52 97.11 4.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.196 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.59 141.07 51.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.911 0.386 . . . . 0.0 111.326 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.74 161.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.247 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -148.01 156.15 42.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.652 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.06 151.67 45.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.912 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.34 -79.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.708 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.26 -89.74 0.17 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.136 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.61 -2.4 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.691 2.261 . . . . 0.0 112.767 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p -136.91 -174.81 3.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.857 0.36 . . . . 0.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 85' ' ' GLN . 2.5 tt -152.18 149.96 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.608 ' HD2' ' O ' ' A' ' 59' ' ' VAL . 8.0 tpt180 -123.21 133.28 54.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.727 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -123.81 146.61 48.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.466 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.79 137.3 15.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.884 0.373 . . . . 0.0 111.737 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -131.66 153.42 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.317 178.171 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.7 pt20 -154.03 169.45 23.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.287 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.9 tttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.884 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 p80 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.802 0.334 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -89.12 -178.38 5.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -93.65 115.34 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -96.38 13.45 27.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -77.2 -173.7 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.8 m -97.25 77.52 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.51 -19.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.861 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.497 179.84 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 121.165 0.507 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -102.97 154.96 18.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.4 118.04 27.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.955 -178.243 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.782 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -114.68 80.94 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.465 177.258 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.674 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 4.8 m-20 -102.44 65.34 0.93 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.465 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' SER . 11.7 mtt -136.83 -108.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.105 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.589 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.4 t -132.65 147.42 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -59.38 -14.58 27.62 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 119.985 -1.102 . . . . 0.0 111.754 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.432 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.8 pt-20 . . . . . 0 C--N 1.33 -0.277 0 C-N-CA 122.138 0.175 . . . . 0.0 110.757 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' HD21 ' A' ' 30' ' ' LEU . 62.7 Cg_endo . . . . . 0 N--CA 1.457 -0.648 0 CA-C-O 120.76 0.233 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 70' ' ' ILE . . . -54.71 -6.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.523 HG23 ' HD2' ' A' ' 40' ' ' PRO . 70.1 t -48.58 -32.1 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.56 -39.6 67.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.527 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.612 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.56 -47.5 85.23 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.94 179.375 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -57.97 -51.06 71.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 6.1 pt-20 -71.71 -13.23 61.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.98 -27.38 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.111 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.519 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.8 mmm -47.68 -55.65 16.22 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.388 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 68.6 Cg_endo -73.77 -37.25 3.06 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.837 1.691 . . . . 0.0 111.609 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.7 2.39 6.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.262 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -47.22 152.92 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.895 0.379 . . . . 0.0 111.269 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 11.9 mmmt -135.65 -167.87 2.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -87.0 42.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 157.3 55.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.727 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 1.7 pt-20 -72.19 155.0 40.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.65 0.262 . . . . 0.0 111.0 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.2 mt -158.12 152.66 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.215 0.531 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 tp -143.9 156.64 44.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.567 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -146.58 108.99 4.48 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.559 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.782 HG13 ' HB3' ' A' ' 30' ' ' LEU . 57.4 t -121.93 127.55 75.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 1.4 t -129.05 100.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.267 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -125.9 -172.62 2.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.306 0.574 . . . . 0.0 111.978 -176.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.589 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -117.54 109.51 16.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.36 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 65.94 2.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.907 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.69 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.858 2.372 . . . . 0.0 112.147 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -92.89 23.22 4.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.193 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 m -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.747 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.71 66.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.885 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.605 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 78.9 m-20 -99.77 51.22 0.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.396 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.835 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.95 118.21 10.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.649 -176.24 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 43.5 mm -51.22 -47.41 88.14 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.898 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.673 ' HB3' HG22 ' A' ' 95' ' ' ILE . 27.8 Cg_endo -60.82 -29.1 87.52 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.263 1.976 . . . . 0.0 111.841 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.835 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -55.14 -38.46 68.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.98 -45.09 95.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.585 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.612 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -68.07 -24.42 65.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 15.6 ttt-85 -72.26 -36.56 69.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.339 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.88 -55.41 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.302 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -28.44 68.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 109.768 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.09 88.53 1.39 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.011 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.577 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -96.48 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.385 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.606 HG21 ' HA ' ' A' ' 97' ' ' LYS . 12.6 m -79.69 -87.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.826 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 80' ' ' THR . 91.8 t -113.14 127.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 111.234 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.8 mm? -123.58 107.35 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.472 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -123.55 159.33 29.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.623 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.945 HG22 ' HB3' ' A' ' 93' ' ' TYR . 28.4 pt -142.8 172.27 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 111.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.418 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -153.71 173.82 15.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.343 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -137.51 139.71 40.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.972 0.415 . . . . 0.0 111.365 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 57.0 m-20 -117.21 -137.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.241 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -73.63 -106.84 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.085 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -87.47 20.02 1.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.769 2.313 . . . . 0.0 112.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.492 HG22 ' CG ' ' A' ' 62' ' ' ASP . 41.7 p -138.57 173.73 11.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.988 0.423 . . . . 0.0 111.152 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.557 HG12 ' CE2' ' A' ' 93' ' ' TYR . 8.0 tt -136.71 130.15 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.287 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.578 ' HB2' HG13 ' A' ' 60' ' ' VAL . 1.5 ttm180 -123.18 136.44 54.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.138 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.945 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -128.02 164.84 21.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.921 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.37 153.37 31.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.673 HG22 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -136.62 155.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.796 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.508 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -155.2 170.58 21.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 111.478 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.727 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.9 tttp . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.435 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.855 0.359 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -87.53 137.75 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -72.08 132.57 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -105.93 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.789 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.19 -73.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -121.77 8.88 10.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.72 138.61 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.511 -179.894 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 56' ' ' ILE . 5.8 p-10 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.111 0.482 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.436 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 4.7 m-85 -103.48 161.8 13.56 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -134.6 146.42 49.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.326 0.584 . . . . 0.0 112.489 -178.07 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.926 HD23 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -134.28 91.15 2.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.315 177.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.663 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 37.9 t0 -101.79 58.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.742 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.467 ' C ' ' HB3' ' A' ' 61' ' ' SER . 46.6 mtt -137.32 -110.53 0.18 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.644 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 62' ' ' ASP . 9.9 p -135.55 164.28 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.262 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -96.49 79.02 0.73 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.389 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.489 0.185 . . . . 0.0 110.878 -179.594 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.926 ' HG2' HD23 ' A' ' 30' ' ' LEU . 31.7 Cg_exo . . . . . 0 C--O 1.23 0.1 0 N-CA-C 112.536 0.168 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.61 ' CA ' HD13 ' A' ' 70' ' ' ILE . . . -65.26 -17.5 64.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.357 0.598 . . . . 0.0 110.246 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 46' ' ' GLU . 55.0 t -57.67 -27.76 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.823 177.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.2 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.312 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.579 ' OG1' HG23 ' A' ' 70' ' ' ILE . 3.0 m -51.75 -68.13 0.19 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 48.8 mt -61.46 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.167 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 3.3 tt0 -65.3 -18.6 65.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.738 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.04 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.261 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.531 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.2 mmt -46.16 -55.12 14.36 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.871 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 48' ' ' MET . 39.3 Cg_endo -66.39 -56.71 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.714 1.609 . . . . 0.0 111.756 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -73.56 18.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.807 179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -44.55 151.37 0.27 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.773 0.321 . . . . 0.0 111.322 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -130.21 -179.61 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.19 61.63 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.834 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.72 43.49 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -65.3 150.51 48.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 110.815 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.55 ' N ' ' HG3' ' A' ' 55' ' ' GLU . 1.8 mt -154.03 156.11 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.561 HD21 ' CG2' ' A' ' 70' ' ' ILE . 9.5 tp -146.75 161.05 41.44 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.21 0.528 . . . . 0.0 111.201 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -150.48 140.03 21.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 177.299 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.84 144.34 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.013 0.435 . . . . 0.0 111.172 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.76 97.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.167 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.526 ' HB2' HD21 ' A' ' 68' ' ' ASN . 0.3 OUTLIER -151.06 179.33 8.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -178.287 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.42 137.65 53.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 179.561 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 11.3 p -159.51 139.51 8.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.042 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.81 -12.87 36.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.675 2.25 . . . . 0.0 112.087 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -95.15 -160.84 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -113.54 -5.43 13.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.6 149.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.238 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.526 HD21 ' HB2' ' A' ' 61' ' ' SER . 4.4 m-20 -112.81 -169.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.097 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.697 ' ND2' HG12 ' A' ' 70' ' ' ILE . 5.6 p-10 -72.57 -55.06 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.901 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.728 HD11 ' HG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.98 -51.18 83.61 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.523 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 31.9 Cg_endo -62.79 -41.51 30.0 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.428 2.085 . . . . 0.0 112.837 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -25.63 65.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.095 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 10.1 m-20 -71.58 -61.78 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.192 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -60.97 -38.95 87.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -65.15 -27.48 68.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -62.92 -69.05 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -14.78 61.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.34 96.4 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.493 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.641 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 33.7 t80 -82.98 -98.78 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.653 0.263 . . . . 0.0 110.904 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 m -137.57 -77.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.893 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 25.8 t -109.99 114.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.187 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.535 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -123.23 101.77 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.348 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.69 158.5 31.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.635 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 33.0 pt -141.87 168.08 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 111.76 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 84' ' ' ILE . 3.7 mt-30 -152.4 155.64 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.483 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.39 141.92 45.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -109.74 -79.47 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.846 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.36 -97.51 0.46 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.087 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.31 6.88 5.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.243 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.1 p -135.89 172.21 13.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.037 0.446 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 4.0 tt -148.0 145.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.874 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 111.453 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 4.4 m-85 -131.68 130.76 42.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.72 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -133.94 157.24 41.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.387 178.512 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.73 157.43 39.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.641 ' HB2' ' HE2' ' A' ' 79' ' ' TYR . 3.0 tptp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.741 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.34 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -67.05 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -91.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.46 157.61 35.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.031 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.44 21.45 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.893 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.68 126.33 39.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.007 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -134.33 28.66 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.515 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.674 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.4 t70 . . . . . 0 N--CA 1.467 0.418 0 CA-C-O 120.96 0.41 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.494 ' HB3' HD12 ' A' ' 57' ' ' LEU . 9.9 t80 -103.92 168.31 9.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.707 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.0 ptt85 -134.61 130.4 36.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 40' ' ' PRO . 1.9 tm? -123.06 78.67 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.41 -0.813 . . . . 0.0 108.973 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.63 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -102.06 70.12 1.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.762 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -136.7 -111.31 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 178.367 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 62' ' ' ASP . 10.5 p -135.57 144.74 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.809 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.1 76.41 1.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.276 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.73 0.3 . . . . 0.0 111.138 -179.428 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB3' HD21 ' A' ' 30' ' ' LEU . 31.7 Cg_exo . . . . . 0 CA--C 1.529 0.26 0 CA-C-O 120.815 0.256 . . . . 0.0 112.461 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.68 4.7 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -48.16 -34.34 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -38.38 66.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.954 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.687 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.5 -57.63 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 9.8 mt -61.52 -54.23 45.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.48 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.35 -33.24 65.48 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.228 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -44.3 -61.49 1.49 Allowed 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 mtm -76.37 138.44 67.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 51' ' ' LEU . 63.0 Cg_endo -83.09 11.24 40.64 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.753 -0.936 . . . . 0.0 113.593 -10.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -71.91 16.54 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.135 -0.353 . . . . 0.0 111.664 -177.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.638 HD12 ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -71.12 179.28 2.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.352 . . . . 0.0 111.177 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -126.12 -148.15 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HA ' ' HE2' ' A' ' 97' ' ' LYS . 18.8 mtmt -107.36 58.51 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 110.85 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.585 ' H ' ' HD3' ' A' ' 97' ' ' LYS . . . 126.36 93.05 0.87 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.67 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -124.1 -173.15 2.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.711 0.291 . . . . 0.0 110.984 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -160.43 162.48 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.001 -179.376 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 44' ' ' THR . 15.2 tp -144.22 162.9 35.18 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.229 0.538 . . . . 0.0 111.398 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 2.6 mt-10 -147.82 141.62 25.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.403 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 25.4 t -141.18 131.1 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 111.602 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.63 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 36.1 t -133.1 84.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.196 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -124.71 166.91 15.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.27 -178.628 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -118.38 135.76 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.494 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 19.3 p -159.25 143.31 11.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.134 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.6 Cg_exo -70.95 -11.32 29.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.711 2.274 . . . . 0.0 112.046 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -93.08 -164.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -112.74 -17.52 12.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -117.68 153.49 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 2.3 m-20 -125.81 177.81 6.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.067 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.68 -42.48 64.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.936 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.75 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -60.04 -49.82 89.27 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 50.5 Cg_endo -67.27 -43.46 6.12 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.189 1.926 . . . . 0.0 112.244 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.406 HD12 HG12 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -64.96 -32.58 74.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 3.8 m-20 -64.13 -57.6 9.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -61.63 -39.55 91.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 75' ' ' ARG . 3.8 mtp180 -62.6 -32.21 73.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.672 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -61.94 -67.89 0.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -33.28 72.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.575 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.14 95.03 1.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.04 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.87 -168.77 1.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.661 0.267 . . . . 0.0 110.285 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.683 HG22 HG23 ' A' ' 81' ' ' VAL . 96.7 m -77.26 -62.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.728 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.8 t -127.44 132.34 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.334 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -133.28 100.29 4.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.407 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.47 156.91 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.874 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.22 175.24 4.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.091 0.472 . . . . 0.0 111.804 -179.102 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.531 ' O ' HG13 ' A' ' 91' ' ' ILE . 17.1 mt-30 -154.04 166.95 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.439 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -145.4 145.46 31.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.877 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.6 -83.09 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.11 -97.27 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.202 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.15 5.92 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.52 2.147 . . . . 0.0 112.449 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -138.08 174.49 10.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 111.163 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 85' ' ' GLN . 3.1 tt -145.17 144.19 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.741 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.56 138.39 54.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.928 0.394 . . . . 0.0 111.119 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.9 m-85 -123.86 149.47 45.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.205 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.39 138.39 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.926 0.393 . . . . 0.0 111.746 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -129.34 161.34 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.534 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.728 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -152.07 145.7 24.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.67 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.718 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.822 0.344 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.72 3.81 5.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -82.98 -55.69 4.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -109.07 4.02 22.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 6' ' ' HIS . 0.7 OUTLIER -115.72 76.51 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.33 166.41 22.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.59 6.3 23.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.433 0.158 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.537 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -134.48 161.11 35.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 111.478 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -135.1 121.18 19.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.508 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.846 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -107.66 77.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.07 65.15 0.86 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.461 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.635 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -137.16 -104.93 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.05 178.835 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.405 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 13.0 p -134.56 137.04 51.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.57 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . -72.94 77.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.846 ' HB2' HD21 ' A' ' 30' ' ' LEU . 3.0 Cg_exo . . . . . 0 CA--C 1.529 0.234 0 CA-C-O 120.698 0.208 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . . . -59.48 1.94 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.916 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 40' ' ' PRO . 59.8 t -51.18 -27.87 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.372 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.99 -36.83 67.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.697 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 51.7 m -57.46 -52.35 65.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.016 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tp -60.96 -63.13 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.1 -39.51 13.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.948 0.404 . . . . 0.0 110.406 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.23 -61.58 1.14 Allowed 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.458 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 mmt -76.97 138.85 65.39 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' C ' HD23 ' A' ' 51' ' ' LEU . 66.9 Cg_endo -83.27 13.79 34.04 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.643 -0.982 . . . . 0.0 113.336 -11.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 47' ' ' ALA . 35.8 mt-30 -70.41 10.55 0.45 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.177 -0.327 . . . . 0.0 111.824 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.3 pt? -72.12 -177.35 2.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.72 -160.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.56 29.39 0.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.957 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.96 91.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.493 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.837 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -116.93 173.8 6.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.567 0.222 . . . . 0.0 110.755 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 55' ' ' GLU . 5.8 mt -159.22 157.53 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.235 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -143.66 161.51 38.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.092 0.472 . . . . 0.0 111.396 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.42 119.29 8.69 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.158 175.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.706 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 47.5 t -117.95 111.8 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 111.368 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 1.6 t -117.75 89.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.657 ' HB2' HD22 ' A' ' 68' ' ' ASN . 62.9 m -129.18 172.74 11.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.691 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -117.59 125.15 50.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 4.0 p -159.27 147.31 13.52 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.7 Cg_exo -71.3 -23.4 24.19 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.126 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -175.4 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.82 -32.28 11.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 93' ' ' TYR . 1.5 tt -119.93 148.73 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.657 HD22 ' HB2' ' A' ' 61' ' ' SER . 3.9 m-20 -98.93 173.86 6.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.54 -22.05 61.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.646 HD12 ' HG ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -67.65 -54.5 17.52 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 68' ' ' ASN . 21.2 Cg_exo -65.84 -35.39 35.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.277 1.985 . . . . 0.0 111.688 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -21.28 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.604 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -62.68 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.74 -39.78 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -56.53 -40.53 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.744 179.084 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.4 -52.42 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.065 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -68.3 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.114 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.14 98.06 0.11 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.845 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.791 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 45.6 p90 -98.97 -166.02 1.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.488 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.787 HG21 ' HD2' ' A' ' 97' ' ' LYS . 1.4 m -125.83 -40.88 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.504 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.635 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 73.3 t -144.43 115.08 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.609 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.38 95.86 4.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.106 -178.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.97 163.27 21.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.3 pt -142.59 178.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 111.986 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.36 -172.09 4.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.243 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -144.56 142.41 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 111.226 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -118.03 -154.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.246 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -64.98 -99.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.107 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -90.74 16.31 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.744 2.296 . . . . 0.0 112.536 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.532 HG22 ' OD2' ' A' ' 62' ' ' ASP . 11.5 p -137.26 -170.72 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.001 0.429 . . . . 0.0 111.059 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt -143.19 147.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.605 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -123.79 142.87 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.063 0.459 . . . . 0.0 111.178 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.706 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.8 m-85 -131.39 155.79 46.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.564 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.7 143.93 20.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.613 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.609 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -134.98 158.62 41.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.236 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.635 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -154.11 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.837 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.1 tptp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.516 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.837 0.351 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 128.27 50.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -79.67 101.49 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 33.93 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.96 95.08 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -112.07 -13.22 13.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 p -68.9 109.92 4.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.566 -179.943 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' A' ' 58' ' ' GLU . 37.5 t0 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 57' ' ' LEU . 1.1 m-85 -103.78 136.55 43.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.758 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -103.52 135.68 44.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 112.384 -176.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.699 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.4 tm? -130.56 81.16 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.339 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.645 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.51 71.79 1.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.788 -176.685 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.438 ' HB3' ' H ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -136.86 -112.02 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.096 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.535 HG22 ' OD1' ' A' ' 62' ' ' ASP . 47.9 t -134.87 133.31 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.69 103.43 0.32 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' H ' ' ND2' ' A' ' 69' ' ' ASN . 5.2 tt0 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.604 0.24 . . . . 0.0 110.96 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 62.7 Cg_endo . . . . . 0 CA--C 1.53 0.299 0 CA-C-O 120.818 0.258 . . . . 0.0 112.614 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.82 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.55 4.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.448 ' H ' ' C ' ' A' ' 40' ' ' PRO . 54.1 t -52.91 -29.29 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 110.106 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.96 -34.0 66.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.639 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -64.26 -52.22 59.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.067 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.29 -57.6 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 47' ' ' ALA . 16.8 pt-20 -50.1 -40.57 46.14 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.53 -53.19 4.46 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.474 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.3 137.13 64.47 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 173.289 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' C ' HD13 ' A' ' 51' ' ' LEU . 65.0 Cg_endo -83.34 11.42 41.21 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.668 -0.972 . . . . 0.0 113.243 -11.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 47' ' ' ALA . 10.1 mm100 -73.02 25.9 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.46 -159.58 0.06 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.713 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -141.8 -155.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.448 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.713 ' H ' ' HD3' ' A' ' 52' ' ' LYS . 6.6 mttp -91.57 30.14 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.63 73.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.213 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.713 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -78.8 171.43 15.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 55' ' ' GLU . 61.5 mt -154.87 162.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.034 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.611 ' HG ' ' N ' ' A' ' 58' ' ' GLU . 4.3 tp -159.59 162.05 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.019 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.611 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -149.11 133.06 17.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.725 -176.311 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.699 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -139.25 132.23 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.849 0.356 . . . . 0.0 111.66 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -135.32 97.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.223 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.85 171.1 14.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.44 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.535 ' OD1' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.24 138.34 52.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.352 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.9 t -159.33 133.02 4.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.009 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 29.1 Cg_exo -61.64 -30.9 86.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.558 2.172 . . . . 0.0 112.129 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -81.4 -170.91 3.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -112.35 -17.09 12.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.68 137.48 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -100.12 127.19 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.606 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 35' ' ' GLU . 19.0 p-10 -72.52 -58.71 3.16 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.82 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 15.3 mm -56.85 -54.05 58.39 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.2 Cg_exo -58.28 -32.94 97.1 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.331 2.021 . . . . 0.0 112.7 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 6.5 tp -61.51 -30.95 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.03 -58.05 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.068 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -63.51 -32.46 73.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.2 ttt-85 -68.87 -31.64 70.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -61.7 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.64 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -70.95 -24.66 62.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.309 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.7 103.37 1.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.994 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.39 -164.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.639 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 97' ' ' LYS . 2.6 m -72.77 -82.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 46.6 t -116.43 123.99 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.093 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.624 HD12 ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -123.71 103.43 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.699 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.87 164.97 21.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.217 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.927 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -137.6 179.06 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.248 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.34 -177.0 6.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -150.37 138.87 20.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.053 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -122.57 -131.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.417 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.74 -123.66 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.167 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.7 29.89 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.915 2.41 . . . . 0.0 112.308 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 62' ' ' ASP . 2.0 p -147.6 -177.8 5.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 85' ' ' GLN . 14.3 tt -142.84 148.52 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.844 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.509 ' HB2' HG13 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -139.19 135.52 34.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.86 0.362 . . . . 0.0 111.257 -178.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.927 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.79 159.53 29.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.591 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.45 152.98 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 111.645 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.536 HG22 HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -133.35 155.17 40.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.338 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.492 ' N ' HD12 ' A' ' 95' ' ' ILE . 5.7 pt20 -154.35 157.16 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.713 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 34.6 tttm . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.799 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.3 m80 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.741 0.305 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -92.16 21.06 5.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.28 -64.19 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.977 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -171.96 3.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -89.6 162.84 15.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.83 162.98 13.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.8 p -108.74 72.81 0.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.567 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.2 t0 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 57' ' ' LEU . 1.4 t80 -105.33 137.63 42.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.8 -176.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.4 OUTLIER -103.89 131.73 50.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.48 -178.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.881 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -123.76 86.79 2.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.047 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.658 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 41.8 t0 -102.27 64.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.8 mtp -136.66 -109.44 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.322 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 62' ' ' ASP . 10.9 p -133.93 143.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.975 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -74.09 94.29 0.79 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.46 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.642 ' HB3' HD11 ' A' ' 30' ' ' LEU . 6.6 Cg_endo . . . . . 0 CA--C 1.531 0.327 0 N-CA-C 113.379 0.492 . . . . 0.0 113.379 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HA ' HG23 ' A' ' 70' ' ' ILE . . . -57.94 -0.68 0.09 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.0 t -52.22 -35.85 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.713 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 46' ' ' GLU . . . -71.16 -36.74 72.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.602 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.909 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.27 -42.57 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.196 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 1.2 tp -68.01 -55.62 11.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.329 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.662 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.23 -15.3 56.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.143 0.497 . . . . 0.0 110.754 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HB1' ' OH ' ' A' ' 79' ' ' TYR . . . -74.63 -34.73 62.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.817 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.607 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.3 -47.83 87.38 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.461 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 14.8 Cg_exo -68.53 -51.55 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.006 1.804 . . . . 0.0 111.408 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -73.23 15.26 0.24 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.635 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.607 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -53.22 161.4 0.89 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 111.677 -178.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.2 -162.94 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.469 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.67 39.72 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 110.808 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . -174.94 67.81 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.438 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.609 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -110.17 152.92 25.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 111.414 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.4 mt -159.63 152.81 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.279 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 95' ' ' ILE . 1.3 tp -160.67 137.73 9.08 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.147 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.652 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -118.75 137.93 53.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.091 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.881 HG13 ' HB3' ' A' ' 30' ' ' LEU . 15.2 t -139.9 150.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 0.0 112.359 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -154.95 100.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.752 178.027 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 33' ' ' VAL . 59.7 m -144.07 167.92 21.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.958 0.409 . . . . 0.0 111.506 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -121.75 137.1 54.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.5 t -159.26 126.71 2.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.71 -12.99 36.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.385 2.057 . . . . 0.0 112.043 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 66' ' ' SER . 35.0 mt-30 -86.02 -155.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 1.6 m -126.6 -56.51 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.302 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.685 HG23 HD23 ' A' ' 72' ' ' LEU . 1.3 mp -77.63 74.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.611 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -136.47 5.08 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.067 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.763 ' HB2' HD13 ' A' ' 72' ' ' LEU . 2.8 m-20 -72.44 126.16 29.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.068 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 46.9 mm -53.83 -45.72 98.74 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.055 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.832 ' HB3' HG22 ' A' ' 95' ' ' ILE . 35.9 Cg_endo -63.6 -23.31 70.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.876 . . . . 0.0 111.772 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 69' ' ' ASN . 2.4 mp -64.64 -31.3 72.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -46.49 80.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.595 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.909 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -72.8 -29.94 63.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.364 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.625 ' HB2' ' HG ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -72.94 -52.54 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 19.1 t30 -50.52 -51.42 47.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.765 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -56.82 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.389 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.07 107.49 0.75 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.972 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -126.02 -135.85 0.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.558 0.218 . . . . 0.0 110.758 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.49 HG21 ' HA ' ' A' ' 97' ' ' LYS . 3.2 m -110.43 -78.66 0.59 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.798 0.332 . . . . 0.0 110.977 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.517 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 4.0 t -121.27 121.15 64.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.349 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.3 mm? -123.59 106.18 10.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -130.16 139.16 50.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.851 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.949 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -127.07 166.36 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.994 0.426 . . . . 0.0 111.571 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.42 142.88 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.89 152.78 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.855 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -121.62 -78.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.82 -99.97 0.59 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.67 5.61 6.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.606 2.204 . . . . 0.0 112.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 p -141.13 174.91 10.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.066 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.419 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.8 tt -149.85 134.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -123.81 130.64 52.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.949 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -124.01 161.18 26.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.701 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.97 146.38 23.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.537 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.832 HG22 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -123.9 155.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.009 177.758 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.517 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.39 -170.56 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 111.343 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ttt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.777 0.322 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.62 145.52 40.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.488 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.53 -53.48 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.0 110.922 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -126.91 9.75 6.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -94.37 45.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -134.24 119.03 18.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -95.38 112.06 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -78.11 141.4 38.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.96 -26.28 11.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.14 161.32 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 m -104.49 143.26 33.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.22 103.85 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.49 70.79 0.23 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.613 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.86 116.37 28.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.733 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 ' HG3' ' A' ' 17' ' ' ARG . 12.7 t -125.69 88.92 53.42 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 102.18 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.538 2.159 . . . . 0.0 112.351 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HG3' HG12 ' A' ' 15' ' ' VAL . 14.2 mtt180 -128.26 167.78 16.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.002 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.95 -12.5 61.98 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.32 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.0 p -118.89 164.66 15.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.804 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 159.59 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mtm -61.53 -46.3 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -131.44 -174.56 3.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.727 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.65 110.56 13.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 mm -110.39 25.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.825 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.52 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 2.3 t -87.13 -51.14 0.43 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.61 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 48.3 Cg_exo -56.44 95.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.243 1.962 . . . . 0.0 112.301 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 22.6 t70 -61.27 -76.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.633 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.652 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -134.26 164.82 26.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 112.21 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.804 ' HG3' ' HB2' ' A' ' 58' ' ' GLU . 4.4 ttt-85 -134.38 114.09 12.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.938 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.692 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -109.6 77.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.537 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' HA ' ' H ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.64 67.62 0.9 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.49 -107.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.242 178.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 62' ' ' ASP . 85.3 t -134.9 139.99 46.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.504 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -66.75 89.13 0.15 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.389 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -85.83 132.91 42.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.21 -27.83 28.61 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.5 2.133 . . . . 0.0 112.191 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.69 134.8 75.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.975 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.06 89.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.624 2.216 . . . . 0.0 112.261 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.824 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 64.3 t80 -140.37 -53.83 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.446 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.824 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 52.8 Cg_endo -70.27 -72.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.164 1.909 . . . . 0.0 112.771 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.829 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -55.89 -3.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.53 -29.01 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.343 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.76 -36.12 67.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.868 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -57.42 -54.14 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.091 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.33 -47.69 84.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.151 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 4.8 pt-20 -64.38 -20.29 66.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.749 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HB1' ' OE2' ' A' ' 55' ' ' GLU . . . -72.85 -30.23 63.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.12 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.559 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 6.3 mmm -51.33 -54.77 34.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.692 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 48' ' ' MET . 58.7 Cg_endo -70.61 -39.69 4.65 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.785 1.657 . . . . 0.0 111.687 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.09 7.07 2.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.336 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.31 152.13 0.46 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.608 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -134.91 -165.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.779 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -85.44 45.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.464 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.14 0.38 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.007 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.67 ' H ' ' HB2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -122.21 158.49 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.628 HG13 ' O ' ' A' ' 55' ' ' GLU . 10.9 mt -159.65 154.18 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.327 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.652 HD12 ' H ' ' A' ' 28' ' ' TYR . 3.5 tp -140.39 154.47 46.72 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.119 0.485 . . . . 0.0 110.834 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.804 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 3.8 mt-10 -141.6 111.98 6.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.692 HG13 ' HB3' ' A' ' 30' ' ' LEU . 49.0 t -118.39 123.13 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.745 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.472 ' H ' ' HA ' ' A' ' 31' ' ' ASP . 97.5 t -126.14 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.806 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -126.44 162.91 24.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.443 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.817 ' HB3' HG22 ' A' ' 90' ' ' THR . 1.4 p30 -118.16 132.04 56.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.709 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 142.53 17.05 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.077 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.93 -24.94 23.75 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.483 2.122 . . . . 0.0 112.138 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -83.58 -163.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -119.75 -24.85 6.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.67 138.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -88.72 127.21 35.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -72.56 -74.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.936 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.829 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 8.4 mm -50.64 -51.78 62.23 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 51.0 Cg_exo -55.94 -33.37 88.83 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.193 1.929 . . . . 0.0 112.628 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -61.06 -36.3 79.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.85 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 -57.35 10.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -60.63 -35.16 75.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.289 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -64.29 -35.62 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.06 -64.62 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -26.86 68.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.672 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.38 94.32 0.77 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.946 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -154.83 0.39 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.52 HG21 ' HE3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -90.79 -64.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.638 0.256 . . . . 0.0 111.04 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.688 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 2.7 t -125.42 122.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.35 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.551 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -126.72 104.61 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.791 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.59 157.88 39.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.116 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -139.95 166.08 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.0 tt0 -154.42 156.66 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.443 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.474 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -131.82 158.43 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -123.96 -79.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.14 -100.3 0.44 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.163 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.29 10.38 3.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.643 2.229 . . . . 0.0 112.327 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 62' ' ' ASP . 4.8 p -145.6 177.7 8.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 86' ' ' GLN . 18.0 tt -146.76 145.7 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 129.89 32.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.93 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.13 163.14 21.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.503 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -154.54 151.99 29.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.042 0.449 . . . . 0.0 111.596 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -134.56 162.64 38.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.243 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.688 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 3.4 pt20 -153.53 177.36 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.67 ' HB2' ' H ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mtt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.821 0.343 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.87 100.08 2.46 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.393 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 t -113.54 114.78 26.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.9 m -132.71 128.39 36.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -95.58 -177.49 4.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.878 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -168.18 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -105.44 91.88 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.85 -67.95 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -99.02 165.28 11.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -113.91 111.18 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.36 101.8 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -64.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.012 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.76 -124.5 2.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.63 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.77 24.57 11.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.55 72.66 73.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.03 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.56 157.52 28.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.566 2.177 . . . . 0.0 112.247 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 -135.85 149.65 49.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.98 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.7 -115.32 1.25 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.533 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.51 -176.92 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.884 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -102.44 -2.93 27.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.28 99.34 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.05 86.73 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 26' ' ' PRO . 5.9 m120 -94.21 104.55 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.72 -38.15 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.1 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 t -101.85 -51.24 0.16 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.84 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 52.4 Cg_exo -53.18 100.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.246 1.964 . . . . 0.0 112.509 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 7.2 t0 -64.53 -81.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.992 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.629 ' H ' HD12 ' A' ' 57' ' ' LEU . 4.2 m-85 -134.83 166.83 22.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 111.721 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 138.6 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.046 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.798 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -131.37 77.97 1.8 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.793 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -103.48 69.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.397 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 61' ' ' SER . 35.9 mtt -136.85 -111.85 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.121 0.486 . . . . 0.0 111.228 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 57.9 t -135.92 126.9 43.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.73 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -68.82 100.29 0.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.321 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 37' ' ' CYS . 14.3 pt-20 -99.07 153.48 37.77 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.165 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.94 -21.35 26.15 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.757 2.305 . . . . 0.0 112.431 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.49 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -75.73 146.85 80.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.806 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.47 -12.61 21.36 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.552 2.168 . . . . 0.0 112.383 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.415 ' HB3' ' HA ' ' A' ' 40' ' ' PRO . 8.3 m-85 -94.13 154.53 40.56 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.942 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.798 ' HB2' HD21 ' A' ' 30' ' ' LEU . 1.9 Cg_endo -84.28 7.92 54.09 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.951 -1.271 . . . . 0.0 112.529 0.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -58.02 0.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.927 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.4 p -52.46 -25.12 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.307 0.575 . . . . 0.0 110.014 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.92 -36.8 67.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.646 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.628 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -53.18 -55.21 26.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.891 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -51.66 66.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -59.65 -21.6 60.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.14 -179.119 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.52 -34.05 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.566 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.4 mmm -49.24 -55.39 21.68 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.684 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 16.2 Cg_exo -67.73 -37.36 16.34 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.139 1.893 . . . . 0.0 111.882 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.71 4.29 4.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.516 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.639 HD13 ' HE2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -46.44 155.92 0.2 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.906 0.384 . . . . 0.0 111.536 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.63 -91.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.38 3.52 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . 157.57 99.21 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.781 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -103.09 -177.43 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 55' ' ' GLU . 4.4 mt -159.4 153.94 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.072 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.629 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -134.79 156.52 48.73 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.058 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.71 110.26 6.35 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.095 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 30' ' ' LEU . 98.8 t -117.71 124.61 73.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.472 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 87.5 t -131.91 96.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.6 p -130.41 176.63 7.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.773 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.502 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -117.31 131.39 56.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.299 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.415 ' SG ' ' HA3' ' A' ' 34' ' ' GLY . 70.0 m -143.84 130.88 10.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.12 4.51 4.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.48 2.12 . . . . 0.0 112.371 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -127.35 -159.99 0.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 t -111.14 -27.56 8.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mt -56.68 128.54 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.337 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.611 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -92.91 125.54 37.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -72.87 -73.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.179 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 41' ' ' ALA . 2.5 mm -46.28 -51.74 32.3 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.822 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 32.2 Cg_exo -60.57 -30.1 89.91 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.334 2.023 . . . . 0.0 112.725 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.4 tp -61.11 -33.02 72.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.811 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.6 4.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -59.63 -35.67 74.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.914 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -64.88 -37.12 86.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -58.08 10.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.741 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -64.72 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.37 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.57 82.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.997 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.435 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -86.34 -170.63 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.692 0.282 . . . . 0.0 110.636 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.435 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -76.89 -66.64 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.003 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 11.9 t -126.71 128.6 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.621 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -131.01 100.08 5.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.94 167.92 14.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.088 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.5 pt -137.59 -177.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.499 ' O ' HG13 ' A' ' 91' ' ' ILE . 3.5 mt-30 -154.51 178.65 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.33 142.21 26.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 0.0 111.306 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.29 -138.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.306 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.94 -116.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.163 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.54 27.08 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.616 2.211 . . . . 0.0 112.543 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.4 p -142.05 -177.69 5.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 111.036 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.523 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.1 tt -149.41 150.46 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.863 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.422 ' HB2' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -139.64 140.77 37.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.919 0.39 . . . . 0.0 111.368 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.93 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -127.88 144.9 51.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.129 178.349 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.32 150.91 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 111.481 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.621 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -131.85 157.4 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 178.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.705 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.8 pt20 -154.47 158.57 40.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 111.259 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.781 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 25.2 tttp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.745 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.06 -26.66 52.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.58 171.46 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.883 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 t -130.74 166.89 19.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -77.03 99.51 5.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.07 -68.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -132.83 111.75 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -136.43 179.17 6.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -67.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -121.11 46.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.11 40.83 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 m -122.43 60.77 1.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.73 149.6 51.43 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.404 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.3 mt -135.71 160.91 37.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.861 0.362 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.605 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 11.3 t -93.17 -50.6 0.27 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.647 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 52.9 Cg_exo -55.39 -21.94 31.87 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.163 1.909 . . . . 0.0 112.368 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.2 167.76 6.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.25 104.11 1.29 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.626 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.02 89.33 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.837 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -137.73 18.14 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtp -97.47 -56.1 2.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.46 -19.25 33.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -64.5 105.25 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 tt -89.64 146.64 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.84 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 1.6 t -113.91 -52.1 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.745 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.84 ' HD2' ' H ' ' A' ' 25' ' ' VAL . 20.3 Cg_endo -60.43 98.62 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.169 1.913 . . . . 0.0 112.326 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 33.8 t70 -64.2 -78.13 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.178 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.666 ' H ' HD12 ' A' ' 57' ' ' LEU . 5.8 m-85 -134.4 165.66 24.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.431 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -134.82 135.46 41.77 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.581 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.843 HD21 ' HA ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -125.89 76.74 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.273 178.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.52 66.64 0.88 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.948 0.404 . . . . 0.0 111.463 -178.415 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 61' ' ' SER . 2.3 mtt -137.06 -106.4 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.347 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 35' ' ' GLU . 11.7 p -134.12 142.55 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -61.53 -20.34 58.98 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.31 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 33' ' ' VAL . 6.8 tt0 -59.48 144.74 83.86 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.5 91.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.629 2.22 . . . . 0.0 112.315 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -89.14 166.88 19.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.515 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.55 -57.06 2.58 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.383 2.055 . . . . 0.0 112.636 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -122.42 76.68 44.6 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.843 ' HA ' HD21 ' A' ' 30' ' ' LEU . 66.5 Cg_endo -92.46 -129.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.096 2.531 . . . . 0.0 112.366 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.88 -4.16 0.28 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.968 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.25 -28.01 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.239 0.542 . . . . 0.0 110.024 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.41 -40.45 64.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.538 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.35 -54.14 49.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.066 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 16.4 mt -61.43 -49.31 77.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.138 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 pt-20 -65.29 -18.29 65.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.657 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.88 -29.2 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.952 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.593 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.95 -54.79 33.45 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.449 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.7 Cg_endo -69.64 -36.89 10.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.864 1.709 . . . . 0.0 111.586 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.91 5.74 3.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.6 161.76 0.12 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.958 0.409 . . . . 0.0 111.753 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -131.7 -95.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.813 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -14.75 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.804 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 178.86 92.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.184 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.776 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -99.25 -176.69 3.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 111.434 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.7 mt -159.61 154.62 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.204 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -136.69 156.2 48.85 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.13 0.491 . . . . 0.0 111.194 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -140.28 116.5 10.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.056 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.706 HG13 ' HB3' ' A' ' 30' ' ' LEU . 52.6 t -118.26 113.63 42.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.635 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 72.9 t -118.66 92.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.822 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.4 p -133.0 168.61 18.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.362 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.89 118.47 32.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.358 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.6 t -137.44 120.67 11.59 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.955 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.91 -25.6 70.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.519 2.146 . . . . 0.0 112.133 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -87.85 164.07 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -91.04 -22.8 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.002 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.24 118.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.367 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.99 118.2 14.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -72.68 -75.67 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.789 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 7.1 mm -48.57 -51.51 51.73 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.022 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.607 ' HB3' HD12 ' A' ' 82' ' ' LEU . 51.4 Cg_exo -57.21 -36.97 99.15 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.224 1.95 . . . . 0.0 112.849 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER -57.14 -33.42 67.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.884 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.75 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 2.1 m-20 -66.97 -58.67 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.034 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.553 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -61.13 -34.98 75.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.209 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -65.9 -36.12 82.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 -60.91 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -59.9 2.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.535 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.28 88.09 0.57 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.022 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -151.89 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.248 . . . . 0.0 110.343 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 97' ' ' LYS . 1.2 m -93.33 -75.34 0.5 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.577 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 48.1 t -120.4 123.06 69.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mm? -123.61 105.4 9.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.792 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -134.34 157.59 45.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 93' ' ' TYR . 35.4 pt -140.15 179.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.594 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -154.07 166.88 31.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 179.121 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -125.93 125.15 42.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 0.0 111.215 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.31 82.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.377 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.44 145.69 7.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.949 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -90.9 43.23 2.47 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.573 -1.428 . . . . 0.0 112.652 0.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.7 p -142.9 -172.21 3.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.872 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 85' ' ' GLN . 6.3 tt -149.53 142.59 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.855 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -123.93 133.03 53.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.173 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.514 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -123.66 148.15 46.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.745 178.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.98 151.72 28.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.949 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -136.17 158.34 38.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.222 178.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.577 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER -154.12 153.44 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.292 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.776 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 9.4 tttp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.793 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.854 0.359 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.75 -130.71 3.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.562 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -100.02 178.73 4.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 110.952 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -113.02 -75.51 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.84 -52.89 2.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.994 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -74.78 151.24 39.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 133.84 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -100.89 -4.52 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.057 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -60.8 129.4 41.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -127.24 -177.36 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.63 165.61 19.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 t -116.44 -79.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.85 -119.32 4.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 84.15 1.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 0.0 110.9 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.19 153.54 81.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.071 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.46 -162.3 2.88 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.572 -1.429 . . . . 0.0 112.462 0.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 17' ' ' ARG . 10.7 mtt180 -124.72 116.08 21.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.37 21.69 36.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.482 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.0 m -78.27 151.84 32.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.336 . . . . 0.0 110.89 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 0.01 53.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.977 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.1 mtm -138.03 151.37 47.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -115.64 174.54 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.96 102.28 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.983 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -89.04 -72.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.957 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.4 -51.86 0.26 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.255 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.34 93.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.256 1.971 . . . . 0.0 112.136 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.659 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 16.3 t70 -72.71 -77.07 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.382 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.604 ' H ' HD12 ' A' ' 57' ' ' LEU . 25.2 m-85 -134.61 162.04 33.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 111.841 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 127.48 30.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.345 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.576 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -117.57 82.1 1.77 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.568 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.52 67.06 0.89 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.47 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.645 ' O ' ' HA ' ' A' ' 61' ' ' SER . 93.0 mtp -136.94 -109.85 0.19 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.251 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.19 150.34 29.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -84.66 55.77 5.0 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.472 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.64 124.94 29.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.0 110.785 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.77 82.7 1.68 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.522 2.148 . . . . 0.0 112.54 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.646 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -140.2 -55.18 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.42 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.646 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 94.9 Cg_endo -84.01 -144.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.194 1.93 . . . . 0.0 112.251 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.65 71.79 14.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.741 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 38' ' ' PRO . 99.0 Cg_endo -86.24 -93.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.701 2.268 . . . . 0.0 112.893 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -56.36 -8.54 0.53 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.439 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 49.4 t -46.9 -34.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.65 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.18 65.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.166 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.761 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -52.55 -50.41 62.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.47 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.84 -55.39 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.599 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 42.2 mt-10 -59.53 -19.27 47.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.46 -34.1 67.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.658 ' HG3' ' HB3' ' A' ' 77' ' ' HIS . 5.4 mmm -49.02 -55.77 18.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.213 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 22.0 Cg_exo -64.38 -37.49 39.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.995 1.797 . . . . 0.0 111.544 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 6.15 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.42 145.43 0.27 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -141.5 -168.81 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.631 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -87.56 23.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.03 97.93 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.464 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.727 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -130.58 155.44 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 0.0 110.819 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -159.6 158.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -145.51 158.57 43.82 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.001 0.429 . . . . 0.0 111.196 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 117.65 9.94 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.197 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 30' ' ' LEU . 41.6 t -118.42 115.26 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.549 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.9 t -119.41 88.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.138 0.494 . . . . 0.0 110.123 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -129.72 170.66 13.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.401 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.57 121.96 42.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.618 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -153.21 149.4 21.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 59.1 Cg_endo -72.01 -42.92 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.557 2.171 . . . . 0.0 112.426 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.51 155.24 40.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -64.39 -63.69 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.38 142.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.006 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 17.6 t30 -110.38 -176.2 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -72.52 -35.67 68.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.644 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.693 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm -69.17 -50.71 19.78 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 43.1 Cg_endo -66.56 -44.68 5.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.135 1.89 . . . . 0.0 112.368 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -30.88 71.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.013 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -60.46 3.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.736 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.761 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -62.0 -33.79 74.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -64.14 -29.98 71.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.544 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -66.95 -61.45 1.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.607 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.658 ' HB3' ' HG3' ' A' ' 48' ' ' MET . 0.1 OUTLIER -68.15 -20.41 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.648 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.61 93.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.817 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.417 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -91.56 -156.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 110.533 179.057 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.642 HG21 ' HD2' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -90.77 -64.23 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.767 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 40.4 t -128.76 120.8 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.276 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.541 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -123.56 102.58 7.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.394 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.86 160.37 27.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.887 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.527 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.6 pt -142.0 171.62 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.4 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.508 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.0 mt-30 -154.31 158.87 40.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.414 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -129.8 144.39 51.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.973 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -125.77 -121.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.481 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.02 -112.26 0.51 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.215 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.17 19.75 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.724 2.283 . . . . 0.0 112.477 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.3 p -138.29 -178.78 5.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 111.101 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 85' ' ' GLN . 5.4 tt -149.43 147.91 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.823 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -131.09 131.06 43.94 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.206 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -123.43 134.34 53.96 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.998 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.97 150.76 47.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.199 0.523 . . . . 0.0 111.806 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.541 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.15 156.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.188 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.767 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -146.98 172.16 14.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.936 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.727 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 12.1 tptt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.786 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.728 0.299 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.94 -7.33 70.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 t -88.95 -60.66 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.5 p -116.55 127.71 54.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -80.13 176.26 9.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -116.03 101.8 9.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -120.33 15.47 12.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.22 -28.13 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.831 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.21 102.84 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -44.29 43.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.15 169.89 16.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 t -110.24 -27.85 8.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.6 114.25 2.7 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 mt -131.87 -165.52 1.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.1 m -104.53 149.16 37.1 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.24 -37.62 1.46 Allowed 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.521 -1.449 . . . . 0.0 112.531 0.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.75 145.14 28.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.001 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.28 -142.43 11.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.585 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.43 -60.56 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -89.64 153.17 20.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -66.85 143.59 56.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.04 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -90.97 102.12 14.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -105.53 40.21 1.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.047 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.6 pt -134.59 -177.32 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 m -59.12 143.32 84.68 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.806 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 88.8 Cg_exo -48.65 -81.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.628 2.219 . . . . 0.0 112.802 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 20.9 t0 57.11 72.67 0.5 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -103.38 164.94 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.066 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 6.9 ttt180 -133.65 142.56 48.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.619 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.838 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.7 tm? -132.93 89.91 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.885 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.685 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.37 66.06 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.543 -177.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mtt -136.36 -111.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.323 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.769 HG13 ' H ' ' A' ' 35' ' ' GLU . 7.5 p -134.56 160.5 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -74.34 13.54 4.71 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.523 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.769 ' H ' HG13 ' A' ' 33' ' ' VAL . 3.2 tt0 -104.75 124.52 36.6 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.56 0.219 . . . . 0.0 110.558 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.0 96.29 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.522 2.148 . . . . 0.0 112.621 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 m -125.16 -54.72 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.178 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 81.5 Cg_endo -85.85 -120.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.281 1.988 . . . . 0.0 112.112 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -126.09 66.99 61.45 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.711 0.291 . . . . 0.0 110.596 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . 87.5 Cg_endo -83.12 -99.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.676 2.251 . . . . 0.0 112.892 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -60.65 -0.43 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.4 t -49.27 -36.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.05 -34.67 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.74 -47.23 86.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.272 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 44.6 mt -64.45 -47.05 80.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.359 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.4 -12.38 61.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 0.0 110.803 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.25 63.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.111 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.564 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -52.49 -46.92 95.0 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.804 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 15.8 Cg_exo -67.75 -59.51 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.919 1.746 . . . . 0.0 111.408 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -73.76 20.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.53 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.1 153.29 0.7 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.014 0.435 . . . . 0.0 111.61 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 -160.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.3 53.64 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.43 52.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.643 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.806 ' HB2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -68.46 177.52 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.066 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -159.26 149.69 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.622 HD22 HG23 ' A' ' 44' ' ' THR . 16.0 tp -134.74 162.59 31.93 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.247 0.546 . . . . 0.0 111.095 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -147.56 136.45 22.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.487 176.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.838 HG13 ' HB3' ' A' ' 30' ' ' LEU . 41.1 t -141.5 138.71 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 111.752 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 97.6 t -140.42 107.95 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.769 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.2 -177.69 5.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.438 . . . . 0.0 111.797 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' HG22 ' A' ' 90' ' ' THR . 0.2 OUTLIER -118.01 120.87 39.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.783 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.37 108.16 2.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.64 -26.12 77.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.554 2.169 . . . . 0.0 112.277 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -73.02 -174.4 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -106.31 -27.7 10.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.94 133.72 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.555 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -95.19 136.11 35.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -72.58 -75.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.84 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 9.2 mm -46.4 -52.12 31.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.198 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 44.8 Cg_exo -58.97 -33.1 98.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.257 1.971 . . . . 0.0 112.613 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.2 tp -61.36 -29.23 69.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.96 0.409 . . . . 0.0 110.788 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.45 -52.5 21.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -69.26 -27.88 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -72.24 -36.04 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.709 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -64.21 -59.6 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -42.01 95.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.638 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 102.53 2.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.781 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.461 ' HB3' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -105.49 -106.11 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.869 HG22 HG23 ' A' ' 81' ' ' VAL . 55.4 m -140.52 -72.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.308 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.869 HG23 HG22 ' A' ' 80' ' ' THR . 53.2 t -117.17 118.26 58.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.344 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 71' ' ' PRO . 3.0 mm? -123.94 100.54 6.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.97 156.88 40.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.886 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -140.21 167.18 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.309 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -154.59 151.29 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -126.62 156.82 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.929 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.28 -84.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.797 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.14 -112.0 2.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.103 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.83 10.44 2.89 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.0 112.192 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.52 HG22 ' OD1' ' A' ' 62' ' ' ASP . 25.3 p -136.09 176.97 8.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.017 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.442 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.5 tt -151.38 142.9 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -127.91 142.25 51.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.116 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.886 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -123.51 155.82 36.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.32 143.08 20.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.463 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.596 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -129.16 161.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.556 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.684 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.3 pt20 -153.96 161.93 41.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.907 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ttm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.34 72.79 2.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.77 143.59 26.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -117.69 25.57 10.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.21 38.93 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.99 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -105.79 -31.45 8.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.949 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.59 103.84 4.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 169.86 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 135.28 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -110.96 39.85 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.18 130.41 36.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.4 -23.05 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.87 80.18 0.36 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.29 23.04 14.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.038 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.59 102.58 44.82 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.996 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.49 29.48 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.563 2.176 . . . . 0.0 112.509 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -20.51 58.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.973 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.74 -137.18 5.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.453 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.1 m -128.64 120.67 27.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -118.04 121.54 40.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.24 73.55 8.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -64.6 164.66 11.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -74.65 -168.04 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.998 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.707 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -110.28 -170.68 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.992 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER -64.83 -51.69 55.6 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.2 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.707 ' HD2' ' HB ' ' A' ' 24' ' ' ILE . 11.1 Cg_endo -54.59 100.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.158 1.905 . . . . 0.0 111.902 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.777 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 36.0 t70 -78.6 -80.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.555 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.741 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.03 166.48 22.94 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 142.61 46.4 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 40' ' ' PRO . 1.4 tm? -134.53 84.39 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.535 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p-10 -104.06 69.13 0.93 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.451 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -136.52 -108.42 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 0.0 111.398 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.774 HG12 ' H ' ' A' ' 35' ' ' GLU . 58.1 t -134.38 142.29 41.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -12.5 11.46 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.198 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.774 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -61.96 159.59 35.63 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.379 0.133 . . . . 0.0 110.715 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.31 86.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.457 2.104 . . . . 0.0 112.218 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . 1.2 m -74.68 161.91 75.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.985 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.39 -35.95 37.26 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.461 2.107 . . . . 0.0 112.222 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.62 65.31 54.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.583 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 63.2 Cg_endo -93.96 -123.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.014 2.476 . . . . 0.0 112.805 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.934 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.2 -4.38 0.35 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 p -47.62 -34.08 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 110.707 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.99 -39.7 65.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.228 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.644 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -53.41 -54.04 42.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 tp -62.04 -40.25 95.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.913 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.64 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -67.2 -20.54 65.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.567 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.7 64.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.62 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.78 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 19.1 mmt -48.47 -56.38 14.78 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 23.7 Cg_exo -62.62 -44.03 19.14 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.975 1.783 . . . . 0.0 111.288 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.25 12.53 0.56 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.585 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.48 148.59 0.14 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -174.92 4.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.941 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.22 32.91 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 176.03 101.54 0.15 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.415 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.834 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -135.93 158.55 44.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.789 0.328 . . . . 0.0 111.097 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.1 mt -159.62 156.96 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.431 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.741 HD12 ' H ' ' A' ' 28' ' ' TYR . 1.4 tp -147.98 159.05 44.3 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.183 0.516 . . . . 0.0 111.293 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.43 134.87 26.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.021 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 30' ' ' LEU . 38.9 t -134.09 123.91 45.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 111.326 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 77.9 t -127.5 94.46 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.77 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.7 p -135.39 170.23 16.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.221 0.534 . . . . 0.0 111.72 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -117.82 124.57 48.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.37 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 49.3 t -144.57 116.24 5.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.67 -30.39 92.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.575 2.183 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -77.91 -163.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -119.07 -24.21 6.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.169 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.35 122.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.774 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -80.14 124.45 28.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.54 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -73.89 -87.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.934 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 6.6 mm -46.45 -54.07 20.49 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.774 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -59.41 -26.29 81.42 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.071 1.847 . . . . 0.0 112.989 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.5 tp -65.55 -38.77 90.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.846 0.355 . . . . 0.0 110.841 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -49.54 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.62 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.644 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -71.51 -27.13 63.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -71.94 -34.99 69.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.28 -64.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 3.6 t-80 -64.68 -30.32 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.87 96.76 0.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.59 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' HB2' ' HE1' ' A' ' 48' ' ' MET . 0.4 OUTLIER -93.29 -104.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.639 0.257 . . . . 0.0 110.809 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -133.5 -69.05 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.32 . . . . 0.0 110.825 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.707 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 2.3 t -126.21 121.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 74' ' ' ALA . 3.8 mm? -123.37 104.85 9.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.401 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.9 156.99 46.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.691 0.282 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.25 173.21 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 111.588 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.55 ' O ' HG13 ' A' ' 91' ' ' ILE . 9.8 mt-30 -154.22 162.71 41.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -144.02 149.4 36.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.05 -81.77 0.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.15 -88.17 0.15 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.356 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.79 -1.28 9.49 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.754 2.302 . . . . 0.0 112.891 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -136.48 175.94 9.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.902 0.382 . . . . 0.0 111.189 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 85' ' ' GLN . 4.6 tt -146.81 143.46 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.63 135.22 53.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.278 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.465 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -123.51 145.34 48.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.31 148.58 25.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.212 0.53 . . . . 0.0 111.937 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -131.6 157.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.048 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.707 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -148.48 178.74 8.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.834 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 6.7 tptt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.689 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.794 0.331 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.52 23.35 12.78 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.542 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.35 147.69 49.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 t -117.0 -73.04 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -111.14 16.44 21.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -62.27 153.72 29.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -77.99 -8.43 58.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.999 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.28 120.01 15.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.072 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.42 ' HB2' ' H ' ' A' ' 10' ' ' HIS . 1.7 p-80 -112.22 -160.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.42 ' H ' ' HB2' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -74.25 88.98 2.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -160.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.5 72.03 5.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -129.19 68.62 0.54 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.466 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.716 HD12 HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.81 -42.92 4.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.807 0.337 . . . . 0.0 110.963 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.716 HG13 HD12 ' A' ' 14' ' ' LEU . 18.1 m -103.35 147.5 34.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.128 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.3 -156.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.464 2.109 . . . . 0.0 112.2 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.416 HH11 ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -69.59 91.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.009 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.78 97.62 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.312 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.0 m -64.11 -70.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.766 0.317 . . . . 0.0 111.194 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -117.58 -174.94 2.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.919 0.39 . . . . 0.0 111.113 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -164.31 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.975 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.59 66.68 1.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -118.11 30.47 7.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.58 HG22 ' H ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -111.86 173.75 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.95 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 2.0 t -63.68 -50.35 72.24 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.654 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 23.5 Cg_endo -60.33 95.06 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.102 1.868 . . . . 0.0 112.02 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.65 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -59.49 -74.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.391 -179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.656 ' H ' HD12 ' A' ' 57' ' ' LEU . 10.9 t80 -134.44 164.67 26.94 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.56 141.88 46.8 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 30' ' ' LEU . 1.2 tm? -134.17 83.56 2.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.076 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.64 67.63 0.91 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.567 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 61' ' ' SER . 1.0 OUTLIER -136.5 -110.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 35' ' ' GLU . 34.5 t -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.448 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.9 -5.8 15.57 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.226 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.612 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.3 pt-20 -64.47 159.32 60.68 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.486 0.184 . . . . 0.0 110.839 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.16 93.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.556 2.171 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -90.09 150.72 43.93 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -46.49 -60.5 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.716 2.278 . . . . 0.0 112.791 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.19 73.12 32.16 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.272 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HD2' HG23 ' A' ' 42' ' ' VAL . 83.3 Cg_endo -90.7 -98.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.896 2.397 . . . . 0.0 112.512 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -60.24 -5.24 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.535 HG23 ' HD2' ' A' ' 40' ' ' PRO . 32.7 t -47.02 -32.26 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.45 -44.54 57.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -47.69 -54.55 11.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 45' ' ' LEU . 15.4 mt -62.5 -58.24 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 26.8 mt-10 -60.07 -15.3 22.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 111.135 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.22 -38.49 68.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.535 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.7 mtp -47.91 -54.16 26.26 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.402 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 31.1 Cg_exo -60.51 -59.71 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.757 1.638 . . . . 0.0 111.357 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -73.8 23.74 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.87 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 48' ' ' MET . 1.3 pp -52.03 177.39 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 0.0 111.97 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.875 ' HG2' ' H ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -159.07 164.88 34.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.244 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -73.29 23.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 111.306 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.875 ' H ' ' HG2' ' A' ' 52' ' ' LYS . . . -168.83 69.12 0.16 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HG2' ' HB2' ' A' ' 27' ' ' ASP . 5.0 tm-20 -112.06 152.15 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -160.22 158.24 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.428 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 28' ' ' TYR . 2.5 tp -140.31 163.87 31.61 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.323 0.582 . . . . 0.0 111.156 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.95 128.52 13.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.957 175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.5 t -128.64 114.1 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.896 0.379 . . . . 0.0 111.462 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -118.28 96.5 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.15 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -137.14 172.84 12.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.608 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.432 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.3 p -159.11 140.33 9.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.218 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.77 16.75 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.606 2.204 . . . . 0.0 112.276 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -116.92 -165.83 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -72.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.5 mm -83.79 140.45 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.021 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 1.6 t30 -97.18 -179.16 4.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.69 -38.39 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.739 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm -67.79 -50.45 34.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 33.0 Cg_endo -62.58 -36.91 61.75 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.274 1.982 . . . . 0.0 112.244 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.17 -25.71 65.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -58.62 4.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -63.34 -36.32 83.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -63.51 -30.6 71.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -65.73 -70.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.402 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 1.5 t-80 -57.86 -35.54 71.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.765 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.41 79.89 1.49 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.55 -157.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 97' ' ' LYS . 2.9 m -72.5 -78.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.498 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.619 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 2.0 m -130.19 145.87 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD13 HG22 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -128.35 111.95 13.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.468 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -127.1 159.99 32.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.724 0.297 . . . . 0.0 110.958 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.566 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -140.79 -178.41 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.179 0.514 . . . . 0.0 111.69 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -154.5 -173.86 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.203 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -136.75 116.71 13.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 111.26 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.67 -176.75 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.673 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.8 117.41 1.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.755 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.502 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 82.7 Cg_endo -100.45 66.94 0.32 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 C-N-CA 124.318 -1.118 . . . . 0.0 112.653 0.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 p -147.81 -173.82 4.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 111.27 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.571 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tt -136.2 151.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.515 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.678 HH11 HD22 ' A' ' 94' ' ' LEU . 3.0 tpp85 -123.7 142.75 50.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.893 0.378 . . . . 0.0 111.762 -177.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.626 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 7.9 m-85 -136.54 117.55 14.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.078 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.678 HD22 HH11 ' A' ' 92' ' ' ARG . 0.4 OUTLIER -131.87 146.24 52.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 111.724 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -129.66 161.86 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.356 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.641 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -148.24 154.17 39.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.905 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.629 ' HA ' HG21 ' A' ' 80' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmm . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.849 0.357 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.33 -105.69 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.492 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.96 29.07 7.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.911 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.88 101.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.63 112.9 24.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.763 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.29 70.1 7.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.996 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.35 90.12 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.91 -98.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.45 -165.01 1.83 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -99.87 148.28 24.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -82.7 120.47 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.3 39.75 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.34 160.74 39.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.02 3.29 56.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 p -109.8 122.2 39.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.11 -69.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.461 2.107 . . . . 0.0 112.434 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.428 ' HB2' ' H ' ' A' ' 18' ' ' GLY . 4.8 mtm180 -111.42 -87.33 0.54 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 17' ' ' ARG . . . -140.28 112.3 0.8 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.428 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 86.2 p -96.17 19.27 12.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 0.0 110.912 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.91 -62.55 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.798 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.42 73.58 10.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.821 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -4.55 5.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.966 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -74.64 -179.73 4.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.88 101.37 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.0 m -90.91 132.15 35.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.53 ' HG2' ' HG3' ' A' ' 55' ' ' GLU . 46.5 Cg_exo -56.72 -86.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.624 2.216 . . . . 0.0 112.244 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 5.7 p-10 41.09 64.87 0.9 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.093 0.473 . . . . 0.0 110.745 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.16 160.39 14.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.598 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 10.1 ptt85 -128.53 129.42 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 0.0 111.94 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.705 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -122.23 77.27 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.525 177.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.3 p30 -101.91 68.14 1.12 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.728 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' SER . 10.5 mtt -137.13 -112.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.889 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.406 ' H ' ' HB3' ' A' ' 32' ' ' MET . 7.6 p -135.57 143.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.987 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 111.12 3.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.327 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -122.81 140.73 33.78 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.646 0.26 . . . . 0.0 110.946 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 35' ' ' GLU . 23.9 Cg_exo -64.67 -41.65 18.35 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.732 2.288 . . . . 0.0 112.336 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 32.4 t -54.25 126.05 52.43 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.094 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 28.4 Cg_exo -61.86 88.31 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.626 2.217 . . . . 0.0 112.137 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.822 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -139.71 -53.71 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.211 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.822 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 41.3 Cg_endo -67.83 -70.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.121 1.881 . . . . 0.0 112.332 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.67 0.79 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 40' ' ' PRO . 14.4 t -48.69 -32.64 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.391 . . . . 0.0 110.567 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . . . -72.93 -37.94 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.632 HG23 HD22 ' A' ' 57' ' ' LEU . 1.9 m -58.07 -59.02 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.243 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.88 -32.56 67.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.73 -28.21 63.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 110.509 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.6 -26.94 61.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.402 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.529 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 32.6 mmt -53.72 -54.85 41.7 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.652 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 59.8 Cg_endo -71.01 -39.68 3.93 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.815 1.677 . . . . 0.0 111.595 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.91 6.91 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.07 150.48 0.58 Allowed 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.917 0.389 . . . . 0.0 111.252 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 54.2 mmtt -145.88 -159.31 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.445 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.02 16.49 4.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 65.35 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.877 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.724 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 20.8 tt0 -86.67 146.73 26.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.67 0.271 . . . . 0.0 110.406 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.2 mp -155.53 153.44 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 44' ' ' THR . 15.0 tp -142.85 164.99 28.59 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.305 0.574 . . . . 0.0 111.146 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -149.46 135.02 18.51 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 30' ' ' LEU . 15.4 t -137.85 132.31 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.11 0.481 . . . . 0.0 111.624 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.5 t -136.84 83.04 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.029 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.4 p -123.58 175.16 6.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.65 125.92 51.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.463 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 147.62 16.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.75 5.0 6.46 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.25 161.77 27.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.02 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.4 m -72.08 -52.27 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.67 143.73 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' H ' ' HG2' ' A' ' 71' ' ' PRO . 2.9 t-20 -134.3 -172.3 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -72.33 -47.49 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.765 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -59.52 -49.33 92.75 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 41.7 Cg_endo -66.47 -41.14 12.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.119 1.88 . . . . 0.0 112.505 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -21.27 64.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -62.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -57.41 -41.21 79.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.677 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.628 ' HA ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.957 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -66.75 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -59.39 4.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.563 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.74 100.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.463 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.651 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.8 p90 -90.41 -171.63 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 111.65 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.479 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 28.6 m -115.29 -49.72 2.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.08 176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.711 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 t -139.23 115.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.138 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.614 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -122.67 100.21 6.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -178.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.32 150.15 50.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.11 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.463 . . . . 0.0 111.626 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 91' ' ' ILE . 1.6 tm0? -145.44 171.34 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.65 126.43 46.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.165 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -174.16 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.47 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.07 121.96 2.11 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.709 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 78.4 Cg_endo -102.15 62.25 0.58 Allowed 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.759 1.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.3 p -148.87 -174.57 4.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.98 0.419 . . . . 0.0 111.534 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 85' ' ' GLN . 8.1 tt -142.38 145.53 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -123.74 146.56 48.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.108 0.48 . . . . 0.0 111.499 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 3.1 m-85 -132.02 131.05 42.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.017 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.33 143.74 46.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 111.402 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.614 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.43 157.06 39.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.682 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.711 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -154.47 166.03 34.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.724 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.6 tttp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.791 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttp . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.705 0.288 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.25 129.58 9.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.499 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.9 t -123.1 -28.51 4.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.747 0.308 . . . . 0.0 110.961 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.92 128.75 45.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.47 137.35 53.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.999 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -115.41 -172.24 2.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.842 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.2 -72.32 0.59 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.937 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -86.9 175.79 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -72.2 -175.87 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -46.04 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.02 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.32 -172.42 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.6 p -77.28 -170.08 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.21 -90.74 0.67 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.52 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.54 81.96 1.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.885 0.374 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.6 113.2 9.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.62 -17.99 8.32 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.656 2.237 . . . . 0.0 112.619 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -119.9 106.01 11.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.163 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.48 14.53 63.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.508 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 p -85.02 -167.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.652 0.263 . . . . 0.0 110.874 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -54.35 113.23 1.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 tpt -115.22 -70.05 0.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.99 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 -64.49 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -133.1 135.84 45.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.569 ' HB ' ' HD1' ' A' ' 28' ' ' TYR . 3.3 mp -129.5 124.63 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.032 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.607 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -96.67 -53.64 0.21 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.294 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 25' ' ' VAL . 49.7 Cg_endo -67.69 117.38 4.83 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.928 1.752 . . . . 0.0 112.018 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.646 ' HB3' HD12 ' A' ' 56' ' ' ILE . 5.0 p-10 48.46 87.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.399 0.619 . . . . 0.0 111.509 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.637 ' H ' HD12 ' A' ' 57' ' ' LEU . 52.7 t80 -102.53 147.0 27.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.7 mtt85 -104.9 135.88 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.2 tm? -134.54 82.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.327 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -103.13 66.77 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.9 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -136.29 -112.61 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.119 0.485 . . . . 0.0 111.266 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG22 ' OD1' ' A' ' 62' ' ' ASP . 6.4 t -135.01 152.46 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.794 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.78 -7.56 16.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.096 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.86 159.01 66.69 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.481 0.181 . . . . 0.0 110.841 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.98 89.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.483 2.122 . . . . 0.0 112.197 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . 1.2 m -81.69 159.58 66.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.977 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.29 -52.63 4.54 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.569 2.179 . . . . 0.0 112.542 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -133.22 65.26 72.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.336 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.473 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 63.8 Cg_endo -93.13 -109.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.871 2.381 . . . . 0.0 112.496 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.883 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -59.52 -4.24 0.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 9.8 p -47.12 -33.38 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.46 -39.44 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.119 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 3.6 m -55.72 -55.3 33.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.834 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.567 ' O ' ' HE2' ' A' ' 48' ' ' MET . 95.2 mt -57.39 -52.7 64.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.272 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 5.9 pt-20 -68.55 -11.37 59.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.53 -39.57 67.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.458 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.567 ' HE2' ' O ' ' A' ' 45' ' ' LEU . 53.2 mtm -53.51 -53.7 53.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.65 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 48' ' ' MET . 53.4 Cg_endo -67.83 -52.08 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.677 1.584 . . . . 0.0 111.313 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -73.85 19.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.834 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -51.4 178.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.415 0.626 . . . . 0.0 111.795 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HD2' ' HE2' ' A' ' 53' ' ' LYS . 31.6 mmtt -149.0 -144.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HE2' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.45 26.73 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.313 . . . . 0.0 111.159 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 97' ' ' LYS . . . 126.12 84.19 0.52 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.613 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.591 ' N ' ' HB3' ' A' ' 97' ' ' LYS . 5.3 pt-20 -74.84 -179.81 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -159.91 -178.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.766 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.637 HD12 ' H ' ' A' ' 28' ' ' TYR . 6.5 tp -158.85 156.0 28.84 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.05 101.25 3.14 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.988 175.323 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 70' ' ' ILE . 1.4 p -119.32 131.54 71.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.822 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 12.2 t -132.47 111.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.194 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -143.02 177.44 8.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 0.0 111.419 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' HG22 ' A' ' 33' ' ' VAL . 5.1 p-10 -117.9 130.53 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 129.78 3.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.073 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.93 -17.79 22.17 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.527 2.151 . . . . 0.0 112.231 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.73 156.4 16.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.951 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -40.48 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 72' ' ' LEU . 1.5 mp -65.55 109.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.544 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -102.35 165.21 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.21 -75.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.883 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 2.4 mm -44.86 -53.3 16.09 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.544 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 22.8 Cg_endo -62.19 -39.31 49.24 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.959 1.772 . . . . 0.0 113.047 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.596 HD13 HG23 ' A' ' 67' ' ' ILE . 5.1 tp -65.5 -22.14 66.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 111.148 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.12 -58.38 3.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.87 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.854 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -60.14 -41.17 92.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.793 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -63.28 -31.6 72.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.41 -66.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.21 -64.19 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.15 104.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.62 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.854 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.8 p90 -90.64 -163.23 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.253 0.549 . . . . 0.0 111.466 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 2.2 m -115.22 -54.68 2.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.343 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.695 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.4 t -140.22 114.2 6.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.389 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.793 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.09 102.84 8.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -124.02 151.5 43.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.645 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.986 HG22 ' HB3' ' A' ' 93' ' ' TYR . 23.0 pt -136.08 165.1 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.407 . . . . 0.0 111.466 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -154.55 159.73 41.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -125.66 154.67 42.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.46 -85.13 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.786 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.52 -105.89 1.35 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.976 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.33 12.37 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.46 2.107 . . . . 0.0 112.086 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -140.8 179.44 6.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 93' ' ' TYR . 20.7 tt -146.88 144.26 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.574 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 136.45 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.986 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.93 159.93 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.181 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.08 146.88 24.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.793 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.98 160.67 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.669 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.695 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -153.95 156.53 37.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.942 0.401 . . . . 0.0 111.338 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HB3' ' N ' ' A' ' 55' ' ' GLU . 4.2 tptp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.583 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.829 0.347 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.67 -159.94 8.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.536 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 p -102.53 9.21 39.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 111.053 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.34 149.66 27.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -67.7 -74.78 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -69.77 152.93 44.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -84.51 158.65 20.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -64.51 149.25 48.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.992 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -126.11 156.18 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.83 104.93 16.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.996 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.98 157.32 16.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -119.68 -62.57 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.99 -142.14 8.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -112.96 160.81 17.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.32 143.82 45.69 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.183 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.39 104.65 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.565 2.177 . . . . 0.0 112.288 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 17' ' ' ARG . 10.0 mmm180 -69.96 134.14 48.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.37 -45.27 96.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.492 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.07 167.45 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.891 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -103.94 152.19 22.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.19 122.54 42.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.004 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.23 101.75 13.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.15 14.78 20.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.5 pt -99.34 6.06 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.039 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 t -98.51 -50.92 0.21 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.797 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 68.7 Cg_exo -51.76 111.45 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.197 1.932 . . . . 0.0 112.637 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -76.11 -76.74 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.343 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.5 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 3.4 t80 -135.54 164.28 28.18 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.996 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -134.66 113.73 12.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.848 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.804 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -109.05 81.93 1.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.51 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.58 68.91 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.471 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 61' ' ' SER . 16.4 mtt -136.24 -109.23 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.324 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 62' ' ' ASP . 21.7 t -134.73 138.68 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.9 70.22 2.33 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.425 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 21.4 tt0 -121.3 140.07 30.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.525 0.203 . . . . 0.0 110.519 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 13.1 Cg_endo -56.61 -50.36 12.02 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.72 2.28 . . . . 0.0 112.601 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.5 122.13 38.28 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.171 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.11 160.59 94.39 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.133 -0.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.506 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -76.48 114.04 34.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . 3.5 Cg_endo -88.01 -55.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.335 2.69 . . . . 0.0 112.598 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.848 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -52.85 -0.38 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 39' ' ' TYR . 93.8 t -47.17 -30.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.63 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.61 64.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -54.87 -50.98 67.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.34 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.425 HD11 ' OD1' ' A' ' 73' ' ' ASP . 71.3 mt -61.77 -52.87 62.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.375 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -66.41 -13.38 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.137 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.62 -40.1 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.254 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 10.1 mtm -48.14 -52.99 37.18 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 51' ' ' LEU . 30.2 Cg_exo -60.5 -60.05 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.742 1.628 . . . . 0.0 111.434 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -74.61 24.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.954 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.54 -159.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 112.02 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.746 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -165.89 -174.7 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.191 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -83.4 36.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 150.58 102.76 0.25 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.489 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.908 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -124.48 177.74 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 55' ' ' GLU . 17.9 mt -159.47 161.7 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' CD1' ' HB3' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -160.67 130.25 4.99 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.472 -0.768 . . . . 0.0 111.423 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 1.2 mt-10 -118.71 118.36 31.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.765 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 30' ' ' LEU . 58.9 t -118.53 113.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.994 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.638 HG22 ' HE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -117.49 94.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 110.435 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -126.71 166.59 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.128 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' HB3' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -117.74 133.16 56.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.622 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 t -152.13 132.39 7.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.13 -18.04 24.15 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.488 2.125 . . . . 0.0 112.281 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.47 -162.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -117.64 -17.37 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mt -68.16 127.67 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.785 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -94.48 126.62 39.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.23 -82.43 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.848 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 7.3 mm -44.51 -54.82 11.45 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -61.25 -24.09 78.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.004 1.803 . . . . 0.0 112.921 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.8 tt -69.55 -33.46 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 45' ' ' LEU . 3.6 m-20 -66.41 -53.48 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -62.37 -36.29 81.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 75' ' ' ARG . 11.2 ttp180 -66.62 -33.13 74.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.81 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -60.58 -61.04 2.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.544 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 0.8 OUTLIER -67.74 -62.12 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 91.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.73 -164.21 1.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.0 110.345 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.588 HG21 ' HG2' ' A' ' 97' ' ' LYS . 24.3 m -82.35 -79.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 22.0 t -112.13 117.62 55.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.567 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.73 116.04 22.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -147.06 155.12 41.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.997 HG22 ' HB3' ' A' ' 93' ' ' TYR . 20.6 pt -135.1 170.25 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.004 0.431 . . . . 0.0 111.561 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.76 148.45 25.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.64 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.95 149.17 50.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.889 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -118.1 -83.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.19 -90.15 0.18 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.446 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.62 3.14 8.04 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.649 2.233 . . . . 0.0 112.812 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 62' ' ' ASP . 32.2 p -145.4 174.93 10.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.508 HG12 ' CE1' ' A' ' 93' ' ' TYR . 16.5 tt -144.43 139.8 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.836 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.638 ' HE ' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -124.01 132.7 53.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.348 -177.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.997 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.75 156.33 34.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.34 145.33 22.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 112.105 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.567 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -132.63 153.08 37.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.124 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.61 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.4 OUTLIER -154.6 175.26 13.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 111.235 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.908 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.77 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.837 0.351 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.37 -1.25 31.19 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.634 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 t -90.12 120.04 30.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.971 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 t -114.82 109.43 18.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -137.85 44.13 2.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -116.89 95.26 4.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.905 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -119.93 119.79 34.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -110.82 179.75 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.81 96.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -88.12 167.62 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.985 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.0 p -71.99 -57.53 4.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -137.14 99.88 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.85 74.4 0.27 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.612 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.81 137.49 34.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.715 0.293 . . . . 0.0 110.829 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.99 102.01 38.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.113 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -78.6 -1.58 11.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.602 2.202 . . . . 0.0 112.325 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.13 16.29 6.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.032 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.21 -33.66 0.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.523 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.91 169.02 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.775 0.321 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -94.6 163.37 13.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.998 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.5 ptm -93.49 -12.28 30.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.758 ' HD2' HD11 ' A' ' 56' ' ' ILE . 43.1 pttt -81.07 -172.35 3.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.804 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -134.35 147.39 50.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.957 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.622 HG22 ' HB3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -130.31 116.73 37.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.894 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.636 HG23 ' HA ' ' A' ' 55' ' ' GLU . 47.5 t -68.27 -55.0 13.42 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.957 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.622 ' HB3' HG22 ' A' ' 24' ' ' ILE . 69.6 Cg_endo -89.72 164.5 35.72 Favored 'Cis proline' 0 C--N 1.357 0.992 0 C-N-CA 124.621 -0.991 . . . . 0.0 111.897 -2.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 56' ' ' ILE . 39.8 t0 -68.98 -89.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.733 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.837 ' H ' HD12 ' A' ' 57' ' ' LEU . 10.5 t80 -136.62 166.41 23.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.391 . . . . 0.0 111.758 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.55 ' NH2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -134.56 105.99 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.802 178.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.705 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.1 tm? -103.83 81.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.7 m-20 -103.62 66.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.149 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.24 -105.83 0.21 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.0 t -134.33 148.82 29.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.499 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -81.54 55.58 4.86 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.621 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' HG3' ' HB2' ' A' ' 37' ' ' CYS . 3.1 pt-20 -79.69 159.01 72.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.531 0.205 . . . . 0.0 110.759 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -93.24 21.5 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.953 2.435 . . . . 0.0 112.732 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.634 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 1.3 m -84.88 149.7 54.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.902 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.98 66.82 8.73 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.583 2.189 . . . . 0.0 112.26 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.876 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 11.9 m-85 -140.25 -52.84 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.978 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.876 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 23.6 Cg_endo -62.11 -85.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.406 2.071 . . . . 0.0 113.337 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.786 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -56.87 -2.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 5.4 t -45.49 -35.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.6 -46.57 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.275 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 74' ' ' ALA . 54.7 m -49.44 -46.93 48.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.623 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 45' ' ' LEU . 19.3 mt -63.48 -57.38 10.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.282 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 mm-40 -64.76 -10.58 28.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.014 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -73.67 -40.37 63.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.154 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -51.97 -47.67 90.54 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.991 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.3 Cg_endo -69.98 -51.76 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.711 1.607 . . . . 0.0 111.759 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 14.3 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.401 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.15 156.06 0.18 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.999 0.428 . . . . 0.0 111.868 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -125.75 -164.91 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -88.32 40.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.844 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.4 113.27 1.52 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.29 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.893 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 15.8 pt-20 -135.3 -177.05 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.758 HD11 ' HD2' ' A' ' 22' ' ' LYS . 1.6 mt -161.04 152.08 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.272 0.558 . . . . 0.0 111.141 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.837 HD12 ' H ' ' A' ' 28' ' ' TYR . 4.7 tp -127.02 158.98 35.5 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -144.35 107.77 4.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.196 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 30' ' ' LEU . 45.5 t -117.57 112.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.616 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 90.6 t -118.59 94.73 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.694 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.2 p -125.5 171.83 10.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.897 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -118.04 122.6 43.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.581 179.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.24 131.27 8.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.971 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.48 -8.65 18.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.596 2.198 . . . . 0.0 112.314 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -97.0 -167.32 1.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.957 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.38 -26.09 8.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 mt -66.85 123.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.76 130.4 37.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.843 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.62 -70.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.101 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.786 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 2.8 mm -49.64 -52.49 50.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.1 Cg_exo -57.61 -43.25 52.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.272 1.981 . . . . 0.0 112.87 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.34 -21.98 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.203 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -71.99 -57.88 3.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.95 -41.7 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.708 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.17 -33.75 75.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.006 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.26 -61.08 2.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.569 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.598 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 8.9 m170 -72.37 -69.08 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.19 103.94 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 51.3 p90 -92.93 -162.4 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.126 0.488 . . . . 0.0 111.328 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.466 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -113.25 -52.75 2.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.258 176.129 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.834 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 48.1 t -143.95 118.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.171 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.683 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -122.95 115.18 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.964 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.15 155.46 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.952 HG22 ' HB3' ' A' ' 93' ' ' TYR . 19.4 pt -133.05 167.1 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.479 . . . . 0.0 111.601 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 91' ' ' ILE . 30.6 tt0 -154.63 165.44 36.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.413 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -132.1 147.33 52.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.798 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -107.85 -81.4 0.56 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.636 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.31 -92.53 0.22 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.815 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.33 3.66 7.14 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.803 2.336 . . . . 0.0 112.033 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' OD2' ' A' ' 62' ' ' ASP . 25.0 p -136.47 -178.24 5.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.7 tt -143.34 151.1 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -140.03 131.79 27.44 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.815 0.341 . . . . 0.0 111.302 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.952 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.05 140.46 53.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.246 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.87 157.01 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.683 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.22 162.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.614 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.834 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.79 155.6 34.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.893 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.502 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.801 0.334 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.5 169.67 14.34 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 t -133.49 -79.28 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.78 155.99 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.009 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -95.23 -33.49 12.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.97 163.92 22.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.13 148.63 48.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -118.01 -165.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -69.38 164.29 23.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.92 -179.82 4.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 p -119.44 88.12 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -118.4 65.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.69 142.25 20.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.473 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 138.03 42.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.747 0.308 . . . . 0.0 111.007 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.14 108.07 44.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.08 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.76 -23.97 52.83 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.644 2.229 . . . . 0.0 112.373 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -43.76 88.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.13 25.32 10.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.471 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -167.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 0.0 110.872 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.7 -27.88 66.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.1 mtt -78.34 134.7 37.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.952 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.99 -176.3 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.038 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -99.73 -70.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mt -129.47 103.94 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.113 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -113.06 -53.48 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.486 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD2' ' H ' ' A' ' 25' ' ' VAL . 72.0 Cg_exo -51.28 115.2 1.91 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.004 1.803 . . . . 0.0 112.159 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.556 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 27.6 t70 -94.07 -80.37 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.675 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.471 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.91 168.42 19.36 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.651 -0.819 . . . . 0.0 112.656 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 13.2 mtp180 -134.82 118.01 16.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.721 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.016 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -116.47 78.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.947 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.9 67.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.391 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 61' ' ' SER . 15.5 mtt -136.46 -110.65 0.19 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 111.504 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 62' ' ' ASP . 84.8 t -135.41 122.95 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.79 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.429 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . -68.13 92.48 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.228 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -81.87 162.62 56.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.44 0.162 . . . . 0.0 110.709 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 96.4 Cg_endo -78.66 34.66 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.529 2.152 . . . . 0.0 112.535 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 7.6 m -132.06 153.44 81.35 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.904 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.77 -22.01 21.94 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.653 2.235 . . . . 0.0 112.656 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HA ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -96.72 154.62 38.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.026 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 1.016 ' HB2' HD21 ' A' ' 30' ' ' LEU . 4.1 Cg_exo -82.06 0.38 49.61 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.629 1.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.595 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -55.34 -2.55 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.946 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.614 HG23 ' HA ' ' A' ' 39' ' ' TYR . 79.2 t -51.91 -28.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.046 0.45 . . . . 0.0 110.05 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -70.57 -38.74 74.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.23 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.544 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -58.51 -46.35 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.944 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 73' ' ' ASP . 1.2 tp -67.79 -39.26 84.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.783 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.556 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 2.5 pt-20 -72.12 -17.29 61.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.648 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.56 -36.75 68.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.875 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.659 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 22.0 mtp -49.6 -54.14 34.14 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.383 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 18.3 Cg_exo -65.45 -45.61 6.8 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.021 1.814 . . . . 0.0 111.485 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -73.23 12.78 0.51 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.55 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.643 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.56 159.1 0.1 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.09 0.471 . . . . 0.0 111.935 -179.289 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -142.6 -160.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.631 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -86.78 33.51 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 25' ' ' VAL . . . 150.2 114.96 0.71 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.305 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.814 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -121.17 166.75 13.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.645 0.26 . . . . 0.0 110.907 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 55' ' ' GLU . 10.6 mm -159.22 149.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -160.69 131.12 5.28 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.907 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -121.73 132.93 54.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.551 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.48 126.63 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.585 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 2.2 t -125.75 101.53 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.0 m -142.41 169.82 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.231 0.539 . . . . 0.0 112.073 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.16 129.2 55.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.196 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 68' ' ' ASN . 30.5 p -156.83 136.52 8.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.333 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.92 -25.65 8.76 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.461 2.107 . . . . 0.0 112.263 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.35 -162.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -140.12 10.37 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.859 ' HA ' HD13 ' A' ' 72' ' ' LEU . 44.5 mm -111.35 -26.9 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.89 0.376 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 63' ' ' CYS . 7.6 m120 -52.1 -12.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.534 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.875 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 1.9 m-20 -50.9 119.34 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.539 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.724 HG12 HG21 ' A' ' 59' ' ' VAL . 22.7 mm -51.65 -49.93 80.16 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.311 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 36.9 Cg_exo -62.0 -22.32 74.04 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.139 1.893 . . . . 0.0 111.965 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.875 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -62.4 -39.34 92.92 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.108 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.508 ' HB3' HD13 ' A' ' 45' ' ' LEU . 14.2 m-20 -59.75 -45.56 91.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 79' ' ' TYR . . . -70.46 -23.33 62.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.607 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -38.54 66.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.537 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -56.53 -58.72 6.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.457 ' HB2' ' SD ' ' A' ' 48' ' ' MET . 73.6 m80 -69.36 -45.16 70.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.322 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.16 87.88 1.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.162 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -87.7 -140.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -97.85 -72.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.807 0.337 . . . . 0.0 110.991 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 26.3 t -127.68 123.63 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.4 mm? -123.44 101.65 7.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.91 158.3 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.473 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.935 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -138.82 172.06 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 91' ' ' ILE . 26.3 mt-30 -154.36 156.33 36.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.215 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 152.53 51.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.791 0.329 . . . . 0.0 111.22 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -122.72 -78.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 89' ' ' PRO . . . -139.99 -106.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HD3' ' HA3' ' A' ' 88' ' ' GLY . 2.8 Cg_exo -75.84 10.04 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.71 2.274 . . . . 0.0 111.949 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 67.7 p -138.98 170.73 15.44 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.9 tt -150.93 136.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.046 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -127.93 140.43 52.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.326 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.935 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -123.66 166.19 15.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.947 178.229 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.44 144.8 21.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.525 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -129.25 149.57 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.388 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.444 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 5.4 pt20 -142.94 155.92 44.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.791 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 10.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.815 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.27 -25.12 4.82 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.452 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.34 -64.82 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.773 0.32 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.7 p -131.61 142.37 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -87.13 -91.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 -86.41 0.2 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.071 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -140.14 -163.52 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.933 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -74.43 -169.76 0.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.44 17.47 4.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.037 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -72.34 117.98 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -123.67 -178.8 4.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.025 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.18 153.28 32.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.22 140.73 28.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.45 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.09 163.06 22.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.34 . . . . 0.0 111.012 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.97 131.84 50.2 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.33 101.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.577 2.185 . . . . 0.0 112.201 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -121.44 -48.41 2.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.77 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.45 18.41 3.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.346 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.7 56.35 3.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 111.019 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -82.71 5.31 21.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.73 103.69 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -79.23 -77.25 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -134.44 -73.63 0.48 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.122 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.439 HD13 ' NZ ' ' A' ' 52' ' ' LYS . 1.1 tt -111.01 -43.14 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.205 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.786 HG23 ' HB ' ' A' ' 56' ' ' ILE . 2.5 p -53.88 134.04 57.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.834 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.654 ' HB3' HG22 ' A' ' 56' ' ' ILE . 12.7 Cg_exo -71.89 146.16 85.03 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.495 1.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.37 -72.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.326 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.59 ' HB2' HD11 ' A' ' 57' ' ' LEU . 62.8 m-85 -134.17 160.83 36.62 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.81 0.338 . . . . 0.0 111.638 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 144.71 46.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.837 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.622 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.1 tm? -134.3 81.41 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.514 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.0 p-10 -103.22 65.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.89 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 61' ' ' SER . 6.2 mtp -137.2 -105.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 32' ' ' MET . 2.4 t -134.93 156.79 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.381 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.54 -9.6 13.49 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.198 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.775 ' HG3' ' H ' ' A' ' 37' ' ' CYS . 9.2 pt-20 -60.23 165.05 5.54 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 122.122 0.169 . . . . 0.0 110.987 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.582 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 27.9 Cg_endo -62.92 3.67 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.649 2.233 . . . . 0.0 112.729 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.775 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 1.2 m -109.47 153.68 42.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.815 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HD2' HD21 ' A' ' 30' ' ' LEU . 61.5 Cg_endo -74.42 -62.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.557 -1.435 . . . . 0.0 112.572 0.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.595 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 96.9 m-85 -69.98 -59.35 4.45 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.792 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' O ' ' HB2' ' A' ' 39' ' ' TYR . 74.0 Cg_endo -104.17 -80.94 0.0 OUTLIER 'Cis proline' 0 C--N 1.357 1.025 0 CA-C-N 119.321 0.793 . . . . 0.0 112.144 -0.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -64.75 6.97 0.18 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.471 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' A' ' 39' ' ' TYR . 1.4 p -53.29 -27.48 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.457 . . . . 0.0 110.178 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.574 ' HB1' ' CG ' ' A' ' 28' ' ' TYR . . . -73.44 -37.28 65.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.705 178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 74' ' ' ALA . 2.8 m -54.23 -63.72 1.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.321 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.453 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 20.9 mt -56.29 -38.22 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.275 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 4.9 tt0 -64.55 -28.76 69.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.639 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB2' ' CD2' ' A' ' 28' ' ' TYR . . . -73.08 -24.21 60.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.744 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 38.6 mmt -57.2 -55.88 39.59 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.703 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 11.7 Cg_exo -70.45 -44.49 1.58 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.117 1.878 . . . . 0.0 111.554 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.86 8.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.382 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -44.0 154.39 0.11 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.98 0.419 . . . . 0.0 111.552 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.439 ' NZ ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.33 -157.71 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.836 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -78.02 8.44 4.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.133 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' OXT' ' A' ' 97' ' ' LYS . . . 160.78 82.09 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.804 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -81.91 172.34 13.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.786 ' HB ' HG23 ' A' ' 25' ' ' VAL . 4.5 mt -160.27 155.97 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 28' ' ' TYR . 1.1 tp -139.59 161.17 38.17 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.019 0.437 . . . . 0.0 111.247 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -143.18 113.17 7.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -118.12 114.97 46.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.395 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 61.1 t -119.05 94.24 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.09 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -130.75 173.69 10.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.521 . . . . 0.0 111.771 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.401 ' OD2' HG22 ' A' ' 90' ' ' THR . 0.7 OUTLIER -117.43 130.85 56.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.337 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.54 117.45 3.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.93 -17.83 61.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.679 2.253 . . . . 0.0 112.09 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -108.85 -163.49 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 t -102.57 -18.46 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -69.98 130.56 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -137.09 129.73 30.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.294 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.33 -48.73 69.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.73 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -56.96 -55.73 40.82 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.53 ' HA ' HD11 ' A' ' 82' ' ' LEU . 28.8 Cg_endo -62.57 -33.6 77.57 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.644 1.563 . . . . 0.0 112.201 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -29.46 68.93 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -57.39 12.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.719 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -66.51 -37.73 85.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 29.9 ttt-85 -63.43 -54.98 28.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.592 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -47.88 -55.01 10.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.214 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -70.13 -71.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.532 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.99 98.74 0.15 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.707 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.6 p90 -88.78 -165.35 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 0.0 111.406 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.594 HG21 ' HD2' ' A' ' 97' ' ' LYS . 39.5 m -112.16 -52.24 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.057 175.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 41.3 t -141.84 116.6 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -122.53 105.01 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.619 -178.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -123.66 163.62 20.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.648 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.882 HG22 ' HB3' ' A' ' 93' ' ' TYR . 15.5 pt -139.91 168.3 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.431 . . . . 0.0 111.433 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.5 mt-30 -154.42 155.76 35.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.39 154.4 50.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -123.45 -80.56 0.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.63 -97.52 0.36 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.406 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 9.55 3.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.401 HG22 ' OD2' ' A' ' 62' ' ' ASP . 47.5 p -146.37 176.4 9.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.955 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.0 tt -145.04 140.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.654 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 92' ' ' ARG . 3.7 ttm-85 -133.2 132.55 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.882 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.39 164.7 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.829 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.92 158.6 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.904 0.383 . . . . 0.0 111.443 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -134.47 162.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.922 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.778 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -154.5 156.21 36.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.629 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.62 -153.76 8.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.551 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.7 p -109.91 8.09 24.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.5 p -95.07 150.96 19.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.49 106.07 8.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.984 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -132.11 176.87 8.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 172.29 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.81 44.06 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.19 -70.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -112.44 53.03 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -68.17 -73.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.991 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.18 111.97 20.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.978 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.67 30.45 8.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.93 -41.15 16.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.332 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.517 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 4.2 t -87.39 -52.08 0.41 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.378 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 71.8 Cg_endo -76.32 107.83 2.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.162 1.908 . . . . 0.0 112.278 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.81 122.19 28.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.25 78.18 1.89 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.481 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.96 37.39 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -99.32 75.67 2.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.86 -57.92 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.85 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -104.04 123.78 47.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -84.95 146.25 27.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.953 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 mm -106.54 -26.55 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.974 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -124.56 138.01 30.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.149 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 52.0 Cg_exo -54.38 -92.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.862 2.375 . . . . 0.0 112.634 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 26.2 t0 56.11 73.43 0.44 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.591 ' HB2' HD12 ' A' ' 57' ' ' LEU . 1.8 m-85 -107.98 141.9 38.92 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.308 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 7.8 mtp85 -111.46 137.33 49.41 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.844 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.7 tm? -126.71 89.12 2.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.295 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.708 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.12 62.5 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.62 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 78.3 mtp -136.69 -112.68 0.18 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.385 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.621 ' HA ' ' HB2' ' A' ' 61' ' ' SER . 2.5 t -134.67 155.7 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.66 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.8 70.16 2.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.107 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 12.0 tt0 -86.45 139.36 33.8 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.537 0.208 . . . . 0.0 110.77 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 52.2 Cg_endo -69.55 -24.14 30.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.542 2.162 . . . . 0.0 112.789 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.491 ' HB2' ' HG2' ' A' ' 35' ' ' GLU . 45.9 m -56.63 145.01 62.92 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.999 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.22 78.72 3.14 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.562 2.175 . . . . 0.0 112.256 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.871 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 6.0 t80 -137.59 -53.28 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.519 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.871 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 32.8 Cg_endo -63.59 -82.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.3 2.0 . . . . 0.0 112.491 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.989 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -61.67 12.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -52.64 -31.65 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.81 -43.28 59.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -54.94 -45.05 74.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.11 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.91 -53.56 48.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.6 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 7.5 pt-20 -67.73 -10.38 52.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.648 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -73.79 -39.33 64.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.582 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.89 -48.96 70.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.604 -178.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.6 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 18.3 Cg_exo -65.89 -54.83 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 121.978 1.785 . . . . 0.0 111.387 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.62 18.22 0.13 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.907 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.7 157.52 0.37 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.924 0.392 . . . . 0.0 111.452 -179.324 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -138.52 -170.85 2.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.94 9.09 29.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.66 61.79 0.32 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.697 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -82.7 148.81 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 55' ' ' GLU . 29.6 mt -156.99 158.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.2 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.685 HD21 HG21 ' A' ' 70' ' ' ILE . 1.3 tp -160.58 142.11 12.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.656 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.714 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.981 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.844 HG13 ' HB3' ' A' ' 30' ' ' LEU . 18.7 t -139.3 142.52 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.032 0.444 . . . . 0.0 111.739 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -146.91 109.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.169 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.621 ' HB2' ' HA ' ' A' ' 33' ' ' VAL . 93.4 p -150.57 -175.52 5.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.575 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.78 119.88 36.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 41.1 t -137.03 106.6 8.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.954 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -30.64 77.24 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.462 2.108 . . . . 0.0 112.196 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HB3' ' H ' ' A' ' 66' ' ' SER . 0.9 OUTLIER -89.57 -162.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 8.5 t -108.61 -19.87 13.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 mt -55.8 119.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.061 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -74.67 137.48 42.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.911 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -73.25 -90.96 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.537 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.989 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -48.38 -51.03 54.09 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.374 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.673 ' HG2' ' HD2' ' A' ' 93' ' ' TYR . 71.6 Cg_exo -52.59 -35.14 66.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.42 2.08 . . . . 0.0 113.186 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.4 tp -58.94 -41.04 86.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.08 -57.44 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.202 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -62.34 -35.74 80.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.348 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -67.79 -31.5 71.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.91 -62.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.677 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -70.26 -37.29 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.06 107.84 3.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.946 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.458 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -110.24 -162.6 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.047 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.458 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 2.4 m -82.82 -74.76 0.34 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.159 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 23.3 t -116.59 122.0 68.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.436 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 71' ' ' PRO . 2.4 mm? -128.52 97.11 4.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.196 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.59 141.07 51.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.911 0.386 . . . . 0.0 111.326 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.74 161.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.247 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -148.01 156.15 42.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.652 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.06 151.67 45.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.912 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.34 -79.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.708 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.26 -89.74 0.17 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.136 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.61 -2.4 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.691 2.261 . . . . 0.0 112.767 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p -136.91 -174.81 3.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.857 0.36 . . . . 0.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 85' ' ' GLN . 2.5 tt -152.18 149.96 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.608 ' HD2' ' O ' ' A' ' 59' ' ' VAL . 8.0 tpt180 -123.21 133.28 54.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.727 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -123.81 146.61 48.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.466 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.79 137.3 15.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.884 0.373 . . . . 0.0 111.737 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -131.66 153.42 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.317 178.171 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.7 pt20 -154.03 169.45 23.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.287 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.9 tttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.884 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.775 0.322 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.03 -162.28 22.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.596 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.3 m -104.77 -46.07 4.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.911 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.26 -176.92 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.63 -53.58 49.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -136.65 133.15 35.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.931 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -89.12 -178.38 5.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -93.65 115.34 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -96.38 13.45 27.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -77.2 -173.7 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.8 m -97.25 77.52 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.51 -19.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.861 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.95 86.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.497 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.76 155.83 34.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.784 0.326 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.98 146.35 35.45 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.34 -43.92 0.63 Allowed 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.716 -1.369 . . . . 0.0 112.247 0.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.45 -178.25 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.24 -135.34 8.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.407 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.53 33.52 2.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.955 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -69.87 148.05 49.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.34 10.79 6.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.95 -23.02 13.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.54 59.01 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.563 HG13 HG22 ' A' ' 25' ' ' VAL . 3.2 pt -134.55 -18.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.011 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -133.37 152.62 79.63 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.066 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.872 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 50.4 Cg_exo -56.72 -81.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.631 2.221 . . . . 0.0 112.409 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 41.9 67.57 0.56 Allowed 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 121.165 0.507 . . . . 0.0 110.565 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -102.97 154.96 18.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.4 118.04 27.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.955 -178.243 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.782 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -114.68 80.94 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.465 177.258 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.674 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 4.8 m-20 -102.44 65.34 0.93 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.465 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' SER . 11.7 mtt -136.83 -108.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.105 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.589 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.4 t -132.65 147.42 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -59.38 -14.58 27.62 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 119.985 -1.102 . . . . 0.0 111.754 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.8 pt-20 -60.03 161.11 13.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 122.138 0.175 . . . . 0.0 110.757 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.18 77.01 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.397 2.065 . . . . 0.0 112.241 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -67.16 168.76 10.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.477 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.11 -42.95 56.28 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.215 1.943 . . . . 0.0 112.295 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -134.18 74.75 67.01 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' HD21 ' A' ' 30' ' ' LEU . 62.7 Cg_endo -96.29 -136.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.269 2.646 . . . . 0.0 112.65 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 70' ' ' ILE . . . -54.71 -6.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.523 HG23 ' HD2' ' A' ' 40' ' ' PRO . 70.1 t -48.58 -32.1 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.56 -39.6 67.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.527 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.612 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.56 -47.5 85.23 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.94 179.375 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -57.97 -51.06 71.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 6.1 pt-20 -71.71 -13.23 61.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.98 -27.38 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.111 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.519 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.8 mmm -47.68 -55.65 16.22 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.388 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 68.6 Cg_endo -73.77 -37.25 3.06 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.837 1.691 . . . . 0.0 111.609 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.7 2.39 6.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.262 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -47.22 152.92 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.895 0.379 . . . . 0.0 111.269 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 11.9 mmmt -135.65 -167.87 2.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -87.0 42.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 157.3 55.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.872 ' HB2' ' HG2' ' A' ' 26' ' ' PRO . 1.7 pt-20 -72.19 155.0 40.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.65 0.262 . . . . 0.0 111.0 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.2 mt -158.12 152.66 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.215 0.531 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 tp -143.9 156.64 44.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.567 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -146.58 108.99 4.48 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.559 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.782 HG13 ' HB3' ' A' ' 30' ' ' LEU . 57.4 t -121.93 127.55 75.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 1.4 t -129.05 100.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.267 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -125.9 -172.62 2.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.306 0.574 . . . . 0.0 111.978 -176.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.589 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -117.54 109.51 16.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.36 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 65.94 2.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.907 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.69 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.858 2.372 . . . . 0.0 112.147 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -92.89 23.22 4.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.193 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 m -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.747 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.71 66.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.885 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.605 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 78.9 m-20 -99.77 51.22 0.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.396 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.835 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.95 118.21 10.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.649 -176.24 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 43.5 mm -51.22 -47.41 88.14 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.898 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.673 ' HB3' HG22 ' A' ' 95' ' ' ILE . 27.8 Cg_endo -60.82 -29.1 87.52 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.263 1.976 . . . . 0.0 111.841 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.835 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -55.14 -38.46 68.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.98 -45.09 95.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.585 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.612 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -68.07 -24.42 65.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 15.6 ttt-85 -72.26 -36.56 69.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.339 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.88 -55.41 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.302 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -28.44 68.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 109.768 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.09 88.53 1.39 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.011 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.577 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -96.48 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.385 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.606 HG21 ' HA ' ' A' ' 97' ' ' LYS . 12.6 m -79.69 -87.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.826 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 80' ' ' THR . 91.8 t -113.14 127.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 111.234 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.8 mm? -123.58 107.35 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.472 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -123.55 159.33 29.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.623 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.945 HG22 ' HB3' ' A' ' 93' ' ' TYR . 28.4 pt -142.8 172.27 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 111.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.418 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -153.71 173.82 15.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.343 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -137.51 139.71 40.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.972 0.415 . . . . 0.0 111.365 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 57.0 m-20 -117.21 -137.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.241 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -73.63 -106.84 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.085 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -87.47 20.02 1.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.769 2.313 . . . . 0.0 112.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.492 HG22 ' CG ' ' A' ' 62' ' ' ASP . 41.7 p -138.57 173.73 11.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.988 0.423 . . . . 0.0 111.152 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.557 HG12 ' CE2' ' A' ' 93' ' ' TYR . 8.0 tt -136.71 130.15 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.287 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.578 ' HB2' HG13 ' A' ' 60' ' ' VAL . 1.5 ttm180 -123.18 136.44 54.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.138 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.945 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -128.02 164.84 21.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.921 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.37 153.37 31.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.673 HG22 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -136.62 155.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.796 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.508 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -155.2 170.58 21.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 111.478 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.727 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.9 tttp . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.435 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptp . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.24 160.39 43.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.437 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -102.85 -40.07 6.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.687 0.28 . . . . 0.0 110.932 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 m -122.34 -77.47 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.81 24.51 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.831 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.35 38.5 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.928 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -87.53 137.75 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -72.08 132.57 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -105.93 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.789 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.19 -73.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -121.77 8.88 10.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.72 138.61 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.53 22.22 38.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.511 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.87 -21.26 18.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 110.95 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.52 103.96 55.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.973 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.85 170.72 11.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.491 2.128 . . . . 0.0 112.307 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 159.81 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.26 156.33 48.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.464 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 m -131.2 103.95 6.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.74 25.16 5.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -98.85 -170.3 1.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -131.87 115.7 16.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.1 -176.39 6.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.6 pt -125.0 -1.73 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.28 143.62 34.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.931 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.699 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 39.6 Cg_exo -57.94 -80.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.664 2.243 . . . . 0.0 112.572 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 56' ' ' ILE . 5.8 p-10 41.8 75.08 0.09 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.111 0.482 . . . . 0.0 110.961 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.436 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 4.7 m-85 -103.48 161.8 13.56 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -134.6 146.42 49.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.326 0.584 . . . . 0.0 112.489 -178.07 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.926 HD23 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -134.28 91.15 2.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.315 177.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.663 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 37.9 t0 -101.79 58.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.742 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.467 ' C ' ' HB3' ' A' ' 61' ' ' SER . 46.6 mtt -137.32 -110.53 0.18 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.644 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 62' ' ' ASP . 9.9 p -135.55 164.28 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.262 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -96.49 79.02 0.73 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.389 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.742 ' HG3' ' H ' ' A' ' 37' ' ' CYS . 4.8 pt-20 -100.77 160.86 25.62 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.489 0.185 . . . . 0.0 110.878 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.28 -11.42 31.93 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.763 2.308 . . . . 0.0 112.475 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.742 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -119.33 74.15 15.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.143 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HG3' ' HB2' ' A' ' 69' ' ' ASN . 84.3 Cg_endo -89.38 -169.32 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.821 2.348 . . . . 0.0 112.68 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.643 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . 5.4 t80 -140.21 -54.95 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.178 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.926 ' HG2' HD23 ' A' ' 30' ' ' LEU . 31.7 Cg_exo -65.25 -31.2 53.82 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.211 1.941 . . . . 0.0 112.536 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.61 ' CA ' HD13 ' A' ' 70' ' ' ILE . . . -65.26 -17.5 64.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.357 0.598 . . . . 0.0 110.246 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 46' ' ' GLU . 55.0 t -57.67 -27.76 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.823 177.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.2 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.312 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.579 ' OG1' HG23 ' A' ' 70' ' ' ILE . 3.0 m -51.75 -68.13 0.19 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 48.8 mt -61.46 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.167 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 3.3 tt0 -65.3 -18.6 65.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.738 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.04 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.261 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.531 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.2 mmt -46.16 -55.12 14.36 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.871 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 48' ' ' MET . 39.3 Cg_endo -66.39 -56.71 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.714 1.609 . . . . 0.0 111.756 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -73.56 18.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.807 179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -44.55 151.37 0.27 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.773 0.321 . . . . 0.0 111.322 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -130.21 -179.61 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.19 61.63 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.834 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.72 43.49 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.699 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 0.9 OUTLIER -65.3 150.51 48.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 110.815 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.55 ' N ' ' HG3' ' A' ' 55' ' ' GLU . 1.8 mt -154.03 156.11 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.561 HD21 ' CG2' ' A' ' 70' ' ' ILE . 9.5 tp -146.75 161.05 41.44 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.21 0.528 . . . . 0.0 111.201 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -150.48 140.03 21.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 177.299 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.84 144.34 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.013 0.435 . . . . 0.0 111.172 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.76 97.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.167 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.526 ' HB2' HD21 ' A' ' 68' ' ' ASN . 0.3 OUTLIER -151.06 179.33 8.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -178.287 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.42 137.65 53.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 179.561 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 11.3 p -159.51 139.51 8.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.042 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.81 -12.87 36.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.675 2.25 . . . . 0.0 112.087 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -95.15 -160.84 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -113.54 -5.43 13.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.6 149.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.238 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.526 HD21 ' HB2' ' A' ' 61' ' ' SER . 4.4 m-20 -112.81 -169.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.097 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.697 ' ND2' HG12 ' A' ' 70' ' ' ILE . 5.6 p-10 -72.57 -55.06 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.901 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.728 HD11 ' HG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.98 -51.18 83.61 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.523 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 31.9 Cg_endo -62.79 -41.51 30.0 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.428 2.085 . . . . 0.0 112.837 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -25.63 65.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.095 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 10.1 m-20 -71.58 -61.78 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.192 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -60.97 -38.95 87.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -65.15 -27.48 68.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -62.92 -69.05 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -14.78 61.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.34 96.4 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.493 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.641 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 33.7 t80 -82.98 -98.78 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.653 0.263 . . . . 0.0 110.904 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 m -137.57 -77.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.893 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 25.8 t -109.99 114.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.187 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.535 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -123.23 101.77 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.348 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.69 158.5 31.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.635 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 33.0 pt -141.87 168.08 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 111.76 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 84' ' ' ILE . 3.7 mt-30 -152.4 155.64 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.483 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.39 141.92 45.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -109.74 -79.47 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.846 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.36 -97.51 0.46 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.087 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.31 6.88 5.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.243 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.1 p -135.89 172.21 13.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.037 0.446 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 4.0 tt -148.0 145.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.874 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 111.453 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 4.4 m-85 -131.68 130.76 42.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.72 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -133.94 157.24 41.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.387 178.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.73 157.43 39.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.641 ' HB2' ' HE2' ' A' ' 79' ' ' TYR . 3.0 tptp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.741 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.837 0.351 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.83 102.73 0.73 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.475 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.1 31.09 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 m -85.98 67.15 9.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -102.85 -170.63 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -67.6 142.81 56.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.82 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -67.05 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -91.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.46 157.61 35.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.031 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.44 21.45 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.893 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.68 126.33 39.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.007 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -134.33 28.66 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.76 -169.7 43.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -120.3 43.96 2.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.615 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 7.8 t -74.81 -51.56 3.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.549 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 24.5 Cg_exo -63.62 178.97 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.331 2.021 . . . . 0.0 112.199 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -94.39 -49.88 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.847 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.45 -153.21 7.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.467 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.41 -63.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 110.887 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.87 -71.3 0.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -93.74 174.65 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -133.54 80.12 1.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.888 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.83 -167.2 1.74 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 pt -64.78 165.79 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.076 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.2 141.79 27.71 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.551 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 12.0 Cg_endo -55.24 109.93 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.554 2.169 . . . . 0.0 111.798 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.674 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.4 t70 91.29 81.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.165 0.915 . . . . 0.0 111.343 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.494 ' HB3' HD12 ' A' ' 57' ' ' LEU . 9.9 t80 -103.92 168.31 9.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.707 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.0 ptt85 -134.61 130.4 36.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 40' ' ' PRO . 1.9 tm? -123.06 78.67 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.41 -0.813 . . . . 0.0 108.973 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.63 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -102.06 70.12 1.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.762 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -136.7 -111.31 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 178.367 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 62' ' ' ASP . 10.5 p -135.57 144.74 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.809 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.1 76.41 1.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.276 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.737 ' HG3' ' HB2' ' A' ' 37' ' ' CYS . 9.1 pt-20 -92.39 145.73 31.16 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.73 0.3 . . . . 0.0 111.138 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 35' ' ' GLU . 49.5 Cg_exo -55.97 -22.98 41.01 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.724 2.283 . . . . 0.0 112.406 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.737 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 7.3 m -58.55 139.84 85.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.993 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.24 23.06 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.692 2.261 . . . . 0.0 112.607 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.407 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 4.4 m-85 -77.84 -50.23 1.94 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB3' HD21 ' A' ' 30' ' ' LEU . 31.7 Cg_exo -60.5 -75.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.385 2.057 . . . . 0.0 112.461 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.68 4.7 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -48.16 -34.34 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -38.38 66.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.954 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.687 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.5 -57.63 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 9.8 mt -61.52 -54.23 45.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.48 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.35 -33.24 65.48 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.228 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -44.3 -61.49 1.49 Allowed 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 mtm -76.37 138.44 67.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 51' ' ' LEU . 63.0 Cg_endo -83.09 11.24 40.64 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.753 -0.936 . . . . 0.0 113.593 -10.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -71.91 16.54 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.135 -0.353 . . . . 0.0 111.664 -177.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.638 HD12 ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -71.12 179.28 2.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.352 . . . . 0.0 111.177 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -126.12 -148.15 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HA ' ' HE2' ' A' ' 97' ' ' LYS . 18.8 mtmt -107.36 58.51 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 110.85 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.585 ' H ' ' HD3' ' A' ' 97' ' ' LYS . . . 126.36 93.05 0.87 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.67 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -124.1 -173.15 2.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.711 0.291 . . . . 0.0 110.984 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -160.43 162.48 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.001 -179.376 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 44' ' ' THR . 15.2 tp -144.22 162.9 35.18 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.229 0.538 . . . . 0.0 111.398 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 2.6 mt-10 -147.82 141.62 25.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.403 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 25.4 t -141.18 131.1 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 111.602 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.63 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 36.1 t -133.1 84.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.196 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -124.71 166.91 15.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.27 -178.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -118.38 135.76 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.494 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 19.3 p -159.25 143.31 11.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.134 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.6 Cg_exo -70.95 -11.32 29.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.711 2.274 . . . . 0.0 112.046 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -93.08 -164.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -112.74 -17.52 12.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -117.68 153.49 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 2.3 m-20 -125.81 177.81 6.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.067 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -72.68 -42.48 64.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.936 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.75 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -60.04 -49.82 89.27 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 50.5 Cg_endo -67.27 -43.46 6.12 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.189 1.926 . . . . 0.0 112.244 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.406 HD12 HG12 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -64.96 -32.58 74.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 3.8 m-20 -64.13 -57.6 9.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -61.63 -39.55 91.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 75' ' ' ARG . 3.8 mtp180 -62.6 -32.21 73.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.672 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -61.94 -67.89 0.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -33.28 72.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.575 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.14 95.03 1.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.04 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.87 -168.77 1.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.661 0.267 . . . . 0.0 110.285 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.683 HG22 HG23 ' A' ' 81' ' ' VAL . 96.7 m -77.26 -62.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.728 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.8 t -127.44 132.34 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.334 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -133.28 100.29 4.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.407 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.47 156.91 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.874 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.22 175.24 4.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.091 0.472 . . . . 0.0 111.804 -179.102 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.531 ' O ' HG13 ' A' ' 91' ' ' ILE . 17.1 mt-30 -154.04 166.95 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.439 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -145.4 145.46 31.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.877 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.6 -83.09 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.11 -97.27 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.202 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.15 5.92 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.52 2.147 . . . . 0.0 112.449 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -138.08 174.49 10.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 111.163 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 85' ' ' GLN . 3.1 tt -145.17 144.19 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.741 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.56 138.39 54.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.928 0.394 . . . . 0.0 111.119 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.9 m-85 -123.86 149.47 45.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.205 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.39 138.39 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.926 0.393 . . . . 0.0 111.746 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -129.34 161.34 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.534 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.728 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -152.07 145.7 24.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.67 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.718 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 120.793 0.33 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.95 -177.13 39.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.533 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.54 3.63 16.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 110.907 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -116.83 139.16 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -115.21 -70.12 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 0.9 OUTLIER -139.46 98.69 3.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.745 179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.72 3.81 5.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -82.98 -55.69 4.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -109.07 4.02 22.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 6' ' ' HIS . 0.7 OUTLIER -115.72 76.51 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.33 166.41 22.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.59 6.3 23.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.16 -152.48 11.79 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 mt -113.32 32.59 5.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 0.0 111.003 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.512 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 2.7 t -85.41 -51.15 0.52 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.619 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 47.2 Cg_endo -68.47 -57.83 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.226 1.951 . . . . 0.0 112.348 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -114.87 70.59 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.41 -163.07 9.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.546 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.81 111.04 17.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.779 0.323 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -80.37 131.9 35.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.65 111.52 13.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.975 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 172.93 4.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.75 -157.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.851 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -82.91 60.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.362 -179.647 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.05 115.61 10.21 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.052 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.59 161.45 94.39 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.423 -1.49 . . . . 0.0 112.422 0.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.89 -74.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.537 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -134.48 161.11 35.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 111.478 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -135.1 121.18 19.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.508 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.846 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -107.66 77.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.07 65.15 0.86 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.461 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.635 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -137.16 -104.93 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.05 178.835 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.405 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 13.0 p -134.56 137.04 51.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.57 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . -72.94 77.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.56 ' HG2' ' HB2' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -73.81 135.1 77.89 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.11 -14.89 9.45 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.696 2.264 . . . . 0.0 112.594 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' HB2' ' HG2' ' A' ' 35' ' ' GLU . 23.1 m -80.85 154.97 73.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.069 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 50.1 Cg_exo -54.72 -32.89 78.07 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.694 2.263 . . . . 0.0 112.852 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' HA ' HG23 ' A' ' 42' ' ' VAL . 2.9 p90 -86.07 156.43 57.59 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.026 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.846 ' HB2' HD21 ' A' ' 30' ' ' LEU . 3.0 Cg_exo -82.71 5.76 49.55 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 124.037 -1.235 . . . . 0.0 112.546 1.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . . . -59.48 1.94 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.916 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' A' ' 39' ' ' TYR . 59.8 t -51.18 -27.87 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.372 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.99 -36.83 67.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.697 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 51.7 m -57.46 -52.35 65.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.016 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tp -60.96 -63.13 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.1 -39.51 13.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.948 0.404 . . . . 0.0 110.406 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.23 -61.58 1.14 Allowed 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.458 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 mmt -76.97 138.85 65.39 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' C ' HD23 ' A' ' 51' ' ' LEU . 66.9 Cg_endo -83.27 13.79 34.04 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.643 -0.982 . . . . 0.0 113.336 -11.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 47' ' ' ALA . 35.8 mt-30 -70.41 10.55 0.45 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.177 -0.327 . . . . 0.0 111.824 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 51' ' ' LEU . 1.3 pt? -72.12 -177.35 2.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.72 -160.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.56 29.39 0.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.957 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.96 91.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.493 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.837 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -116.93 173.8 6.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.567 0.222 . . . . 0.0 110.755 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 55' ' ' GLU . 5.8 mt -159.22 157.53 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.235 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -143.66 161.51 38.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.092 0.472 . . . . 0.0 111.396 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.42 119.29 8.69 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.158 175.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.706 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 47.5 t -117.95 111.8 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 111.368 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 1.6 t -117.75 89.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.657 ' HB2' HD22 ' A' ' 68' ' ' ASN . 62.9 m -129.18 172.74 11.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.691 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -117.59 125.15 50.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 4.0 p -159.27 147.31 13.52 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.7 Cg_exo -71.3 -23.4 24.19 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.126 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -175.4 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.82 -32.28 11.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 93' ' ' TYR . 1.5 tt -119.93 148.73 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.657 HD22 ' HB2' ' A' ' 61' ' ' SER . 3.9 m-20 -98.93 173.86 6.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 38' ' ' PRO . 15.6 t-20 -72.54 -22.05 61.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.646 HD12 ' HG ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -67.65 -54.5 17.52 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 68' ' ' ASN . 21.2 Cg_exo -65.84 -35.39 35.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.277 1.985 . . . . 0.0 111.688 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -21.28 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.604 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -62.68 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.74 -39.78 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -56.53 -40.53 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.744 179.084 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.4 -52.42 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.065 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -68.3 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.114 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.14 98.06 0.11 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.845 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.791 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 45.6 p90 -98.97 -166.02 1.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.488 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.787 HG21 ' HD2' ' A' ' 97' ' ' LYS . 1.4 m -125.83 -40.88 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.504 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.635 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 73.3 t -144.43 115.08 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.609 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.38 95.86 4.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.106 -178.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.97 163.27 21.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.3 pt -142.59 178.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 111.986 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.36 -172.09 4.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.243 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -144.56 142.41 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 111.226 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -118.03 -154.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.246 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -64.98 -99.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.107 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -90.74 16.31 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.744 2.296 . . . . 0.0 112.536 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.532 HG22 ' OD2' ' A' ' 62' ' ' ASP . 11.5 p -137.26 -170.72 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.001 0.429 . . . . 0.0 111.059 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt -143.19 147.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.605 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -123.79 142.87 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.063 0.459 . . . . 0.0 111.178 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.706 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.8 m-85 -131.39 155.79 46.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.564 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.7 143.93 20.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.613 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.609 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -134.98 158.62 41.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.236 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.635 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -154.11 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.837 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.1 tptp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.516 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mmm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.12 70.63 1.27 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.422 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -2.78 38.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.964 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -78.62 166.43 22.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -125.32 -74.82 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -134.33 166.85 21.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 128.27 50.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -79.67 101.49 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 33.93 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.96 95.08 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -112.07 -13.22 13.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 p -68.9 109.92 4.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.14 50.31 0.81 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.566 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.44 92.02 3.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.764 0.316 . . . . 0.0 110.86 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -57.89 131.41 83.05 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.64 135.15 47.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.426 2.084 . . . . 0.0 112.16 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -95.11 86.15 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.21 140.51 23.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.505 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 p -115.81 11.58 15.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 0.0 110.951 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.83 168.22 19.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.008 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.98 51.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -90.47 12.73 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.999 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -91.99 57.45 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.8 -61.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 54' ' ' GLY . 2.0 m -112.51 122.47 36.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.857 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 82.7 Cg_exo -47.5 -84.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.708 2.272 . . . . 0.0 112.691 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' A' ' 58' ' ' GLU . 37.5 t0 58.03 78.42 0.24 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 57' ' ' LEU . 1.1 m-85 -103.78 136.55 43.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.758 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -103.52 135.68 44.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 112.384 -176.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.699 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.4 tm? -130.56 81.16 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.339 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.645 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.51 71.79 1.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.788 -176.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.438 ' HB3' ' H ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -136.86 -112.02 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.096 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.535 HG22 ' OD1' ' A' ' 62' ' ' ASP . 47.9 t -134.87 133.31 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.69 103.43 0.32 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 5.2 tt0 -123.58 133.88 24.89 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.604 0.24 . . . . 0.0 110.96 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 35' ' ' GLU . 15.2 Cg_exo -69.84 -29.15 23.92 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.85 2.367 . . . . 0.0 112.526 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.419 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 1.1 m -55.55 144.04 55.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.137 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.32 81.43 1.76 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.545 2.164 . . . . 0.0 112.367 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.794 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -140.28 -53.62 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.3 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.794 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 62.7 Cg_endo -74.26 -72.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.205 1.937 . . . . 0.0 112.614 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.82 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.55 4.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.448 ' H ' ' C ' ' A' ' 40' ' ' PRO . 54.1 t -52.91 -29.29 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 110.106 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.96 -34.0 66.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.639 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -64.26 -52.22 59.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.067 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.29 -57.6 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 47' ' ' ALA . 16.8 pt-20 -50.1 -40.57 46.14 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.53 -53.19 4.46 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.474 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.3 137.13 64.47 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 173.289 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' C ' HD13 ' A' ' 51' ' ' LEU . 65.0 Cg_endo -83.34 11.42 41.21 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.668 -0.972 . . . . 0.0 113.243 -11.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 47' ' ' ALA . 10.1 mm100 -73.02 25.9 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.46 -159.58 0.06 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.713 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -141.8 -155.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.448 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.713 ' H ' ' HD3' ' A' ' 52' ' ' LYS . 6.6 mttp -91.57 30.14 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 25' ' ' VAL . . . 154.63 73.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.213 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.857 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -78.8 171.43 15.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 55' ' ' GLU . 61.5 mt -154.87 162.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.034 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.611 ' HG ' ' N ' ' A' ' 58' ' ' GLU . 4.3 tp -159.59 162.05 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.019 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.611 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -149.11 133.06 17.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.725 -176.311 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.699 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -139.25 132.23 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.849 0.356 . . . . 0.0 111.66 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -135.32 97.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.223 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.85 171.1 14.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.44 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.535 ' OD1' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.24 138.34 52.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.352 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.9 t -159.33 133.02 4.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.009 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 29.1 Cg_exo -61.64 -30.9 86.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.558 2.172 . . . . 0.0 112.129 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -81.4 -170.91 3.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -112.35 -17.09 12.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.68 137.48 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -100.12 127.19 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.606 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 35' ' ' GLU . 19.0 p-10 -72.52 -58.71 3.16 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.82 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 15.3 mm -56.85 -54.05 58.39 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.2 Cg_exo -58.28 -32.94 97.1 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.331 2.021 . . . . 0.0 112.7 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 6.5 tp -61.51 -30.95 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.03 -58.05 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.068 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -63.51 -32.46 73.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.2 ttt-85 -68.87 -31.64 70.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -61.7 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.64 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -70.95 -24.66 62.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.309 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.7 103.37 1.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.994 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.39 -164.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.639 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 97' ' ' LYS . 2.6 m -72.77 -82.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 46.6 t -116.43 123.99 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.093 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.624 HD12 ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -123.71 103.43 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.699 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.87 164.97 21.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.217 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.927 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -137.6 179.06 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.248 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.34 -177.0 6.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -150.37 138.87 20.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.053 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -122.57 -131.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.417 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.74 -123.66 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.167 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.7 29.89 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.915 2.41 . . . . 0.0 112.308 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 62' ' ' ASP . 2.0 p -147.6 -177.8 5.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 85' ' ' GLN . 14.3 tt -142.84 148.52 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.844 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.509 ' HB2' HG13 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -139.19 135.52 34.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.86 0.362 . . . . 0.0 111.257 -178.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.927 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.79 159.53 29.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.591 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.45 152.98 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 111.645 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.536 HG22 HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -133.35 155.17 40.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.338 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.492 ' N ' HD12 ' A' ' 95' ' ' ILE . 5.7 pt20 -154.35 157.16 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.713 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 34.6 tttm . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.799 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 mtm . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.737 0.303 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.85 -16.53 10.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.436 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -75.38 81.95 2.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.75 -166.14 1.04 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.09 75.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -90.31 117.37 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.855 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -92.16 21.06 5.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.28 -64.19 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.977 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -171.96 3.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -89.6 162.84 15.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.83 162.98 13.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.8 p -108.74 72.81 0.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.35 24.96 7.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.85 129.87 49.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.952 0.406 . . . . 0.0 111.007 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.27 136.39 25.86 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.005 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.66 -41.98 7.55 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.601 2.201 . . . . 0.0 112.318 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -137.25 153.01 50.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.27 142.42 41.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.46 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.15 47.69 0.87 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.929 0.395 . . . . 0.0 110.911 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -87.33 -72.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.843 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.95 151.08 22.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.816 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 -78.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.053 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -140.11 116.66 10.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.119 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.14 -75.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 54' ' ' GLY . 5.0 m -86.12 136.09 36.39 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.48 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.604 ' HD3' ' HG3' ' A' ' 55' ' ' GLU . 72.1 Cg_endo -87.08 -68.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.526 2.151 . . . . 0.0 112.822 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.567 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.2 t0 50.29 65.07 1.55 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 57' ' ' LEU . 1.4 t80 -105.33 137.63 42.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.8 -176.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.4 OUTLIER -103.89 131.73 50.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.48 -178.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.881 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -123.76 86.79 2.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.047 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.658 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 41.8 t0 -102.27 64.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.8 mtp -136.66 -109.44 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.322 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 62' ' ' ASP . 10.9 p -133.93 143.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.975 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -74.09 94.29 0.79 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.46 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.807 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 16.3 tt0 -120.58 145.18 40.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.807 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 41.6 Cg_exo -26.69 -109.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.346 3.364 . . . . 0.0 114.639 -178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -141.04 58.78 9.69 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.234 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.633 ' HG2' ' HD2' ' A' ' 40' ' ' PRO . 98.5 Cg_endo -89.75 -52.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.54 2.16 . . . . 0.0 112.366 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.916 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -140.94 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.794 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.916 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 6.6 Cg_endo -49.34 -94.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.808 2.338 . . . . 0.0 113.379 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HA ' HG23 ' A' ' 70' ' ' ILE . . . -57.94 -0.68 0.09 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 39' ' ' TYR . 3.0 t -52.22 -35.85 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.713 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 46' ' ' GLU . . . -71.16 -36.74 72.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.602 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.909 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.27 -42.57 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.196 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 1.2 tp -68.01 -55.62 11.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.329 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.662 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.23 -15.3 56.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.143 0.497 . . . . 0.0 110.754 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HB1' ' OH ' ' A' ' 79' ' ' TYR . . . -74.63 -34.73 62.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.817 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.607 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.3 -47.83 87.38 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.461 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 14.8 Cg_exo -68.53 -51.55 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.006 1.804 . . . . 0.0 111.408 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -73.23 15.26 0.24 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.635 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.607 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -53.22 161.4 0.89 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 111.677 -178.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.2 -162.94 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.469 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.67 39.72 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 110.808 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . -174.94 67.81 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.438 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.609 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -110.17 152.92 25.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 111.414 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.4 mt -159.63 152.81 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.279 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 95' ' ' ILE . 1.3 tp -160.67 137.73 9.08 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.147 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.652 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -118.75 137.93 53.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.091 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.881 HG13 ' HB3' ' A' ' 30' ' ' LEU . 15.2 t -139.9 150.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 0.0 112.359 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -154.95 100.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.752 178.027 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 33' ' ' VAL . 59.7 m -144.07 167.92 21.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.958 0.409 . . . . 0.0 111.506 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -121.75 137.1 54.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.5 t -159.26 126.71 2.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.71 -12.99 36.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.385 2.057 . . . . 0.0 112.043 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 66' ' ' SER . 35.0 mt-30 -86.02 -155.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 1.6 m -126.6 -56.51 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.302 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.685 HG23 HD23 ' A' ' 72' ' ' LEU . 1.3 mp -77.63 74.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.611 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -136.47 5.08 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.067 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.763 ' HB2' HD13 ' A' ' 72' ' ' LEU . 2.8 m-20 -72.44 126.16 29.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.068 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 46.9 mm -53.83 -45.72 98.74 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.055 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.832 ' HB3' HG22 ' A' ' 95' ' ' ILE . 35.9 Cg_endo -63.6 -23.31 70.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.876 . . . . 0.0 111.772 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 69' ' ' ASN . 2.4 mp -64.64 -31.3 72.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -46.49 80.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.595 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.909 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -72.8 -29.94 63.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.364 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.625 ' HB2' ' HG ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -72.94 -52.54 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 19.1 t30 -50.52 -51.42 47.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.765 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -56.82 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.389 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.07 107.49 0.75 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.972 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -126.02 -135.85 0.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.558 0.218 . . . . 0.0 110.758 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.49 HG21 ' HA ' ' A' ' 97' ' ' LYS . 3.2 m -110.43 -78.66 0.59 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.798 0.332 . . . . 0.0 110.977 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.517 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 4.0 t -121.27 121.15 64.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.349 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.3 mm? -123.59 106.18 10.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -130.16 139.16 50.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.851 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.949 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -127.07 166.36 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.994 0.426 . . . . 0.0 111.571 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.42 142.88 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.89 152.78 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.855 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -121.62 -78.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.82 -99.97 0.59 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.67 5.61 6.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.606 2.204 . . . . 0.0 112.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 p -141.13 174.91 10.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.066 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.419 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.8 tt -149.85 134.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -123.81 130.64 52.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.949 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -124.01 161.18 26.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.701 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.97 146.38 23.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.537 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.832 HG22 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -123.9 155.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.009 177.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.517 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.39 -170.56 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 111.343 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.2 m80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.787 0.327 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -95.38 112.06 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -78.11 141.4 38.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.96 -26.28 11.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.14 161.32 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 m -104.49 143.26 33.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.22 103.85 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.613 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 22.6 t70 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.652 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -134.26 164.82 26.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 112.21 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.804 ' HG3' ' HB2' ' A' ' 58' ' ' GLU . 4.4 ttt-85 -134.38 114.09 12.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.938 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.692 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -109.6 77.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.537 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.472 ' HA ' ' H ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.64 67.62 0.9 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.49 -107.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.242 178.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 62' ' ' ASP . 85.3 t -134.9 139.99 46.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.504 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -66.75 89.13 0.15 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.389 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 110.858 -179.805 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.455 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 52.8 Cg_endo . . . . . 0 CA--C 1.53 0.276 0 N-CA-C 112.771 0.258 . . . . 0.0 112.771 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.829 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -55.89 -3.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.53 -29.01 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.343 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.76 -36.12 67.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.868 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -57.42 -54.14 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.091 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.33 -47.69 84.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.151 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 4.8 pt-20 -64.38 -20.29 66.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.749 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HB1' ' OE2' ' A' ' 55' ' ' GLU . . . -72.85 -30.23 63.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.12 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.559 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 6.3 mmm -51.33 -54.77 34.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.692 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 48' ' ' MET . 58.7 Cg_endo -70.61 -39.69 4.65 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.785 1.657 . . . . 0.0 111.687 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.09 7.07 2.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.336 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.31 152.13 0.46 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.608 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -134.91 -165.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.779 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -85.44 45.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.464 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.14 0.38 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.007 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.67 ' H ' ' HB2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -122.21 158.49 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.628 HG13 ' O ' ' A' ' 55' ' ' GLU . 10.9 mt -159.65 154.18 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.327 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.652 HD12 ' H ' ' A' ' 28' ' ' TYR . 3.5 tp -140.39 154.47 46.72 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.119 0.485 . . . . 0.0 110.834 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.804 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 3.8 mt-10 -141.6 111.98 6.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.692 HG13 ' HB3' ' A' ' 30' ' ' LEU . 49.0 t -118.39 123.13 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.745 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.472 ' H ' ' HA ' ' A' ' 31' ' ' ASP . 97.5 t -126.14 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.806 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -126.44 162.91 24.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.443 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.817 ' HB3' HG22 ' A' ' 90' ' ' THR . 1.4 p30 -118.16 132.04 56.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.709 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 142.53 17.05 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.077 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.93 -24.94 23.75 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.483 2.122 . . . . 0.0 112.138 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -83.58 -163.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -119.75 -24.85 6.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.67 138.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -88.72 127.21 35.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -72.56 -74.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.936 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.829 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 8.4 mm -50.64 -51.78 62.23 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 51.0 Cg_exo -55.94 -33.37 88.83 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.193 1.929 . . . . 0.0 112.628 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -61.06 -36.3 79.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.85 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 -57.35 10.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -60.63 -35.16 75.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.289 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -64.29 -35.62 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.06 -64.62 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -26.86 68.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.672 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.38 94.32 0.77 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.946 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -154.83 0.39 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.52 HG21 ' HE3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -90.79 -64.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.638 0.256 . . . . 0.0 111.04 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.688 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 2.7 t -125.42 122.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.35 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.551 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -126.72 104.61 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.791 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.59 157.88 39.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.116 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -139.95 166.08 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.0 tt0 -154.42 156.66 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.443 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.474 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -131.82 158.43 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -123.96 -79.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.14 -100.3 0.44 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.163 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.29 10.38 3.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.643 2.229 . . . . 0.0 112.327 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 62' ' ' ASP . 4.8 p -145.6 177.7 8.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 86' ' ' GLN . 18.0 tt -146.76 145.7 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 129.89 32.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.93 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.13 163.14 21.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.503 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -154.54 151.99 29.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.042 0.449 . . . . 0.0 111.596 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -134.56 162.64 38.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.243 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.688 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 3.4 pt20 -153.53 177.36 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.67 ' HB2' ' H ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.794 0.33 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -105.44 91.88 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.85 -67.95 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -99.02 165.28 11.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -113.91 111.18 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.36 101.8 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -64.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.012 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.63 -179.785 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 7.2 t0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.524 0.202 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.629 ' H ' HD12 ' A' ' 57' ' ' LEU . 4.2 m-85 -134.83 166.83 22.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 111.721 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 138.6 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.046 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.798 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -131.37 77.97 1.8 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.793 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -103.48 69.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.397 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 61' ' ' SER . 35.9 mtt -136.85 -111.85 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.121 0.486 . . . . 0.0 111.228 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 57.9 t -135.92 126.9 43.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.73 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -68.82 100.29 0.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.321 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.165 -179.562 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.798 ' HB2' HD21 ' A' ' 30' ' ' LEU . 1.9 Cg_endo . . . . . 0 CA--C 1.53 0.297 0 CA-C-O 120.615 0.173 . . . . 0.0 112.529 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -58.02 0.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.927 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.4 p -52.46 -25.12 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.307 0.575 . . . . 0.0 110.014 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.92 -36.8 67.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.646 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.628 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -53.18 -55.21 26.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.891 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -51.66 66.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -59.65 -21.6 60.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.14 -179.119 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.52 -34.05 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.566 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.4 mmm -49.24 -55.39 21.68 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.684 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 16.2 Cg_exo -67.73 -37.36 16.34 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.139 1.893 . . . . 0.0 111.882 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.71 4.29 4.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.516 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.639 HD13 ' HE2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -46.44 155.92 0.2 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.906 0.384 . . . . 0.0 111.536 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.63 -91.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.38 3.52 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . 157.57 99.21 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.781 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -103.09 -177.43 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 55' ' ' GLU . 4.4 mt -159.4 153.94 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.072 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.629 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -134.79 156.52 48.73 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.058 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.71 110.26 6.35 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.095 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 30' ' ' LEU . 98.8 t -117.71 124.61 73.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.472 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 87.5 t -131.91 96.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.6 p -130.41 176.63 7.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.773 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.502 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -117.31 131.39 56.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.299 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.415 ' SG ' ' HA3' ' A' ' 34' ' ' GLY . 70.0 m -143.84 130.88 10.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.12 4.51 4.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.48 2.12 . . . . 0.0 112.371 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -127.35 -159.99 0.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 t -111.14 -27.56 8.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mt -56.68 128.54 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.337 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.611 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.4 OUTLIER -92.91 125.54 37.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.51 HD22 ' H ' ' A' ' 69' ' ' ASN . 2.0 m-80 -72.87 -73.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.179 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 41' ' ' ALA . 2.5 mm -46.28 -51.74 32.3 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.822 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 32.2 Cg_exo -60.57 -30.1 89.91 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.334 2.023 . . . . 0.0 112.725 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.4 tp -61.11 -33.02 72.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.811 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.6 4.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -59.63 -35.67 74.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.914 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -64.88 -37.12 86.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -58.08 10.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.741 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -64.72 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.37 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.57 82.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.997 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.435 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -86.34 -170.63 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.692 0.282 . . . . 0.0 110.636 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.435 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -76.89 -66.64 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.003 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 11.9 t -126.71 128.6 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.621 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -131.01 100.08 5.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.94 167.92 14.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.088 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.5 pt -137.59 -177.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.499 ' O ' HG13 ' A' ' 91' ' ' ILE . 3.4 mt-30 -154.51 178.65 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.33 142.21 26.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 0.0 111.306 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.29 -138.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.306 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.94 -116.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.163 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.54 27.08 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.616 2.211 . . . . 0.0 112.543 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.4 p -142.05 -177.69 5.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 111.036 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.523 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.1 tt -149.41 150.46 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.863 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.422 ' HB2' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -139.64 140.77 37.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.919 0.39 . . . . 0.0 111.368 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.93 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -127.88 144.9 51.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.129 178.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.446 HD21 ' NE2' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -138.32 150.91 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 111.481 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.621 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -131.85 157.4 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 178.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.705 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.8 pt20 -154.47 158.57 40.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 111.259 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.781 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 25.2 tttp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.745 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.746 0.308 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -132.83 111.75 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -136.43 179.17 6.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -67.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -121.11 46.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.11 40.83 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 m -122.43 60.77 1.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.404 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 33.8 t70 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.557 0.218 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.666 ' H ' HD12 ' A' ' 57' ' ' LEU . 5.8 m-85 -134.4 165.66 24.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.431 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -134.82 135.46 41.77 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.581 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.843 HD21 ' HA ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -125.89 76.74 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.273 178.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.52 66.64 0.88 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.948 0.404 . . . . 0.0 111.463 -178.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 61' ' ' SER . 2.3 mtt -137.06 -106.4 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.347 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 35' ' ' GLU . 11.7 p -134.12 142.55 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -61.53 -20.34 58.98 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.31 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 33' ' ' VAL . 6.8 tt0 . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.843 ' HA ' HD21 ' A' ' 30' ' ' LEU . 66.5 Cg_endo . . . . . 0 N--CA 1.459 -0.513 0 CA-C-O 120.663 0.193 . . . . 0.0 112.366 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.88 -4.16 0.28 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.968 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.25 -28.01 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.239 0.542 . . . . 0.0 110.024 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.41 -40.45 64.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.538 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.35 -54.14 49.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.066 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 16.4 mt -61.43 -49.31 77.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.138 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 pt-20 -65.29 -18.29 65.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.657 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.88 -29.2 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.952 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.593 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.95 -54.79 33.45 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.449 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.7 Cg_endo -69.64 -36.89 10.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.864 1.709 . . . . 0.0 111.586 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.91 5.74 3.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.6 161.76 0.12 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.958 0.409 . . . . 0.0 111.753 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -131.7 -95.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.813 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -14.75 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.804 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 178.86 92.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.184 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.776 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -99.25 -176.69 3.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 111.434 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.7 mt -159.61 154.62 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.204 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -136.69 156.2 48.85 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.13 0.491 . . . . 0.0 111.194 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -140.28 116.5 10.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.056 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.706 HG13 ' HB3' ' A' ' 30' ' ' LEU . 52.6 t -118.26 113.63 42.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.635 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 72.9 t -118.66 92.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.822 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.4 p -133.0 168.61 18.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.362 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.89 118.47 32.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.358 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.6 t -137.44 120.67 11.59 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.955 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.91 -25.6 70.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.519 2.146 . . . . 0.0 112.133 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -87.85 164.07 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -91.04 -22.8 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.002 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.24 118.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.367 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.99 118.2 14.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -72.68 -75.67 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.789 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 7.1 mm -48.57 -51.51 51.73 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.022 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.607 ' HB3' HD12 ' A' ' 82' ' ' LEU . 51.4 Cg_exo -57.21 -36.97 99.15 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.224 1.95 . . . . 0.0 112.849 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER -57.14 -33.42 67.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.884 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.75 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 2.1 m-20 -66.97 -58.67 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.034 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.553 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -61.13 -34.98 75.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.209 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -65.9 -36.12 82.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 -60.91 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -59.9 2.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.535 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.28 88.09 0.57 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.022 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -151.89 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.248 . . . . 0.0 110.343 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 97' ' ' LYS . 1.2 m -93.33 -75.34 0.5 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.577 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 48.1 t -120.4 123.06 69.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mm? -123.61 105.4 9.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.792 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -134.34 157.59 45.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 93' ' ' TYR . 35.4 pt -140.15 179.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.594 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -154.07 166.88 31.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 179.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.407 HE21 HD12 ' A' ' 91' ' ' ILE . 1.2 tt0 -125.93 125.15 42.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 0.0 111.215 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.31 82.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.377 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.44 145.69 7.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.949 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -90.9 43.23 2.47 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.573 -1.428 . . . . 0.0 112.652 0.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.7 p -142.9 -172.21 3.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.872 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 85' ' ' GLN . 6.3 tt -149.53 142.59 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.855 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -123.93 133.03 53.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.173 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.514 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -123.66 148.15 46.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.745 178.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.98 151.72 28.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.949 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -136.17 158.34 38.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.222 178.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.577 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER -154.12 153.44 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.292 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.776 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 9.4 tttp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.793 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 p80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.793 0.33 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 133.84 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -100.89 -4.52 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.057 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -60.8 129.4 41.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -127.24 -177.36 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.63 165.61 19.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 t -116.44 -79.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.501 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.659 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 16.3 t70 . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.454 0.169 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.604 ' H ' HD12 ' A' ' 57' ' ' LEU . 25.2 m-85 -134.61 162.04 33.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 111.841 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 127.48 30.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.345 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.576 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -117.57 82.1 1.77 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.568 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.52 67.06 0.89 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.47 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.645 ' O ' ' HA ' ' A' ' 61' ' ' SER . 93.0 mtp -136.94 -109.85 0.19 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.251 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.19 150.34 29.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.524 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -84.66 55.77 5.0 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.472 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.0 110.785 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo . . . . . 0 N--CA 1.46 -0.48 0 N-CA-C 112.893 0.305 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -56.36 -8.54 0.53 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.439 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 49.4 t -46.9 -34.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.65 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.18 65.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.166 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.761 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -52.55 -50.41 62.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.47 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.84 -55.39 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.599 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 42.2 mt-10 -59.53 -19.27 47.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.46 -34.1 67.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.658 ' HG3' ' HB3' ' A' ' 77' ' ' HIS . 5.4 mmm -49.02 -55.77 18.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.213 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 22.0 Cg_exo -64.38 -37.49 39.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.995 1.797 . . . . 0.0 111.544 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 6.15 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.42 145.43 0.27 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -141.5 -168.81 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.631 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -87.56 23.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.03 97.93 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.464 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.727 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -130.58 155.44 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 0.0 110.819 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -159.6 158.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -145.51 158.57 43.82 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.001 0.429 . . . . 0.0 111.196 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 117.65 9.94 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.197 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 30' ' ' LEU . 41.6 t -118.42 115.26 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.549 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.9 t -119.41 88.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.138 0.494 . . . . 0.0 110.123 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -129.72 170.66 13.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.401 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.57 121.96 42.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.618 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -153.21 149.4 21.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 59.1 Cg_endo -72.01 -42.92 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.557 2.171 . . . . 0.0 112.426 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.51 155.24 40.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -64.39 -63.69 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.38 142.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.006 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 17.6 t30 -110.38 -176.2 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -72.52 -35.67 68.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.644 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.693 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm -69.17 -50.71 19.78 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 43.1 Cg_endo -66.56 -44.68 5.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.135 1.89 . . . . 0.0 112.368 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -30.88 71.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.013 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -60.46 3.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.736 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.761 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -62.0 -33.79 74.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -64.14 -29.98 71.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.544 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -66.95 -61.45 1.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.607 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.658 ' HB3' ' HG3' ' A' ' 48' ' ' MET . 0.1 OUTLIER -68.15 -20.41 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.648 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.61 93.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.817 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.417 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -91.56 -156.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 110.533 179.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.642 HG21 ' HD2' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -90.77 -64.23 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.767 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 40.4 t -128.76 120.8 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.276 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.541 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -123.56 102.58 7.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.394 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.86 160.37 27.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.887 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.527 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.6 pt -142.0 171.62 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.4 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.508 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.0 mt-30 -154.31 158.87 40.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.414 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -129.8 144.39 51.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.973 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -125.77 -121.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.481 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.02 -112.26 0.51 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.215 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.17 19.75 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.724 2.283 . . . . 0.0 112.477 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.3 p -138.29 -178.78 5.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 111.101 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 85' ' ' GLN . 5.4 tt -149.43 147.91 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.823 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -131.09 131.06 43.94 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.206 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -123.43 134.34 53.96 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.998 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.97 150.76 47.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.199 0.523 . . . . 0.0 111.806 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.541 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.15 156.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.188 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.767 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -146.98 172.16 14.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.936 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.727 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 12.1 tptt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.786 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 t60 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.775 0.321 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -120.33 15.47 12.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.22 -28.13 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.831 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.21 102.84 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -44.29 43.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.15 169.89 16.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 t -110.24 -27.85 8.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 20.9 t0 . . . . . 0 C--O 1.233 0.2 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -103.38 164.94 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.066 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 6.9 ttt180 -133.65 142.56 48.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.619 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.838 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.7 tm? -132.93 89.91 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.885 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.685 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.37 66.06 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.543 -177.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mtt -136.36 -111.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.323 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.769 HG13 ' H ' ' A' ' 35' ' ' GLU . 7.5 p -134.56 160.5 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -74.34 13.54 4.71 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.523 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.769 ' H ' HG13 ' A' ' 33' ' ' VAL . 3.2 tt0 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.56 0.219 . . . . 0.0 110.558 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . 87.5 Cg_endo . . . . . 0 CA--C 1.531 0.347 0 N-CA-C 112.892 0.305 . . . . 0.0 112.892 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -60.65 -0.43 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.4 t -49.27 -36.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.05 -34.67 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.74 -47.23 86.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.272 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 44.6 mt -64.45 -47.05 80.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.359 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.4 -12.38 61.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 0.0 110.803 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.25 63.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.111 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.564 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -52.49 -46.92 95.0 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.804 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 15.8 Cg_exo -67.75 -59.51 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.919 1.746 . . . . 0.0 111.408 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -73.76 20.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.53 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.1 153.29 0.7 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.014 0.435 . . . . 0.0 111.61 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 -160.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.3 53.64 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.43 52.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.643 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -68.46 177.52 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.066 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -159.26 149.69 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.622 HD22 HG23 ' A' ' 44' ' ' THR . 16.0 tp -134.74 162.59 31.93 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.247 0.546 . . . . 0.0 111.095 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -147.56 136.45 22.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.487 176.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.838 HG13 ' HB3' ' A' ' 30' ' ' LEU . 41.1 t -141.5 138.71 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 111.752 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 97.6 t -140.42 107.95 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.769 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.2 -177.69 5.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.438 . . . . 0.0 111.797 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' HG22 ' A' ' 90' ' ' THR . 0.2 OUTLIER -118.01 120.87 39.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.783 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.37 108.16 2.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.64 -26.12 77.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.554 2.169 . . . . 0.0 112.277 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -73.02 -174.4 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -106.31 -27.7 10.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.94 133.72 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.555 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -95.19 136.11 35.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -72.58 -75.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.84 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 9.2 mm -46.4 -52.12 31.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.198 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 44.8 Cg_exo -58.97 -33.1 98.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.257 1.971 . . . . 0.0 112.613 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.2 tp -61.36 -29.23 69.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.96 0.409 . . . . 0.0 110.788 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.45 -52.5 21.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -69.26 -27.88 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -72.24 -36.04 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.709 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -64.21 -59.6 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -64.59 -42.01 95.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.638 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 102.53 2.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.781 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.461 ' HB3' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -105.49 -106.11 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.869 HG22 HG23 ' A' ' 81' ' ' VAL . 55.4 m -140.52 -72.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.308 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.869 HG23 HG22 ' A' ' 80' ' ' THR . 53.2 t -117.17 118.26 58.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.344 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 71' ' ' PRO . 3.0 mm? -123.94 100.54 6.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.97 156.88 40.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.886 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -140.21 167.18 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.309 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -154.59 151.29 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -126.62 156.82 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.929 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.28 -84.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.797 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.14 -112.0 2.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.103 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.83 10.44 2.89 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.0 112.192 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.52 HG22 ' OD1' ' A' ' 62' ' ' ASP . 25.3 p -136.09 176.97 8.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.017 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.442 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.5 tt -151.38 142.9 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -127.91 142.25 51.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.116 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.886 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -123.51 155.82 36.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.32 143.08 20.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.463 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.596 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -129.16 161.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.556 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.684 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.3 pt20 -153.96 161.93 41.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.907 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.771 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.59 103.84 4.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 169.86 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 135.28 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -110.96 39.85 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.18 130.41 36.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.4 -23.05 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.446 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.777 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 36.0 t70 . . . . . 0 C--O 1.231 0.112 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.741 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.03 166.48 22.94 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 142.61 46.4 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 40' ' ' PRO . 1.4 tm? -134.53 84.39 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.535 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p-10 -104.06 69.13 0.93 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.451 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -136.52 -108.42 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 0.0 111.398 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.774 HG12 ' H ' ' A' ' 35' ' ' GLU . 58.1 t -134.38 142.29 41.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -12.5 11.46 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.198 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.774 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.379 0.133 . . . . 0.0 110.715 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 63.2 Cg_endo . . . . . 0 N--CA 1.458 -0.615 0 N-CA-C 112.805 0.271 . . . . 0.0 112.805 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.934 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.2 -4.38 0.35 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 p -47.62 -34.08 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 110.707 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.99 -39.7 65.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.228 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.644 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -53.41 -54.04 42.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 tp -62.04 -40.25 95.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.913 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.64 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -67.2 -20.54 65.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.567 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.7 64.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.62 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.78 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 19.1 mmt -48.47 -56.38 14.78 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 23.7 Cg_exo -62.62 -44.03 19.14 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.975 1.783 . . . . 0.0 111.288 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.25 12.53 0.56 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.585 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.48 148.59 0.14 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -174.92 4.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.941 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.22 32.91 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 176.03 101.54 0.15 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.415 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.834 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -135.93 158.55 44.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.789 0.328 . . . . 0.0 111.097 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.1 mt -159.62 156.96 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.431 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.741 HD12 ' H ' ' A' ' 28' ' ' TYR . 1.4 tp -147.98 159.05 44.3 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.183 0.516 . . . . 0.0 111.293 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.43 134.87 26.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.021 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 30' ' ' LEU . 38.9 t -134.09 123.91 45.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 111.326 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 77.9 t -127.5 94.46 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.77 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.7 p -135.39 170.23 16.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.221 0.534 . . . . 0.0 111.72 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -117.82 124.57 48.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.37 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 49.3 t -144.57 116.24 5.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.67 -30.39 92.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.575 2.183 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -77.91 -163.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -119.07 -24.21 6.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.169 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.35 122.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.774 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -80.14 124.45 28.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.54 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -73.89 -87.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.934 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 6.6 mm -46.45 -54.07 20.49 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.774 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -59.41 -26.29 81.42 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.071 1.847 . . . . 0.0 112.989 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.5 tp -65.55 -38.77 90.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.846 0.355 . . . . 0.0 110.841 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -49.54 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.62 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.644 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -71.51 -27.13 63.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -71.94 -34.99 69.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.28 -64.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.448 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 3.6 t-80 -64.68 -30.32 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.87 96.76 0.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.59 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' HB2' ' HE1' ' A' ' 48' ' ' MET . 0.4 OUTLIER -93.29 -104.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.639 0.257 . . . . 0.0 110.809 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -133.5 -69.05 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.32 . . . . 0.0 110.825 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.707 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 2.3 t -126.21 121.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 74' ' ' ALA . 3.8 mm? -123.37 104.85 9.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.401 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.9 156.99 46.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.691 0.282 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.25 173.21 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 111.588 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.55 ' O ' HG13 ' A' ' 91' ' ' ILE . 9.8 mt-30 -154.22 162.71 41.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -144.02 149.4 36.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.05 -81.77 0.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.15 -88.17 0.15 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.356 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.79 -1.28 9.49 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.754 2.302 . . . . 0.0 112.891 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -136.48 175.94 9.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.902 0.382 . . . . 0.0 111.189 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 85' ' ' GLN . 4.6 tt -146.81 143.46 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.63 135.22 53.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.278 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.465 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -123.51 145.34 48.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.31 148.58 25.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.212 0.53 . . . . 0.0 111.937 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -131.6 157.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.048 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.707 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -148.48 178.74 8.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.834 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 6.7 tptt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.689 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.864 0.364 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -77.99 -8.43 58.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.999 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.28 120.01 15.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.072 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.42 ' HB2' ' H ' ' A' ' 10' ' ' HIS . 1.7 p-80 -112.22 -160.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.42 ' H ' ' HB2' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -74.25 88.98 2.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -160.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.5 72.03 5.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.466 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.65 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.066 0 N-CA-C 111.391 0.145 . . . . 0.0 111.391 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.656 ' H ' HD12 ' A' ' 57' ' ' LEU . 10.9 t80 -134.44 164.67 26.94 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.56 141.88 46.8 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 30' ' ' LEU . 1.2 tm? -134.17 83.56 2.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.076 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.64 67.63 0.91 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.567 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 61' ' ' SER . 1.0 OUTLIER -136.5 -110.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 35' ' ' GLU . 34.5 t -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.448 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.476 ' HA3' HD21 ' A' ' 68' ' ' ASN . . . -63.9 -5.8 15.57 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.226 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.612 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.3 pt-20 . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.486 0.184 . . . . 0.0 110.839 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HD2' HG23 ' A' ' 42' ' ' VAL . 83.3 Cg_endo . . . . . 0 N--CA 1.458 -0.593 0 CA-C-O 120.6 0.166 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -60.24 -5.24 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.535 HG23 ' HD2' ' A' ' 40' ' ' PRO . 32.7 t -47.02 -32.26 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.45 -44.54 57.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -47.69 -54.55 11.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 45' ' ' LEU . 15.4 mt -62.5 -58.24 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 26.8 mt-10 -60.07 -15.3 22.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 111.135 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.22 -38.49 68.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.535 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.7 mtp -47.91 -54.16 26.26 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.402 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 31.1 Cg_exo -60.51 -59.71 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.757 1.638 . . . . 0.0 111.357 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -73.8 23.74 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.87 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 48' ' ' MET . 1.3 pp -52.03 177.39 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 0.0 111.97 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.875 ' HG2' ' H ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -159.07 164.88 34.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.244 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -73.29 23.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 111.306 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.875 ' H ' ' HG2' ' A' ' 52' ' ' LYS . . . -168.83 69.12 0.16 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HG2' ' HB2' ' A' ' 27' ' ' ASP . 5.0 tm-20 -112.06 152.15 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -160.22 158.24 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.428 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 28' ' ' TYR . 2.5 tp -140.31 163.87 31.61 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.323 0.582 . . . . 0.0 111.156 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.95 128.52 13.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.957 175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.5 t -128.64 114.1 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.896 0.379 . . . . 0.0 111.462 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -118.28 96.5 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.15 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -137.14 172.84 12.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.608 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.432 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.3 p -159.11 140.33 9.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.218 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.77 16.75 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.606 2.204 . . . . 0.0 112.276 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -116.92 -165.83 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -72.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.5 mm -83.79 140.45 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.021 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -97.18 -179.16 4.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.69 -38.39 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.739 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm -67.79 -50.45 34.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 33.0 Cg_endo -62.58 -36.91 61.75 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.274 1.982 . . . . 0.0 112.244 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.17 -25.71 65.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -58.62 4.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -63.34 -36.32 83.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -63.51 -30.6 71.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -65.73 -70.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.402 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 1.5 t-80 -57.86 -35.54 71.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.765 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.41 79.89 1.49 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.55 -157.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 97' ' ' LYS . 2.9 m -72.5 -78.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.498 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.619 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 2.0 m -130.19 145.87 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.568 HD13 HG22 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -128.35 111.95 13.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.468 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -127.1 159.99 32.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.724 0.297 . . . . 0.0 110.958 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.566 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -140.79 -178.41 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.179 0.514 . . . . 0.0 111.69 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -154.5 -173.86 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.203 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -136.75 116.71 13.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 111.26 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.67 -176.75 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.673 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.8 117.41 1.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.755 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.502 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 82.7 Cg_endo -100.45 66.94 0.32 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 C-N-CA 124.318 -1.118 . . . . 0.0 112.653 0.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 p -147.81 -173.82 4.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 111.27 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.571 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tt -136.2 151.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.515 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.678 HH11 HD22 ' A' ' 94' ' ' LEU . 3.0 tpp85 -123.7 142.75 50.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.893 0.378 . . . . 0.0 111.762 -177.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.626 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 7.9 m-85 -136.54 117.55 14.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.078 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.678 HD22 HH11 ' A' ' 92' ' ' ARG . 0.4 OUTLIER -131.87 146.24 52.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 111.724 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -129.66 161.86 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.356 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.641 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -148.24 154.17 39.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.905 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.629 ' HA ' HG21 ' A' ' 80' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.33 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.35 90.12 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.91 -98.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.45 -165.01 1.83 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -99.87 148.28 24.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -82.7 120.47 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.3 39.75 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.093 0.473 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.16 160.39 14.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.598 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 10.1 ptt85 -128.53 129.42 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 0.0 111.94 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.705 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -122.23 77.27 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.525 177.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.3 p30 -101.91 68.14 1.12 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.728 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' SER . 10.5 mtt -137.13 -112.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.889 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.406 ' H ' ' HB3' ' A' ' 32' ' ' MET . 7.6 p -135.57 143.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.987 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 111.12 3.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.327 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.646 0.26 . . . . 0.0 110.946 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 42' ' ' VAL . 41.3 Cg_endo . . . . . 0 CA--C 1.53 0.299 0 CA-C-O 120.826 0.261 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.67 0.79 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 40' ' ' PRO . 14.4 t -48.69 -32.64 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.391 . . . . 0.0 110.567 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . . . -72.93 -37.94 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.632 HG23 HD22 ' A' ' 57' ' ' LEU . 1.9 m -58.07 -59.02 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.243 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.88 -32.56 67.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.73 -28.21 63.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 110.509 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.6 -26.94 61.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.402 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.529 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 32.6 mmt -53.72 -54.85 41.7 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.652 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 59.8 Cg_endo -71.01 -39.68 3.93 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.815 1.677 . . . . 0.0 111.595 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.91 6.91 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.07 150.48 0.58 Allowed 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.917 0.389 . . . . 0.0 111.252 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 54.2 mmtt -145.88 -159.31 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.445 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.02 16.49 4.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 65.35 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.877 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.724 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 20.8 tt0 -86.67 146.73 26.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.67 0.271 . . . . 0.0 110.406 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.2 mp -155.53 153.44 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 44' ' ' THR . 15.0 tp -142.85 164.99 28.59 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.305 0.574 . . . . 0.0 111.146 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -149.46 135.02 18.51 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 30' ' ' LEU . 15.4 t -137.85 132.31 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.11 0.481 . . . . 0.0 111.624 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.5 t -136.84 83.04 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.029 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.4 p -123.58 175.16 6.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.65 125.92 51.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.463 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 147.62 16.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.75 5.0 6.46 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.25 161.77 27.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.02 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.4 m -72.08 -52.27 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.67 143.73 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' H ' ' HG2' ' A' ' 71' ' ' PRO . 2.9 t-20 -134.3 -172.3 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -72.33 -47.49 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.765 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -59.52 -49.33 92.75 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 41.7 Cg_endo -66.47 -41.14 12.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.119 1.88 . . . . 0.0 112.505 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -21.27 64.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -62.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -57.41 -41.21 79.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.677 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.628 ' HA ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.957 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -66.75 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -59.39 4.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.563 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.74 100.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.463 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.651 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.8 p90 -90.41 -171.63 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 111.65 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.479 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 28.6 m -115.29 -49.72 2.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.08 176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.711 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 t -139.23 115.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.138 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.614 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -122.67 100.21 6.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -178.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.32 150.15 50.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.11 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.463 . . . . 0.0 111.626 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 91' ' ' ILE . 1.6 tm0? -145.44 171.34 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.65 126.43 46.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.165 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -174.16 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.47 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.07 121.96 2.11 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.709 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 78.4 Cg_endo -102.15 62.25 0.58 Allowed 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.759 1.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.3 p -148.87 -174.57 4.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.98 0.419 . . . . 0.0 111.534 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 85' ' ' GLN . 8.1 tt -142.38 145.53 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -123.74 146.56 48.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.108 0.48 . . . . 0.0 111.499 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 3.1 m-85 -132.02 131.05 42.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.017 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.33 143.74 46.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 111.402 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.614 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.43 157.06 39.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.682 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.711 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -154.47 166.03 34.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.724 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.6 tttp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.791 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.7 m80 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.768 0.318 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.2 -72.32 0.59 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.937 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -86.9 175.79 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -72.2 -175.87 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -46.04 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.02 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.32 -172.42 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.6 p -77.28 -170.08 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.52 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.646 ' HB3' HD12 ' A' ' 56' ' ' ILE . 5.0 p-10 . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 121.399 0.619 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.637 ' H ' HD12 ' A' ' 57' ' ' LEU . 52.7 t80 -102.53 147.0 27.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.7 mtt85 -104.9 135.88 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.2 tm? -134.54 82.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.327 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -103.13 66.77 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.9 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -136.29 -112.61 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.119 0.485 . . . . 0.0 111.266 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG22 ' OD1' ' A' ' 62' ' ' ASP . 6.4 t -135.01 152.46 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.794 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.78 -7.56 16.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.096 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.481 0.181 . . . . 0.0 110.841 179.561 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HA ' HD23 ' A' ' 30' ' ' LEU . 63.8 Cg_endo . . . . . 0 N--CA 1.457 -0.643 0 CA-C-O 120.645 0.185 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.883 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -59.52 -4.24 0.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 9.8 p -47.12 -33.38 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.46 -39.44 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.119 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 3.6 m -55.72 -55.3 33.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.834 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.567 ' O ' ' HE2' ' A' ' 48' ' ' MET . 95.2 mt -57.39 -52.7 64.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.272 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 5.9 pt-20 -68.55 -11.37 59.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.53 -39.57 67.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.458 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.567 ' HE2' ' O ' ' A' ' 45' ' ' LEU . 53.2 mtm -53.51 -53.7 53.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.65 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 48' ' ' MET . 53.4 Cg_endo -67.83 -52.08 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.677 1.584 . . . . 0.0 111.313 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -73.85 19.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.834 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -51.4 178.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.415 0.626 . . . . 0.0 111.795 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HD2' ' HE2' ' A' ' 53' ' ' LYS . 31.6 mmtt -149.0 -144.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HE2' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.45 26.73 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.313 . . . . 0.0 111.159 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 97' ' ' LYS . . . 126.12 84.19 0.52 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.613 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.591 ' N ' ' HB3' ' A' ' 97' ' ' LYS . 5.3 pt-20 -74.84 -179.81 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -159.91 -178.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.766 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.637 HD12 ' H ' ' A' ' 28' ' ' TYR . 6.5 tp -158.85 156.0 28.84 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.05 101.25 3.14 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.988 175.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 70' ' ' ILE . 1.4 p -119.32 131.54 71.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.822 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 12.2 t -132.47 111.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.194 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -143.02 177.44 8.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 0.0 111.419 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' HG22 ' A' ' 33' ' ' VAL . 5.1 p-10 -117.9 130.53 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 129.78 3.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.073 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.93 -17.79 22.17 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.527 2.151 . . . . 0.0 112.231 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.73 156.4 16.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.951 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -40.48 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 72' ' ' LEU . 1.5 mp -65.55 109.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.544 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -102.35 165.21 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.21 -75.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.883 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 2.4 mm -44.86 -53.3 16.09 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.544 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 22.8 Cg_endo -62.19 -39.31 49.24 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.959 1.772 . . . . 0.0 113.047 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.596 HD13 HG23 ' A' ' 67' ' ' ILE . 5.1 tp -65.5 -22.14 66.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 111.148 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.12 -58.38 3.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.87 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.854 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -60.14 -41.17 92.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.793 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -63.28 -31.6 72.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.41 -66.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.21 -64.19 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.15 104.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.62 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.854 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.8 p90 -90.64 -163.23 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.253 0.549 . . . . 0.0 111.466 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 2.2 m -115.22 -54.68 2.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.343 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.695 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.4 t -140.22 114.2 6.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.389 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.793 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.09 102.84 8.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -124.02 151.5 43.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.645 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.986 HG22 ' HB3' ' A' ' 93' ' ' TYR . 23.0 pt -136.08 165.1 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.407 . . . . 0.0 111.466 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -154.55 159.73 41.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -125.66 154.67 42.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.46 -85.13 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.786 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.52 -105.89 1.35 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.976 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.33 12.37 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.46 2.107 . . . . 0.0 112.086 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -140.8 179.44 6.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 93' ' ' TYR . 20.7 tt -146.88 144.26 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.574 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 136.45 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.986 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.93 159.93 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.181 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.08 146.88 24.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.793 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.98 160.67 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.669 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.695 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -153.95 156.53 37.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.942 0.401 . . . . 0.0 111.338 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HB3' ' N ' ' A' ' 55' ' ' GLU . 4.2 tptp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.583 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.787 0.327 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -84.51 158.65 20.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -64.51 149.25 48.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.992 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -126.11 156.18 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.83 104.93 16.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.996 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.98 157.32 16.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -119.68 -62.57 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.144 0 N-CA-C 110.343 -0.244 . . . . 0.0 110.343 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.5 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 3.4 t80 -135.54 164.28 28.18 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.996 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -134.66 113.73 12.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.848 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.804 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -109.05 81.93 1.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.51 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.58 68.91 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.471 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 61' ' ' SER . 16.4 mtt -136.24 -109.23 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.324 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 62' ' ' ASP . 21.7 t -134.73 138.68 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.9 70.22 2.33 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.425 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.525 0.203 . . . . 0.0 110.519 -179.747 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . 3.5 Cg_endo . . . . . 0 N--CA 1.461 -0.405 0 CA-C-O 120.8 0.25 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.848 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -52.85 -0.38 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' ' 40' ' ' PRO . 93.8 t -47.17 -30.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.63 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.61 64.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -54.87 -50.98 67.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.34 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.425 HD11 ' OD1' ' A' ' 73' ' ' ASP . 71.3 mt -61.77 -52.87 62.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.375 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -66.41 -13.38 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.137 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.62 -40.1 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.254 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 10.1 mtm -48.14 -52.99 37.18 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 51' ' ' LEU . 30.2 Cg_exo -60.5 -60.05 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.742 1.628 . . . . 0.0 111.434 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -74.61 24.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.954 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.54 -159.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 112.02 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.746 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -165.89 -174.7 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.191 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -83.4 36.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 150.58 102.76 0.25 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.489 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.908 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -124.48 177.74 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 55' ' ' GLU . 17.9 mt -159.47 161.7 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.5 ' CD1' ' HB3' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -160.67 130.25 4.99 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.472 -0.768 . . . . 0.0 111.423 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 1.2 mt-10 -118.71 118.36 31.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.765 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 30' ' ' LEU . 58.9 t -118.53 113.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.994 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.638 HG22 ' HE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -117.49 94.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 110.435 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -126.71 166.59 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.128 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.424 ' HB3' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -117.74 133.16 56.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.622 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 t -152.13 132.39 7.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.13 -18.04 24.15 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.488 2.125 . . . . 0.0 112.281 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.47 -162.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -117.64 -17.37 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mt -68.16 127.67 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.785 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -94.48 126.62 39.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.23 -82.43 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.848 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 7.3 mm -44.51 -54.82 11.45 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -61.25 -24.09 78.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.004 1.803 . . . . 0.0 112.921 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.8 tt -69.55 -33.46 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 45' ' ' LEU . 3.6 m-20 -66.41 -53.48 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -62.37 -36.29 81.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 75' ' ' ARG . 11.2 ttp180 -66.62 -33.13 74.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.81 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -60.58 -61.04 2.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.544 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 0.8 OUTLIER -67.74 -62.12 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 91.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.73 -164.21 1.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.0 110.345 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.588 HG21 ' HG2' ' A' ' 97' ' ' LYS . 24.3 m -82.35 -79.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 22.0 t -112.13 117.62 55.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.567 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.73 116.04 22.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -147.06 155.12 41.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.997 HG22 ' HB3' ' A' ' 93' ' ' TYR . 20.6 pt -135.1 170.25 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.004 0.431 . . . . 0.0 111.561 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.76 148.45 25.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.64 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.95 149.17 50.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.889 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -118.1 -83.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.19 -90.15 0.18 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.446 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.62 3.14 8.04 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.649 2.233 . . . . 0.0 112.812 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 62' ' ' ASP . 32.2 p -145.4 174.93 10.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.508 HG12 ' CE1' ' A' ' 93' ' ' TYR . 16.5 tt -144.43 139.8 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.836 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.638 ' HE ' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -124.01 132.7 53.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.348 -177.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.997 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.75 156.33 34.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.34 145.33 22.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 112.105 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.567 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -132.63 153.08 37.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.124 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.61 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.4 OUTLIER -154.6 175.26 13.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 111.235 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.908 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.77 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.795 0.331 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -119.93 119.79 34.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -110.82 179.75 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.81 96.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -88.12 167.62 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.985 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.0 p -71.99 -57.53 4.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -137.14 99.88 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.612 -179.798 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 56' ' ' ILE . 39.8 t0 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.575 0.226 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.837 ' H ' HD12 ' A' ' 57' ' ' LEU . 10.5 t80 -136.62 166.41 23.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.391 . . . . 0.0 111.758 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.56 105.99 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.802 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.705 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.1 tm? -103.83 81.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.7 m-20 -103.62 66.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.149 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.24 -105.83 0.21 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.0 t -134.33 148.82 29.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.499 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -81.54 55.58 4.86 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.621 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.531 0.205 . . . . 0.0 110.759 179.825 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . 23.6 Cg_endo . . . . . 0 CA--C 1.531 0.359 0 N-CA-C 113.337 0.476 . . . . 0.0 113.337 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.786 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -56.87 -2.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 5.4 t -45.49 -35.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.6 -46.57 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.275 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 74' ' ' ALA . 54.7 m -49.44 -46.93 48.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.623 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 45' ' ' LEU . 19.3 mt -63.48 -57.38 10.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.282 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 mm-40 -64.76 -10.58 28.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.014 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -73.67 -40.37 63.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.154 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -51.97 -47.67 90.54 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.991 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.3 Cg_endo -69.98 -51.76 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.711 1.607 . . . . 0.0 111.759 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 14.3 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.401 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.15 156.06 0.18 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.999 0.428 . . . . 0.0 111.868 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -125.75 -164.91 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -88.32 40.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.844 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.4 113.27 1.52 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.29 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.893 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 15.8 pt-20 -135.3 -177.05 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -161.04 152.08 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.272 0.558 . . . . 0.0 111.141 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.837 HD12 ' H ' ' A' ' 28' ' ' TYR . 4.7 tp -127.02 158.98 35.5 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -144.35 107.77 4.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.196 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 30' ' ' LEU . 45.5 t -117.57 112.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.616 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 90.6 t -118.59 94.73 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.694 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.2 p -125.5 171.83 10.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.897 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -118.04 122.6 43.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.581 179.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.24 131.27 8.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.971 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.48 -8.65 18.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.596 2.198 . . . . 0.0 112.314 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -97.0 -167.32 1.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.957 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.38 -26.09 8.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 mt -66.85 123.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.76 130.4 37.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.843 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.62 -70.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.101 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.786 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 2.8 mm -49.64 -52.49 50.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.1 Cg_exo -57.61 -43.25 52.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.272 1.981 . . . . 0.0 112.87 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.34 -21.98 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.203 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -71.99 -57.88 3.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.95 -41.7 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.708 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.17 -33.75 75.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.006 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.26 -61.08 2.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.569 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.598 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 8.9 m170 -72.37 -69.08 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.19 103.94 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 51.3 p90 -92.93 -162.4 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.126 0.488 . . . . 0.0 111.328 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.466 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -113.25 -52.75 2.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.258 176.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.834 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 48.1 t -143.95 118.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.171 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.683 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -122.95 115.18 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.964 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.15 155.46 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.952 HG22 ' HB3' ' A' ' 93' ' ' TYR . 19.4 pt -133.05 167.1 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.479 . . . . 0.0 111.601 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 91' ' ' ILE . 30.6 tt0 -154.63 165.44 36.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.413 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -132.1 147.33 52.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.798 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -107.85 -81.4 0.56 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.636 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.31 -92.53 0.22 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.815 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.33 3.66 7.14 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.803 2.336 . . . . 0.0 112.033 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' OD2' ' A' ' 62' ' ' ASP . 25.0 p -136.47 -178.24 5.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.7 tt -143.34 151.1 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -140.03 131.79 27.44 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.815 0.341 . . . . 0.0 111.302 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.952 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.05 140.46 53.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.246 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.87 157.01 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.683 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.22 162.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.614 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.834 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.79 155.6 34.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.893 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.502 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.847 0.356 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.13 148.63 48.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -118.01 -165.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -69.38 164.29 23.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.92 -179.82 4.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 p -119.44 88.12 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -118.4 65.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.473 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.556 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 27.6 t70 . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.471 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.91 168.42 19.36 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.651 -0.819 . . . . 0.0 112.656 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 13.2 mtp180 -134.82 118.01 16.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.721 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.016 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -116.47 78.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.947 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.9 67.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.391 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 61' ' ' SER . 15.5 mtt -136.46 -110.65 0.19 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 111.504 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 62' ' ' ASP . 84.8 t -135.41 122.95 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.79 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.429 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . -68.13 92.48 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.228 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.44 0.162 . . . . 0.0 110.709 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 1.016 ' HB2' HD21 ' A' ' 30' ' ' LEU . 4.1 Cg_exo . . . . . 0 CA--C 1.529 0.265 0 N-CA-C 112.629 0.204 . . . . 0.0 112.629 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.595 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -55.34 -2.55 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.946 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' A' ' 40' ' ' PRO . 79.2 t -51.91 -28.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.046 0.45 . . . . 0.0 110.05 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -70.57 -38.74 74.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.23 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.544 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -58.51 -46.35 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.944 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 73' ' ' ASP . 1.2 tp -67.79 -39.26 84.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.783 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.556 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 2.5 pt-20 -72.12 -17.29 61.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.648 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.56 -36.75 68.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.875 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.659 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 22.0 mtp -49.6 -54.14 34.14 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.383 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 18.3 Cg_exo -65.45 -45.61 6.8 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.021 1.814 . . . . 0.0 111.485 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -73.23 12.78 0.51 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.55 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.643 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.56 159.1 0.1 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.09 0.471 . . . . 0.0 111.935 -179.289 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -142.6 -160.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.631 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -86.78 33.51 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.2 114.96 0.71 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.305 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.814 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -121.17 166.75 13.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.645 0.26 . . . . 0.0 110.907 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 55' ' ' GLU . 10.6 mm -159.22 149.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -160.69 131.12 5.28 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.907 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -121.73 132.93 54.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.551 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.48 126.63 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.585 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 2.2 t -125.75 101.53 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.0 m -142.41 169.82 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.231 0.539 . . . . 0.0 112.073 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.16 129.2 55.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.196 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 68' ' ' ASN . 30.5 p -156.83 136.52 8.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.333 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.92 -25.65 8.76 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.461 2.107 . . . . 0.0 112.263 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.35 -162.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -140.12 10.37 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.859 ' HA ' HD13 ' A' ' 72' ' ' LEU . 44.5 mm -111.35 -26.9 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.89 0.376 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 63' ' ' CYS . 7.6 m120 -52.1 -12.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.534 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.875 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 1.9 m-20 -50.9 119.34 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.539 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.724 HG12 HG21 ' A' ' 59' ' ' VAL . 22.7 mm -51.65 -49.93 80.16 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.311 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 36.9 Cg_exo -62.0 -22.32 74.04 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.139 1.893 . . . . 0.0 111.965 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.875 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -62.4 -39.34 92.92 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.108 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.508 ' HB3' HD13 ' A' ' 45' ' ' LEU . 14.2 m-20 -59.75 -45.56 91.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 79' ' ' TYR . . . -70.46 -23.33 62.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.607 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -38.54 66.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.537 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.53 -58.72 6.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.457 ' HB2' ' SD ' ' A' ' 48' ' ' MET . 73.6 m80 -69.36 -45.16 70.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.322 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.16 87.88 1.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.162 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -87.7 -140.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -97.85 -72.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.807 0.337 . . . . 0.0 110.991 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 26.3 t -127.68 123.63 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.4 mm? -123.44 101.65 7.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.91 158.3 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.473 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.935 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -138.82 172.06 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 91' ' ' ILE . 26.3 mt-30 -154.36 156.33 36.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.215 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 152.53 51.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.791 0.329 . . . . 0.0 111.22 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -122.72 -78.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 89' ' ' PRO . . . -139.99 -106.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HD3' ' HA3' ' A' ' 88' ' ' GLY . 2.8 Cg_exo -75.84 10.04 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.71 2.274 . . . . 0.0 111.949 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 67.7 p -138.98 170.73 15.44 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.9 tt -150.93 136.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.046 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -127.93 140.43 52.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.326 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.935 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -123.66 166.19 15.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.947 178.229 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.44 144.8 21.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.525 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -129.25 149.57 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.388 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.444 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 5.4 pt20 -142.94 155.92 44.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.791 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 10.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.815 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.685 0.279 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -140.14 -163.52 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.933 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -74.43 -169.76 0.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.44 17.47 4.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.037 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -72.34 117.98 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -123.67 -178.8 4.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.025 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.18 153.28 32.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.45 179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.418 0.151 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.59 ' HB2' HD11 ' A' ' 57' ' ' LEU . 62.8 m-85 -134.17 160.83 36.62 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.81 0.338 . . . . 0.0 111.638 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 144.71 46.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.837 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.622 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.1 tm? -134.3 81.41 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.514 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.0 p-10 -103.22 65.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.89 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 61' ' ' SER . 6.2 mtp -137.2 -105.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 32' ' ' MET . 2.4 t -134.93 156.79 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.381 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.54 -9.6 13.49 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.198 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 C--N 1.329 -0.283 0 C-N-CA 122.122 0.169 . . . . 0.0 110.987 179.708 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 42' ' ' VAL . 74.0 Cg_endo . . . . . 0 N--CA 1.457 -0.627 0 CA-C-O 121.071 0.363 . . . . 0.0 112.144 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -64.75 6.97 0.18 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.471 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.4 p -53.29 -27.48 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.457 . . . . 0.0 110.178 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.574 ' HB1' ' CG ' ' A' ' 28' ' ' TYR . . . -73.44 -37.28 65.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.705 178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 74' ' ' ALA . 2.8 m -54.23 -63.72 1.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.321 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.453 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 20.9 mt -56.29 -38.22 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.275 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 4.9 tt0 -64.55 -28.76 69.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.639 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB2' ' CD2' ' A' ' 28' ' ' TYR . . . -73.08 -24.21 60.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.744 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 38.6 mmt -57.2 -55.88 39.59 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.703 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 11.7 Cg_exo -70.45 -44.49 1.58 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.117 1.878 . . . . 0.0 111.554 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.86 8.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.382 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -44.0 154.39 0.11 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.98 0.419 . . . . 0.0 111.552 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -124.33 -157.71 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.836 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -78.02 8.44 4.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.133 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' OXT' ' A' ' 97' ' ' LYS . . . 160.78 82.09 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.804 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -81.91 172.34 13.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 55' ' ' GLU . 4.5 mt -160.27 155.97 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 28' ' ' TYR . 1.1 tp -139.59 161.17 38.17 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.019 0.437 . . . . 0.0 111.247 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -143.18 113.17 7.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -118.12 114.97 46.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.395 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 61.1 t -119.05 94.24 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.09 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -130.75 173.69 10.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.521 . . . . 0.0 111.771 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.401 ' OD2' HG22 ' A' ' 90' ' ' THR . 0.7 OUTLIER -117.43 130.85 56.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.337 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.54 117.45 3.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.93 -17.83 61.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.679 2.253 . . . . 0.0 112.09 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -108.85 -163.49 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 t -102.57 -18.46 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -69.98 130.56 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -137.09 129.73 30.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.294 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.33 -48.73 69.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.73 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -56.96 -55.73 40.82 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.53 ' HA ' HD11 ' A' ' 82' ' ' LEU . 28.8 Cg_endo -62.57 -33.6 77.57 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.644 1.563 . . . . 0.0 112.201 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -29.46 68.93 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -57.39 12.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.719 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -66.51 -37.73 85.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 29.9 ttt-85 -63.43 -54.98 28.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.592 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -47.88 -55.01 10.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.214 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -70.13 -71.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.532 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.99 98.74 0.15 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.707 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.6 p90 -88.78 -165.35 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 0.0 111.406 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.594 HG21 ' HD2' ' A' ' 97' ' ' LYS . 39.5 m -112.16 -52.24 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.057 175.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 41.3 t -141.84 116.6 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -122.53 105.01 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.619 -178.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -123.66 163.62 20.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.648 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.882 HG22 ' HB3' ' A' ' 93' ' ' TYR . 15.5 pt -139.91 168.3 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.431 . . . . 0.0 111.433 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.5 mt-30 -154.42 155.76 35.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.39 154.4 50.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -123.45 -80.56 0.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.63 -97.52 0.36 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.406 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 9.55 3.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.401 HG22 ' OD2' ' A' ' 62' ' ' ASP . 47.5 p -146.37 176.4 9.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.955 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.0 tt -145.04 140.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.654 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 92' ' ' ARG . 3.7 ttm-85 -133.2 132.55 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.882 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.39 164.7 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.829 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.92 158.6 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.904 0.383 . . . . 0.0 111.443 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -134.47 162.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.922 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.778 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -154.5 156.21 36.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.629 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.822 0.344 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 172.29 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.81 44.06 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.19 -70.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -112.44 53.03 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -68.17 -73.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.991 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.18 111.97 20.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.978 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.856 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 56' ' ' ILE . 26.2 t0 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.591 ' HB2' HD12 ' A' ' 57' ' ' LEU . 1.8 m-85 -107.98 141.9 38.92 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.308 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 7.8 mtp85 -111.46 137.33 49.41 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.844 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.7 tm? -126.71 89.12 2.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.295 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.708 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.12 62.5 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.62 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 78.3 mtp -136.69 -112.68 0.18 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.385 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.621 ' HA ' ' HB2' ' A' ' 61' ' ' SER . 2.5 t -134.67 155.7 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.66 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' HA2' ' ND2' ' A' ' 69' ' ' ASN . . . -79.8 70.16 2.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.107 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-O 120.537 0.208 . . . . 0.0 110.77 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 42' ' ' VAL . 32.8 Cg_endo . . . . . 0 CA--C 1.53 0.278 0 CA-C-O 120.869 0.279 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.989 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -61.67 12.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -52.64 -31.65 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.81 -43.28 59.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -54.94 -45.05 74.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.11 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.91 -53.56 48.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.6 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 7.5 pt-20 -67.73 -10.38 52.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.648 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -73.79 -39.33 64.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.582 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.89 -48.96 70.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.604 -178.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.6 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 18.3 Cg_exo -65.89 -54.83 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 121.978 1.785 . . . . 0.0 111.387 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.62 18.22 0.13 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.907 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.7 157.52 0.37 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.924 0.392 . . . . 0.0 111.452 -179.324 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -138.52 -170.85 2.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.94 9.09 29.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.66 61.79 0.32 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.654 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -82.7 148.81 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 55' ' ' GLU . 29.6 mt -156.99 158.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.2 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.685 HD21 HG21 ' A' ' 70' ' ' ILE . 1.3 tp -160.58 142.11 12.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.656 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.714 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.981 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.844 HG13 ' HB3' ' A' ' 30' ' ' LEU . 18.7 t -139.3 142.52 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.032 0.444 . . . . 0.0 111.739 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -146.91 109.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.169 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.621 ' HB2' ' HA ' ' A' ' 33' ' ' VAL . 93.4 p -150.57 -175.52 5.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.575 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.78 119.88 36.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 41.1 t -137.03 106.6 8.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.954 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -30.64 77.24 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.462 2.108 . . . . 0.0 112.196 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HB3' ' H ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -89.57 -162.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 8.5 t -108.61 -19.87 13.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 mt -55.8 119.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.061 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -74.67 137.48 42.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.911 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.505 ' ND2' ' HA2' ' A' ' 34' ' ' GLY . 49.3 t30 -73.25 -90.96 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.537 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.989 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -48.38 -51.03 54.09 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.374 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.673 ' HG2' ' HD2' ' A' ' 93' ' ' TYR . 71.6 Cg_exo -52.59 -35.14 66.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.42 2.08 . . . . 0.0 113.186 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.4 tp -58.94 -41.04 86.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.08 -57.44 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.202 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -62.34 -35.74 80.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.348 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -67.79 -31.5 71.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.91 -62.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.677 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -70.26 -37.29 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.06 107.84 3.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.946 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.458 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -110.24 -162.6 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.047 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.458 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 2.4 m -82.82 -74.76 0.34 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.159 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 23.3 t -116.59 122.0 68.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.436 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 71' ' ' PRO . 2.4 mm? -128.52 97.11 4.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.196 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.59 141.07 51.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.911 0.386 . . . . 0.0 111.326 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.74 161.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.247 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -148.01 156.15 42.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.652 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.06 151.67 45.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.912 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.34 -79.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.708 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.26 -89.74 0.17 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.136 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.61 -2.4 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.691 2.261 . . . . 0.0 112.767 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p -136.91 -174.81 3.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.857 0.36 . . . . 0.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 85' ' ' GLN . 2.5 tt -152.18 149.96 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.608 ' HD2' ' O ' ' A' ' 59' ' ' VAL . 8.0 tpt180 -123.21 133.28 54.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.727 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -123.81 146.61 48.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.466 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.79 137.3 15.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.884 0.373 . . . . 0.0 111.737 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -131.66 153.42 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.317 178.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.7 pt20 -154.03 169.45 23.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.287 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.9 tttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.884 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 p80 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.802 0.334 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -89.12 -178.38 5.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -93.65 115.34 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -96.38 13.45 27.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -77.2 -173.7 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.8 m -97.25 77.52 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.51 -19.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.861 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.497 179.84 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 121.165 0.507 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -102.97 154.96 18.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.4 118.04 27.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.955 -178.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.782 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -114.68 80.94 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.465 177.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.674 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 4.8 m-20 -102.44 65.34 0.93 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.465 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' SER . 11.7 mtt -136.83 -108.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.105 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.589 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.4 t -132.65 147.42 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -59.38 -14.58 27.62 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 119.985 -1.102 . . . . 0.0 111.754 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.432 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.8 pt-20 . . . . . 0 C--N 1.33 -0.277 0 C-N-CA 122.138 0.175 . . . . 0.0 110.757 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' HD21 ' A' ' 30' ' ' LEU . 62.7 Cg_endo . . . . . 0 N--CA 1.457 -0.648 0 CA-C-O 120.76 0.233 . . . . 0.0 112.65 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 70' ' ' ILE . . . -54.71 -6.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.523 HG23 ' HD2' ' A' ' 40' ' ' PRO . 70.1 t -48.58 -32.1 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.56 -39.6 67.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.527 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.612 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.56 -47.5 85.23 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.94 179.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -57.97 -51.06 71.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 6.1 pt-20 -71.71 -13.23 61.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.98 -27.38 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.111 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.519 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.8 mmm -47.68 -55.65 16.22 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.388 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 68.6 Cg_endo -73.77 -37.25 3.06 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.837 1.691 . . . . 0.0 111.609 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.7 2.39 6.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.262 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -47.22 152.92 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.895 0.379 . . . . 0.0 111.269 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 11.9 mmmt -135.65 -167.87 2.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -87.0 42.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 157.3 55.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.727 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 1.7 pt-20 -72.19 155.0 40.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.65 0.262 . . . . 0.0 111.0 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.2 mt -158.12 152.66 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.215 0.531 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 tp -143.9 156.64 44.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.567 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -146.58 108.99 4.48 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.559 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.782 HG13 ' HB3' ' A' ' 30' ' ' LEU . 57.4 t -121.93 127.55 75.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 1.4 t -129.05 100.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.267 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -125.9 -172.62 2.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.306 0.574 . . . . 0.0 111.978 -176.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.589 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -117.54 109.51 16.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.36 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 65.94 2.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.907 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.69 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.858 2.372 . . . . 0.0 112.147 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -92.89 23.22 4.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.193 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 m -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.747 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.71 66.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.885 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.605 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 78.9 m-20 -99.77 51.22 0.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.396 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.835 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.95 118.21 10.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.649 -176.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 43.5 mm -51.22 -47.41 88.14 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.898 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.673 ' HB3' HG22 ' A' ' 95' ' ' ILE . 27.8 Cg_endo -60.82 -29.1 87.52 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.263 1.976 . . . . 0.0 111.841 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.835 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -55.14 -38.46 68.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.98 -45.09 95.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.585 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.612 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -68.07 -24.42 65.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 15.6 ttt-85 -72.26 -36.56 69.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.339 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -63.88 -55.41 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.302 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -28.44 68.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 109.768 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.09 88.53 1.39 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.011 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.577 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -96.48 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.385 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.606 HG21 ' HA ' ' A' ' 97' ' ' LYS . 12.6 m -79.69 -87.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.826 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 80' ' ' THR . 91.8 t -113.14 127.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 111.234 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.8 mm? -123.58 107.35 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.472 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -123.55 159.33 29.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.623 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.945 HG22 ' HB3' ' A' ' 93' ' ' TYR . 28.4 pt -142.8 172.27 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 111.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.418 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -153.71 173.82 15.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.343 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -137.51 139.71 40.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.972 0.415 . . . . 0.0 111.365 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 57.0 m-20 -117.21 -137.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.241 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -73.63 -106.84 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.085 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -87.47 20.02 1.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.769 2.313 . . . . 0.0 112.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.492 HG22 ' CG ' ' A' ' 62' ' ' ASP . 41.7 p -138.57 173.73 11.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.988 0.423 . . . . 0.0 111.152 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.557 HG12 ' CE2' ' A' ' 93' ' ' TYR . 8.0 tt -136.71 130.15 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.287 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.578 ' HB2' HG13 ' A' ' 60' ' ' VAL . 1.5 ttm180 -123.18 136.44 54.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.138 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.945 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -128.02 164.84 21.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.921 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.37 153.37 31.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.673 HG22 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -136.62 155.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.796 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.508 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -155.2 170.58 21.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 111.478 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.727 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.9 tttp . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.435 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.855 0.359 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -87.53 137.75 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -72.08 132.57 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -105.93 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.789 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.19 -73.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -121.77 8.88 10.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.72 138.61 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.511 -179.894 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 56' ' ' ILE . 5.8 p-10 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.111 0.482 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.436 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 4.7 m-85 -103.48 161.8 13.56 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -134.6 146.42 49.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.326 0.584 . . . . 0.0 112.489 -178.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.926 HD23 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -134.28 91.15 2.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.315 177.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.663 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 37.9 t0 -101.79 58.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.742 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.467 ' C ' ' HB3' ' A' ' 61' ' ' SER . 46.6 mtt -137.32 -110.53 0.18 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.644 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 62' ' ' ASP . 9.9 p -135.55 164.28 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.262 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -96.49 79.02 0.73 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.389 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.489 0.185 . . . . 0.0 110.878 -179.594 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.926 ' HG2' HD23 ' A' ' 30' ' ' LEU . 31.7 Cg_exo . . . . . 0 C--O 1.23 0.1 0 N-CA-C 112.536 0.168 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.61 ' CA ' HD13 ' A' ' 70' ' ' ILE . . . -65.26 -17.5 64.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.357 0.598 . . . . 0.0 110.246 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 46' ' ' GLU . 55.0 t -57.67 -27.76 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.823 177.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.2 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.312 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.579 ' OG1' HG23 ' A' ' 70' ' ' ILE . 3.0 m -51.75 -68.13 0.19 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 48.8 mt -61.46 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.167 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 3.3 tt0 -65.3 -18.6 65.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.738 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.04 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.261 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.531 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.2 mmt -46.16 -55.12 14.36 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.871 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 48' ' ' MET . 39.3 Cg_endo -66.39 -56.71 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.714 1.609 . . . . 0.0 111.756 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -73.56 18.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.807 179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -44.55 151.37 0.27 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.773 0.321 . . . . 0.0 111.322 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -130.21 -179.61 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.19 61.63 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.834 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.72 43.49 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -65.3 150.51 48.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 110.815 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.55 ' N ' ' HG3' ' A' ' 55' ' ' GLU . 1.8 mt -154.03 156.11 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.561 HD21 ' CG2' ' A' ' 70' ' ' ILE . 9.5 tp -146.75 161.05 41.44 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.21 0.528 . . . . 0.0 111.201 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -150.48 140.03 21.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 177.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.84 144.34 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.013 0.435 . . . . 0.0 111.172 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.76 97.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.167 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.526 ' HB2' HD21 ' A' ' 68' ' ' ASN . 0.3 OUTLIER -151.06 179.33 8.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -178.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.42 137.65 53.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 179.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 11.3 p -159.51 139.51 8.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.042 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.81 -12.87 36.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.675 2.25 . . . . 0.0 112.087 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -95.15 -160.84 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -113.54 -5.43 13.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.6 149.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.238 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.526 HD21 ' HB2' ' A' ' 61' ' ' SER . 4.4 m-20 -112.81 -169.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.097 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.697 ' ND2' HG12 ' A' ' 70' ' ' ILE . 5.6 p-10 -72.57 -55.06 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.901 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.728 HD11 ' HG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.98 -51.18 83.61 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 31.9 Cg_endo -62.79 -41.51 30.0 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.428 2.085 . . . . 0.0 112.837 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -25.63 65.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.095 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 10.1 m-20 -71.58 -61.78 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.192 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -60.97 -38.95 87.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -65.15 -27.48 68.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -62.92 -69.05 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -14.78 61.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.34 96.4 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.493 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.641 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 33.7 t80 -82.98 -98.78 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.653 0.263 . . . . 0.0 110.904 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 m -137.57 -77.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.893 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 25.8 t -109.99 114.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.187 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.535 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -123.23 101.77 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.348 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.69 158.5 31.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.635 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 33.0 pt -141.87 168.08 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 111.76 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 84' ' ' ILE . 3.7 mt-30 -152.4 155.64 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.483 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.39 141.92 45.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -109.74 -79.47 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.846 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.36 -97.51 0.46 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.087 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.31 6.88 5.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.243 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.1 p -135.89 172.21 13.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.037 0.446 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 4.0 tt -148.0 145.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.874 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 111.453 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 4.4 m-85 -131.68 130.76 42.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.72 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -133.94 157.24 41.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.387 178.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.73 157.43 39.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.641 ' HB2' ' HE2' ' A' ' 79' ' ' TYR . 3.0 tptp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.741 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.34 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -67.05 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -91.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.46 157.61 35.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.031 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.44 21.45 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.893 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.68 126.33 39.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.007 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -134.33 28.66 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.515 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.674 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.4 t70 . . . . . 0 N--CA 1.467 0.418 0 CA-C-O 120.96 0.41 . . . . 0.0 111.343 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.494 ' HB3' HD12 ' A' ' 57' ' ' LEU . 9.9 t80 -103.92 168.31 9.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.707 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.0 ptt85 -134.61 130.4 36.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 40' ' ' PRO . 1.9 tm? -123.06 78.67 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.41 -0.813 . . . . 0.0 108.973 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.63 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -102.06 70.12 1.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.762 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -136.7 -111.31 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 178.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 62' ' ' ASP . 10.5 p -135.57 144.74 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.809 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -76.1 76.41 1.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.276 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.73 0.3 . . . . 0.0 111.138 -179.428 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB3' HD21 ' A' ' 30' ' ' LEU . 31.7 Cg_exo . . . . . 0 CA--C 1.529 0.26 0 CA-C-O 120.815 0.256 . . . . 0.0 112.461 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.68 4.7 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -48.16 -34.34 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -38.38 66.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.954 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.687 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.5 -57.63 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 9.8 mt -61.52 -54.23 45.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.48 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.35 -33.24 65.48 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.228 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -44.3 -61.49 1.49 Allowed 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 mtm -76.37 138.44 67.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 51' ' ' LEU . 63.0 Cg_endo -83.09 11.24 40.64 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.753 -0.936 . . . . 0.0 113.593 -10.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -71.91 16.54 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.135 -0.353 . . . . 0.0 111.664 -177.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.638 HD12 ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -71.12 179.28 2.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.352 . . . . 0.0 111.177 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -126.12 -148.15 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HA ' ' HE2' ' A' ' 97' ' ' LYS . 18.8 mtmt -107.36 58.51 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 110.85 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.585 ' H ' ' HD3' ' A' ' 97' ' ' LYS . . . 126.36 93.05 0.87 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.67 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -124.1 -173.15 2.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.711 0.291 . . . . 0.0 110.984 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -160.43 162.48 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.001 -179.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 44' ' ' THR . 15.2 tp -144.22 162.9 35.18 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.229 0.538 . . . . 0.0 111.398 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 2.6 mt-10 -147.82 141.62 25.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.403 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 25.4 t -141.18 131.1 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 111.602 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.63 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 36.1 t -133.1 84.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.196 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -124.71 166.91 15.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.27 -178.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -118.38 135.76 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.494 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 19.3 p -159.25 143.31 11.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.134 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.6 Cg_exo -70.95 -11.32 29.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.711 2.274 . . . . 0.0 112.046 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -93.08 -164.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -112.74 -17.52 12.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -117.68 153.49 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.517 ' ND2' ' HA3' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -125.81 177.81 6.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.067 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.68 -42.48 64.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.936 -178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.75 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -60.04 -49.82 89.27 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 50.5 Cg_endo -67.27 -43.46 6.12 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.189 1.926 . . . . 0.0 112.244 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.406 HD12 HG12 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -64.96 -32.58 74.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 3.8 m-20 -64.13 -57.6 9.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -61.63 -39.55 91.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 75' ' ' ARG . 3.8 mtp180 -62.6 -32.21 73.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.672 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -61.94 -67.89 0.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -33.28 72.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.575 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.14 95.03 1.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.04 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.87 -168.77 1.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.661 0.267 . . . . 0.0 110.285 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.683 HG22 HG23 ' A' ' 81' ' ' VAL . 96.7 m -77.26 -62.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.728 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.8 t -127.44 132.34 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.334 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -133.28 100.29 4.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.407 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.47 156.91 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.874 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.22 175.24 4.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.091 0.472 . . . . 0.0 111.804 -179.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.531 ' O ' HG13 ' A' ' 91' ' ' ILE . 17.1 mt-30 -154.04 166.95 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.439 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -145.4 145.46 31.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.877 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.6 -83.09 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.11 -97.27 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.202 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.15 5.92 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.52 2.147 . . . . 0.0 112.449 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -138.08 174.49 10.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 111.163 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 85' ' ' GLN . 3.1 tt -145.17 144.19 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.741 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.56 138.39 54.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.928 0.394 . . . . 0.0 111.119 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.9 m-85 -123.86 149.47 45.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.205 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.39 138.39 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.926 0.393 . . . . 0.0 111.746 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -129.34 161.34 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.534 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.728 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -152.07 145.7 24.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.67 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.718 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 2.3 t-80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.822 0.344 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.72 3.81 5.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -82.98 -55.69 4.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -109.07 4.02 22.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 6' ' ' HIS . 0.7 OUTLIER -115.72 76.51 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.33 166.41 22.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.59 6.3 23.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 t70 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.433 0.158 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.537 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -134.48 161.11 35.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 111.478 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -135.1 121.18 19.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.508 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.846 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -107.66 77.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.07 65.15 0.86 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.461 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.635 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -137.16 -104.93 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.05 178.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.405 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 13.0 p -134.56 137.04 51.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.584 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -72.94 77.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.846 ' HB2' HD21 ' A' ' 30' ' ' LEU . 3.0 Cg_exo . . . . . 0 CA--C 1.529 0.234 0 CA-C-O 120.698 0.208 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . . . -59.48 1.94 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.916 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 40' ' ' PRO . 59.8 t -51.18 -27.87 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.372 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.99 -36.83 67.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.697 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 51.7 m -57.46 -52.35 65.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.016 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tp -60.96 -63.13 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.1 -39.51 13.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.948 0.404 . . . . 0.0 110.406 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.23 -61.58 1.14 Allowed 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.458 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 mmt -76.97 138.85 65.39 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' C ' HD23 ' A' ' 51' ' ' LEU . 66.9 Cg_endo -83.27 13.79 34.04 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.643 -0.982 . . . . 0.0 113.336 -11.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 47' ' ' ALA . 35.8 mt-30 -70.41 10.55 0.45 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.177 -0.327 . . . . 0.0 111.824 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' H ' HD23 ' A' ' 51' ' ' LEU . 1.3 pt? -72.12 -177.35 2.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.72 -160.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.56 29.39 0.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.957 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.96 91.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.493 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.837 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -116.93 173.8 6.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.567 0.222 . . . . 0.0 110.755 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 55' ' ' GLU . 5.8 mt -159.22 157.53 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.235 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -143.66 161.51 38.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.092 0.472 . . . . 0.0 111.396 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.42 119.29 8.69 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.158 175.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.706 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 47.5 t -117.95 111.8 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 111.368 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 1.6 t -117.75 89.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 32' ' ' MET . 62.9 m -129.18 172.74 11.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.691 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -117.59 125.15 50.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 4.0 p -159.27 147.31 13.52 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.7 Cg_exo -71.3 -23.4 24.19 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.126 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -175.4 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.82 -32.28 11.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 93' ' ' TYR . 1.5 tt -119.93 148.73 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.584 ' ND2' ' HA3' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -98.93 173.86 6.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -72.54 -22.05 61.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.646 HD12 ' HG ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -67.65 -54.5 17.52 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 68' ' ' ASN . 21.2 Cg_exo -65.84 -35.39 35.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.277 1.985 . . . . 0.0 111.688 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -21.28 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.604 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -62.68 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.74 -39.78 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -56.53 -40.53 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.744 179.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -52.42 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.065 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -68.3 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.114 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.14 98.06 0.11 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.845 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.791 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 45.6 p90 -98.97 -166.02 1.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.488 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.787 HG21 ' HD2' ' A' ' 97' ' ' LYS . 1.4 m -125.83 -40.88 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.504 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.635 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 73.3 t -144.43 115.08 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.609 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.38 95.86 4.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.106 -178.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.97 163.27 21.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.3 pt -142.59 178.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 111.986 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.36 -172.09 4.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.243 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -144.56 142.41 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 111.226 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -118.03 -154.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.246 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -64.98 -99.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.107 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -90.74 16.31 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.744 2.296 . . . . 0.0 112.536 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.532 HG22 ' OD2' ' A' ' 62' ' ' ASP . 11.5 p -137.26 -170.72 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.001 0.429 . . . . 0.0 111.059 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt -143.19 147.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.605 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -123.79 142.87 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.063 0.459 . . . . 0.0 111.178 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.706 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.8 m-85 -131.39 155.79 46.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.564 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.7 143.93 20.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.613 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.609 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -134.98 158.62 41.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.236 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.635 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -154.11 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.837 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.1 tptp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.516 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.837 0.351 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 128.27 50.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -79.67 101.49 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 33.93 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.96 95.08 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -112.07 -13.22 13.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 p -68.9 109.92 4.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.566 -179.943 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' A' ' 58' ' ' GLU . 37.5 t0 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 57' ' ' LEU . 1.1 m-85 -103.78 136.55 43.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.758 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -103.52 135.68 44.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 112.384 -176.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.699 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.4 tm? -130.56 81.16 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.339 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.645 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.51 71.79 1.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.788 -176.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.438 ' HB3' ' H ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -136.86 -112.02 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.096 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.535 HG22 ' OD1' ' A' ' 62' ' ' ASP . 47.9 t -134.87 133.31 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.69 103.43 0.32 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.604 0.24 . . . . 0.0 110.96 -179.666 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.51 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 62.7 Cg_endo . . . . . 0 CA--C 1.53 0.299 0 CA-C-O 120.818 0.258 . . . . 0.0 112.614 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.82 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.55 4.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.448 ' H ' ' C ' ' A' ' 40' ' ' PRO . 54.1 t -52.91 -29.29 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 110.106 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.96 -34.0 66.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.639 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -64.26 -52.22 59.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.067 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.29 -57.6 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 47' ' ' ALA . 16.8 pt-20 -50.1 -40.57 46.14 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.53 -53.19 4.46 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.474 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.3 137.13 64.47 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 173.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' C ' HD13 ' A' ' 51' ' ' LEU . 65.0 Cg_endo -83.34 11.42 41.21 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.668 -0.972 . . . . 0.0 113.243 -11.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 47' ' ' ALA . 10.1 mm100 -73.02 25.9 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.46 -159.58 0.06 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.713 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -141.8 -155.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.448 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.713 ' H ' ' HD3' ' A' ' 52' ' ' LYS . 6.6 mttp -91.57 30.14 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.63 73.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.213 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.713 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -78.8 171.43 15.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 55' ' ' GLU . 61.5 mt -154.87 162.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.034 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.611 ' HG ' ' N ' ' A' ' 58' ' ' GLU . 4.3 tp -159.59 162.05 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.019 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.611 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -149.11 133.06 17.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.725 -176.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.699 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -139.25 132.23 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.849 0.356 . . . . 0.0 111.66 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -135.32 97.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.223 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.85 171.1 14.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.44 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.535 ' OD1' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.24 138.34 52.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.352 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.9 t -159.33 133.02 4.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.009 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 29.1 Cg_exo -61.64 -30.9 86.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.558 2.172 . . . . 0.0 112.129 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -81.4 -170.91 3.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -112.35 -17.09 12.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.68 137.48 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -100.12 127.19 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.606 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.776 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -72.52 -58.71 3.16 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.82 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 15.3 mm -56.85 -54.05 58.39 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.2 Cg_exo -58.28 -32.94 97.1 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.331 2.021 . . . . 0.0 112.7 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 6.5 tp -61.51 -30.95 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.03 -58.05 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.068 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -63.51 -32.46 73.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.2 ttt-85 -68.87 -31.64 70.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -61.7 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.64 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -70.95 -24.66 62.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.309 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.7 103.37 1.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.994 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.39 -164.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.639 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 97' ' ' LYS . 2.6 m -72.77 -82.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 46.6 t -116.43 123.99 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.093 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.624 HD12 ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -123.71 103.43 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.699 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.87 164.97 21.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.217 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.927 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -137.6 179.06 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.248 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.34 -177.0 6.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -150.37 138.87 20.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.053 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -122.57 -131.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.417 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.74 -123.66 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.167 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.7 29.89 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.915 2.41 . . . . 0.0 112.308 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 62' ' ' ASP . 2.0 p -147.6 -177.8 5.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 85' ' ' GLN . 14.3 tt -142.84 148.52 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.844 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.509 ' HB2' HG13 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -139.19 135.52 34.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.86 0.362 . . . . 0.0 111.257 -178.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.927 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.79 159.53 29.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.591 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.45 152.98 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 111.645 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.536 HG22 HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -133.35 155.17 40.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.338 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.492 ' N ' HD12 ' A' ' 95' ' ' ILE . 5.7 pt20 -154.35 157.16 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.713 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 34.6 tttm . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.799 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.3 m80 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.741 0.305 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -92.16 21.06 5.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.28 -64.19 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.977 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -171.96 3.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -89.6 162.84 15.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.83 162.98 13.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.8 p -108.74 72.81 0.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.567 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.2 t0 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 57' ' ' LEU . 1.4 t80 -105.33 137.63 42.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.8 -176.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.4 OUTLIER -103.89 131.73 50.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.48 -178.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.881 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -123.76 86.79 2.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.047 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.658 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 41.8 t0 -102.27 64.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.8 mtp -136.66 -109.44 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.322 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 62' ' ' ASP . 10.9 p -133.93 143.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.975 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -74.09 94.29 0.79 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.46 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.642 ' HB3' HD11 ' A' ' 30' ' ' LEU . 6.6 Cg_endo . . . . . 0 CA--C 1.531 0.327 0 N-CA-C 113.379 0.492 . . . . 0.0 113.379 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HA ' HG23 ' A' ' 70' ' ' ILE . . . -57.94 -0.68 0.09 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.0 t -52.22 -35.85 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.713 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 46' ' ' GLU . . . -71.16 -36.74 72.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.602 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.909 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.27 -42.57 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.196 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 1.2 tp -68.01 -55.62 11.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.329 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.662 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.23 -15.3 56.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.143 0.497 . . . . 0.0 110.754 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HB1' ' OH ' ' A' ' 79' ' ' TYR . . . -74.63 -34.73 62.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.817 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.607 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.3 -47.83 87.38 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.461 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 14.8 Cg_exo -68.53 -51.55 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.006 1.804 . . . . 0.0 111.408 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -73.23 15.26 0.24 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.635 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.607 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -53.22 161.4 0.89 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 111.677 -178.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.2 -162.94 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.469 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.67 39.72 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 110.808 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . -174.94 67.81 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.438 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.609 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -110.17 152.92 25.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 111.414 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.4 mt -159.63 152.81 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.279 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 95' ' ' ILE . 1.3 tp -160.67 137.73 9.08 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.147 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.652 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -118.75 137.93 53.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.091 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.881 HG13 ' HB3' ' A' ' 30' ' ' LEU . 15.2 t -139.9 150.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 0.0 112.359 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -154.95 100.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.752 178.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 33' ' ' VAL . 59.7 m -144.07 167.92 21.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.958 0.409 . . . . 0.0 111.506 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -121.75 137.1 54.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.5 t -159.26 126.71 2.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.71 -12.99 36.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.385 2.057 . . . . 0.0 112.043 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 66' ' ' SER . 35.0 mt-30 -86.02 -155.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 1.6 m -126.6 -56.51 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.302 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.685 HG23 HD23 ' A' ' 72' ' ' LEU . 1.3 mp -77.63 74.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.611 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -136.47 5.08 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.067 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.763 ' HB2' HD13 ' A' ' 72' ' ' LEU . 2.8 m-20 -72.44 126.16 29.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.068 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 46.9 mm -53.83 -45.72 98.74 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.055 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.832 ' HB3' HG22 ' A' ' 95' ' ' ILE . 35.9 Cg_endo -63.6 -23.31 70.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.876 . . . . 0.0 111.772 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 69' ' ' ASN . 2.4 mp -64.64 -31.3 72.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -46.49 80.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.595 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.909 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -72.8 -29.94 63.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.364 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.625 ' HB2' ' HG ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -72.94 -52.54 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 19.1 t30 -50.52 -51.42 47.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.765 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -56.82 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.389 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.07 107.49 0.75 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.972 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -126.02 -135.85 0.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.558 0.218 . . . . 0.0 110.758 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.49 HG21 ' HA ' ' A' ' 97' ' ' LYS . 3.2 m -110.43 -78.66 0.59 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.798 0.332 . . . . 0.0 110.977 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.517 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 4.0 t -121.27 121.15 64.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.349 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.3 mm? -123.59 106.18 10.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -130.16 139.16 50.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.851 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.949 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -127.07 166.36 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.994 0.426 . . . . 0.0 111.571 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.42 142.88 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.494 ' H ' HE21 ' A' ' 86' ' ' GLN . 0.0 OUTLIER -123.89 152.78 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.855 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -121.62 -78.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.82 -99.97 0.59 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.67 5.61 6.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.606 2.204 . . . . 0.0 112.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 p -141.13 174.91 10.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.066 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.419 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.8 tt -149.85 134.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -123.81 130.64 52.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.949 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -124.01 161.18 26.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.701 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.97 146.38 23.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.537 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.832 HG22 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -123.9 155.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.009 177.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.517 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.39 -170.56 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 111.343 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ttt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.777 0.322 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.62 145.52 40.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.488 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.53 -53.48 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.82 0.343 . . . . 0.0 110.922 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -126.91 9.75 6.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -94.37 45.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -134.24 119.03 18.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -95.38 112.06 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -78.11 141.4 38.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.96 -26.28 11.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.14 161.32 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.982 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 m -104.49 143.26 33.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.22 103.85 15.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.951 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.49 70.79 0.23 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.613 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.86 116.37 28.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.0 110.733 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 ' HG3' ' A' ' 17' ' ' ARG . 12.7 t -125.69 88.92 53.42 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 102.18 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.538 2.159 . . . . 0.0 112.351 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HG3' HG12 ' A' ' 15' ' ' VAL . 14.2 mtt180 -128.26 167.78 16.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.002 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.95 -12.5 61.98 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.32 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.0 p -118.89 164.66 15.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.804 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 159.59 18.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 mtm -61.53 -46.3 90.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -131.44 -174.56 3.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.727 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.65 110.56 13.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 mm -110.39 25.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.825 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.52 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 2.3 t -87.13 -51.14 0.43 Allowed Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.61 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 48.3 Cg_exo -56.44 95.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.243 1.962 . . . . 0.0 112.301 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 22.6 t70 -61.27 -76.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.633 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.652 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -134.26 164.82 26.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 112.21 -177.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.804 ' HG3' ' HB2' ' A' ' 58' ' ' GLU . 4.4 ttt-85 -134.38 114.09 12.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.938 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.692 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -109.6 77.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.537 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' HA ' ' H ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.64 67.62 0.9 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.49 -107.68 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.242 178.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 62' ' ' ASP . 85.3 t -134.9 139.99 46.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.504 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -66.75 89.13 0.15 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.389 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -85.83 132.91 42.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.624 0.249 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.21 -27.83 28.61 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.5 2.133 . . . . 0.0 112.191 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.69 134.8 75.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.975 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.06 89.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.624 2.216 . . . . 0.0 112.261 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.824 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 64.3 t80 -140.37 -53.83 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.446 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.824 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 52.8 Cg_endo -70.27 -72.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.164 1.909 . . . . 0.0 112.771 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.829 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -55.89 -3.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.4 t -51.53 -29.01 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.343 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.76 -36.12 67.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.868 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.592 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -57.42 -54.14 50.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.091 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.33 -47.69 84.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.151 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 4.8 pt-20 -64.38 -20.29 66.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.749 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.586 ' HB1' ' OE2' ' A' ' 55' ' ' GLU . . . -72.85 -30.23 63.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.12 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.559 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 6.3 mmm -51.33 -54.77 34.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.692 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 48' ' ' MET . 58.7 Cg_endo -70.61 -39.69 4.65 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.785 1.657 . . . . 0.0 111.687 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -73.09 7.07 2.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.336 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.31 152.13 0.46 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.608 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -134.91 -165.97 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.779 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -85.44 45.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.464 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.14 0.38 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.007 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.67 ' H ' ' HB2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -122.21 158.49 29.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.205 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.628 HG13 ' O ' ' A' ' 55' ' ' GLU . 10.9 mt -159.65 154.18 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.327 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.652 HD12 ' H ' ' A' ' 28' ' ' TYR . 3.5 tp -140.39 154.47 46.72 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 121.119 0.485 . . . . 0.0 110.834 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.804 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 3.8 mt-10 -141.6 111.98 6.97 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.271 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.692 HG13 ' HB3' ' A' ' 30' ' ' LEU . 49.0 t -118.39 123.13 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.745 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.472 ' H ' ' HA ' ' A' ' 31' ' ' ASP . 97.5 t -126.14 90.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.806 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -126.44 162.91 24.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.443 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.817 ' HB3' HG22 ' A' ' 90' ' ' THR . 1.4 p30 -118.16 132.04 56.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.709 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 142.53 17.05 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.077 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.93 -24.94 23.75 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.483 2.122 . . . . 0.0 112.138 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -83.58 -163.25 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.761 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.7 t -119.75 -24.85 6.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.993 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.67 138.4 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -88.72 127.21 35.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.742 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -72.56 -74.92 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.936 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.829 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 8.4 mm -50.64 -51.78 62.23 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 51.0 Cg_exo -55.94 -33.37 88.83 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.193 1.929 . . . . 0.0 112.628 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.4 OUTLIER -61.06 -36.3 79.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.85 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.85 -57.35 10.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.592 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -60.63 -35.16 75.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.289 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -64.29 -35.62 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.784 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.06 -64.62 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.776 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.05 -26.86 68.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.672 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.38 94.32 0.77 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.946 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -154.83 0.39 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.52 HG21 ' HE3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -90.79 -64.7 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.638 0.256 . . . . 0.0 111.04 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.688 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 2.7 t -125.42 122.51 62.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.35 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.551 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -126.72 104.61 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.791 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.59 157.88 39.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.116 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -139.95 166.08 20.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.488 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.0 tt0 -154.42 156.66 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.443 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.474 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -131.82 158.43 41.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -123.96 -79.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.746 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.14 -100.3 0.44 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.163 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.29 10.38 3.02 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.643 2.229 . . . . 0.0 112.327 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 62' ' ' ASP . 4.8 p -145.6 177.7 8.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 86' ' ' GLN . 18.0 tt -146.76 145.7 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.27 129.89 32.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.93 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.13 163.14 21.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.503 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -154.54 151.99 29.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.042 0.449 . . . . 0.0 111.596 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -134.56 162.64 38.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.243 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.688 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 3.4 pt20 -153.53 177.36 11.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 111.204 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.67 ' HB2' ' H ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.906 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mtt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.821 0.343 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.87 100.08 2.46 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.393 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 t -113.54 114.78 26.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.757 0.313 . . . . 0.0 110.998 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.9 m -132.71 128.39 36.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.963 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -95.58 -177.49 4.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.878 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.18 -168.18 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -105.44 91.88 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.85 -67.95 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -99.02 165.28 11.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -113.91 111.18 21.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.36 101.8 9.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -64.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.012 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.76 -124.5 2.54 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.63 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.77 24.57 11.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.55 72.66 73.72 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.03 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.56 157.52 28.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.566 2.177 . . . . 0.0 112.247 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 -135.85 149.65 49.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.98 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.7 -115.32 1.25 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.533 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.51 -176.92 4.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.884 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -102.44 -2.93 27.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.28 99.34 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.05 86.73 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 26' ' ' PRO . 5.9 m120 -94.21 104.55 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.72 -38.15 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.1 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.552 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 t -101.85 -51.24 0.16 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.84 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 52.4 Cg_exo -53.18 100.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.246 1.964 . . . . 0.0 112.509 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.655 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 7.2 t0 -64.53 -81.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.992 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.629 ' H ' HD12 ' A' ' 57' ' ' LEU . 4.2 m-85 -134.83 166.83 22.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 111.721 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.11 138.6 43.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.046 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.798 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -131.37 77.97 1.8 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.793 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -103.48 69.5 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.397 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 61' ' ' SER . 35.9 mtt -136.85 -111.85 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.121 0.486 . . . . 0.0 111.228 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 57.9 t -135.92 126.9 43.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.73 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -68.82 100.29 0.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.321 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 37' ' ' CYS . 14.3 pt-20 -99.07 153.48 37.77 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.6 0.238 . . . . 0.0 111.165 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.94 -21.35 26.15 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.757 2.305 . . . . 0.0 112.431 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.49 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -75.73 146.85 80.57 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.806 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.47 -12.61 21.36 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.552 2.168 . . . . 0.0 112.383 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.415 ' HB3' ' HA ' ' A' ' 40' ' ' PRO . 8.3 m-85 -94.13 154.53 40.56 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.942 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.798 ' HB2' HD21 ' A' ' 30' ' ' LEU . 1.9 Cg_endo -84.28 7.92 54.09 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.951 -1.271 . . . . 0.0 112.529 0.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -58.02 0.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.927 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 40' ' ' PRO . 3.4 p -52.46 -25.12 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.307 0.575 . . . . 0.0 110.014 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.92 -36.8 67.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.646 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.628 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -53.18 -55.21 26.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.891 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -51.66 66.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -59.65 -21.6 60.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.14 -179.119 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.52 -34.05 67.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.116 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.566 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 2.4 mmm -49.24 -55.39 21.68 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.684 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 16.2 Cg_exo -67.73 -37.36 16.34 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.139 1.893 . . . . 0.0 111.882 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.71 4.29 4.18 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.516 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.639 HD13 ' HE2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -46.44 155.92 0.2 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.906 0.384 . . . . 0.0 111.536 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -126.63 -91.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.38 3.52 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . 157.57 99.21 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.413 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.781 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -103.09 -177.43 3.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.995 0.426 . . . . 0.0 111.329 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.607 HG13 ' O ' ' A' ' 55' ' ' GLU . 4.4 mt -159.4 153.94 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.072 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.629 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -134.79 156.52 48.73 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.087 0.47 . . . . 0.0 111.058 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.71 110.26 6.35 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.095 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 30' ' ' LEU . 98.8 t -117.71 124.61 73.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.472 -177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 87.5 t -131.91 96.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.692 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 32' ' ' MET . 26.6 p -130.41 176.63 7.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.773 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.502 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -117.31 131.39 56.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.299 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.415 ' SG ' ' HA3' ' A' ' 34' ' ' GLY . 70.0 m -143.84 130.88 10.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.12 4.51 4.73 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.48 2.12 . . . . 0.0 112.371 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -127.35 -159.99 0.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 t -111.14 -27.56 8.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mt -56.68 128.54 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.337 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.611 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.4 OUTLIER -92.91 125.54 37.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.51 HD22 ' H ' ' A' ' 69' ' ' ASN . 2.0 m-80 -72.87 -73.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.179 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 41' ' ' ALA . 2.5 mm -46.28 -51.74 32.3 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.822 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 32.2 Cg_exo -60.57 -30.1 89.91 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.334 2.023 . . . . 0.0 112.725 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.4 tp -61.11 -33.02 72.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.811 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.6 4.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.817 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -59.63 -35.67 74.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.914 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -64.88 -37.12 86.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -58.08 10.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.741 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.84 -64.72 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.37 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.57 82.53 0.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.997 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.435 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -86.34 -170.63 3.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.692 0.282 . . . . 0.0 110.636 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.435 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -76.89 -66.64 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.003 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.705 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 11.9 t -126.71 128.6 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.621 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -131.01 100.08 5.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.94 167.92 14.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.088 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.5 pt -137.59 -177.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 111.282 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.499 ' O ' HG13 ' A' ' 91' ' ' ILE . 3.4 mt-30 -154.51 178.65 9.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.33 142.21 26.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.873 0.368 . . . . 0.0 111.306 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.29 -138.25 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.306 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -68.94 -116.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.163 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.54 27.08 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.616 2.211 . . . . 0.0 112.543 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.4 p -142.05 -177.69 5.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 111.036 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.523 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.1 tt -149.41 150.46 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.863 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.422 ' HB2' HG22 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -139.64 140.77 37.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.919 0.39 . . . . 0.0 111.368 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.93 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -127.88 144.9 51.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.129 178.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.446 HD21 ' NE2' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -138.32 150.91 47.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 111.481 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.621 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -131.85 157.4 43.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.513 178.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.705 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.8 pt20 -154.47 158.57 40.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.807 0.337 . . . . 0.0 111.259 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.781 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 25.2 tttp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.745 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.85 0.357 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.06 -26.66 52.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.58 171.46 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.883 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 t -130.74 166.89 19.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -77.03 99.51 5.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.07 -68.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -132.83 111.75 11.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -136.43 179.17 6.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.89 -67.4 1.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.951 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -121.11 46.73 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.11 40.83 3.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 m -122.43 60.77 1.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.73 149.6 51.43 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.404 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.3 mt -135.71 160.91 37.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.861 0.362 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.605 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 11.3 t -93.17 -50.6 0.27 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.647 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 52.9 Cg_exo -55.39 -21.94 31.87 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.163 1.909 . . . . 0.0 112.368 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.2 167.76 6.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.25 104.11 1.29 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.626 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.02 89.33 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.837 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -137.73 18.14 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.1 mtp -97.47 -56.1 2.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.46 -19.25 33.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -64.5 105.25 0.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.859 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 tt -89.64 146.64 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.84 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 1.6 t -113.91 -52.1 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.745 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.84 ' HD2' ' H ' ' A' ' 25' ' ' VAL . 20.3 Cg_endo -60.43 98.62 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.169 1.913 . . . . 0.0 112.326 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 55' ' ' GLU . 33.8 t70 -64.2 -78.13 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.178 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.666 ' H ' HD12 ' A' ' 57' ' ' LEU . 5.8 m-85 -134.4 165.66 24.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.923 0.392 . . . . 0.0 111.431 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -134.82 135.46 41.77 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.581 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.843 HD21 ' HA ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -125.89 76.74 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.273 178.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.52 66.64 0.88 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.948 0.404 . . . . 0.0 111.463 -178.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 61' ' ' SER . 2.3 mtt -137.06 -106.4 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.347 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 35' ' ' GLU . 11.7 p -134.12 142.55 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -61.53 -20.34 58.98 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.31 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 33' ' ' VAL . 6.8 tt0 -59.48 144.74 83.86 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.5 91.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.629 2.22 . . . . 0.0 112.315 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -89.14 166.88 19.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.515 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.55 -57.06 2.58 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.383 2.055 . . . . 0.0 112.636 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -122.42 76.68 44.6 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.002 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.843 ' HA ' HD21 ' A' ' 30' ' ' LEU . 66.5 Cg_endo -92.46 -129.39 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.096 2.531 . . . . 0.0 112.366 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.88 -4.16 0.28 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.968 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.25 -28.01 4.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.239 0.542 . . . . 0.0 110.024 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.699 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.41 -40.45 64.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.538 177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.553 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.35 -54.14 49.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.066 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.75 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 16.4 mt -61.43 -49.31 77.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.138 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 pt-20 -65.29 -18.29 65.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.944 0.402 . . . . 0.0 110.657 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.88 -29.2 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.952 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.593 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.95 -54.79 33.45 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.449 -179.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.7 Cg_endo -69.64 -36.89 10.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.864 1.709 . . . . 0.0 111.586 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.91 5.74 3.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.303 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.6 161.76 0.12 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.958 0.409 . . . . 0.0 111.753 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -131.7 -95.58 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.813 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -14.75 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.835 0.35 . . . . 0.0 110.804 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 178.86 92.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.184 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.776 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -99.25 -176.69 3.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 111.434 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.7 mt -159.61 154.62 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.204 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.8 OUTLIER -136.69 156.2 48.85 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.13 0.491 . . . . 0.0 111.194 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -140.28 116.5 10.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.056 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.706 HG13 ' HB3' ' A' ' 30' ' ' LEU . 52.6 t -118.26 113.63 42.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.635 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 72.9 t -118.66 92.13 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.822 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' MET . 37.4 p -133.0 168.61 18.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.362 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.89 118.47 32.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.358 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 35.6 t -137.44 120.67 11.59 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.955 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.91 -25.6 70.5 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.519 2.146 . . . . 0.0 112.133 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -87.85 164.07 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -91.04 -22.8 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.002 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -57.24 118.72 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.367 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -71.99 118.2 14.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -72.68 -75.67 0.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.789 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 7.1 mm -48.57 -51.51 51.73 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.022 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.607 ' HB3' HD12 ' A' ' 82' ' ' LEU . 51.4 Cg_exo -57.21 -36.97 99.15 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.224 1.95 . . . . 0.0 112.849 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.6 OUTLIER -57.14 -33.42 67.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.907 0.384 . . . . 0.0 110.884 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.75 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 2.1 m-20 -66.97 -58.67 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.034 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.553 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -61.13 -34.98 75.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.209 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -65.9 -36.12 82.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 -60.91 2.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -59.9 2.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.535 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.28 88.09 0.57 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.022 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.06 -151.89 0.2 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.622 0.248 . . . . 0.0 110.343 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 97' ' ' LYS . 1.2 m -93.33 -75.34 0.5 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.577 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 48.1 t -120.4 123.06 69.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 71' ' ' PRO . 1.1 mm? -123.61 105.4 9.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.792 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -134.34 157.59 45.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.911 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 93' ' ' TYR . 35.4 pt -140.15 179.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.594 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.48 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -154.07 166.88 31.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.388 179.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.407 HE21 HD12 ' A' ' 91' ' ' ILE . 1.2 tt0 -125.93 125.15 42.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.807 0.336 . . . . 0.0 111.215 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.31 82.26 1.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.377 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.44 145.69 7.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.949 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -90.9 43.23 2.47 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.573 -1.428 . . . . 0.0 112.652 0.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.7 p -142.9 -172.21 3.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.872 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 85' ' ' GLN . 6.3 tt -149.53 142.59 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.855 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -123.93 133.03 53.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.173 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.514 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -123.66 148.15 46.75 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.745 178.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.98 151.72 28.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.03 0.443 . . . . 0.0 111.949 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -136.17 158.34 38.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.222 178.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.577 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.3 OUTLIER -154.12 153.44 31.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.292 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.776 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 9.4 tttp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.793 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.854 0.359 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.75 -130.71 3.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.562 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 m -100.02 178.73 4.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 110.952 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -113.02 -75.51 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.84 -52.89 2.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.994 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -74.78 151.24 39.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.36 133.84 54.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -100.89 -4.52 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.057 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -60.8 129.4 41.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -127.24 -177.36 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.63 165.61 19.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.8 t -116.44 -79.03 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.85 -119.32 4.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 84.15 1.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 0.0 110.9 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.19 153.54 81.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.071 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.46 -162.3 2.88 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.572 -1.429 . . . . 0.0 112.462 0.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 17' ' ' ARG . 10.7 mtt180 -124.72 116.08 21.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.37 21.69 36.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.482 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.0 m -78.27 151.84 32.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.336 . . . . 0.0 110.89 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 0.01 53.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.977 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.1 mtm -138.03 151.37 47.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -115.64 174.54 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.96 102.28 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.983 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -89.04 -72.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.957 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.4 -51.86 0.26 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.255 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.34 93.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.256 1.971 . . . . 0.0 112.136 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.659 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 16.3 t70 -72.71 -77.07 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.382 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.604 ' H ' HD12 ' A' ' 57' ' ' LEU . 25.2 m-85 -134.61 162.04 33.42 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.97 0.414 . . . . 0.0 111.841 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.2 127.48 30.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.345 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.576 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -117.57 82.1 1.77 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.568 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.52 67.06 0.89 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.47 -178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.645 ' O ' ' HA ' ' A' ' 61' ' ' SER . 93.0 mtp -136.94 -109.85 0.19 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.099 0.476 . . . . 0.0 111.251 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.7 t -135.19 150.34 29.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -84.66 55.77 5.0 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.472 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.64 124.94 29.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.547 0.213 . . . . 0.0 110.785 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.77 82.7 1.68 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.522 2.148 . . . . 0.0 112.54 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.646 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -140.2 -55.18 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.42 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.646 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 94.9 Cg_endo -84.01 -144.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.194 1.93 . . . . 0.0 112.251 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.65 71.79 14.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.741 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 38' ' ' PRO . 99.0 Cg_endo -86.24 -93.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.701 2.268 . . . . 0.0 112.893 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.693 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -56.36 -8.54 0.53 Allowed 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.439 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 49.4 t -46.9 -34.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 0.0 110.65 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.1 -40.18 65.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.166 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.761 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -52.55 -50.41 62.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.47 -179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.84 -55.39 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.599 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 42.2 mt-10 -59.53 -19.27 47.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.873 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.46 -34.1 67.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.917 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.658 ' HG3' ' HB3' ' A' ' 77' ' ' HIS . 5.4 mmm -49.02 -55.77 18.96 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.213 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 22.0 Cg_exo -64.38 -37.49 39.25 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.995 1.797 . . . . 0.0 111.544 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 6.15 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.413 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.42 145.43 0.27 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -141.5 -168.81 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.631 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -87.56 23.63 1.89 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 178.03 97.93 0.11 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.464 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.727 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -130.58 155.44 46.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 0.0 110.819 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -159.6 158.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -145.51 158.57 43.82 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 121.001 0.429 . . . . 0.0 111.196 179.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 117.65 9.94 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.197 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 30' ' ' LEU . 41.6 t -118.42 115.26 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.549 -177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.9 t -119.41 88.73 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.138 0.494 . . . . 0.0 110.123 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.645 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.7 p -129.72 170.66 13.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.401 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.57 121.96 42.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.618 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -153.21 149.4 21.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 63' ' ' CYS . 59.1 Cg_endo -72.01 -42.92 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.557 2.171 . . . . 0.0 112.426 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.51 155.24 40.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.037 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -64.39 -63.69 1.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.025 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -76.38 142.96 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.006 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 17.6 t30 -110.38 -176.2 2.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -72.52 -35.67 68.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.644 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.693 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm -69.17 -50.71 19.78 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 43.1 Cg_endo -66.56 -44.68 5.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.135 1.89 . . . . 0.0 112.368 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -30.88 71.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.013 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -60.46 3.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.736 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.761 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -62.0 -33.79 74.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -64.14 -29.98 71.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.544 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -66.95 -61.45 1.94 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.607 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.658 ' HB3' ' HG3' ' A' ' 48' ' ' MET . 0.1 OUTLIER -68.15 -20.41 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.648 179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.61 93.62 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.817 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.417 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -91.56 -156.11 0.44 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 110.533 179.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.642 HG21 ' HD2' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -90.77 -64.23 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.852 0.358 . . . . 0.0 111.035 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.767 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 40.4 t -128.76 120.8 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.276 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.541 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -123.56 102.58 7.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.394 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -123.86 160.37 27.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.887 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.527 HG22 ' HB3' ' A' ' 93' ' ' TYR . 26.6 pt -142.0 171.62 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.4 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.508 ' O ' HG13 ' A' ' 91' ' ' ILE . 10.0 mt-30 -154.31 158.87 40.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.414 ' HG3' HD12 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -129.8 144.39 51.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.973 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -125.77 -121.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.481 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.02 -112.26 0.51 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.215 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.17 19.75 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.724 2.283 . . . . 0.0 112.477 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.3 p -138.29 -178.78 5.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.999 0.428 . . . . 0.0 111.101 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 85' ' ' GLN . 5.4 tt -149.43 147.91 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.823 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -131.09 131.06 43.94 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.206 -178.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -123.43 134.34 53.96 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.998 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.97 150.76 47.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.199 0.523 . . . . 0.0 111.806 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.541 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.15 156.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.188 178.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.767 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -146.98 172.16 14.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.936 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.727 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 12.1 tptt . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.786 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.728 0.299 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.94 -7.33 70.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 t -88.95 -60.66 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.885 0.374 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.5 p -116.55 127.71 54.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -80.13 176.26 9.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -116.03 101.8 9.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -120.33 15.47 12.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.22 -28.13 59.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.831 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.21 102.84 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.911 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 -44.29 43.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.15 169.89 16.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.979 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.5 t -110.24 -27.85 8.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.6 114.25 2.7 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.5 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.2 mt -131.87 -165.52 1.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.1 m -104.53 149.16 37.1 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.24 -37.62 1.46 Allowed 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.521 -1.449 . . . . 0.0 112.531 0.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.75 145.14 28.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.001 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.28 -142.43 11.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.585 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.43 -60.56 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.35 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -89.64 153.17 20.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -66.85 143.59 56.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.04 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -90.97 102.12 14.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -105.53 40.21 1.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.047 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.6 pt -134.59 -177.32 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 m -59.12 143.32 84.68 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.806 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 88.8 Cg_exo -48.65 -81.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.628 2.219 . . . . 0.0 112.802 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 20.9 t0 57.11 72.67 0.5 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -103.38 164.94 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.066 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 6.9 ttt180 -133.65 142.56 48.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 111.619 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.838 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.7 tm? -132.93 89.91 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.885 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.685 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.37 66.06 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 111.543 -177.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mtt -136.36 -111.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.323 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.769 HG13 ' H ' ' A' ' 35' ' ' GLU . 7.5 p -134.56 160.5 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -74.34 13.54 4.71 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.523 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.769 ' H ' HG13 ' A' ' 33' ' ' VAL . 3.2 tt0 -104.75 124.52 36.6 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.56 0.219 . . . . 0.0 110.558 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.0 96.29 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.522 2.148 . . . . 0.0 112.621 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 m -125.16 -54.72 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.178 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.599 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 81.5 Cg_endo -85.85 -120.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.281 1.988 . . . . 0.0 112.112 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -126.09 66.99 61.45 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.711 0.291 . . . . 0.0 110.596 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . 87.5 Cg_endo -83.12 -99.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.676 2.251 . . . . 0.0 112.892 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.84 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -60.65 -0.43 0.27 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.4 t -49.27 -36.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -73.05 -34.67 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.74 -47.23 86.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.272 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 44.6 mt -64.45 -47.05 80.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.359 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -70.4 -12.38 61.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.918 0.389 . . . . 0.0 110.803 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.26 -39.25 63.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.111 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.564 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -52.49 -46.92 95.0 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.804 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 15.8 Cg_exo -67.75 -59.51 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.919 1.746 . . . . 0.0 111.408 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -73.76 20.4 0.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.53 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.1 153.29 0.7 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.014 0.435 . . . . 0.0 111.61 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 -160.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.839 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.3 53.64 0.83 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.43 52.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.643 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.806 ' HB2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -68.46 177.52 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.066 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -159.26 149.69 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.622 HD22 HG23 ' A' ' 44' ' ' THR . 16.0 tp -134.74 162.59 31.93 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.247 0.546 . . . . 0.0 111.095 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -147.56 136.45 22.09 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.487 176.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.838 HG13 ' HB3' ' A' ' 30' ' ' LEU . 41.1 t -141.5 138.71 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.062 0.458 . . . . 0.0 111.752 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 97.6 t -140.42 107.95 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.769 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.2 -177.69 5.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.021 0.438 . . . . 0.0 111.797 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' HG22 ' A' ' 90' ' ' THR . 0.2 OUTLIER -118.01 120.87 39.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.783 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.37 108.16 2.96 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.902 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.64 -26.12 77.9 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.554 2.169 . . . . 0.0 112.277 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -73.02 -174.4 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.012 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 m -106.31 -27.7 10.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.94 133.72 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.555 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -95.19 136.11 35.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -72.58 -75.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.84 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 9.2 mm -46.4 -52.12 31.14 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.198 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 44.8 Cg_exo -58.97 -33.1 98.61 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.257 1.971 . . . . 0.0 112.613 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 3.2 tp -61.36 -29.23 69.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.96 0.409 . . . . 0.0 110.788 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.45 -52.5 21.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -69.26 -27.88 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.051 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 32.0 ttt-85 -72.24 -36.04 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.709 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -64.21 -59.6 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -64.59 -42.01 95.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.638 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.41 102.53 2.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.781 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.461 ' HB3' ' H ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -105.49 -106.11 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.575 -0.157 . . . . 0.0 110.575 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.869 HG22 HG23 ' A' ' 81' ' ' VAL . 55.4 m -140.52 -72.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.748 0.308 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.869 HG23 HG22 ' A' ' 80' ' ' THR . 53.2 t -117.17 118.26 58.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.344 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 71' ' ' PRO . 3.0 mm? -123.94 100.54 6.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.97 156.88 40.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.823 0.344 . . . . 0.0 111.083 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.886 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -140.21 167.18 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.309 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -154.59 151.29 28.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.6 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -126.62 156.82 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.929 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.28 -84.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.797 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.14 -112.0 2.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.103 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.83 10.44 2.89 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.448 2.099 . . . . 0.0 112.192 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.52 HG22 ' OD1' ' A' ' 62' ' ' ASP . 25.3 p -136.09 176.97 8.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.017 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.442 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.5 tt -151.38 142.9 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -127.91 142.25 51.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.116 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.886 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -123.51 155.82 36.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.32 143.08 20.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 111.463 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.596 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -129.16 161.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.556 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.684 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.3 pt20 -153.96 161.93 41.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 111.067 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.907 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ttm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.795 0.331 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.34 72.79 2.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.77 143.59 26.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -117.69 25.57 10.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.21 38.93 3.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.99 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -105.79 -31.45 8.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.949 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.59 103.84 4.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.18 169.86 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.038 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.24 135.28 47.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -110.96 39.85 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.18 130.41 36.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.842 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.4 -23.05 4.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.87 80.18 0.36 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.29 23.04 14.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 0.0 111.038 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.59 102.58 44.82 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.996 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.49 29.48 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.563 2.176 . . . . 0.0 112.509 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -20.51 58.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.973 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.74 -137.18 5.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.453 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.1 m -128.64 120.67 27.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -118.04 121.54 40.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.24 73.55 8.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.788 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -64.6 164.66 11.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -74.65 -168.04 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.998 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.707 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -110.28 -170.68 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.992 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.597 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER -64.83 -51.69 55.6 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.2 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.707 ' HD2' ' HB ' ' A' ' 24' ' ' ILE . 11.1 Cg_endo -54.59 100.42 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.158 1.905 . . . . 0.0 111.902 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.777 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 36.0 t70 -78.6 -80.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.555 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.741 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.03 166.48 22.94 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 142.61 46.4 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 40' ' ' PRO . 1.4 tm? -134.53 84.39 2.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.535 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p-10 -104.06 69.13 0.93 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.451 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -136.52 -108.42 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.055 0.455 . . . . 0.0 111.398 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.774 HG12 ' H ' ' A' ' 35' ' ' GLU . 58.1 t -134.38 142.29 41.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.447 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -12.5 11.46 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.198 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.774 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -61.96 159.59 35.63 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.379 0.133 . . . . 0.0 110.715 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.31 86.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.457 2.104 . . . . 0.0 112.218 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . 1.2 m -74.68 161.91 75.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.985 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.39 -35.95 37.26 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.461 2.107 . . . . 0.0 112.222 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.62 65.31 54.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.583 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 63.2 Cg_endo -93.96 -123.46 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.014 2.476 . . . . 0.0 112.805 -178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.934 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.2 -4.38 0.35 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 p -47.62 -34.08 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 110.707 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.99 -39.7 65.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.228 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.644 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -53.41 -54.04 42.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 tp -62.04 -40.25 95.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.913 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.64 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -67.2 -20.54 65.72 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 110.567 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.7 64.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.62 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.78 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 19.1 mmt -48.47 -56.38 14.78 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 23.7 Cg_exo -62.62 -44.03 19.14 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.975 1.783 . . . . 0.0 111.288 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -73.25 12.53 0.56 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.585 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -41.48 148.59 0.14 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -174.92 4.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.941 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.22 32.91 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 176.03 101.54 0.15 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.415 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.834 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -135.93 158.55 44.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.789 0.328 . . . . 0.0 111.097 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.1 mt -159.62 156.96 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.431 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.741 HD12 ' H ' ' A' ' 28' ' ' TYR . 1.4 tp -147.98 159.05 44.3 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.183 0.516 . . . . 0.0 111.293 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.43 134.87 26.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.021 175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 30' ' ' LEU . 38.9 t -134.09 123.91 45.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.968 0.413 . . . . 0.0 111.326 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 77.9 t -127.5 94.46 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.77 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 32' ' ' MET . 24.7 p -135.39 170.23 16.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.221 0.534 . . . . 0.0 111.72 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -117.82 124.57 48.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.37 179.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 49.3 t -144.57 116.24 5.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.67 -30.39 92.13 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.575 2.183 . . . . 0.0 112.224 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -77.91 -163.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -119.07 -24.21 6.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.169 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.35 122.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.774 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -80.14 124.45 28.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.54 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -73.89 -87.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.934 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 6.6 mm -46.45 -54.07 20.49 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.774 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -59.41 -26.29 81.42 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.071 1.847 . . . . 0.0 112.989 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.5 tp -65.55 -38.77 90.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.846 0.355 . . . . 0.0 110.841 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -49.54 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.62 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.644 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -71.51 -27.13 63.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -71.94 -34.99 69.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -63.28 -64.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.998 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 3.6 t-80 -64.68 -30.32 71.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.87 96.76 0.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.59 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' HB2' ' HE1' ' A' ' 48' ' ' MET . 0.4 OUTLIER -93.29 -104.23 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.639 0.257 . . . . 0.0 110.809 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -133.5 -69.05 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.32 . . . . 0.0 110.825 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.707 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 2.3 t -126.21 121.06 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 74' ' ' ALA . 3.8 mm? -123.37 104.85 9.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.401 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -132.9 156.99 46.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.691 0.282 . . . . 0.0 111.111 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.25 173.21 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.044 0.45 . . . . 0.0 111.588 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.55 ' O ' HG13 ' A' ' 91' ' ' ILE . 9.8 mt-30 -154.22 162.71 41.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.388 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -144.02 149.4 36.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.05 -81.77 0.63 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.15 -88.17 0.15 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.356 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.79 -1.28 9.49 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.754 2.302 . . . . 0.0 112.891 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -136.48 175.94 9.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.902 0.382 . . . . 0.0 111.189 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 85' ' ' GLN . 4.6 tt -146.81 143.46 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.77 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.63 135.22 53.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.278 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.465 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -123.51 145.34 48.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.666 179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.31 148.58 25.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.212 0.53 . . . . 0.0 111.937 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -131.6 157.09 43.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.048 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.707 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -148.48 178.74 8.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.917 0.389 . . . . 0.0 111.045 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.834 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 6.7 tptt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.689 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.794 0.331 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.52 23.35 12.78 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.542 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.35 147.69 49.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.2 t -117.0 -73.04 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -111.14 16.44 21.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -62.27 153.72 29.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -77.99 -8.43 58.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.999 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.28 120.01 15.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.072 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.42 ' HB2' ' H ' ' A' ' 10' ' ' HIS . 1.7 p-80 -112.22 -160.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.42 ' H ' ' HB2' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -74.25 88.98 2.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.822 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -160.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.5 72.03 5.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -129.19 68.62 0.54 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.466 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.716 HD12 HG13 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -107.81 -42.92 4.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.807 0.337 . . . . 0.0 110.963 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.716 HG13 HD12 ' A' ' 14' ' ' LEU . 18.1 m -103.35 147.5 34.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.128 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.3 -156.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.464 2.109 . . . . 0.0 112.2 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.416 HH11 ' HB3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -69.59 91.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.009 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.78 97.62 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.312 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.0 m -64.11 -70.62 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.766 0.317 . . . . 0.0 111.194 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -117.58 -174.94 2.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.919 0.39 . . . . 0.0 111.113 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -164.31 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.975 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.59 66.68 1.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -118.11 30.47 7.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.58 HG22 ' H ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -111.86 173.75 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.95 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.588 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 2.0 t -63.68 -50.35 72.24 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.654 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 23.5 Cg_endo -60.33 95.06 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.102 1.868 . . . . 0.0 112.02 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.65 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -59.49 -74.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.391 -179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.656 ' H ' HD12 ' A' ' 57' ' ' LEU . 10.9 t80 -134.44 164.67 26.94 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.145 0.498 . . . . 0.0 112.188 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.56 141.88 46.8 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.096 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 30' ' ' LEU . 1.2 tm? -134.17 83.56 2.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.076 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -103.64 67.63 0.91 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.567 -178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 61' ' ' SER . 1.0 OUTLIER -136.5 -110.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 35' ' ' GLU . 34.5 t -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.448 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.476 ' HA3' HD21 ' A' ' 68' ' ' ASN . . . -63.9 -5.8 15.57 Favored Glycine 0 CA--C 1.517 0.191 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.226 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.612 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.3 pt-20 -64.47 159.32 60.68 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.486 0.184 . . . . 0.0 110.839 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.16 93.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.556 2.171 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -90.09 150.72 43.93 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.829 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -46.49 -60.5 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.716 2.278 . . . . 0.0 112.791 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.19 73.12 32.16 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.272 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.535 ' HD2' HG23 ' A' ' 42' ' ' VAL . 83.3 Cg_endo -90.7 -98.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.896 2.397 . . . . 0.0 112.512 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.814 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -60.24 -5.24 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.535 HG23 ' HD2' ' A' ' 40' ' ' PRO . 32.7 t -47.02 -32.26 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.45 -44.54 57.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.094 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.608 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -47.69 -54.55 11.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.719 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 45' ' ' LEU . 15.4 mt -62.5 -58.24 8.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.553 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 26.8 mt-10 -60.07 -15.3 22.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.358 . . . . 0.0 111.135 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.22 -38.49 68.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.535 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.7 mtp -47.91 -54.16 26.26 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.402 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 31.1 Cg_exo -60.51 -59.71 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.757 1.638 . . . . 0.0 111.357 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -73.8 23.74 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.87 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 48' ' ' MET . 1.3 pp -52.03 177.39 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.463 0.649 . . . . 0.0 111.97 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.875 ' HG2' ' H ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -159.07 164.88 34.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.244 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -73.29 23.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.725 0.298 . . . . 0.0 111.306 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.875 ' H ' ' HG2' ' A' ' 52' ' ' LYS . . . -168.83 69.12 0.16 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HG2' ' HB2' ' A' ' 27' ' ' ASP . 5.0 tm-20 -112.06 152.15 28.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.132 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.1 mt -160.22 158.24 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.428 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 28' ' ' TYR . 2.5 tp -140.31 163.87 31.61 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.323 0.582 . . . . 0.0 111.156 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.95 128.52 13.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.957 175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 48.5 t -128.64 114.1 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.896 0.379 . . . . 0.0 111.462 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -118.28 96.5 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.15 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -137.14 172.84 12.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.608 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.432 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 16.3 p -159.11 140.33 9.48 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.218 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -80.77 16.75 1.53 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.606 2.204 . . . . 0.0 112.276 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -116.92 -165.83 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.988 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.31 -72.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.011 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.5 mm -83.79 140.45 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.021 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -97.18 -179.16 4.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.69 -38.39 67.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.739 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.814 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm -67.79 -50.45 34.04 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 33.0 Cg_endo -62.58 -36.91 61.75 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.274 1.982 . . . . 0.0 112.244 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.17 -25.71 65.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 -58.62 4.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -63.34 -36.32 83.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -63.51 -30.6 71.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -65.73 -70.67 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.402 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 1.5 t-80 -57.86 -35.54 71.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.765 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.41 79.89 1.49 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.86 -0.685 . . . . 0.0 112.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.55 -157.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 97' ' ' LYS . 2.9 m -72.5 -78.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.498 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.619 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 2.0 m -130.19 145.87 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.011 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.568 HD13 HG22 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -128.35 111.95 13.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.468 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -127.1 159.99 32.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.724 0.297 . . . . 0.0 110.958 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.566 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -140.79 -178.41 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.179 0.514 . . . . 0.0 111.69 -179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -154.5 -173.86 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.203 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -136.75 116.71 13.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 111.26 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.67 -176.75 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.673 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.8 117.41 1.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.755 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.502 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 82.7 Cg_endo -100.45 66.94 0.32 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 C-N-CA 124.318 -1.118 . . . . 0.0 112.653 0.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 p -147.81 -173.82 4.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 111.27 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.571 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tt -136.2 151.93 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.515 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.678 HH11 HD22 ' A' ' 94' ' ' LEU . 3.0 tpp85 -123.7 142.75 50.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.893 0.378 . . . . 0.0 111.762 -177.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.626 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 7.9 m-85 -136.54 117.55 14.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.078 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.678 HD22 HH11 ' A' ' 92' ' ' ARG . 0.4 OUTLIER -131.87 146.24 52.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 111.724 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -129.66 161.86 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.356 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.641 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -148.24 154.17 39.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.905 179.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.629 ' HA ' HG21 ' A' ' 80' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmm . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.849 0.357 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.33 -105.69 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.492 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.96 29.07 7.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.911 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.88 101.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.94 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.63 112.9 24.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.763 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.29 70.1 7.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.996 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -97.35 90.12 4.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.798 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.91 -98.41 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.45 -165.01 1.83 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.883 0.373 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -99.87 148.28 24.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.85 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -82.7 120.47 25.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.3 39.75 2.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.034 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.34 160.74 39.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.02 3.29 56.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.963 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 p -109.8 122.2 39.84 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.11 -69.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.461 2.107 . . . . 0.0 112.434 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.428 ' HB2' ' H ' ' A' ' 18' ' ' GLY . 4.8 mtm180 -111.42 -87.33 0.54 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 17' ' ' ARG . . . -140.28 112.3 0.8 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.428 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 86.2 p -96.17 19.27 12.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 0.0 110.912 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.91 -62.55 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.798 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.42 73.58 10.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.821 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -4.55 5.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.966 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -74.64 -179.73 4.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.88 101.37 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.0 m -90.91 132.15 35.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.53 ' HG2' ' HG3' ' A' ' 55' ' ' GLU . 46.5 Cg_exo -56.72 -86.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.624 2.216 . . . . 0.0 112.244 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 5.7 p-10 41.09 64.87 0.9 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.093 0.473 . . . . 0.0 110.745 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.16 160.39 14.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.598 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 10.1 ptt85 -128.53 129.42 45.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.152 0.501 . . . . 0.0 111.94 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.705 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -122.23 77.27 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.525 177.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.3 p30 -101.91 68.14 1.12 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.728 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' SER . 10.5 mtt -137.13 -112.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.889 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.406 ' H ' ' HB3' ' A' ' 32' ' ' MET . 7.6 p -135.57 143.41 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.987 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 111.12 3.6 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.327 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -122.81 140.73 33.78 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.646 0.26 . . . . 0.0 110.946 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 35' ' ' GLU . 23.9 Cg_exo -64.67 -41.65 18.35 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.732 2.288 . . . . 0.0 112.336 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 32.4 t -54.25 126.05 52.43 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.094 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 28.4 Cg_exo -61.86 88.31 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.626 2.217 . . . . 0.0 112.137 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.822 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 0.1 OUTLIER -139.71 -53.71 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.211 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.822 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 41.3 Cg_endo -67.83 -70.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.121 1.881 . . . . 0.0 112.332 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -57.67 0.79 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 40' ' ' PRO . 14.4 t -48.69 -32.64 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.391 . . . . 0.0 110.567 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . . . -72.93 -37.94 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.632 HG23 HD22 ' A' ' 57' ' ' LEU . 1.9 m -58.07 -59.02 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.243 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tp -57.88 -32.56 67.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.165 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.415 ' OE1' ' HA ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.73 -28.21 63.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 110.509 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.6 -26.94 61.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.402 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.529 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 32.6 mmt -53.72 -54.85 41.7 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.652 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 59.8 Cg_endo -71.01 -39.68 3.93 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.815 1.677 . . . . 0.0 111.595 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.91 6.91 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.381 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.07 150.48 0.58 Allowed 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.917 0.389 . . . . 0.0 111.252 -179.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 54.2 mmtt -145.88 -159.31 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.785 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.445 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -87.02 16.49 4.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.185 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 65.35 0.16 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.877 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.724 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 20.8 tt0 -86.67 146.73 26.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.67 0.271 . . . . 0.0 110.406 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 55' ' ' GLU . 1.2 mp -155.53 153.44 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.632 HD22 HG23 ' A' ' 44' ' ' THR . 15.0 tp -142.85 164.99 28.59 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.305 0.574 . . . . 0.0 111.146 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -149.46 135.02 18.51 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 176.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 30' ' ' LEU . 15.4 t -137.85 132.31 43.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.11 0.481 . . . . 0.0 111.624 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 73.5 t -136.84 83.04 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.029 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 32' ' ' MET . 1.4 p -123.58 175.16 6.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.65 125.92 51.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.463 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.05 147.62 16.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.925 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.75 5.0 6.46 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.575 2.183 . . . . 0.0 112.65 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.25 161.77 27.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.02 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.4 m -72.08 -52.27 17.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.67 143.73 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' H ' ' HG2' ' A' ' 71' ' ' PRO . 2.9 t-20 -134.3 -172.3 2.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -72.33 -47.49 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.759 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.765 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -59.52 -49.33 92.75 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 41.7 Cg_endo -66.47 -41.14 12.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.119 1.88 . . . . 0.0 112.505 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -21.27 64.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -62.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.651 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -57.41 -41.21 79.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.677 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.628 ' HA ' ' HD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.49 -29.73 70.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.957 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -66.75 -65.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.727 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.49 -59.39 4.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.563 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.74 100.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.463 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.651 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.8 p90 -90.41 -171.63 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.242 0.544 . . . . 0.0 111.65 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.479 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 28.6 m -115.29 -49.72 2.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.08 176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.711 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 26.8 t -139.23 115.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.138 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.614 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -122.67 100.21 6.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.635 -178.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.32 150.15 50.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.8 pt -135.11 175.85 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.463 . . . . 0.0 111.626 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 91' ' ' ILE . 1.6 tm0? -145.44 171.34 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.65 126.43 46.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.165 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -174.16 2.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.47 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 89' ' ' PRO . . . -140.07 121.96 2.11 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.709 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 78.4 Cg_endo -102.15 62.25 0.58 Allowed 'Cis proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.759 1.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.3 p -148.87 -174.57 4.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.98 0.419 . . . . 0.0 111.534 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 85' ' ' GLN . 8.1 tt -142.38 145.53 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.574 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -123.74 146.56 48.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.108 0.48 . . . . 0.0 111.499 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 3.1 m-85 -132.02 131.05 42.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.017 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.33 143.74 46.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.0 0.429 . . . . 0.0 111.402 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.614 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.43 157.06 39.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.682 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.711 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 2.2 pt20 -154.47 166.03 34.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.724 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.6 tttp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.791 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttp . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.705 0.288 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.25 129.58 9.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.499 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.9 t -123.1 -28.51 4.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.747 0.308 . . . . 0.0 110.961 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.92 128.75 45.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.47 137.35 53.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.999 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -115.41 -172.24 2.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.842 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -91.2 -72.32 0.59 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.937 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -86.9 175.79 8.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -72.2 -175.87 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.968 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -46.04 3.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.02 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.32 -172.42 2.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.068 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.6 p -77.28 -170.08 1.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.21 -90.74 0.67 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.52 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.54 81.96 1.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.885 0.374 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.6 113.2 9.27 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.62 -17.99 8.32 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.656 2.237 . . . . 0.0 112.619 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -119.9 106.01 11.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.163 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.48 14.53 63.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.508 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.8 p -85.02 -167.55 1.87 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.652 0.263 . . . . 0.0 110.874 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -54.35 113.23 1.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 tpt -115.22 -70.05 0.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.99 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 -64.49 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -133.1 135.84 45.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.569 ' HB ' ' HD1' ' A' ' 28' ' ' TYR . 3.3 mp -129.5 124.63 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.032 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.607 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -96.67 -53.64 0.21 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.294 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 25' ' ' VAL . 49.7 Cg_endo -67.69 117.38 4.83 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.928 1.752 . . . . 0.0 112.018 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.646 ' HB3' HD12 ' A' ' 56' ' ' ILE . 5.0 p-10 48.46 87.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.399 0.619 . . . . 0.0 111.509 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.637 ' H ' HD12 ' A' ' 57' ' ' LEU . 52.7 t80 -102.53 147.0 27.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.7 mtt85 -104.9 135.88 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 59' ' ' VAL . 2.2 tm? -134.54 82.5 1.97 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.327 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER -103.13 66.77 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.9 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -136.29 -112.61 0.19 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.119 0.485 . . . . 0.0 111.266 178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG22 ' OD1' ' A' ' 62' ' ' ASP . 6.4 t -135.01 152.46 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.794 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.78 -7.56 16.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.096 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.86 159.01 66.69 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.481 0.181 . . . . 0.0 110.841 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.98 89.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.483 2.122 . . . . 0.0 112.197 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 40' ' ' PRO . 1.2 m -81.69 159.58 66.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.977 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.29 -52.63 4.54 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.569 2.179 . . . . 0.0 112.542 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -133.22 65.26 72.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.336 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.473 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 63.8 Cg_endo -93.13 -109.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.871 2.381 . . . . 0.0 112.496 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.883 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -59.52 -4.24 0.59 Allowed 'General case' 0 N--CA 1.461 0.088 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 9.8 p -47.12 -33.38 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.969 0.414 . . . . 0.0 110.724 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.46 -39.44 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.119 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 3.6 m -55.72 -55.3 33.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.834 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.567 ' O ' ' HE2' ' A' ' 48' ' ' MET . 95.2 mt -57.39 -52.7 64.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.272 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 5.9 pt-20 -68.55 -11.37 59.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.17 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.53 -39.57 67.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.458 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.567 ' HE2' ' O ' ' A' ' 45' ' ' LEU . 53.2 mtm -53.51 -53.7 53.88 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.65 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 48' ' ' MET . 53.4 Cg_endo -67.83 -52.08 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.677 1.584 . . . . 0.0 111.313 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -73.85 19.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.834 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -51.4 178.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.415 0.626 . . . . 0.0 111.795 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HD2' ' HE2' ' A' ' 53' ' ' LYS . 31.6 mmtt -149.0 -144.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HE2' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -84.45 26.73 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.313 . . . . 0.0 111.159 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 97' ' ' LYS . . . 126.12 84.19 0.52 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.613 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.591 ' N ' ' HB3' ' A' ' 97' ' ' LYS . 5.3 pt-20 -74.84 -179.81 4.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 110.946 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -159.91 -178.17 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.766 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.637 HD12 ' H ' ' A' ' 28' ' ' TYR . 6.5 tp -158.85 156.0 28.84 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.359 0.6 . . . . 0.0 111.422 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.05 101.25 3.14 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.988 175.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 70' ' ' ILE . 1.4 p -119.32 131.54 71.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.822 -176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 12.2 t -132.47 111.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.194 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -143.02 177.44 8.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.909 0.385 . . . . 0.0 111.419 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' OD1' HG22 ' A' ' 33' ' ' VAL . 5.1 p-10 -117.9 130.53 56.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.3 129.78 3.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.073 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.93 -17.79 22.17 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.527 2.151 . . . . 0.0 112.231 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.73 156.4 16.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.951 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -40.48 69.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.918 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 72' ' ' LEU . 1.5 mp -65.55 109.04 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.544 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -102.35 165.21 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.21 -75.88 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.883 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 2.4 mm -44.86 -53.3 16.09 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.544 ' CG ' ' HB2' ' A' ' 68' ' ' ASN . 22.8 Cg_endo -62.19 -39.31 49.24 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 121.959 1.772 . . . . 0.0 113.047 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.596 HD13 HG23 ' A' ' 67' ' ' ILE . 5.1 tp -65.5 -22.14 66.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.693 0.283 . . . . 0.0 111.148 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.12 -58.38 3.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.87 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.854 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -60.14 -41.17 92.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.793 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -63.28 -31.6 72.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.057 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.41 -66.73 0.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -72.21 -64.19 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.858 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.15 104.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.62 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.854 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.8 p90 -90.64 -163.23 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.253 0.549 . . . . 0.0 111.466 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 2.2 m -115.22 -54.68 2.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.343 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.695 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.4 t -140.22 114.2 6.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.389 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.793 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.09 102.84 8.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.871 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -124.02 151.5 43.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.645 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.986 HG22 ' HB3' ' A' ' 93' ' ' TYR . 23.0 pt -136.08 165.1 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.407 . . . . 0.0 111.466 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -154.55 159.73 41.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.681 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -125.66 154.67 42.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.911 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -121.46 -85.13 0.66 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.786 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -127.52 -105.89 1.35 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.976 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.33 12.37 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.46 2.107 . . . . 0.0 112.086 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -140.8 179.44 6.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 93' ' ' TYR . 20.7 tt -146.88 144.26 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.574 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 136.45 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.986 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.93 159.93 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.181 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.08 146.88 24.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.241 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.793 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -131.98 160.67 42.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.669 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.695 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -153.95 156.53 37.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.942 0.401 . . . . 0.0 111.338 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HB3' ' N ' ' A' ' 55' ' ' GLU . 4.2 tptp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.583 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.829 0.347 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.67 -159.94 8.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.536 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 p -102.53 9.21 39.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.813 0.339 . . . . 0.0 111.053 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.34 149.66 27.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -67.7 -74.78 0.11 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.893 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -69.77 152.93 44.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -84.51 158.65 20.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -64.51 149.25 48.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.992 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -126.11 156.18 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.83 104.93 16.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.996 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.98 157.32 16.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -119.68 -62.57 1.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.99 -142.14 8.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.456 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -112.96 160.81 17.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.32 143.82 45.69 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.183 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.39 104.65 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.565 2.177 . . . . 0.0 112.288 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 17' ' ' ARG . 10.0 mmm180 -69.96 134.14 48.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.021 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.37 -45.27 96.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.492 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.07 167.45 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.891 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -103.94 152.19 22.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.19 122.54 42.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.004 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.23 101.75 13.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.15 14.78 20.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.5 pt -99.34 6.06 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.039 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 t -98.51 -50.92 0.21 Allowed Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.797 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 68.7 Cg_exo -51.76 111.45 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.197 1.932 . . . . 0.0 112.637 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -76.11 -76.74 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.343 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.5 ' HB3' ' CD1' ' A' ' 57' ' ' LEU . 3.4 t80 -135.54 164.28 28.18 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.996 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -134.66 113.73 12.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.848 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.804 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -109.05 81.93 1.52 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.51 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.58 68.91 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.471 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 61' ' ' SER . 16.4 mtt -136.24 -109.23 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.324 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 62' ' ' ASP . 21.7 t -134.73 138.68 48.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.9 70.22 2.33 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.425 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 21.4 tt0 -121.3 140.07 30.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.525 0.203 . . . . 0.0 110.519 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 13.1 Cg_endo -56.61 -50.36 12.02 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.72 2.28 . . . . 0.0 112.601 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.5 122.13 38.28 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.171 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.11 160.59 94.39 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.133 -0.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.506 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -76.48 114.04 34.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HB2' ' HG ' ' A' ' 30' ' ' LEU . 3.5 Cg_endo -88.01 -55.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.335 2.69 . . . . 0.0 112.598 -178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.848 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -52.85 -0.38 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 39' ' ' TYR . 93.8 t -47.17 -30.95 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 110.63 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.61 64.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.935 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -54.87 -50.98 67.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.34 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.425 HD11 ' OD1' ' A' ' 73' ' ' ASP . 71.3 mt -61.77 -52.87 62.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.375 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -66.41 -13.38 60.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.137 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.62 -40.1 66.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.254 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 10.1 mtm -48.14 -52.99 37.18 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 51' ' ' LEU . 30.2 Cg_exo -60.5 -60.05 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.742 1.628 . . . . 0.0 111.434 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -74.61 24.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.954 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -61.54 -159.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.092 0.472 . . . . 0.0 112.02 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.746 ' N ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -165.89 -174.7 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.191 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -83.4 36.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' HA2' ' HB3' ' A' ' 97' ' ' LYS . . . 150.58 102.76 0.25 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.489 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.908 ' HG2' ' HB2' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -124.48 177.74 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.009 0.433 . . . . 0.0 111.109 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 55' ' ' GLU . 17.9 mt -159.47 161.7 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' CD1' ' HB3' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -160.67 130.25 4.99 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.472 -0.768 . . . . 0.0 111.423 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 1.2 mt-10 -118.71 118.36 31.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.765 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 30' ' ' LEU . 58.9 t -118.53 113.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.994 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.638 HG22 ' HE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -117.49 94.48 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 110.435 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.4 OUTLIER -126.71 166.59 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.128 -178.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' HB3' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -117.74 133.16 56.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.622 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 t -152.13 132.39 7.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.013 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.13 -18.04 24.15 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.488 2.125 . . . . 0.0 112.281 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.47 -162.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -117.64 -17.37 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.911 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mt -68.16 127.67 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.785 ' HB2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -94.48 126.62 39.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.657 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.23 -82.43 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.848 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 7.3 mm -44.51 -54.82 11.45 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 68' ' ' ASN . 19.7 Cg_endo -61.25 -24.09 78.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.004 1.803 . . . . 0.0 112.921 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 1.8 tt -69.55 -33.46 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.91 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 45' ' ' LEU . 3.6 m-20 -66.41 -53.48 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -62.37 -36.29 81.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.544 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 75' ' ' ARG . 11.2 ttp180 -66.62 -33.13 74.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.81 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -60.58 -61.04 2.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.544 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 0.8 OUTLIER -67.74 -62.12 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.42 91.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.051 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.73 -164.21 1.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.651 0.262 . . . . 0.0 110.345 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.588 HG21 ' HG2' ' A' ' 97' ' ' LYS . 24.3 m -82.35 -79.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.61 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 22.0 t -112.13 117.62 55.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.567 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.73 116.04 22.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.793 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -147.06 155.12 41.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.997 HG22 ' HB3' ' A' ' 93' ' ' TYR . 20.6 pt -135.1 170.25 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.004 0.431 . . . . 0.0 111.561 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.76 148.45 25.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.64 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -127.95 149.17 50.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.889 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -118.1 -83.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.19 -90.15 0.18 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.446 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.62 3.14 8.04 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.649 2.233 . . . . 0.0 112.812 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 62' ' ' ASP . 32.2 p -145.4 174.93 10.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.914 0.388 . . . . 0.0 111.109 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.508 HG12 ' CE1' ' A' ' 93' ' ' TYR . 16.5 tt -144.43 139.8 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.836 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.638 ' HE ' HG22 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -124.01 132.7 53.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.348 -177.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.997 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.75 156.33 34.68 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.34 145.33 22.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 112.105 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.567 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -132.63 153.08 37.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.124 177.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.61 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.4 OUTLIER -154.6 175.26 13.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 0.0 111.235 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.908 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.77 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.837 0.351 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.37 -1.25 31.19 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.634 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 t -90.12 120.04 30.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.971 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 t -114.82 109.43 18.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -137.85 44.13 2.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.945 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -116.89 95.26 4.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.905 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -119.93 119.79 34.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -110.82 179.75 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.81 96.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.908 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -88.12 167.62 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.985 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.0 p -71.99 -57.53 4.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -137.14 99.88 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.85 74.4 0.27 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.612 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.81 137.49 34.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.715 0.293 . . . . 0.0 110.829 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.99 102.01 38.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.113 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -78.6 -1.58 11.73 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.602 2.202 . . . . 0.0 112.325 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.13 16.29 6.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.032 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.21 -33.66 0.62 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.523 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.91 169.02 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.775 0.321 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -94.6 163.37 13.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.998 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.5 ptm -93.49 -12.28 30.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.758 ' HD2' HD11 ' A' ' 56' ' ' ILE . 43.1 pttt -81.07 -172.35 3.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.804 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -134.35 147.39 50.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.957 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.622 HG22 ' HB3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -130.31 116.73 37.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.894 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.636 HG23 ' HA ' ' A' ' 55' ' ' GLU . 47.5 t -68.27 -55.0 13.42 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.957 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.622 ' HB3' HG22 ' A' ' 24' ' ' ILE . 69.6 Cg_endo -89.72 164.5 35.72 Favored 'Cis proline' 0 C--N 1.357 0.992 0 C-N-CA 124.621 -0.991 . . . . 0.0 111.897 -2.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 56' ' ' ILE . 39.8 t0 -68.98 -89.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.733 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.837 ' H ' HD12 ' A' ' 57' ' ' LEU . 10.5 t80 -136.62 166.41 23.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.391 . . . . 0.0 111.758 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.55 ' NH2' ' HG2' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -134.56 105.99 6.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.802 178.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.705 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.1 tm? -103.83 81.24 1.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.993 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 1.7 m-20 -103.62 66.78 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.149 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -136.24 -105.83 0.21 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.492 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.0 t -134.33 148.82 29.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.099 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.78 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.499 ' N ' ' HB2' ' A' ' 61' ' ' SER . . . -81.54 55.58 4.86 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.621 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' HG3' ' HB2' ' A' ' 37' ' ' CYS . 3.1 pt-20 -79.69 159.01 72.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.531 0.205 . . . . 0.0 110.759 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -93.24 21.5 0.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.953 2.435 . . . . 0.0 112.732 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.634 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 1.3 m -84.88 149.7 54.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.902 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.98 66.82 8.73 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.583 2.189 . . . . 0.0 112.26 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.876 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 11.9 m-85 -140.25 -52.84 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.978 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.876 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 23.6 Cg_endo -62.11 -85.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.406 2.071 . . . . 0.0 113.337 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.786 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -56.87 -2.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 5.4 t -45.49 -35.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.692 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.6 -46.57 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.275 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 74' ' ' ALA . 54.7 m -49.44 -46.93 48.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.623 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 45' ' ' LEU . 19.3 mt -63.48 -57.38 10.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.282 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' C ' ' HD2' ' A' ' 49' ' ' PRO . 13.0 mm-40 -64.76 -10.58 28.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.014 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -73.67 -40.37 63.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.154 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -51.97 -47.67 90.54 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.991 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 48' ' ' MET . 55.3 Cg_endo -69.98 -51.76 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.711 1.607 . . . . 0.0 111.759 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.17 14.3 0.32 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.401 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.585 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.15 156.06 0.18 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.999 0.428 . . . . 0.0 111.868 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -125.75 -164.91 1.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.74 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -88.32 40.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.844 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.4 113.27 1.52 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.29 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.893 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 15.8 pt-20 -135.3 -177.05 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.758 HD11 ' HD2' ' A' ' 22' ' ' LYS . 1.6 mt -161.04 152.08 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 121.272 0.558 . . . . 0.0 111.141 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.837 HD12 ' H ' ' A' ' 28' ' ' TYR . 4.7 tp -127.02 158.98 35.5 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -144.35 107.77 4.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.196 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 30' ' ' LEU . 45.5 t -117.57 112.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.616 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 90.6 t -118.59 94.73 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.694 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' MET . 16.2 p -125.5 171.83 10.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.897 -177.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -118.04 122.6 43.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.581 179.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 31.8 p -148.24 131.27 8.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.971 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.48 -8.65 18.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.596 2.198 . . . . 0.0 112.314 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -97.0 -167.32 1.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.957 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.38 -26.09 8.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 mt -66.85 123.32 19.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.76 130.4 37.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.843 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -72.62 -70.23 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.101 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.786 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 2.8 mm -49.64 -52.49 50.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.1 Cg_exo -57.61 -43.25 52.27 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.272 1.981 . . . . 0.0 112.87 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.34 -21.98 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.203 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -71.99 -57.88 3.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.95 -41.7 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.708 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -62.17 -33.75 75.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.006 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -59.26 -61.08 2.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.569 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.598 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 8.9 m170 -72.37 -69.08 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.19 103.94 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 51.3 p90 -92.93 -162.4 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.126 0.488 . . . . 0.0 111.328 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.466 ' OG1' ' HD2' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -113.25 -52.75 2.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.258 176.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.834 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 48.1 t -143.95 118.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.171 176.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.683 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.6 OUTLIER -122.95 115.18 21.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.964 -178.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.15 155.46 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.689 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.952 HG22 ' HB3' ' A' ' 93' ' ' TYR . 19.4 pt -133.05 167.1 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.479 . . . . 0.0 111.601 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.407 ' O ' HG13 ' A' ' 91' ' ' ILE . 30.6 tt0 -154.63 165.44 36.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.413 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -132.1 147.33 52.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.798 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -107.85 -81.4 0.56 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.636 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.31 -92.53 0.22 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.815 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.33 3.66 7.14 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.803 2.336 . . . . 0.0 112.033 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' OD2' ' A' ' 62' ' ' ASP . 25.0 p -136.47 -178.24 5.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' CE1' ' A' ' 93' ' ' TYR . 13.7 tt -143.34 151.1 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.882 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -140.03 131.79 27.44 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.815 0.341 . . . . 0.0 111.302 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.952 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.05 140.46 53.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.246 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.87 157.01 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 111.874 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.683 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -135.22 162.24 38.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.614 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.834 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.79 155.6 34.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.893 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.502 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.801 0.334 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.5 169.67 14.34 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.509 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 t -133.49 -79.28 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.701 0.286 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.78 155.99 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.009 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -95.23 -33.49 12.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.97 163.92 22.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.13 148.63 48.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.063 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -118.01 -165.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.925 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -69.38 164.29 23.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.92 -179.82 4.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.1 p -119.44 88.12 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -118.4 65.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.69 142.25 20.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.473 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 138.03 42.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.747 0.308 . . . . 0.0 111.007 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.14 108.07 44.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.08 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -56.76 -23.97 52.83 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.644 2.229 . . . . 0.0 112.373 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -43.76 88.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.936 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.13 25.32 10.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.471 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -167.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.823 0.344 . . . . 0.0 110.872 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.7 -27.88 66.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.1 mtt -78.34 134.7 37.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.952 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.99 -176.3 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.038 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -99.73 -70.25 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.9 mt -129.47 103.94 9.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.113 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -113.06 -53.48 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.486 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD2' ' H ' ' A' ' 25' ' ' VAL . 72.0 Cg_exo -51.28 115.2 1.91 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.004 1.803 . . . . 0.0 112.159 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.556 ' HB2' ' HG3' ' A' ' 55' ' ' GLU . 27.6 t70 -94.07 -80.37 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.675 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.471 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -135.91 168.42 19.36 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 119.651 -0.819 . . . . 0.0 112.656 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 13.2 mtp180 -134.82 118.01 16.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.721 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.016 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -116.47 78.88 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.947 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -103.9 67.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.391 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 61' ' ' SER . 15.5 mtt -136.46 -110.65 0.19 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.165 0.507 . . . . 0.0 111.504 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 62' ' ' ASP . 84.8 t -135.41 122.95 36.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.79 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.429 ' N ' ' HB3' ' A' ' 61' ' ' SER . . . -68.13 92.48 0.26 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.228 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -81.87 162.62 56.85 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.44 0.162 . . . . 0.0 110.709 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 96.4 Cg_endo -78.66 34.66 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.529 2.152 . . . . 0.0 112.535 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 7.6 m -132.06 153.44 81.35 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.904 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.77 -22.01 21.94 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.653 2.235 . . . . 0.0 112.656 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HA ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -96.72 154.62 38.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.026 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 1.016 ' HB2' HD21 ' A' ' 30' ' ' LEU . 4.1 Cg_exo -82.06 0.38 49.61 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.806 -1.331 . . . . 0.0 112.629 1.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.595 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -55.34 -2.55 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.946 178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.614 HG23 ' HA ' ' A' ' 39' ' ' TYR . 79.2 t -51.91 -28.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.046 0.45 . . . . 0.0 110.05 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 46' ' ' GLU . . . -70.57 -38.74 74.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.23 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.544 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -58.51 -46.35 86.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.944 178.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' HB3' ' A' ' 73' ' ' ASP . 1.2 tp -67.79 -39.26 84.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.783 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.556 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 2.5 pt-20 -72.12 -17.29 61.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.648 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.56 -36.75 68.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.875 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.659 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 22.0 mtp -49.6 -54.14 34.14 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.383 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 18.3 Cg_exo -65.45 -45.61 6.8 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.021 1.814 . . . . 0.0 111.485 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -73.23 12.78 0.51 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.55 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.643 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -46.56 159.1 0.1 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.09 0.471 . . . . 0.0 111.935 -179.289 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -142.6 -160.72 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.631 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -86.78 33.51 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.613 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 25' ' ' VAL . . . 150.2 114.96 0.71 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.305 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.814 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -121.17 166.75 13.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.645 0.26 . . . . 0.0 110.907 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 55' ' ' GLU . 10.6 mm -159.22 149.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -160.69 131.12 5.28 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.907 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -121.73 132.93 54.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.551 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -135.48 126.63 44.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.585 -178.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 2.2 t -125.75 101.53 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 32' ' ' MET . 14.0 m -142.41 169.82 16.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.231 0.539 . . . . 0.0 112.073 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.16 129.2 55.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.196 178.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 68' ' ' ASN . 30.5 p -156.83 136.52 8.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.333 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.92 -25.65 8.76 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.461 2.107 . . . . 0.0 112.263 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.35 -162.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -140.12 10.37 2.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.206 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.859 ' HA ' HD13 ' A' ' 72' ' ' LEU . 44.5 mm -111.35 -26.9 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.89 0.376 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 63' ' ' CYS . 7.6 m120 -52.1 -12.8 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.534 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.875 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 1.9 m-20 -50.9 119.34 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.539 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.724 HG12 HG21 ' A' ' 59' ' ' VAL . 22.7 mm -51.65 -49.93 80.16 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.311 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 36.9 Cg_exo -62.0 -22.32 74.04 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.139 1.893 . . . . 0.0 111.965 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.875 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.7 OUTLIER -62.4 -39.34 92.92 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.108 179.11 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.508 ' HB3' HD13 ' A' ' 45' ' ' LEU . 14.2 m-20 -59.75 -45.56 91.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 79' ' ' TYR . . . -70.46 -23.33 62.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.607 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.9 -38.54 66.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.537 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -56.53 -58.72 6.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.678 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.457 ' HB2' ' SD ' ' A' ' 48' ' ' MET . 73.6 m80 -69.36 -45.16 70.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.322 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.16 87.88 1.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.162 178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -87.7 -140.08 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -97.85 -72.69 0.64 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.807 0.337 . . . . 0.0 110.991 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 26.3 t -127.68 123.63 61.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.4 mm? -123.44 101.65 7.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.91 158.3 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.473 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.935 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -138.82 172.06 14.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.223 0.535 . . . . 0.0 111.732 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 91' ' ' ILE . 26.3 mt-30 -154.36 156.33 36.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.215 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.85 152.53 51.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.791 0.329 . . . . 0.0 111.22 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -122.72 -78.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.464 ' HA3' ' HD3' ' A' ' 89' ' ' PRO . . . -139.99 -106.92 0.69 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HD3' ' HA3' ' A' ' 88' ' ' GLY . 2.8 Cg_exo -75.84 10.04 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.71 2.274 . . . . 0.0 111.949 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 67.7 p -138.98 170.73 15.44 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.9 tt -150.93 136.89 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.046 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -127.93 140.43 52.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.326 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.935 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -123.66 166.19 15.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.947 178.229 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.44 144.8 21.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.821 0.343 . . . . 0.0 111.299 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.525 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -129.25 149.57 33.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.388 178.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.444 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 5.4 pt20 -142.94 155.92 44.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.791 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 10.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.815 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.27 -25.12 4.82 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.452 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.34 -64.82 0.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.773 0.32 . . . . 0.0 110.853 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.7 p -131.61 142.37 49.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -87.13 -91.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 -86.41 0.2 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.071 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -140.14 -163.52 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.933 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -74.43 -169.76 0.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.913 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -133.44 17.47 4.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.037 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -72.34 117.98 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -123.67 -178.8 4.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.025 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 t -78.18 153.28 32.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.22 140.73 28.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.45 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.09 163.06 22.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.815 0.34 . . . . 0.0 111.012 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p -83.97 131.84 50.2 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.33 101.59 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.577 2.185 . . . . 0.0 112.201 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -121.44 -48.41 2.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.77 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.45 18.41 3.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.346 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.7 56.35 3.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 111.019 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -82.71 5.31 21.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.73 103.69 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -79.23 -77.25 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -134.44 -73.63 0.48 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.122 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.439 HD13 ' NZ ' ' A' ' 52' ' ' LYS . 1.1 tt -111.01 -43.14 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.205 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.786 HG23 ' HB ' ' A' ' 56' ' ' ILE . 2.5 p -53.88 134.04 57.24 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.834 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.654 ' HB3' HG22 ' A' ' 56' ' ' ILE . 12.7 Cg_exo -71.89 146.16 85.03 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.495 1.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.37 -72.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.326 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.59 ' HB2' HD11 ' A' ' 57' ' ' LEU . 62.8 m-85 -134.17 160.83 36.62 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.81 0.338 . . . . 0.0 111.638 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 144.71 46.82 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.837 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.622 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.1 tm? -134.3 81.41 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.514 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 2.0 p-10 -103.22 65.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.89 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 61' ' ' SER . 6.2 mtp -137.2 -105.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 32' ' ' MET . 2.4 t -134.93 156.79 40.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.381 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.54 -9.6 13.49 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.198 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.775 ' HG3' ' H ' ' A' ' 37' ' ' CYS . 9.2 pt-20 -60.23 165.05 5.54 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 122.122 0.169 . . . . 0.0 110.987 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.582 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 27.9 Cg_endo -62.92 3.67 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.649 2.233 . . . . 0.0 112.729 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.775 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 1.2 m -109.47 153.68 42.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.815 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HD2' HD21 ' A' ' 30' ' ' LEU . 61.5 Cg_endo -74.42 -62.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.557 -1.435 . . . . 0.0 112.572 0.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.595 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 96.9 m-85 -69.98 -59.35 4.45 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.792 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' O ' ' HB2' ' A' ' 39' ' ' TYR . 74.0 Cg_endo -104.17 -80.94 0.0 OUTLIER 'Cis proline' 0 C--N 1.357 1.025 0 CA-C-N 119.321 0.793 . . . . 0.0 112.144 -0.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -64.75 6.97 0.18 Allowed 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.471 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' A' ' 39' ' ' TYR . 1.4 p -53.29 -27.48 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.457 . . . . 0.0 110.178 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.574 ' HB1' ' CG ' ' A' ' 28' ' ' TYR . . . -73.44 -37.28 65.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.705 178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 74' ' ' ALA . 2.8 m -54.23 -63.72 1.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.321 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.453 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 20.9 mt -56.29 -38.22 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.275 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 4.9 tt0 -64.55 -28.76 69.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.639 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HB2' ' CD2' ' A' ' 28' ' ' TYR . . . -73.08 -24.21 60.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.744 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 38.6 mmt -57.2 -55.88 39.59 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.703 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 48' ' ' MET . 11.7 Cg_exo -70.45 -44.49 1.58 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.117 1.878 . . . . 0.0 111.554 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.86 8.29 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.382 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -44.0 154.39 0.11 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.98 0.419 . . . . 0.0 111.552 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.439 ' NZ ' HD13 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -124.33 -157.71 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.836 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -78.02 8.44 4.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.133 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' OXT' ' A' ' 97' ' ' LYS . . . 160.78 82.09 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.42 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.804 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -81.91 172.34 13.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 111.249 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.786 ' HB ' HG23 ' A' ' 25' ' ' VAL . 4.5 mt -160.27 155.97 3.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.982 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 28' ' ' TYR . 1.1 tp -139.59 161.17 38.17 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.019 0.437 . . . . 0.0 111.247 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -143.18 113.17 7.13 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.469 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -118.12 114.97 46.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.395 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 61.1 t -119.05 94.24 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.09 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -130.75 173.69 10.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.193 0.521 . . . . 0.0 111.771 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.401 ' OD2' HG22 ' A' ' 90' ' ' THR . 0.7 OUTLIER -117.43 130.85 56.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.337 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.54 117.45 3.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.93 -17.83 61.89 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.679 2.253 . . . . 0.0 112.09 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -108.85 -163.49 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 t -102.57 -18.46 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -69.98 130.56 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' HB2' ' CG ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -137.09 129.73 30.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.294 179.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.33 -48.73 69.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.73 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -56.96 -55.73 40.82 Favored Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.53 ' HA ' HD11 ' A' ' 82' ' ' LEU . 28.8 Cg_endo -62.57 -33.6 77.57 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 121.644 1.563 . . . . 0.0 112.201 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -29.46 68.93 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -57.39 12.79 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.719 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -66.51 -37.73 85.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.0 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.548 ' HA ' ' HD2' ' A' ' 79' ' ' TYR . 29.9 ttt-85 -63.43 -54.98 28.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.592 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -47.88 -55.01 10.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.214 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -70.13 -71.29 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.532 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.99 98.74 0.15 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.707 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.777 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 52.6 p90 -88.78 -165.35 1.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.16 0.505 . . . . 0.0 111.406 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.594 HG21 ' HD2' ' A' ' 97' ' ' LYS . 39.5 m -112.16 -52.24 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.057 175.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 41.3 t -141.84 116.6 5.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.996 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -122.53 105.01 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.619 -178.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -123.66 163.62 20.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.648 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.882 HG22 ' HB3' ' A' ' 93' ' ' TYR . 15.5 pt -139.91 168.3 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.431 . . . . 0.0 111.433 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.5 mt-30 -154.42 155.76 35.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.542 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.39 154.4 50.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -123.45 -80.56 0.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.63 -97.52 0.36 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.406 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 9.55 3.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.702 2.268 . . . . 0.0 112.552 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.401 HG22 ' OD2' ' A' ' 62' ' ' ASP . 47.5 p -146.37 176.4 9.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.955 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG12 ' CE1' ' A' ' 93' ' ' TYR . 18.0 tt -145.04 140.48 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.654 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 92' ' ' ARG . 3.7 ttm-85 -133.2 132.55 41.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.844 0.354 . . . . 0.0 111.194 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.882 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.39 164.7 17.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.829 178.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.92 158.6 40.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.904 0.383 . . . . 0.0 111.443 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -134.47 162.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.922 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.778 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -154.5 156.21 36.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.629 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.62 -153.76 8.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.551 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.7 p -109.91 8.09 24.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.762 0.315 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.5 p -95.07 150.96 19.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.49 106.07 8.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.984 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -132.11 176.87 8.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.17 172.29 11.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.81 44.06 1.84 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.19 -70.06 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.961 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -112.44 53.03 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -68.17 -73.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.991 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.18 111.97 20.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.978 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.67 30.45 8.12 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.93 -41.15 16.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.332 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.517 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 4.2 t -87.39 -52.08 0.41 Allowed Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.378 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 71.8 Cg_endo -76.32 107.83 2.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.162 1.908 . . . . 0.0 112.278 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.81 122.19 28.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.25 78.18 1.89 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.481 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.96 37.39 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -99.32 75.67 2.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.873 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.86 -57.92 2.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.85 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -104.04 123.78 47.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.457 HD22 ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -84.95 146.25 27.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.953 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.457 ' H ' HD22 ' A' ' 23' ' ' ASN . 2.1 mm -106.54 -26.55 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.974 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -124.56 138.01 30.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.149 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.697 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 52.0 Cg_exo -54.38 -92.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.862 2.375 . . . . 0.0 112.634 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' H ' ' HB2' ' A' ' 26' ' ' PRO . 26.2 t0 56.11 73.43 0.44 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.591 ' HB2' HD12 ' A' ' 57' ' ' LEU . 1.8 m-85 -107.98 141.9 38.92 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.308 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 7.8 mtp85 -111.46 137.33 49.41 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.844 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.7 tm? -126.71 89.12 2.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.295 177.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.708 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.12 62.5 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.62 -176.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 78.3 mtp -136.69 -112.68 0.18 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.385 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.621 ' HA ' ' HB2' ' A' ' 61' ' ' SER . 2.5 t -134.67 155.7 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.66 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' HA2' ' ND2' ' A' ' 69' ' ' ASN . . . -79.8 70.16 2.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.107 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 12.0 tt0 -86.45 139.36 33.8 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.537 0.208 . . . . 0.0 110.77 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 52.2 Cg_endo -69.55 -24.14 30.95 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.542 2.162 . . . . 0.0 112.789 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.491 ' HB2' ' HG2' ' A' ' 35' ' ' GLU . 45.9 m -56.63 145.01 62.92 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.999 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.22 78.72 3.14 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.562 2.175 . . . . 0.0 112.256 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.871 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 6.0 t80 -137.59 -53.28 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.519 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.871 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 32.8 Cg_endo -63.59 -82.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.3 2.0 . . . . 0.0 112.491 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.989 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -61.67 12.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -52.64 -31.65 16.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.142 0.496 . . . . 0.0 110.018 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.81 -43.28 59.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.601 HG23 ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -54.94 -45.05 74.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.11 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.91 -53.56 48.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.043 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.6 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 7.5 pt-20 -67.73 -10.38 52.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.648 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -73.79 -39.33 64.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.776 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.582 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.89 -48.96 70.31 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.604 -178.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.6 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 18.3 Cg_exo -65.89 -54.83 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 121.978 1.785 . . . . 0.0 111.387 178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.62 18.22 0.13 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.907 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -48.7 157.52 0.37 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.924 0.392 . . . . 0.0 111.452 -179.324 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -138.52 -170.85 2.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.94 9.09 29.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.66 61.79 0.32 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.511 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.697 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -82.7 148.81 27.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 55' ' ' GLU . 29.6 mt -156.99 158.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.2 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.685 HD21 HG21 ' A' ' 70' ' ' ILE . 1.3 tp -160.58 142.11 12.28 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.656 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.714 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -125.71 137.8 53.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.981 -179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.844 HG13 ' HB3' ' A' ' 30' ' ' LEU . 18.7 t -139.3 142.52 33.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.032 0.444 . . . . 0.0 111.739 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -146.91 109.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.169 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.621 ' HB2' ' HA ' ' A' ' 33' ' ' VAL . 93.4 p -150.57 -175.52 5.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.575 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.78 119.88 36.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 41.1 t -137.03 106.6 8.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.954 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -55.79 -30.64 77.24 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.462 2.108 . . . . 0.0 112.196 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' HB3' ' H ' ' A' ' 66' ' ' SER . 0.8 OUTLIER -89.57 -162.7 0.9 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 8.5 t -108.61 -19.87 13.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.4 mt -55.8 119.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.061 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.602 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -74.67 137.48 42.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.911 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.505 ' ND2' ' HA2' ' A' ' 34' ' ' GLY . 49.3 t30 -73.25 -90.96 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.537 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.989 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm -48.38 -51.03 54.09 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.374 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.673 ' HG2' ' HD2' ' A' ' 93' ' ' TYR . 71.6 Cg_exo -52.59 -35.14 66.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.42 2.08 . . . . 0.0 113.186 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 11.4 tp -58.94 -41.04 86.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 110.566 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.08 -57.44 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.202 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -62.34 -35.74 80.04 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.348 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -67.79 -31.5 71.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -57.91 -62.71 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.677 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -70.26 -37.29 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.06 107.84 3.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.946 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.458 ' HD1' ' H ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -110.24 -162.6 0.81 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.755 0.312 . . . . 0.0 111.047 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.458 ' H ' ' HD1' ' A' ' 79' ' ' TYR . 2.4 m -82.82 -74.76 0.34 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.159 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 23.3 t -116.59 122.0 68.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.436 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 71' ' ' PRO . 2.4 mm? -128.52 97.11 4.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.196 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.59 141.07 51.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.911 0.386 . . . . 0.0 111.326 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.74 161.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.247 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -148.01 156.15 42.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.652 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.06 151.67 45.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.912 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.34 -79.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.708 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.26 -89.74 0.17 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.136 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -85.61 -2.4 9.11 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.691 2.261 . . . . 0.0 112.767 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p -136.91 -174.81 3.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.857 0.36 . . . . 0.0 111.1 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 85' ' ' GLN . 2.5 tt -152.18 149.96 13.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.094 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.608 ' HD2' ' O ' ' A' ' 59' ' ' VAL . 8.0 tpt180 -123.21 133.28 54.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.727 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -123.81 146.61 48.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.466 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.79 137.3 15.07 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.884 0.373 . . . . 0.0 111.737 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -131.66 153.42 38.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.317 178.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 3.7 pt20 -154.03 169.45 23.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.928 0.394 . . . . 0.0 111.287 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.654 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.9 tttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.884 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.775 0.322 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.03 -162.28 22.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.596 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.3 m -104.77 -46.07 4.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.359 . . . . 0.0 110.911 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.26 -176.92 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.63 -53.58 49.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -136.65 133.15 35.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.931 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -89.12 -178.38 5.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -93.65 115.34 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -96.38 13.45 27.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -77.2 -173.7 2.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.8 m -97.25 77.52 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.51 -19.65 1.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.861 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.95 86.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.497 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.76 155.83 34.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.784 0.326 . . . . 0.0 110.931 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.0 m -113.98 146.35 35.45 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.34 -43.92 0.63 Allowed 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.716 -1.369 . . . . 0.0 112.247 0.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.45 -178.25 4.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.96 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.24 -135.34 8.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.407 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.53 33.52 2.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.955 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -69.87 148.05 49.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.34 10.79 6.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.95 -23.02 13.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.899 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.54 59.01 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.943 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.563 HG13 HG22 ' A' ' 25' ' ' VAL . 3.2 pt -134.55 -18.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.011 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.563 HG22 HG13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -133.37 152.62 79.63 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.066 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.872 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 50.4 Cg_exo -56.72 -81.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.631 2.221 . . . . 0.0 112.409 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 41.9 67.57 0.56 Allowed 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 121.165 0.507 . . . . 0.0 110.565 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -102.97 154.96 18.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.647 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.4 118.04 27.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.955 -178.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.782 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -114.68 80.94 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.465 177.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.674 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 4.8 m-20 -102.44 65.34 0.93 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.465 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 61' ' ' SER . 11.7 mtt -136.83 -108.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.105 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.589 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 15.4 t -132.65 147.42 31.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -59.38 -14.58 27.62 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 119.985 -1.102 . . . . 0.0 111.754 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.8 pt-20 -60.03 161.11 13.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 122.138 0.175 . . . . 0.0 110.757 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.18 77.01 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.397 2.065 . . . . 0.0 112.241 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -67.16 168.76 10.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.477 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.11 -42.95 56.28 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.215 1.943 . . . . 0.0 112.295 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -134.18 74.75 67.01 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.622 ' HA ' HD21 ' A' ' 30' ' ' LEU . 62.7 Cg_endo -96.29 -136.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.269 2.646 . . . . 0.0 112.65 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.599 ' CB ' HG23 ' A' ' 70' ' ' ILE . . . -54.71 -6.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.523 HG23 ' HD2' ' A' ' 40' ' ' PRO . 70.1 t -48.58 -32.1 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 110.39 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.56 -39.6 67.32 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.527 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.612 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.56 -47.5 85.23 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.94 179.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -57.97 -51.06 71.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 6.1 pt-20 -71.71 -13.23 61.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.767 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 44' ' ' THR . . . -72.98 -27.38 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.111 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.519 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.8 mmm -47.68 -55.65 16.22 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.388 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 68.6 Cg_endo -73.77 -37.25 3.06 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.837 1.691 . . . . 0.0 111.609 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -72.7 2.39 6.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.262 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -47.22 152.92 0.52 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.895 0.379 . . . . 0.0 111.269 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 52' ' ' LYS . 11.9 mmmt -135.65 -167.87 2.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -87.0 42.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 157.3 55.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.872 ' HB2' ' HG2' ' A' ' 26' ' ' PRO . 1.7 pt-20 -72.19 155.0 40.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.65 0.262 . . . . 0.0 111.0 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.612 HG13 ' O ' ' A' ' 55' ' ' GLU . 2.2 mt -158.12 152.66 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.215 0.531 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 tp -143.9 156.64 44.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.567 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -146.58 108.99 4.48 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.559 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.782 HG13 ' HB3' ' A' ' 30' ' ' LEU . 57.4 t -121.93 127.55 75.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 1.4 t -129.05 100.97 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.267 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.3 OUTLIER -125.9 -172.62 2.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.306 0.574 . . . . 0.0 111.978 -176.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.589 ' H ' ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -117.54 109.51 16.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.36 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.68 65.94 2.68 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.907 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.69 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.858 2.372 . . . . 0.0 112.147 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -92.89 23.22 4.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.193 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.4 m -119.44 141.48 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.747 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.71 66.55 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.885 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.605 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 78.9 m-20 -99.77 51.22 0.92 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.396 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.835 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -66.95 118.21 10.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.649 -176.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 43.5 mm -51.22 -47.41 88.14 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.898 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.673 ' HB3' HG22 ' A' ' 95' ' ' ILE . 27.8 Cg_endo -60.82 -29.1 87.52 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.263 1.976 . . . . 0.0 111.841 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.835 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 0.3 OUTLIER -55.14 -38.46 68.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.98 -45.09 95.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.585 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.612 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -68.07 -24.42 65.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.263 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 15.6 ttt-85 -72.26 -36.56 69.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.339 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -63.88 -55.41 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.302 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -28.44 68.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 109.768 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.09 88.53 1.39 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.011 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.577 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -96.48 -158.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.698 0.285 . . . . 0.0 110.385 178.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.606 HG21 ' HA ' ' A' ' 97' ' ' LYS . 12.6 m -79.69 -87.03 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.826 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 80' ' ' THR . 91.8 t -113.14 127.9 70.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.897 0.38 . . . . 0.0 111.234 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.8 mm? -123.58 107.35 11.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.472 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -123.55 159.33 29.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.623 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.945 HG22 ' HB3' ' A' ' 93' ' ' TYR . 28.4 pt -142.8 172.27 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 111.415 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.418 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -153.71 173.82 15.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.343 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -137.51 139.71 40.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.972 0.415 . . . . 0.0 111.365 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 57.0 m-20 -117.21 -137.62 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.241 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -73.63 -106.84 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.085 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -87.47 20.02 1.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.769 2.313 . . . . 0.0 112.572 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.492 HG22 ' CG ' ' A' ' 62' ' ' ASP . 41.7 p -138.57 173.73 11.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.988 0.423 . . . . 0.0 111.152 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.557 HG12 ' CE2' ' A' ' 93' ' ' TYR . 8.0 tt -136.71 130.15 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.287 178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.578 ' HB2' HG13 ' A' ' 60' ' ' VAL . 1.5 ttm180 -123.18 136.44 54.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.138 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.945 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -128.02 164.84 21.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.921 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.37 153.37 31.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.673 HG22 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -136.62 155.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.796 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.508 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -155.2 170.58 21.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 111.478 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.727 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 1.9 tttp . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.435 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptp . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.24 160.39 43.11 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.437 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t -102.85 -40.07 6.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.687 0.28 . . . . 0.0 110.932 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 m -122.34 -77.47 0.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.81 24.51 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.831 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.35 38.5 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.928 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -87.53 137.75 32.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -72.08 132.57 44.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -105.93 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.789 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -137.19 -73.18 0.43 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -121.77 8.88 10.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.72 138.61 57.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.53 22.22 38.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.511 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.87 -21.26 18.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 110.95 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.52 103.96 55.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.973 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.85 170.72 11.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.491 2.128 . . . . 0.0 112.307 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 159.81 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.26 156.33 48.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.464 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 m -131.2 103.95 6.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.361 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.74 25.16 5.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.917 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -98.85 -170.3 1.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -131.87 115.7 16.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.1 -176.39 6.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.6 pt -125.0 -1.73 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.28 143.62 34.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.931 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.699 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 39.6 Cg_exo -57.94 -80.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.664 2.243 . . . . 0.0 112.572 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 56' ' ' ILE . 5.8 p-10 41.8 75.08 0.09 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.111 0.482 . . . . 0.0 110.961 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.436 ' HB2' ' CD1' ' A' ' 57' ' ' LEU . 4.7 m-85 -103.48 161.8 13.56 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -134.6 146.42 49.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.326 0.584 . . . . 0.0 112.489 -178.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.926 HD23 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -134.28 91.15 2.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.315 177.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.663 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 37.9 t0 -101.79 58.52 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.742 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.467 ' C ' ' HB3' ' A' ' 61' ' ' SER . 46.6 mtt -137.32 -110.53 0.18 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.19 0.519 . . . . 0.0 111.644 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 62' ' ' ASP . 9.9 p -135.55 164.28 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.262 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -96.49 79.02 0.73 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.389 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.742 ' HG3' ' H ' ' A' ' 37' ' ' CYS . 4.8 pt-20 -100.77 160.86 25.62 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.489 0.185 . . . . 0.0 110.878 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.28 -11.42 31.93 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.763 2.308 . . . . 0.0 112.475 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.742 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -119.33 74.15 15.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.143 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HG3' ' HB2' ' A' ' 69' ' ' ASN . 84.3 Cg_endo -89.38 -169.32 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.821 2.348 . . . . 0.0 112.68 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.643 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . 5.4 t80 -140.21 -54.95 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.178 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.926 ' HG2' HD23 ' A' ' 30' ' ' LEU . 31.7 Cg_exo -65.25 -31.2 53.82 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.211 1.941 . . . . 0.0 112.536 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.61 ' CA ' HD13 ' A' ' 70' ' ' ILE . . . -65.26 -17.5 64.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.357 0.598 . . . . 0.0 110.246 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 46' ' ' GLU . 55.0 t -57.67 -27.76 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.823 177.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.56 -31.2 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.312 176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.579 ' OG1' HG23 ' A' ' 70' ' ' ILE . 3.0 m -51.75 -68.13 0.19 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 48.8 mt -61.46 -43.15 99.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.167 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 3.3 tt0 -65.3 -18.6 65.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.738 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.04 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.261 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.531 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 1.2 mmt -46.16 -55.12 14.36 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.871 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 48' ' ' MET . 39.3 Cg_endo -66.39 -56.71 0.26 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.714 1.609 . . . . 0.0 111.756 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -73.56 18.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.807 179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -44.55 151.37 0.27 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.773 0.321 . . . . 0.0 111.322 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -130.21 -179.61 5.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -87.19 61.63 6.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.834 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.72 43.49 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.699 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 0.9 OUTLIER -65.3 150.51 48.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.894 0.378 . . . . 0.0 110.815 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.55 ' N ' ' HG3' ' A' ' 55' ' ' GLU . 1.8 mt -154.03 156.11 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.336 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.561 HD21 ' CG2' ' A' ' 70' ' ' ILE . 9.5 tp -146.75 161.05 41.44 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.21 0.528 . . . . 0.0 111.201 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -150.48 140.03 21.56 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 177.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.84 144.34 28.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.013 0.435 . . . . 0.0 111.172 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.663 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -152.76 97.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.167 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.526 ' HB2' HD21 ' A' ' 68' ' ' ASN . 0.3 OUTLIER -151.06 179.33 8.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -178.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.42 137.65 53.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.711 179.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 11.3 p -159.51 139.51 8.64 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.042 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.81 -12.87 36.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.675 2.25 . . . . 0.0 112.087 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -95.15 -160.84 0.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -113.54 -5.43 13.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.15 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.6 149.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.238 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.526 HD21 ' HB2' ' A' ' 61' ' ' SER . 4.4 m-20 -112.81 -169.88 1.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.097 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.697 ' ND2' HG12 ' A' ' 70' ' ' ILE . 5.6 p-10 -72.57 -55.06 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.901 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.728 HD11 ' HG ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -56.98 -51.18 83.61 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 31.9 Cg_endo -62.79 -41.51 30.0 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.428 2.085 . . . . 0.0 112.837 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -25.63 65.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.095 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 10.1 m-20 -71.58 -61.78 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.192 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -60.97 -38.95 87.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -65.15 -27.48 68.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -62.92 -69.05 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -14.78 61.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.34 96.4 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.493 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.641 ' HE2' ' HB2' ' A' ' 97' ' ' LYS . 33.7 t80 -82.98 -98.78 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.653 0.263 . . . . 0.0 110.904 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 m -137.57 -77.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.893 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 25.8 t -109.99 114.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.187 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.535 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -123.23 101.77 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.348 179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.69 158.5 31.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.635 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 33.0 pt -141.87 168.08 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.996 0.427 . . . . 0.0 111.76 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 84' ' ' ILE . 3.7 mt-30 -152.4 155.64 37.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.483 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.39 141.92 45.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.835 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -109.74 -79.47 0.58 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.846 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.36 -97.51 0.46 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.087 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.31 6.88 5.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.243 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.1 p -135.89 172.21 13.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.037 0.446 . . . . 0.0 111.139 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 4.0 tt -148.0 145.27 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.874 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -123.68 147.41 47.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 111.453 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CD2' ' HG3' ' A' ' 71' ' ' PRO . 4.4 m-85 -131.68 130.76 42.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 143.72 44.38 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 111.922 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -133.94 157.24 41.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.387 178.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.548 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -153.73 157.43 39.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.213 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.641 ' HB2' ' HE2' ' A' ' 79' ' ' TYR . 3.0 tptp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.741 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.837 0.351 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.83 102.73 0.73 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.475 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.1 31.09 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.9 m -85.98 67.15 9.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -102.85 -170.63 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -67.6 142.81 56.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.82 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.88 -67.05 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.27 -91.94 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.46 157.61 35.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.818 0.342 . . . . 0.0 111.031 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.44 21.45 11.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.893 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.68 126.33 39.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.007 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -134.33 28.66 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.76 -169.7 43.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -120.3 43.96 2.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 110.921 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.615 ' HB ' ' HD3' ' A' ' 16' ' ' PRO . 7.8 t -74.81 -51.56 3.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.549 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 15' ' ' VAL . 24.5 Cg_exo -63.62 178.97 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.331 2.021 . . . . 0.0 112.199 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -94.39 -49.88 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.847 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.45 -153.21 7.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.467 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.41 -63.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 110.887 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.87 -71.3 0.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -93.74 174.65 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.958 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -133.54 80.12 1.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.888 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.83 -167.2 1.74 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 pt -64.78 165.79 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.076 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.2 141.79 27.71 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.551 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 27' ' ' ASP . 12.0 Cg_endo -55.24 109.93 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.554 2.169 . . . . 0.0 111.798 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.674 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.4 t70 91.29 81.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.165 0.915 . . . . 0.0 111.343 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.494 ' HB3' HD12 ' A' ' 57' ' ' LEU . 9.9 t80 -103.92 168.31 9.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.707 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 8.0 ptt85 -134.61 130.4 36.39 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 40' ' ' PRO . 1.9 tm? -123.06 78.67 1.58 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.41 -0.813 . . . . 0.0 108.973 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.63 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -102.06 70.12 1.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.762 -176.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -136.7 -111.31 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.709 178.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 62' ' ' ASP . 10.5 p -135.57 144.74 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.809 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.517 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -76.1 76.41 1.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.276 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.737 ' HG3' ' HB2' ' A' ' 37' ' ' CYS . 9.1 pt-20 -92.39 145.73 31.16 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.73 0.3 . . . . 0.0 111.138 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.582 ' HA ' HD21 ' A' ' 69' ' ' ASN . 49.5 Cg_exo -55.97 -22.98 41.01 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.724 2.283 . . . . 0.0 112.406 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.737 ' HB2' ' HG3' ' A' ' 35' ' ' GLU . 7.3 m -58.55 139.84 85.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.993 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.24 23.06 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.692 2.261 . . . . 0.0 112.607 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.407 ' HB2' ' HD3' ' A' ' 40' ' ' PRO . 4.4 m-85 -77.84 -50.23 1.94 Allowed Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB3' HD21 ' A' ' 30' ' ' LEU . 31.7 Cg_exo -60.5 -75.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.385 2.057 . . . . 0.0 112.461 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.68 4.7 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 40' ' ' PRO . 5.1 p -48.16 -34.34 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -38.38 66.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.954 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.687 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -61.5 -57.63 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.31 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 73' ' ' ASP . 9.8 mt -61.52 -54.23 45.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.48 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.35 -33.24 65.48 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.228 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -44.3 -61.49 1.49 Allowed 'General case' 0 C--O 1.216 -0.674 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 mtm -76.37 138.44 67.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 51' ' ' LEU . 63.0 Cg_endo -83.09 11.24 40.64 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.753 -0.936 . . . . 0.0 113.593 -10.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -71.91 16.54 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 122.135 -0.353 . . . . 0.0 111.664 -177.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.638 HD12 ' HD2' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -71.12 179.28 2.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.352 . . . . 0.0 111.177 -179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -126.12 -148.15 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.573 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HA ' ' HE2' ' A' ' 97' ' ' LYS . 18.8 mtmt -107.36 58.51 0.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 0.0 110.85 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.585 ' H ' ' HD3' ' A' ' 97' ' ' LYS . . . 126.36 93.05 0.87 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.67 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -124.1 -173.15 2.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.711 0.291 . . . . 0.0 110.984 179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -160.43 162.48 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.001 -179.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 44' ' ' THR . 15.2 tp -144.22 162.9 35.18 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.229 0.538 . . . . 0.0 111.398 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.456 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 2.6 mt-10 -147.82 141.62 25.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.403 175.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 25.4 t -141.18 131.1 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 111.602 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.63 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 36.1 t -133.1 84.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.196 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 32' ' ' MET . 0.0 OUTLIER -124.71 166.91 15.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.27 -178.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -118.38 135.76 54.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.494 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 19.3 p -159.25 143.31 11.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.134 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.6 Cg_exo -70.95 -11.32 29.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.711 2.274 . . . . 0.0 112.046 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -93.08 -164.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.886 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -112.74 -17.52 12.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -117.68 153.49 19.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 -179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.517 ' ND2' ' HA3' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -125.81 177.81 6.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.067 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.582 HD21 ' HA ' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -72.68 -42.48 64.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.936 -178.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.75 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -60.04 -49.82 89.27 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 50.5 Cg_endo -67.27 -43.46 6.12 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.189 1.926 . . . . 0.0 112.244 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.406 HD12 HG12 ' A' ' 67' ' ' ILE . 0.4 OUTLIER -64.96 -32.58 74.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.107 -179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 3.8 m-20 -64.13 -57.6 9.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -61.63 -39.55 91.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 75' ' ' ARG . 3.8 mtp180 -62.6 -32.21 73.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.672 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -61.94 -67.89 0.37 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.78 -33.28 72.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.575 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.14 95.03 1.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.04 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.87 -168.77 1.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.661 0.267 . . . . 0.0 110.285 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.683 HG22 HG23 ' A' ' 81' ' ' VAL . 96.7 m -77.26 -62.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.728 ' HB ' ' HG3' ' A' ' 96' ' ' GLN . 21.8 t -127.44 132.34 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.334 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -133.28 100.29 4.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.407 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -123.47 156.91 34.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.874 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.22 175.24 4.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.091 0.472 . . . . 0.0 111.804 -179.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.531 ' O ' HG13 ' A' ' 91' ' ' ILE . 17.1 mt-30 -154.04 166.95 31.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.439 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -145.4 145.46 31.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.877 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.6 -83.09 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.11 -97.27 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.202 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.15 5.92 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.52 2.147 . . . . 0.0 112.449 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -138.08 174.49 10.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 111.163 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 85' ' ' GLN . 3.1 tt -145.17 144.19 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.741 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -123.56 138.39 54.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.928 0.394 . . . . 0.0 111.119 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.9 m-85 -123.86 149.47 45.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.205 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.39 138.39 16.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.926 0.393 . . . . 0.0 111.746 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 96' ' ' GLN . 0.6 OUTLIER -129.34 161.34 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.534 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.728 ' HG3' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -152.07 145.7 24.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.67 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.718 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 120.793 0.33 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.95 -177.13 39.02 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.533 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.54 3.63 16.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.82 0.343 . . . . 0.0 110.907 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -116.83 139.16 50.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -115.21 -70.12 0.82 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 2.3 t-80 -139.46 98.69 3.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.745 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -128.72 3.81 5.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -82.98 -55.69 4.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -109.07 4.02 22.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 6' ' ' HIS . 0.7 OUTLIER -115.72 76.51 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.922 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.33 166.41 22.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.59 6.3 23.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.952 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.16 -152.48 11.79 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 mt -113.32 32.59 5.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 0.0 111.003 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.512 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 2.7 t -85.41 -51.15 0.52 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.619 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 15' ' ' VAL . 47.2 Cg_endo -68.47 -57.83 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.226 1.951 . . . . 0.0 112.348 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -114.87 70.59 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.41 -163.07 9.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.546 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.81 111.04 17.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.779 0.323 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -80.37 131.9 35.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.65 111.52 13.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.975 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 172.93 4.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.75 -157.44 0.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.851 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 24' ' ' ILE . 0.8 OUTLIER -82.91 60.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.362 -179.647 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.05 115.61 10.21 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.052 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.59 161.45 94.39 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.423 -1.49 . . . . 0.0 112.422 0.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -61.89 -74.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.537 ' H ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -134.48 161.11 35.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.816 0.341 . . . . 0.0 111.478 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -135.1 121.18 19.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.508 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.846 HD21 ' HB2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -107.66 77.01 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 178.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -103.07 65.15 0.86 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.461 -178.036 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.635 ' O ' ' HA ' ' A' ' 61' ' ' SER . 0.8 OUTLIER -137.16 -104.93 0.2 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.05 178.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.405 ' HA ' ' H ' ' A' ' 62' ' ' ASP . 13.0 p -134.56 137.04 51.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.584 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -72.94 77.49 0.81 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.274 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.56 ' HG2' ' HB2' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -73.81 135.1 77.89 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-O 120.522 0.201 . . . . 0.0 110.817 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.11 -14.89 9.45 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.696 2.264 . . . . 0.0 112.594 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' HB2' ' HG2' ' A' ' 35' ' ' GLU . 23.1 m -80.85 154.97 73.26 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.069 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 50.1 Cg_exo -54.72 -32.89 78.07 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.694 2.263 . . . . 0.0 112.852 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' HA ' HG23 ' A' ' 42' ' ' VAL . 2.9 p90 -86.07 156.43 57.59 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.026 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.846 ' HB2' HD21 ' A' ' 30' ' ' LEU . 3.0 Cg_exo -82.71 5.76 49.55 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 124.037 -1.235 . . . . 0.0 112.546 1.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB2' ' CD1' ' A' ' 70' ' ' ILE . . . -59.48 1.94 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.916 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' A' ' 39' ' ' TYR . 59.8 t -51.18 -27.87 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 0.0 110.372 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.99 -36.83 67.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.697 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 51.7 m -57.46 -52.35 65.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.016 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tp -60.96 -63.13 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.276 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -47.1 -39.51 13.36 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.948 0.404 . . . . 0.0 110.406 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.23 -61.58 1.14 Allowed 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.458 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.3 mmt -76.97 138.85 65.39 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' C ' HD23 ' A' ' 51' ' ' LEU . 66.9 Cg_endo -83.27 13.79 34.04 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.643 -0.982 . . . . 0.0 113.336 -11.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 47' ' ' ALA . 35.8 mt-30 -70.41 10.55 0.45 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 122.177 -0.327 . . . . 0.0 111.824 -177.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' H ' HD23 ' A' ' 51' ' ' LEU . 1.3 pt? -72.12 -177.35 2.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.089 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.72 -160.97 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.56 29.39 0.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.957 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 162.96 91.92 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.493 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.837 ' H ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -116.93 173.8 6.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.567 0.222 . . . . 0.0 110.755 179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 55' ' ' GLU . 5.8 mt -159.22 157.53 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.235 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -143.66 161.51 38.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.092 0.472 . . . . 0.0 111.396 179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.42 119.29 8.69 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.158 175.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.706 ' HB ' ' HB2' ' A' ' 93' ' ' TYR . 47.5 t -117.95 111.8 35.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.936 0.398 . . . . 0.0 111.368 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 31' ' ' ASP . 1.6 t -117.75 89.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 32' ' ' MET . 62.9 m -129.18 172.74 11.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.691 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.532 ' OD2' HG22 ' A' ' 90' ' ' THR . 0.4 OUTLIER -117.59 125.15 50.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 4.0 p -159.27 147.31 13.52 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.092 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 11.7 Cg_exo -71.3 -23.4 24.19 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 112.126 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -175.4 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.093 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.82 -32.28 11.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.456 ' HA ' ' HE2' ' A' ' 93' ' ' TYR . 1.5 tt -119.93 148.73 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.584 ' ND2' ' HA3' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -98.93 173.86 6.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 38' ' ' PRO . 15.6 t-20 -72.54 -22.05 61.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.09 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.646 HD12 ' HG ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -67.65 -54.5 17.52 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.758 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 68' ' ' ASN . 21.2 Cg_exo -65.84 -35.39 35.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.277 1.985 . . . . 0.0 111.688 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -21.28 66.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.604 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.5 -62.68 1.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.791 ' HB1' ' HB3' ' A' ' 79' ' ' TYR . . . -59.74 -39.78 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -56.53 -40.53 75.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.744 179.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -52.42 16.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.065 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -68.3 -81.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.114 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.14 98.06 0.11 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.845 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.791 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 45.6 p90 -98.97 -166.02 1.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.126 0.488 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.787 HG21 ' HD2' ' A' ' 97' ' ' LYS . 1.4 m -125.83 -40.88 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.504 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.635 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 73.3 t -144.43 115.08 2.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.609 HD22 ' HB ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -123.38 95.86 4.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.106 -178.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -123.97 163.27 21.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.538 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.3 pt -142.59 178.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.192 0.52 . . . . 0.0 111.986 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.36 -172.09 4.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.243 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -144.56 142.41 30.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 0.0 111.226 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' ' 88' ' ' GLY . 0.9 OUTLIER -118.03 -154.15 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.246 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' A' ' 87' ' ' ASP . . . -64.98 -99.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.107 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -90.74 16.31 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.744 2.296 . . . . 0.0 112.536 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.532 HG22 ' OD2' ' A' ' 62' ' ' ASP . 11.5 p -137.26 -170.72 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.001 0.429 . . . . 0.0 111.059 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG12 ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt -143.19 147.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.605 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -123.79 142.87 50.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.063 0.459 . . . . 0.0 111.178 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.706 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 1.8 m-85 -131.39 155.79 46.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.564 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.7 143.93 20.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.613 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.609 ' HB ' HD22 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -134.98 158.62 41.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.236 177.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.635 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -154.11 163.55 39.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.837 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 2.1 tptp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.516 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mmm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.12 70.63 1.27 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.422 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -2.78 38.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.964 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -78.62 166.43 22.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -125.32 -74.82 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -134.33 166.85 21.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 128.27 50.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -79.67 101.49 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.85 33.93 5.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.96 95.08 5.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -112.07 -13.22 13.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.2 p -68.9 109.92 4.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.14 50.31 0.81 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.566 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.44 92.02 3.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.764 0.316 . . . . 0.0 110.86 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 15' ' ' VAL . 0.4 OUTLIER -57.89 131.41 83.05 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.64 135.15 47.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.426 2.084 . . . . 0.0 112.16 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -95.11 86.15 4.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.21 140.51 23.03 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.505 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.8 p -115.81 11.58 15.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 0.0 110.951 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.83 168.22 19.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.008 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.98 51.96 1.95 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -90.47 12.73 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.999 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -91.99 57.45 3.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.8 -61.74 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 54' ' ' GLY . 2.0 m -112.51 122.47 36.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.857 ' HD2' ' HA ' ' A' ' 55' ' ' GLU . 82.7 Cg_exo -47.5 -84.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.708 2.272 . . . . 0.0 112.691 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' A' ' 58' ' ' GLU . 37.5 t0 58.03 78.42 0.24 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 57' ' ' LEU . 1.1 m-85 -103.78 136.55 43.25 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.758 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -103.52 135.68 44.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.297 0.57 . . . . 0.0 112.384 -176.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.699 ' HB3' HG13 ' A' ' 59' ' ' VAL . 1.4 tm? -130.56 81.16 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.339 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.645 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -102.51 71.79 1.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.788 -176.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.438 ' HB3' ' H ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -136.86 -112.02 0.18 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.096 178.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.535 HG22 ' OD1' ' A' ' 62' ' ' ASP . 47.9 t -134.87 133.31 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.714 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.69 103.43 0.32 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 5.2 tt0 -123.58 133.88 24.89 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.604 0.24 . . . . 0.0 110.96 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 35' ' ' GLU . 15.2 Cg_exo -69.84 -29.15 23.92 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.85 2.367 . . . . 0.0 112.526 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.419 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 1.1 m -55.55 144.04 55.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.137 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.32 81.43 1.76 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.545 2.164 . . . . 0.0 112.367 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.794 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -140.28 -53.62 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.3 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.794 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 62.7 Cg_endo -74.26 -72.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.205 1.937 . . . . 0.0 112.614 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.82 ' HB2' ' HA ' ' A' ' 70' ' ' ILE . . . -58.55 4.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.448 ' H ' ' C ' ' A' ' 40' ' ' PRO . 54.1 t -52.91 -29.29 14.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.98 0.419 . . . . 0.0 110.106 178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . . . -72.96 -34.0 66.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.639 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -64.26 -52.22 59.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.067 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.2 mt -61.29 -57.6 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.251 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 47' ' ' ALA . 16.8 pt-20 -50.1 -40.57 46.14 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 50' ' ' GLN . . . -42.53 -53.19 4.46 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.474 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -77.3 137.13 64.47 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.96 173.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' C ' HD13 ' A' ' 51' ' ' LEU . 65.0 Cg_endo -83.34 11.42 41.21 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.668 -0.972 . . . . 0.0 113.243 -11.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 47' ' ' ALA . 10.1 mm100 -73.02 25.9 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -72.46 -159.58 0.06 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.713 ' HD3' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -141.8 -155.88 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.448 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.713 ' H ' ' HD3' ' A' ' 52' ' ' LYS . 6.6 mttp -91.57 30.14 1.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 110.775 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 25' ' ' VAL . . . 154.63 73.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.213 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.857 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -78.8 171.43 15.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.123 0.487 . . . . 0.0 111.512 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 55' ' ' GLU . 61.5 mt -154.87 162.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.034 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.611 ' HG ' ' N ' ' A' ' 58' ' ' GLU . 4.3 tp -159.59 162.05 35.25 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.019 179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.611 ' N ' ' HG ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -149.11 133.06 17.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.725 -176.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.699 HG13 ' HB3' ' A' ' 30' ' ' LEU . 40.6 t -139.25 132.23 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.849 0.356 . . . . 0.0 111.66 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -135.32 97.66 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.223 178.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.85 171.1 14.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.44 -178.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.535 ' OD1' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -118.24 138.34 52.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.352 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.9 t -159.33 133.02 4.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.009 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 63' ' ' CYS . 29.1 Cg_exo -61.64 -30.9 86.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.558 2.172 . . . . 0.0 112.129 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -81.4 -170.91 3.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -112.35 -17.09 12.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.68 137.48 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -100.12 127.19 46.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.606 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.776 HD22 ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -72.52 -58.71 3.16 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.493 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.82 ' HA ' ' HB2' ' A' ' 41' ' ' ALA . 15.3 mm -56.85 -54.05 58.39 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.683 ' HD3' ' HB ' ' A' ' 70' ' ' ILE . 52.2 Cg_exo -58.28 -32.94 97.1 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.331 2.021 . . . . 0.0 112.7 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 6.5 tp -61.51 -30.95 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.933 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.03 -58.05 4.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.068 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -63.51 -32.46 73.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.2 ttt-85 -68.87 -31.64 70.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -61.7 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.64 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -70.95 -24.66 62.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.309 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.7 103.37 1.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.994 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.461 ' OH ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -104.39 -164.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.639 179.312 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.557 HG21 ' HA ' ' A' ' 97' ' ' LYS . 2.6 m -72.77 -82.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 46.6 t -116.43 123.99 72.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.093 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.624 HD12 ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -123.71 103.43 8.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.699 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.87 164.97 21.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.217 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.927 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -137.6 179.06 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.248 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -154.34 -177.0 6.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.621 179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -150.37 138.87 20.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.053 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -122.57 -131.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.417 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.74 -123.66 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.167 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.7 29.89 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.915 2.41 . . . . 0.0 112.308 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 62' ' ' ASP . 2.0 p -147.6 -177.8 5.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.132 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 85' ' ' GLN . 14.3 tt -142.84 148.52 19.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.844 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.509 ' HB2' HG13 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -139.19 135.52 34.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.86 0.362 . . . . 0.0 111.257 -178.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.927 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -123.79 159.53 29.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.591 179.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.45 152.98 30.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 111.645 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.536 HG22 HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -133.35 155.17 40.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.338 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.492 ' N ' HD12 ' A' ' 95' ' ' ILE . 5.7 pt20 -154.35 157.16 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.713 ' HB3' ' H ' ' A' ' 55' ' ' GLU . 34.6 tttm . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.799 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 mtm . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.737 0.303 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.85 -16.53 10.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.436 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -75.38 81.95 2.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.75 -166.14 1.04 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.09 75.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -90.31 117.37 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.855 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -92.16 21.06 5.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -69.28 -64.19 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.977 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -171.96 3.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -89.6 162.84 15.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.83 162.98 13.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.8 p -108.74 72.81 0.84 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.35 24.96 7.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.512 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.85 129.87 49.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.952 0.406 . . . . 0.0 111.007 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.27 136.39 25.86 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.005 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.66 -41.98 7.55 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.601 2.201 . . . . 0.0 112.318 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -137.25 153.01 50.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.27 142.42 41.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.46 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.15 47.69 0.87 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.929 0.395 . . . . 0.0 110.911 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -87.33 -72.84 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.843 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.95 151.08 22.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.816 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 -78.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.053 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -140.11 116.66 10.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.119 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.14 -75.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 54' ' ' GLY . 5.0 m -86.12 136.09 36.39 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.48 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.604 ' HD3' ' HG3' ' A' ' 55' ' ' GLU . 72.1 Cg_endo -87.08 -68.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.526 2.151 . . . . 0.0 112.822 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.567 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.2 t0 50.29 65.07 1.55 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.484 ' CB ' HD12 ' A' ' 57' ' ' LEU . 1.4 t80 -105.33 137.63 42.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.8 -176.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.4 OUTLIER -103.89 131.73 50.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.48 -178.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.881 ' HB3' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -123.76 86.79 2.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.047 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.658 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 41.8 t0 -102.27 64.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.91 0.386 . . . . 0.0 111.366 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.8 mtp -136.66 -109.44 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.322 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 62' ' ' ASP . 10.9 p -133.93 143.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.975 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 68' ' ' ASN . . . -74.09 94.29 0.79 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.46 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.807 ' HG3' ' HD2' ' A' ' 36' ' ' PRO . 16.3 tt0 -120.58 145.18 40.28 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.807 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 41.6 Cg_exo -26.69 -109.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.346 3.364 . . . . 0.0 114.639 -178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -141.04 58.78 9.69 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.633 ' HG2' ' HD2' ' A' ' 40' ' ' PRO . 98.5 Cg_endo -89.75 -52.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.54 2.16 . . . . 0.0 112.366 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.916 ' H ' ' HD2' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -140.94 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.794 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.916 ' HD2' ' H ' ' A' ' 39' ' ' TYR . 6.6 Cg_endo -49.34 -94.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.808 2.338 . . . . 0.0 113.379 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HA ' HG23 ' A' ' 70' ' ' ILE . . . -57.94 -0.68 0.09 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 39' ' ' TYR . 3.0 t -52.22 -35.85 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.822 0.344 . . . . 0.0 110.713 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 46' ' ' GLU . . . -71.16 -36.74 72.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.602 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.909 HG22 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -56.27 -42.57 77.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.196 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 1.2 tp -68.01 -55.62 11.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.329 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.662 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.23 -15.3 56.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.143 0.497 . . . . 0.0 110.754 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HB1' ' OH ' ' A' ' 79' ' ' TYR . . . -74.63 -34.73 62.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.817 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.607 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -51.3 -47.83 87.38 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.461 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 46' ' ' GLU . 14.8 Cg_exo -68.53 -51.55 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.006 1.804 . . . . 0.0 111.408 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -73.23 15.26 0.24 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.635 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.607 ' HB3' ' O ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -53.22 161.4 0.89 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.016 0.436 . . . . 0.0 111.677 -178.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.2 -162.94 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.469 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.67 39.72 1.41 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.874 0.369 . . . . 0.0 110.808 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA2' ' HG2' ' A' ' 97' ' ' LYS . . . -174.94 67.81 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.438 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.609 ' O ' HG13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -110.17 152.92 25.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.866 0.365 . . . . 0.0 111.414 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.609 HG13 ' O ' ' A' ' 55' ' ' GLU . 3.4 mt -159.63 152.81 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.279 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 95' ' ' ILE . 1.3 tp -160.67 137.73 9.08 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.147 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.652 ' O ' ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -118.75 137.93 53.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.091 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.881 HG13 ' HB3' ' A' ' 30' ' ' LEU . 15.2 t -139.9 150.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.352 0.596 . . . . 0.0 112.359 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -154.95 100.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.752 178.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 33' ' ' VAL . 59.7 m -144.07 167.92 21.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.958 0.409 . . . . 0.0 111.506 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -121.75 137.1 54.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.5 t -159.26 126.71 2.69 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.94 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.71 -12.99 36.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.385 2.057 . . . . 0.0 112.043 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 66' ' ' SER . 35.0 mt-30 -86.02 -155.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.666 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 65' ' ' GLN . 1.6 m -126.6 -56.51 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.302 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.685 HG23 HD23 ' A' ' 72' ' ' LEU . 1.3 mp -77.63 74.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.0 110.964 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.611 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -136.47 5.08 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.067 179.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.763 ' HB2' HD13 ' A' ' 72' ' ' LEU . 2.8 m-20 -72.44 126.16 29.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.068 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 46.9 mm -53.83 -45.72 98.74 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.055 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.832 ' HB3' HG22 ' A' ' 95' ' ' ILE . 35.9 Cg_endo -63.6 -23.31 70.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.115 1.876 . . . . 0.0 111.772 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 69' ' ' ASN . 2.4 mp -64.64 -31.3 72.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -46.49 80.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.595 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.909 ' HB2' HG22 ' A' ' 44' ' ' THR . . . -72.8 -29.94 63.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.364 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.625 ' HB2' ' HG ' ' A' ' 82' ' ' LEU . 0.0 OUTLIER -72.94 -52.54 14.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.713 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 19.1 t30 -50.52 -51.42 47.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.765 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -56.82 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.389 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.07 107.49 0.75 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.972 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -126.02 -135.85 0.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.558 0.218 . . . . 0.0 110.758 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.49 HG21 ' HA ' ' A' ' 97' ' ' LYS . 3.2 m -110.43 -78.66 0.59 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.798 0.332 . . . . 0.0 110.977 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.517 ' HB ' ' HG2' ' A' ' 96' ' ' GLN . 4.0 t -121.27 121.15 64.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.349 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.641 HD13 ' HB ' ' A' ' 95' ' ' ILE . 2.3 mm? -123.59 106.18 10.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.616 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -130.16 139.16 50.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.851 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.949 HG22 ' HB3' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -127.07 166.36 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.994 0.426 . . . . 0.0 111.571 -179.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.42 142.88 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.718 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.494 ' H ' HE21 ' A' ' 86' ' ' GLN . 0.0 OUTLIER -123.89 152.78 42.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.855 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -121.62 -78.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.82 -99.97 0.59 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.67 5.61 6.03 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.606 2.204 . . . . 0.0 112.585 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.2 p -141.13 174.91 10.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.066 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.419 HG12 ' CE1' ' A' ' 93' ' ' TYR . 19.8 tt -149.85 134.95 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -123.81 130.64 52.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.227 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.949 ' HB3' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -124.01 161.18 26.02 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.701 178.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.97 146.38 23.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.537 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.832 HG22 ' HB3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER -123.9 155.27 30.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.009 177.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.517 ' HG2' ' HB ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -154.39 -170.56 3.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.013 0.435 . . . . 0.0 111.343 -179.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HG2' ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 stop_ save_